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Abstract 
The research presented and discussed in this dissertation involves the synthesis of 
transition metal complexes of oxazolinylboranes and cyclopentadienyl-bis(oxazolinyl)borates, 
and their application in catalytic enantioselective olefin hydroamination and acceptorless alcohol 
decarbonylation. 
 Neutral oxazolinylboranes are excellent synthetic intermediates for preparing new borate 
ligands and also developing organometallic complexes. Achiral and optically active 
bis(oxazolinyl)phenylboranes are synthesized by reaction of 2-lithio-2-oxazolide and 0.50 equiv 
of dichlorophenylborane. These bis(oxazolinyl)phenylboranes are oligomeric species in solid 
state resulting from the coordination of an oxazoline to the boron center of another borane 
monomer. 
 The treatment of chiral bis(oxazolinyl)phenylboranes with sodium cyclopentadienide 
provide optically active cyclopentadienyl-bis(oxazolinyl)borates H[PhB(C5H5)(OxR)2] [OxR = 
Ox4S-iPr,Me2, Ox4R-iPr,Me2, Ox4S-tBu]. These optically active proligands react with an equivalent of 
M(NMe2)4 (M = Ti, Zr, Hf) to afford corresponding cyclopentadienyl-bis(oxazolinyl)borato 
group 4 complexes {PhB(C5H4)(OxR)2}M(NMe2)2 in high yields. These group 4 compounds 
catalyze cyclization of aminoalkenes at room temperature or below, providing pyrrolidine, 
piperidine, and azepane with enantiomeric excesses up to 99%. Our mechanistic investigations 
suggest a non-insertive mechanism involving concerted C−N/C−H bond formation in the turn-
over limiting step of the catalytic cycle. 
 Among cyclopentadienyl-bis(oxazolinyl)borato group 4 catalysts, the zirconium complex 
{PhB(C5H4)(Ox4S-iPr,Me2)2}Zr(NMe2)2 ({S-2}Zr(NMe2)2) displays highest activity and 
enantioselectivity. Interestingly, {S-2}Zr(NMe2)2 also desymmetrizes olefin moieties of achiral 
ix 
 
non-conjugated aminodienes and aminodiynes during cyclization. The cyclization of 
aminodienes catalyzed by {S-2}Zr(NMe2)2 affords diastereomeric mixture of cis and trans cylic 
amines with high diasteromeric ratios and excellent enantiomeric excesses. Similarly, the 
desymmetrization of alkyne moieties in {S-2}Zr(NMe2)2-catalyzed cyclization of aminodiynes 
provides corresponding cyclic imines bearing quaternary stereocenters with enantiomeric 
excesses up to 93%. These stereoselective desymmetrization reactions are significantly affected 
by concentration of the substrate, temperature, and the presence of a noncyclizable primary 
amine. In addition, both the diastereomeric ratios and enantiomeric excesses of the products are 
markedly enhanced by N-deuteration of the substrates. 
 Notably, the cationic zirconium-monoamide complex [{S-2}Zr(NMe2)][B(C6F5)4] 
obtained from neutral {S-2}Zr(NMe2)2 cyclizes primary aminopentenes providing pyrrolidines 
with S-configuration; whereas {S-2}Zr(NMe2)2 provides R-configured pyrrolidines. The yttrium 
complex {S-2}YCH2SiMe3 also affords S-configured pyrrolidines by cyclization of 
aminopentenes, however the enantiomeric excesses of products are low. An alternative optically 
active yttrium complex {PhB(C5H4)(Ox4S-tBu)2}YCH2SiMe3 ({S-3}YCH2SiMe3) is synthesized, 
which displays highly enantioselective in the cyclization of aminoalkenes at room temperature 
affording S-configured cyclic amines with enantiomeric excesses up to 96%. A noninsertive 
mechanism involving a six-membered transition state by a concerted C−N bond formation and 
N−H bond cleavage is proposed for {S-3}YCH2SiMe3 system based on the kinetic, 
spectroscopic, and stereochemical features. 
 In the end, a series of bis- and tris(oxazolinyl)borato iridium and rhodium complexes are 
synthesized with bis(oxazolinyl)phenylborane [PhB(OxMe2)2]n, tris(oxazolinyl)borane 
[B(OxMe2)3]n, and tris(4,4-dimethyl-2-oxazolinyl)phenylborate [ToM]−. All these new and other 
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known rhodium and iridium complexes were examined in acceptorless dehydrogenative 
decarbonylation of primary alcohols. The catalysts survey shows that the compound ToMIr(η4-
C8H12) is the most active for the conversion of primary alcohols into alkane, H2, and CO at 180 
°C in toluene. Several aliphatic and aromatic primary alcohols are decarbonylated in the catalytic 
conditions. Furthermore, ToMIr(η4-C8H12) is also able to decarbonylate polyols such as ethylene 
glycol and glycerol to syngas (H2 and CO) at 180 °C. 
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Chapter 1 – Introduction 
General Introduction 
Since the landmark discovery of ferrocene in 1951-52,1 metallocenes are one of the most 
developed and versatile catalyst classes used in a range of catalytic transformations such as 
olefin polymerizations, hydrogenations, and carbon-element bond formations.2 Bent-sandwich 
group 3 and group 4 complexes are among these metallocene catalysts, which mediate a range of 
processes via insertion and sigma-bond metathesis pathways. If the two cyclopentadienyl ligands 
of a bent-sandwich complex are linked to a bridging element (i.e. ansa-metallocene), the 
reactivity of the metal center increases (Figure 1.1).3 
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 Figure 1.1: Group 
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containing, mixed Cp–Ln (Ln = chiral donor group) ligand could provide reactive and stereo-rigid 
compounds for enantioselective catalysis by reducing the effective electron count while 
maintaining the mutually-cis configuration of orbitals. 
In this context, we are interested on developing highly enantioselective catalysts for 
hydroamination/cyclization of aminoolefins because enantioselective cyclohydroamination 
affords optically active nitrogen-heterocycles via addition of amine N−H bond across a carbon-
carbon unsaturated bond in an intramolecular fashion (eq 1.1).13 
R4
H
N
R3
R1 R2
n
N
R4
R3 R
2
R1
n
enantioselective catalyst (1.1)
 
Optically active nitrogen-heterocycles are important moieties in many natural products and 
biologically active molecules, which are valuable in chemical and pharmaceutical industries 
(Figure 1.3). Hence, the development of enantioselective hydroamination catalysts and 
understanding the reaction mechanisms are extremely important for synthesizing enantiopure 
cyclic amines. 
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Figure 1.3. Selective examples of biologically active molecules containing nitrogen-heterocycles 
 
 C1-symmetric chiral lanthanocenes are the first enantioselective catalysts, which cyclize 
aminoolefins to cyclic amines bearing a stereocenter at 2-position with enantiomeric excesses up 
to 74% (Figure 1.4, i). However, these chiral lanthanocenes undergo facile epimerization under 
the reaction conditions via reversible protolytic cleavage of metal-cyclopentadienyl bonds, 
leading to an equilibrium mixture of diastereomeric complexes (Scheme 1.1).12 Therefore, the 
enantioselectivity of the chiral lanthanocenes is limited by their epimeric ratio in solution. 
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Figure 1.4. Selected enantioselective catalysts for hydroamination/cyclization of aminoolefins 
 
Scheme 1.1. Proposed mechanism for the epimerization of chiral lanthanocene complexes during 
hydroamination reaction 
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The limitation of the chiral cyclopentadienyl based hydroamination catalysts has 
stimulated the development of cyclopentadienyl-free catalyst systems. Bisoxazolinato rare earth 
catalysts exhibit moderate enantioselectivities to afford optically active 2-methylpyrrolidines and 
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2-methylpiperidines (Figure 1.4, ii).14 Several diamidobinaphthyl,15 and aminothiophenolate16 
group 3 complexes were synthesized, which are active catalysts in hydroamination/cyclization of 
aminoolefins at room or higher temperatures. However, none of these catalysts provide cyclic 
amines with more than 90% ee. Significant improvement of enantioselectivity was observed for 
binaphtholate-supported scandium, yttrium, and lutetium catalysts (Figure 1.4, iii).17,18 
Enantiomeric excesses up to 95% were achieved using these rare-earth binaphtholate catalysts, 
however only two pyrrolidines having greater than 90% ee were obtained. 
Besides rare-earth catalysts, several optically active cyclopentadienyl free group 4 
catalysts have been developed. The cationic aminophenolate zirconium complex cyclizes only 
secondary aminoalkenes with enatiomeric excesses up to 82% ee.19 In contrast to the cationic 
zirconium catalysts, neutral zirconium catalysts generally cyclize only primary aminoolefins. 
Chiral bis(phosphinic amido)20 and binaphthalenedicarboxamide21 zirconium complexes are 
moderate enantioselective in hydroamination/cyclization. Chiral bis(amidate)zirconium 
complexes exhibit significantly high enantioselectivity affording pyrrolidines up to 93% ee 
(Figure 1.4, iv).22 Notably, group 4-catalyzed hydroamination typically requires elevated 
temperature (90-135 °C) and longer reaction time. Recently, several other catalyst systems have 
also been explored. A binaphtholate tantalum complex has been reported, and highest 81% ee 
was observed in cyclization of aminoalkenes.23 A chiral magnesium phenoxyamine complex 
affords pyrrolidines with good enantioselectivity (up to 93% ee) (Figure 1.4 vi).24 Additionally, 
several optically active pyrrolidines are obtained up to 91% ee using a binaphthyl-based rhodium 
catalyst (Figure 1.4, v).25,26  
Nevertheless, despite significant advances, only a few hydroamination catalysts display 
good enantioselectivity (above 90% ee). Additionally, all these catalysts display high 
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enantioselectivity only for a very limited number of substrates. Furthermore, the current catalytic 
systems are associated with many other synthetic problems in hydroamination such as more 
general substrate applicability, functional group tolerance, and improve diastereoselectivity.  
The potential of catalytic hydroamination reactions for preparing valuable optically active 
amines was the inspiration for the work described in this thesis. The necessity of stereo-rigid 
chiral ligand-metal systems with easily tuned steric properties of the ancillary ligand led us to 
develop a new class of optically active ligands, cyclopentadienyl-bis(oxazolinyl)borates.  
MLn
B
O
N
O
N
Ph
R
R*
*
δ+
δ−
stereogenic center
 
The availability of an array of substituted enantiopure chiral oxazolines should allow for 
the facile synthesis of ligands with variable steric pockets.27 Additionally, the stereogenic center 
at 4-position of oxazoline would be in close proximity to the metal center, which might create 
excellent stereo-induction near metal center in catalysis. The following chapters describe the 
development of this new ligand class, and their group 3 and group 4 complexes. Additionally, the 
catalytic activity of the metal complexes in stereoselective olefin hydroamination will be 
discussed.  
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Thesis Organization 
 The thesis is composed of six chapters. Chapter 1 gives a general introduction of the 
research topic discussed in this dissertation. As the dissertation describes a diverse range of 
topics, the relevant literature review and references are given in the introduction of each chapter 
to provide an adequate understanding to the reader about the significance of the results. Majority 
of the materials in Chapter 2 through 5 are taken from the articles to be submitted for 
publication. Some of the results are already published in literature. 
 Chapter 2 describes the synthesis and characterization of group 4 complexes containing 
cyclopentadienyl-bis(oxazolinyl)borate ligands, and their catalytic activity in enantioselective 
cyclohydroamination of aminoolefins. Additionally, the detailed mechanistic investigations and 
proposed catalytic cycle of these group 4-catalyzed hydroamination have been discussed. 
 Chapter 3 illustrates the desymmetrizing hydroamination/cyclization of achiral dialkenyl- 
and dialkynylamines catalyzed by a highly enantioselective cyclopentadienyl-
bis(oxazolinyl)borato zirconium(IV) complex. The effect of dilution, temperature, and isotopic 
perturbation on diastereoselectivity and enantioselectivity is describes in order to optimize the 
both diastereo- and enantioselectivity of the azacycle products. 
 Chapter 4 reports the catalytic activity and mechanism of cyclopentadienyl-
bis(oxazolinyl)borato yttrium-catalyzed enantioselective cyclohydroamination of aminoalkenes. 
The stereochemical and mechanistic features of these yttrium catalysts are also compared to 
analogous zirconium catalysts. 
Chapter 5 describes the acceptorless decarbonylation of primary alcohols and polyols to 
alkanes and sys-gas under thermal conditions catalyzed by bis- and tris(oxazolinyl)borato 
iridium compounds. 
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Chapter 2. Neutral cyclopentadienyl-bis(oxazolinyl)borato group 4 complexes as catalysts 
for enantioselective hydroamination of aminoolefins 
 
Modified from a paper submitted to J. Am. Chem. Soc. 
Kuntal Manna,‡ Arkady Ellern, Aaron D. Sadow* 
 
Abstract  
Cs- and C1-symmetric cyclopentadienyl-bis(oxazolinyl)borato group 4 complexes of type 
{PhB(C5H4)(OxR)2}M(NMe2)2 (M = Ti, Zr, Hf; OxR = 4,4-dimethyl-2-oxazoline, 4S-isopropyl-
5,5-dimethyl-2-oxazoline, 4S-tert-butyl-2-oxazoline, 4R-isopropyl-5,5-dimethyl-2-oxazoline) are 
highly active precatalysts for intramolecular hydroamination of aminoolefins. These group 4 
complexes are synthesized by the reaction of optically active ligands H[PhB(C5H5)(OxR)2] with 
an equivalent of M(NMe2)4. These compounds catalyze cyclization of aminoalkenes at room 
temperature or below, providing pyrrolidine, piperidine, and azepane with enantiomeric excesses 
up to 99%. The cyclization rate is first order dependence on both aminopentene and precatalyst. 
Substrate saturation on initial reaction rate was observed, which indicates the existence of 
reversible substrate-catalyst association preceding the turnover-limiting step in the catalytic 
cycle. The nonzero x-intercept in the initial rate plots that coincides with concentration of the 
catalyst indicates that 1.0 equiv. of substrate is required to activate the precatalyst. The observed 
isotopic perturbation of enantioselectivity (IPE) eliminates intramolecular [2π + 2π] 
cycloaddition of a metal-imido alkene intermediate as possible mechanisms for C−N bond 
                                                           
‡
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formation. Primary kinetic isotope effect was measured, which indicates the cleavage of 
N−H/N−D bond in the turnover limiting step, and also exhibits the favor of one diastereomeric 
pathways over the other. Secondary aminopentene is not cyclized, however cyclization occurs in 
presence of non-cyclizable primary amine. The zirconium monoamide complex 
{PhB(C5H4)(Ox4S-iPr,Me2)2}ZrCl(NMe2) was synthesized and is seen to be inactive in 
hydroamination. The accumulated data including the rate law, the KIE, isotopic perturbation of 
enantioselectivity, and the KIE for the two enantiotopic pathways are less consistent with olefin 
insertion as possible mechanisms for C−N bond formation. A non-insertive mechanism 
involving concerted C−N/C−H bond formation is proposed. The cyclopentadienyl-
mono(oxazolinyl)borate ligand H[Ph2B(C5H5)(Ox4S-iPr,Me2)] was synthesized, and its zirconium 
complex was inactive in hydroamination/cyclization of aminoolefin at room temperature, which 
suggest the involvement of both oxazoline with the metal center to activate the precatalyst 
{PhB(C5H4)(Ox4S-iPr,Me2)2}Zr(NMe2)2. 
 
Introduction 
Asymmetric olefin hydroamination is a facile and promising approach for the synthesis of 
optically active nitrogen heterocycles, which are important in commodity and specialty 
chemicals, medicinal compounds, and natural products preparations.1 Despite significant 
progresses, the synthesis of efficient, configurationally stable, and highly enantioselective 
catalysts is still challenging to solve synthetic problems in hydroamination such as general 
substrate applicability, enantioselectivity, diastereoselectivity, enantioselective intermolecular 
hydroamination, and anti-Markonikov additions. Products with high optical purities are limited 
to a few choice pyrrolidines even in the well-studied intramolecular hydroamination/cyclization; 
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asymmetric olefin hydroaminations that afford functionalized pyrrolidines, piperidines, and 
homopiperidines (among many valuable chiral N-heterocycles) are not developed.  
Still, great progress is highlighted by catalyst advances with metallocene-based and 
axially chiral lanthanide compounds,2,3,4,5,6,7,8,9,10 alkali metal coordination complexes,11 and C1-, 
C2-, and C3-symmetric alkaline earth metal catalysts.12 Breakthroughs in zirconium-catalyzed 
alkene hydroamination include axially chiral cationic bis(aryloxy),13 bis(amido),14 a highly 
enantioselective bis(amidate),15,16 and bis(carboxyamide)17 complexes (or similar Ta-based 
systems)18 as precatalysts. C1-symmetric mixed Cp*(oxazolinyl-aryloxo)zirconium and 
constrained geometry-type catalysts uniquely depart from the predominant axially chiral ligand 
design.19 A single example of a highly enantioselective late transition-metal (rhodium-based) 
aminopentene cyclization catalyst has been reported.20 Although these systems are generally 
limited to pyrrolidines, highly efficient and selective intramolecular catalysts may provide 
strategies for addressing some of the tougher challenges in olefin hydroamination. 
In this context, catalyst synthesis and screening accompanied by mechanistic tests should 
help advance the field. Most detailed studies involving hydroamination/cyclization mechanism 
have involved d0 complexes including lanthanide,21,5d,10, 22 actinide,23 alkaline earth metal,24,25,26 
and zirconium,23,27,28,29 and all of the catalytic cycles associated with these catalysts typically are 
proposed to have metal-amido resting states. From that point, the proposed mechanisms for C−N 
bond formation are remarkable divergent to include (A) olefin insertion into M−N bonds and (B) 
[2π+2π] cycloaddition to metal-imido that involve four-centered transition state. 
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Scheme 2.1. The σ-bond insertive mechanism for cyclohydroamination 
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Scheme 2.2. Imido mechanism for cyclohydroamination 
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A few interesting and sometimes conflicting observations, however, provide some 
guidance. First, the primary-in-magnitude isotope effect suggests that the intramolecular 
cyclization of the metal-amidoalkene catalyst resting state is not a simple unimolecular process 
in almost any conversion.21,5d,27 Perhaps an even more compelling observation is that cis/trans 
ratio is increased at high substrate concentration or by addition of propylamine in the 
diastereoselective cyclization of chiral racemic aminoalkenes by achiral catalysts; in addition, the 
cis/trans ratio is lowered by N-deuteration.21 A second interesting observation in zirconium-
catalyzed hydroamination involves primary and secondary aminoalkenes as substrates and 
cationic and neutral precatalysts. The cationic catalyst system Cp2ZrMe2/B(C6F5)3 is only active 
for secondary aminoalkenes, and the authors suggest catalyst deactivation occurs with primary 
amines through the formation of inactive, neutral zirconium imidoalkene species.13,30 In contrast, 
several neutral zirconium catalysts cyclize primary but not secondary aminoalkenes; such 
observation is often invoked as support for a zirconium imido intermediate prior to [2π+2π] 
cycloaddition. 
 Notably, the reaction of imidozirconium compounds and olefins (Scheme 2.2) is not 
independently established (although Zr=NR and alkyne cycloadditions are well known).31a In 
fact, mixtures of an isolated zirconium-imido and alkenes returned starting materials.31b 
Furthermore, isolation of the immediate organometallic products (i.e., a metal-alkylamine or a 
azametallacyclobutane) formed from either of these steps has not yet been described for a d0 or 
fnd0 metal compound. However, the vinylamine product of alkyne insertion into a hafnium-
nitrogen bond was recently isolated and characterized,32 In addition, a molybdenum amido and 
alkyne react to provide a d2 vinylamine.33 Interestingly, conclusive evidence for olefin insertion 
into dn metal amidos (n ≠ 0) has been provided in palladium systems.34,35 
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These unusual features, as well as the potential for amine synthesis, motivated our 
investigations of group 4-catalyzed aminoalkene cyclization using 
bis(oxazolinyl)cyclopentadienyl borate ligands.36,37 We envisioned that C1-symmetric 
cyclopentadienyl-bis(oxazolinyl)borate supported metal complexes could be highly 
enantioselective hydroamination catalysts, because of the close proximity of the stereogenic 
center of the oxazolines to the metal center. Additionally, these complexes would be non-
epimerizable unlike the C1-symmetric chiral lanthanocenes, due the lack of stereogenic center on 
the cyclopentadienyl ring. Herein, we report the synthesis and catalytic activity of 
cyclopentadienyl-bis(oxazolinyl)borate supported group 4 complexes for 
hydroamination/cyclization of aminoolefins, which exhibit high catalytic activity and excellent 
enantioselectivity (>95%) in a number of azacycles. The substrates scope, and the effect of 
temperature, solvents and additives to the enantioselectivity will be discussed. Our studies have 
attempted to address a range of synthetic and mechanistic issues, including the precatalyst 
conformation, the coordinating properties of the oxazoline moieties in the borate ligands, relative 
rate and stereoselectivity of titanium, zirconium, and hafnium based precatalysts, the valence 
needed for catalysis, and the effect of the oxazoline group on catalyst’s stability, activity, and 
stereoselectivity. 
 
Results and discussion 
Synthesis and Characterization of Proligands  
Four dianionic cyclopentadienyl-bis(oxazolinyl)borates are prepared as protonated 
species (Scheme 2.3).10,29,36 The achiral proligand H[PhB(C5H5)(OxMe2)2] (H2{1}; OxMe2 = 4,4-
dimethyl-2-oxazolinyl), the chiral 4-isopropyl oxazolinyl H[PhB(C5H5)(Ox4S-iPr,Me2)2] (H2{S-2}; 
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Ox4S-iPr,Me2 = 4S-isopropyl-5,5-dimethyl-2-oxazolinyl) and its readily-available enantiomer 
H[PhB(C5H5)(Ox4R-iPr,Me2)2]; (H2{R-2}; R-Ox4R-iPr,Me2 = 4R-isopropyl-5,5-dimethyl-2-oxazolinyl), 
and the optically-active 4-tert-butyl oxazoline H[PhB(C5H5)(Ox4S-tBu)2] (H2{S-3}; Ox4S-tBu = 4S-
tert-butyl-2-oxazolinyl) are all synthesized following a similar route in two steps from the 
appropriate 2H-oxazolines 2H-OxR: 2H-OxMe2, 2H-Ox4S-iPr,Me2, 2H-Ox4R-iPr,Me2, 2H-Ox4S-tBu via 
neutral bis(oxazolinyl)phenylborane PhB(OxR)2 intermediates (Scheme 2.3).37 These borane 
intermediates are critical to the overall ligand synthesis. The steric bulk of the oxazoline 
substituents in 2Li-OxMe2, 2Li-Ox4S- iPr,Me2, 2Li-Ox4R-iPr,Me2, and 2Li-Ox4S-tBu slow the addition of 
a third oxazolide preventing the formation of oxazolinylborates. This approach works well for 
the synthesis of the oligomeric bis(4,4-dimethyl-2-oxazolinyl)phenylborane [PhB(OxMe2)2]n (4). 
However, 4S-isopropyl-2-oxazoline apparently does not have sufficient bulk, and the attempted 
synthesis of bis(4S-isopropyl-2-oxazolinyl)phenylborane affords an inseparable mixture of 
PhB(Ox4S-iPr)2 and Li[PhB(Ox4S-iPr)3].36,38 
 
Scheme 2.3. Synthesis of proligands H[PhB(C5H5)(OxR)2] from achiral and chiral 2H-
oxazolines. 
 
 
The isolable dimethyl-substituted 4 guided our preparation of chiral derivatives, and 5,5-
dimethyl-4S-isopropyl-oxazoline (2H-Ox4S-iPr,Me2) was targeted to provide an optically active 
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oxazolinylborane intermediate. Deprotonation of 2H-Ox4S-iPr,Me2 with nBuLi in THF at −78 °C 
occurs selectively at the 2-position to give the 5,5-dimethyl-4S-isopropyl-2-lithio-2-oxazolide 
(2Li-Ox4S-iPr,Me2). Addition of 0.5 equiv. of PhBCl2 to the THF solution of 2Li-Ox4S-iPr,Me2 is 
followed by stirring at room temperature for 14 h to provide bis(5,5-dimethyl-4S-isopropyl-2-
oxazolinyl)phenylborane PhB(Ox4S-iPr,Me2)2 (S-5). The preparation of PhB(Ox4R-iPr,Me2)2 (R-5) 
proceeds similarly, but PhB(Ox4S-tBu)2 (S-6) is synthesized using tert-butyllithium for the 
deprotonation of 4S-tert-butyl-2-oxazoline.  
The crude yellow solid bis(oxazolinyl)phenylboranes contain variable amounts of LiCl, 
but are sufficiently pure for further synthetic work. The solid state 11B NMR spectroscopy 
indicates that [PhB(OxMe2)2]n is a complicated mixtures of oligomeric species resulting from the 
coordination of an oxazoline to the boron center of another PhB(OxMe2)2 monomer.37 In 
acetonitrile-d3, solvent coordination to the boron center gave a single 11B NMR signal at −8.1 
ppm assigned to the adduct Ph(OxMe2)2B(NCMe). In non-coordinating toluene-d8 solvent, 
[PhB(OxMe2)2]n does not provide an observable signal 11B NMR spectra acquired at room 
temperature or at elevated temperature (350 K). However, two 11B NMR resonances were 
detected at −5.2  and −11.0 ppm in a spectrum acquired at 220 K. Comparison of these low 
temperature chemical shift values to those obtained for acetonitrile adducts of [PhB(OxMe2)2]n 
suggest that intermolecular O-oxazoline and N-oxazoline coordination provides two distinct 
boron sites. At room temperature in non-coordinating solvent (toluene-d8 or benzene-d6), the 
exchange process is in the so-called intermediate regime, which obscures the signals. 
The other bis(oxazolinyl)phenylboranes have similar spectroscopic properties, and 11B 
and 15N NMR chemical shifts and infrared C=N stretching frequencies for 4, S-5, R-5 and S-6 are 
20 
 
reported in Table 2.1. The 11B NMR values are consistent with neutral, four-coordinate boron 
centers and suggest that a neutral donor (i.e., acetonitrile-d3) coordinated to the boron center.39 
 
Table 2.1. 11B, 15N NMR chemical shift and νCN values for bis(oxazolinyl)phenylboranes (4-6), 
cyclopentadienyl-bis(oxazolinyl)phenylborates (H2{1}-H2{3}, and 2H-oxazolines. 
Compound 11B NMR (δ)a 15N NMR (δ)a νCN (KBr, cm-1) [α]D20 b 
H[PhB(C5H5)(OxMe2)2] 
(H2[1]) 
−15.3, −15.6,  
−16.0 
−172 1589 n.a. 
H[PhB(C5H5)(Ox4S-iPr,Me2)2] 
(H2[S-2]) 
−15.7 br −179.1 1584, 1567 –62.9° 
H[PhB(C5H5)(Ox4R-iPr,Me2)2] 
(H2[R-2]) 
−15.7 br −179.1 1582, 1560 +63.2° 
H[PhB(C5H5)(Ox4S-tBu)2] 
(H2[S-3]) 
−14.9, −15.3,     
−15.6. 
−190.9 1595, 1588 −139.1° 
PhB(OxMe2)2 (4) −8.1 −147.0 1621, 1601 n.a. 
PhB(OxS-iPr,Me2)2 (S-5)  −7.5 −131.6 1588 n.a. 
PhB(OxR-iPr,Me2)2 (R-5) −7.5 −131.6 1588 n.a. 
PhB(OxS-tBu)2 (S-6) −7.3 −124.3 1617, 1590 n.a. 
H[Ph2B(Ox4S-iPr,Me2)(C5H5)] 
(H2[S-7]) 
 −10.0, −11.5,  
−12.4 
−155.2 1594 −55.2° 
2H-Ox4S-iPr,Me2  n.a. −143.3 1632 cm-1 −35.2° 
2H-Ox4R-iPr,Me2 n.a. −143.3 1632 cm-1 +34.8° 
2H-Ox4S-tBu n.a. −148.0 1635 cm-1 −104° 
a Measured in acetonitrile-d3 solvent. b Measured in benzene. 
 
The bis(oxazolinyl)phenylboranes 4-6 react with Na[C5H5] in THF to provide the desired 
mixed oxazoline-cyclopentadienylborates Na[PhB(C5H5)(OxR)2]. The crude products are purified 
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by column chromatography to yield the proligands H[PhB(C5H5)(OxR)2]. These compounds are 
all light yellow solids that are soluble in benzene, methylene chloride, and THF.   
The isolated ligands 1-4 are each a mixture of three isomers, as indicated by 1H and 11B 
NMR spectroscopy (Table 2.1). The 1H NMR spectra of these mixtures were complicated by 
overlapping resonances in the phenyl, cyclopentadienyl, and oxazoline regions and were not 
useful for characterization or assessment of purity. 11B NMR spectroscopy is more informative, 
and the three resonances in the 11B NMR spectrum of achiral 1 are upfield compared to that of 
borane 4 (as an acetonitrile adduct), as expected for a boron center in an anionic four coordinated 
borate.39 Thus, 1-C5H5(BR3), 2-C5H5B(BR3), and 5-C5H5B(BR3) connectivity accounts for the 
three isomers. Borylcyclopentadienyl compounds are well known to form mixtures of isomers.40 
In a 1H-15N HBQC experiment on 1, correlations from the oxazoline methyl and methylene 
resonances provided an 15N NMR chemical shift of −172 ppm (on the CH3NO2 scale) that is 45 
ppm upfield of 4,4-dimethyl-2-oxazoline (−127 ppm). For comparison, the 15N NMR chemical 
shift of N-protonated oxazoline in Ir(κ2-(OxMe2)2BPh(OxMe2H)](η4-C8H12)]OTf is −206 ppm.41 In 
the IR spectrum of 1, a single oxazoline-based band (νCN = 1589 cm-1, KBr) was observed at 
lower energy than that of 4,4-dimethyl-2-oxazoline (νCN = 1630 cm-1). Thus, upfield 15N NMR 
and IR data are consistent with proton-oxazoline interactions through the imidine nitrogen, 
where the proton either bridges between the two nitrogen or rapidly exchanges.  
In case of optically-active bis(oxazolinyl)borate ligands H2[S-2] and H2[R-2], only one 
broad 11B signal at −15.7 ppm (232 Hz at half-height) was resolved. Again, the 1H NMR 
spectrum contained overlapping resonances for the isomers. The 11B NMR signals for H2[S-3] 
were well-separated. Interestingly and in contrast to H2[1], two νCN bands were detected in the 
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IR spectra of H2[S-2], H2[R-2], and H2[S-3]. The wavenumber for these bands appeared at lower 
energy by 40-50 cm-1 than uncoordinated oxazoline.  
A chiral cyclopentadienyl(oxazolinyl)diphenylborate, synthesized for comparison with 
the bis(oxazolinyl)borates 1-3, is prepared by reaction of 2Li-Ox4S-iPr,Me2 and Ph2BCl followed by 
addition Na[C5H5]. Exhaustive purification by silica gel column chromatography yields 
H[Ph2B(C5H5)(Ox4S-iPr,Me2)] (H2[S-7]) in modest yield. Three 11B NMR resonances indicated that 
this cyclopentadienyl-mono(oxazoline)borate is also a mixture of three isomers. Unexpectedly, 
the 15N NMR signal modestly shifted upfield (−155 ppm), less than H2[S-2]; the proton is shared 
or rapidly exchanges between two oxazolines in the latter (oxazoline:H = 2:1), whereas we 
expected the oxazoline in the former is fully protonated (oxazoline:H = 1:1). Presumably, the 
nitrogen-proton interaction is not the only variable governing the 15N NMR chemical shift of 
these compounds. 
O
N
H
O
NB
1) 1.06 equiv. nBuLi
2) 0.98 equiv. Ph2BCl
3) Na[C5H5]
4) silica gel
Ph
Ph
C5H5
H2[S-7]
(1)
 
 
Synthesis and Characterization of Mixed Cyclopentadienyl-Oxazolinylborate Group 4 
Compounds  
 
The general scheme for preparation of group 4 complexes containing mixed 
cyclopentadienyl-oxazolinylborate ligands involves the interaction of homoleptic dimethylamide 
compounds M(NMe2)4 (M = Ti, Zr, Hf) with H2{1}, H2{S-2}, H2{R-2}, H2{S-3} and H2{7} (eq 
2). However, the conditions for synthesis and the complex stability vary for the metal-ligand 
pairs.  
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The achiral proligand H2{1} and M(NMe2)4 (M = Zr, Hf) react rapidly in benzene at 
room temperature affording {PhB(C5H4)(OxMe2)2}Zr(NMe2)2 ({1}Zr(NMe2)2) and 
{PhB(C5H4)(OxMe2)2}Zr(NMe2)2 ({1}Hf(NMe2)2). 1H NMR spectra of micromolar-scale 
experiments in benzene-d6 indicated that the reactions proceed to completion within 10 min. 
Analytically pure materials are obtained by evaporation of the benzene and HNMe2 byproduct in 
98% isolated yield for both zirconium and hafnium compounds.  
 
 
The spectroscopic data for {1}Zr(NMe2)2 and {1}Hf(NMe2)2 are similar (Table 2.2). 
Upon coordination and amine elimination, the 1H NMR multiplets associated with the three 
C5H5B isomers are replaced with two resonances assigned to C5H4B in a Cs-symmetric molecule. 
One set of oxazoline resonances was observed as two singlets for inequivalent methyl groups and 
two doublets for the inequivalent CH2. This pattern did not vary in 1H NMR spectra of the 
zirconium and hafnium compounds acquired at temperatures from 190 K and 300 K in toluene-
d8. 1H-15N HMBC experiments contained a correlation between oxazoline methyl and nitrogen, 
and the 15N NMR chemical shifts for the oxazoline nitrogen in zirconium and hafnium 
compounds at −135 and −132 ppm are only slightly upfield of non-coordinated 2H-4,4-dimethyl-
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2-oxazoline (−127 ppm). The 15N NMR chemical shift of {κ3-PhB(OxMe2)3}Zr(NMe2)3 is −140 
ppm, in which oxazoline coordination to Zr is unambiguous; in the current system, the small 
change in 15N NMR data of complexes vs. 2H-oxazoline does not distinguish two simultaneously 
coordinated oxazolines from one coordinated oxazoline rapidly exchanging with a pendent 
oxazoline. Analytically pure {1}Zr(NMe2)2 and {1}Hf(NMe2)2, obtained from evaporation of 
benzene solutions, were analyzed by IR spectroscopy, and only one νCN band was observed for 
each compound (both at 1595 cm-1; KBr). From these data, either (a) the C5H4B group and both 
oxazolines are bonded to the metal center or (b) the C5H4B group and only one oxazoline is 
coordinated, and the pendent oxazoline and coordinated oxazoline exchange rapidly on the 1H 
NMR timescale in solution and the IR timescale in the solid state. 
Slow diffusion of pentane into a solution of {1}Zr(NMe2)2 dissolved in THF and cooled 
to 243 K provided X-ray quality crystals of {1}Zr(NMe2)2THF, in which only one oxazoline was 
coordinated to the zirconium center (Figure 2.1a). The coordination geometry of zirconium is 
described as that of a squashed 4-legged piano stool such that Cpcentroid−Zr−N (NMe2: 125.8 and 
135.0° OxMe2: 99.4°) and Cpcentroid−Zr−O (101.2°) angles. The dimethylamide groups are 
transoid (N−Zr−N: 120.26°), as are the oxazoline and THF ligands (N−Zr−O: 159.4°). The site 
trans to the cyclopentadienyl ring is unoccupied. The unit cell contains four, symmetry-related 
molecules (Z = 4), but the model does not reveal close contacts between the pendent oxazoline 
nitrogen and the other molecules in the unit cell.  
The solid-state infrared spectrum of {1}Zr(NMe2)2THF revealed that this structure and 
the structure of {1}Zr(NMe2)2 are not equivalent. In particular, two νCN stretching frequencies at 
1610 cm-1 (pendant oxazoline) and 1533 cm-1 (Zr-OxMe2) were observed for crystals from THF. 
Furthermore, the conformation of {1}Zr(NMe2)2THF in the solid state is not representative of 
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the solution structure. At room temperature, the signals in 1H NMR spectrum 
of{1}Zr(NMe2)2THF were identical to those of  {1}Zr(NMe2)2 in the absence of THF and those 
of THF in the absence of {1}Zr(NMe2)2. Interestingly, the 1H NMR spectrum of 
{1}Zr(NMe2)2THF at 190 K contained only two broad single resonances, one assigned to 
oxazoline methyl and the other to oxazoline methylene groups. The two methyl groups on each 
oxazoline are expected to remain chemically inequivalent at all temperatures, and a rigid 
structure for {1}Zr(NMe2)2(THF) should contain either two or four methyl signals (depending on 
the structure). Thus, the fluxional process is too fast on the 1H NMR timescale to resolve a rigid 
structure. The hafnium analog {1}Hf(NMe2)2 is also fluxional in the presence of 1 equiv. of 
THF, and the resonances (observed at room temperature) assigned to oxazoline methyl 
substituents and the methylene group coalesce into two broad singlets at 190 K. 
 
Table 2.2. 11B, 15N NMR chemical shifts and νCN values for cyclopentadienyl-
bis(oxazolinyl)borate group 4 complexes. 
Compound 11B NMR (δ) 
acetonitrile-d3 
15N NMR (δ) 
acetonitrile-
d3 
νCN 
 
(KBr, 
cm-1) 
[α]D20 
(C6H6) 
{PhB(C5H4)(OxMe2)2}Zr(NMe2)2 
{1}Zr(NMe2)2; amorphous 
−14.5 −135.4 1595 n.a. 
{PhB(C5H4)(OxMe2)2}Zr(NMe2)2 
{1}Zr(NMe2)2; crystallized 
−14.5 n.a. 1603, 
1505 
n.a. 
{PhB(C5H4)(OxMe2)2}Zr(NMe2)2THF   
{1}Zr(NMe2)2THF 
−14.5 n.a. 1610, 
1533 
n.a. 
{PhB(C5H4)(OxMe2)2}Hf(NMe2)2 
{1}Hf(NMe2)2 
−14.6 −132.3 1595 n.a. 
{PhB(C5H4)(Ox4S-iPr,Me2)2}Zr(NMe2)2  
{S-2}Zr(NMe2)2 
−14.5 −152.6,  
−155.0 
1565 –124.7° 
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{PhB(C5H4)(Ox4R-iPr,Me2)2}Zr(NMe2)2  
{R-2}Zr(NMe2)2  
−14.5 −152.3,  
−155.1 
1559 +122.6° 
{PhB(C5H4)(Ox4S-iPr,Me2)2}Hf(NMe2)2 
{S-2}Hf(NMe2)2 
−14.6 −148.8,  
−150.7 
1559 –86.98° 
{PhB(C5H4)(Ox4S-iPr,Me2)2}Ti(NMe2)2 
{S-2}Ti(NMe2)2 
−14.8 −153.8,  
−156.1 
1560 –94.71° 
{PhB(C5H4)(Ox4S-tBu)2}Zr(NMe2)2 
{S-3}Zr(NMe2)2 
−14.4 –145.4,  
–148.1 
1608, 
1506 
–139.13° 
{PhB(C5H4)(Ox4S-iPr,Me2)2}ZrCl(NMe2)  
{S-2}ZrCl(NMe2) 
−16.4 –153.4,  
–154.9 
1578, 
1567 
−111.4° 
{Ph2B(C5H4)(Ox4S-iPr,Me2)}Zr(NMe2)2  
{S-7}Zr(NMe2)2 
−11.7 −155.2 1562 –82.02° 
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Figure 2.1a. ORTEP diagram of {PhB(C5H4)(OxMe2)2}Zr(NMe2)2THF ({1}Zr(NMe2)2THF). 
Ellipsoids are plotted at 50% probability, and hydrogen atoms are not illustrated for clarity. 
Atomic distances (Å): Zr1−N2, 2.321(1); Zr1−N3, 2.045(1); Zr1−N4, 2.062(1); Zr1−O3, 
2.415(1). 
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Figure 2.1b. ORTEP diagram of {PhB(C5H4)(OxMe2)2}Zr(NMe2)2 ({1}Zr(NMe2)2). Ellipsoids 
are plotted at 50% probability, and hydrogen atoms are not illustrated for clarity. Atomic 
distances (Å): Zr1−N1, 2.255(1); Zr1−N3, 2.031(2); Zr1−N4, 2.035(2).  
 
We therefore pursued THF-free, X-ray quality crystals of {1}Zr(NMe2)2, which were 
obtained by slow diffusion of pentane into toluene solutions of {1}Zr(NMe2)2 cooled to 243 K. 
As in {1}Zr(NMe2)2THF, the [PhB(C5H4)(OxMe2)2] ligand bonds to Zr in the THF-free 
compound through the C5H4B and one oxazoline group (Zr1−N1, 2.25 Å), while the second 
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oxazoline is not coordinated to Zr (Zr1−N2, 4.31 Å). The geometry at zirconium is that of a 
three-legged piano stool; the Cpcentroid−Zr−NOxazoline angle (103.1°) is similar to that of the THF-
adduct, while the  Cpcentroid−Zr−NMe2 angles (110.47 and 122.35°) are smaller than in 
[1]Zr(NMe2)2THF. The Zr-NMe2 distances (Zr1−N3, Zr1−N4) are slightly shorter in 
[1]Zr(NMe2)2 than in the THF adduct (just outside of 3σ), and the Zr−OxMe2 distance is 0.066 Å 
shorter in the THF-free species. We wished to identify whether this compound would provide the 
same IR spectrum as the material obtained from evaporation of benzene. In fact, a spectrum of 
the crystalline sample (KBr) contained two bands in the IR at 1603 and 1505 cm-1 assigned to 
νCN stretching frequencies of non-coordinated and Zr-coordinated oxazolines. This IR data 
contrasts that of the material obtained by evaporation, where only one νCN band at 1595 cm-1 was 
observed. 
In contrast, the reaction of Ti(NMe2)4 with H2{1} in benzene at room temperature 
provides a mixture of unidentified products. The 1H NMR spectrum does not have the same 
spectral signatures as noted above for {1}Zr(NMe2)2. 1H NMR spectra of reaction mixtures in 
benzene-d6 or toluene-d8 contained vinylic resonances from isomers of C5H5B; the conversion of 
these signals to those associated with a single Cs-symmetric compound was not observed even 
upon heating at 120 °C. HNMe2 was observed in spectra of reaction mixtures within 10 min. 
which indicated that some ligand substitution occurred. Four 11B resonances were detected 
ranging from 33.6 to −14.7 ppm, and the upfield 11B NMR signal also suggested that a borane 
was among the reaction products. 
The chiral, 4S-isopropyl-5,5-dimethyl-2-oxazoline-based proligand H2[S-2] and 
M(NMe2)4 (M = Ti, Zr, Hf) react in benzene at room temperature, providing {S-2}M(NMe2)2 in 
excellent yield (eq 4; Ti: 25 h, 86%; Zr: 7 h, 96%; Hf: 7 h, 92%).  
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The opposite enantiomer {R-2}Zr(NMe2)2 is prepared from H2[R-2] and Zr(NMe2)4. As 
expected, the NMR and IR spectroscopic features of {S-2}Zr(NMe2)2 and {R-2}Zr(NMe2)2 are 
identical. Two sets of oxazoline resonances (e.g, two septets and four doublets assigned to the 
isopropyl groups and four singlets for the 5-methyl groups) and four downfield multiplets 
ranging from 6.7 to 6.06 ppm for the cyclopentadienyl group suggested C1-symmetric species for 
{S-2}Zr(NMe2)2. Two singlets are observed for the two inequivalent dimethylamide ligands. 
Additionally, the broad 11B NMR resonance at −15.7 ppm resulting from overlapping signals 
from isomers of H2[S-2] is replaced with a sharper signal at −14.5 ppm (122 Hz at half-height). 
The compounds {S-2}Ti(NMe2)2 and {S-2}Hf(NMe2)2 have similar 1H NMR spectra. The C-
stereocenters in the molecule necessarily render the two oxazolines inequivalent, so 1H NMR 
spectroscopy does not distinguish between zero, one, or two coordinated oxazolines. However, 
15N NMR and IR spectroscopy suggests that both oxazolines coordinate to the metal centers in 
{S-2}M(NMe2)2. Two 15N NMR signals were observed at −152.6 and −155.0 in comparison to 
−143 for 2H-Ox4S-iPr,Me2. Additionally, only one CN stretching frequency was observed in the IR 
at 1565 cm-1. A νCN associated with a non-coordinated oxazoline, based on the higher energy νCN 
of 2H-Ox4S-iPr,Me2 (1632 cm-1), was not detected.  
 The solution structure was further probed with a 1H-1H NOESY experiment to identify 
which groups on the ancillary ligand interact with the presumed reactive sites that are occupied 
by NMe2 groups in [S-2]Zr(NMe2)2, and correlations and assignments are illustrated in Figure 
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2.2. First, the S-2 intraligand correlations establish the metal-ligand conformations that are 
sufficiently populated to provide NOEs. The two sets of correlations discerned are oxazoline-
C5H4 correlations and oxazoline-oxazoline correlations. Interestingly, the former correlations 
only involve the lateral 2- and 5- hydrogen on the C5H4 group (Figure 2.2A) to methyl and 
isopropyl groups of both oxazolines. No correlations between the oxazoline and the 3- and 4- 
hydrogen were observed in the NOESY. The lateral correlations suggest significant population 
of configurations in which the zirconium-ligand interaction contains one dissociated oxazoline 
{η5-κ1-Ph(OxiPr,Me2)B(C5H4)(OxiPr,Me2)}Zr(NMe2)2. The significance of this conformation is 
further suggested by the X-ray crystal structure of {1}Zr(NMe2)2. However, there are also 
through-space correlations between the two oxazolines that suggest both oxazolines coordinate 
to zirconium for on an NOE-significant timescale. Thus, we suggest that these two 
conformations dominate the geometry of {S-2}Zr(NMe2)2 and exchange rapidly on the NMR 
time scale (eq 5).  
 
Furthermore, the intra- and inter-oxazoline correlations are useful to establish the relative 
orientation of the two oxazolines (Figure 2.2B). Based on these assignments and NOEs between 
oxazoline and NMe2 ligands, we can assign the signals for the inequivalent NMe2 groups and the 
overall configuration of the zirconium center (Figure 2.2C).  
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Figure 2.2: Through-space correlations in [S-2]Zr(NMe2)2. 
 
Interestingly, the "back" NMe2 in Figure 2.2 at 2.83 ppm correlatations show through-
space interactions with the "back" oxazoline, whereas the "front" NMe2 at 2.70 contained 
correlations with resonances from both oxazoline rings. Thus, the open space between the 
cyclopentadiene and the "back" oxazoline is occupied by a dimethylamide group, and the other 
dimethylamide group is situated between the two oxazoline rings in the di-coordinated 
conformer.  
A second optically active zirconium complex {PhB(C5H4)(Ox4S-tBu)2}Zr(NMe2)2 {S-
3}Zr(NMe2)2 is prepared by reaction of H2{S-3} and Zr(NMe2)4 in benzene at room temperature 
for 20 min. In its 1H NMR spectrum, two singlet resonances at 0.85 and 0.84 ppm were assigned 
to tert-butyl substituents on two inequivalent oxazoline groups, and four downfield multiplets 
ranging from 6.74 to 6.09 ppm were assigned to the cyclopentadienyl group. Likewise and as in 
S-2, two singlets for two inequivalent dimethylamido groups were observed, and the overall 
pattern was consistent with C1 symmetry. In the 11B spectrum, a sharp resonance at −14.4 ppm 
indicated that a single product was formed. The complex {S-3}Zr(NMe2)2 decomposes in 
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benzene at room temperature (t1/2 = 2 h), leading to HNMe2 and unidentified oxazolinylborate 
products. 
 In contrast, {S-2}M(NMe2)2 complexes (M = Ti, Zr, Hf) are unchanged in benzene even 
after 36 h at room temperature. 
 
Additionally, several compounds were required to test (a) the reactive valencies required 
for hydroamination catalysis and (b) the nature of ancillary ligand-zirconium interaction and its 
impact on cyclization and enantioselectivity. The compound {S-2}ZrNMe2Cl was prepared to 
address the former point. Reaction of H2[S-2] and 2 equiv. of KCH2C6H5 affords K2[S-2]. 
Reaction of K2[S-2] and ZrCl4 in THF at room temperature provides {S-2}ZrCl2 within 30 min.   
Two septets, four doublets, and four singlets in the 1H NMR spectrum (tetrahydrofuran-
d8) assigned to oxazoline isopropyl and methyl groups were consistent with inequivalent 
oxazolines expected for a C1-symmetric complex. Four multiplets in the downfield region from 
6.88 to 6.23 ppm were attributed to the cyclopentadienyl group in {S-2}ZrCl2. The complex is 
unchanged in THF-d8 for 7 days at room temperature, however, broad signals were observed in 
1H NMR spectra of {S-2}ZrCl2 after the solvent was evaporated and the residue was redissolved 
in tetrahydrofuran-d8. Therefore, the complex {S-2}ZrCl2 is best prepared in situ for the 
synthesis of {S-2}Zr(NMe2)Cl.  
The desired compound {S-2}Zr(NMe2)Cl is prepared by of one equiv. of LiNMe2 to {S-
2}ZrCl2 (generated in situ). The complex was isolated by removal of volatiles from the reaction 
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mixture in vacuo, followed by benzene extraction with 79% isolated yield. A mixture of two 
diastereomers is formed (in 4:1 ratio as detected by 1H NMR spectroscopy of tetrahydrofuran-d8 
solutions) because the zirconium in {S-2}Zr(NMe2)Cl is a stereocenter. The 1H NMR resonances 
associated with the ancillary ligand in each of the two diastereomers indicated the (expected) C1-
symmetry. Two sets of oxazoline resonances, one singlet for dimethylamido group, and four 
multiplets for the cyclopentadienyl group were observed for each of the C1-symmetric 
diastereomers. The 4:1 diastereomeric ratio remains unchanged in THF at room temperature after 
12 h.  
 
A mono(oxazolinyl)borato zirconium {S-7}Zr(NMe2)2 compound is prepared by reaction 
of H[Ph2B(C5H5)(Ox4S-iPrMe2)] (H2{S-7}) and Zr(NMe2)4. The treatment of isomeric mixture of 
H2{S-7} with 1 equiv. of Zr(NMe2)4 in benzene at room temperature formed {S-7}Zr(NMe2)2 
after 20 min with 92% isolated yield. The 1H NMR spectrum of {S-7}Zr(NMe2)2 in benzene is 
constant at room temperature over at least 12 h. 
 
One set of oxazoline resonances (i.e., one septet and two doublets assigned to the 
isopropyl groups and two singlets for the 5-methyl groups), two singlets for two inequivalent 
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dimethylamido groups, and four downfield multiplets for the cyclopentadienyl group suggest a 
C1-symmetric species for {S-7}Zr(NMe2)2. The 1H NMR pattern did not change at variable 
temperatures ranging from 190 K and 320 K in toluene-d8. Additionally, three 11B NMR 
resonance at −10.0, −11.5 and −12.4 ppm from isomers of H2[S-7] is converted to a single 
resonance at −11.7 ppm. In infrared, one νCN at 1562 cm-1 for {S-7}Zr(NMe2)2 indicates that the 
oxazoline is coordinated to the zirconium center. 
 
Catalytic Hydroamination/Cyclization of Aminoalkenes 
The bis(oxazolinyl)cyclopentadienylborate-coordinated bis(amido) group 4 compounds 
{1}Zr(NMe2)2, {1}Hf(NMe2)2, {S-2}Zr(NMe2)2, {S-2}Hf(NMe2)2, {S-2}Ti(NMe2)2, {R-
2}Zr(NMe2)2, and {S-3}Zr(NMe2)2  catalyze the cyclization of aminoalkenes to give racemic and 
optically-enriched pyrrolidine, piperidine, azepane, and indoline products at room temperature 
(Tables 2.3-2.5). These tables are organized by substrate type: Table 2.3 gives conditions for 
cyclization of aminopentenes 8a-13a that have aliphatic or aromatic 3,3-disubsititution; Table 
2.4 contains 6 and 7-membered rings from substrates 14a-17a; Table 2.5 contains cyclizations of 
substrates 18a-23a that give indoline, halogenated, acetal, and internal alkenes. In contrast, {S-
2}Zr(NMe2)Cl and {S-7}Zr(NMe2)2 are not precatalysts for cyclization of aminoalkenes under 
the conditions tested. 
The general rates of cyclization depend on the metal center, ancillary ligand, and 
substrate. Some general trends (for which exceptions) are summarized as follows. The metal 
center affects the reaction rate following the trend Zr > Hf >> Ti. For example, the apparent 
reaction rate (based on time required for conversion to 95%) for cyclization of aminopentene 8a 
is greater for {1}Zr(NMe2)2 than {1}Hf(NMe2)2 (Table 2.3, entries 1 and 2). {S-2}Zr(NMe2)2 is 
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a significantly more effective precatalyst than {S-2}Hf(NMe2)2, and in many cases only starting 
materials were detected in mixtures of {S-2}Ti(NMe2)2 and aminopentenes (allowed to stand at 
room temperature for extended times). In fact, only three of the most highly reactive substrates 
diphenyl 8a, tris(allyl) 11a and cyclohexyl 12a are cyclized by {S-2}Ti(NMe2)2 at room 
temperature with appreciable conversion. 
 For zirconium diamide catalysts, the oxazoline substituents on the ancillary ligand affect 
hydroamination rates, generally following the trend {S-2}Zr(NMe2)2 > {1}Zr(NMe2)2 > {S-
3}Zr(NMe2)2. For example, diphenyl substrate 8a is cyclized to pyrrolidine 8b in 1.25 h by {S-
2}Zr(NMe2)2, 11 h by {1}Zr(NMe2)2, and 18 by {S-3}Zr(NMe2)2 (Table 3, entries 3, 1, and 14). 
This trend applies to the formation of most pyrrolidine, azepane, and indoline products found in 
Tables 2.3–2.5. However, achiral 4,4-dimethyl-2-oxazoline-based {1}Zr(NMe2)2 is a more active 
catalyst than {S-2}Zr(NMe2)2 for unsubstituted aminopentene 13a (Table 2.3, entries 46 and 47) 
and aminohexenes 14a and 15a (Table 2.4, entries 1 and 2; entries 5 and 6); the unsubstituted 
aminopentene is readily cyclized by {1}Zr(NMe2)2 at room temperature, but {S-2}Hf(NMe2)2, 
{S-2}Ti(NMe2)2, and {S-3}Zr(NMe2)2 are not precatalysts for this cyclization, and {S-
2}Zr(NMe2)2 requires temperatures of 110 °C for only a few turnovers.  
 
Table 2.3. Catalytic cyclization of aminopentenes with achiral and optically active group 4 
compounds coordinated by mixed cyclopentadienyl bis(oxazolinyl)borato ligands. a 
Reactant to 
Product  
Entry Precatalyst Solvent Time (h) Yield 
(%) 
ee (%)b 
 
 
1 
2 
 
3 
4 
5 
6 
{1}Zr(NMe2)2 
{1}Hf(NMe2)2 
 
{S-2}Zr(NMe2)2 
{S-2}Zr(NMe2)2 
{S-2}Zr(NMe2)2 
{S-2}Zr(NMe2)2 
C6D6 
C6D6 
 
C6D6 
C6D6 
THF-d8 
CD2Cl2 
11 
24 
 
1.25 
6 
5 
5 
90 
29 
 
95 
95c 
95 
95 
racemic 
racemic 
 
93 (R) 
93 (R) 
95 (R) 
93 (R) 
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7 
 
8 
 
9 
10 
11 
12 
13 
 
14 
{S-2}Zr(NMe2)2 
 
{R-2}Zr(NMe2)2 
 
{S-2}Hf(NMe2)2 
{S-2}Hf(NMe2)2 
{S-2}Hf(NMe2)2 
{S-2}Hf(NMe2)2 
{S-2}Ti(NMe2)2 
 
{S-3}Zr(NMe2)2 
C7D8 
 
C6D6 
 
C6D6 
C7D8 
CD2Cl2 
THF-d8 
C6D6 
 
C6D6 
5 d 
 
1.25 
 
5 
15 
15 
20 
5 d 
 
18 
98e 
 
95 
 
97 
98d 
96d 
98d 
93 
 
95 
98 (R)f 
 
93 (S) 
 
91 (R) 
96 (R)f 
94 (R) 
96 (R)f 
76 (R) 
 
93 (R) 
 
 
15 
 
16 
17 
 
18 
19 
20 
 
21 
{1}Zr(NMe2)2 
 
{S-2}Zr(NMe2)2 
{R-2}Zr(NMe2)2 
 
{S-2}Hf(NMe2)2 
[S-2}Hf(NMe2)2 
{S-2}Ti(NMe2)2 
 
{S-3}Zr(NMe2)2 
C6D6 
 
C6D6 
C6D6 
 
C6D6 
C7D8 
C6D6 
 
C6D6 
11 
 
4 
4 
 
20 
8 
48 
 
11 
88 
 
88 
88 
 
90 
85d 
0 
 
77 
racemic 
 
92 (R) 
92 (S) 
 
94 (R) 
95 (R)f 
- 
 
88 (R) 
 
 
22 
 
23 
24 
 
25 
26 
 
27 
{1}Zr(NMe2)2 
 
{S-2}Zr(NMe2)2 
{S-2}Zr(NMe2)2 
 
{S-2}Hf(NMe2)2 
{S-2}Ti(NMe2)2 
 
{S-3}Zr(NMe2)2 
C6D6 
 
C6D6 
C7D8 
 
C6D6 
C6D6 
 
C6D6 
11 
 
7 
8 d 
 
20 
72 
 
48 
85 
 
89 
95e 
 
90 
0 
 
20 
racemic 
 
89 
93 
 
87 
- 
 
- 
 
 
28 
 
29 
30 
31 
 
32 
33 
34 
 
35 
{1}Zr(NMe2)2 
 
{S-2}Zr(NMe2)2 
{S-2}Zr(NMe2)2 
{S-2}Zr(NMe2)2 
 
{S-2}Hf(NMe2)2 
{S-2}Hf(NMe2)2 
{S-2}Ti(NMe2)2 
 
{S-3}Zr(NMe2)2 
C6D6 
 
C6D6 
CD2Cl2 
THF-d8 
 
C6D6 
C7D8 
C6D6 
 
C6D6 
11 
 
0.75 
1 
1.25 
 
5 
20 
5 d 
 
30 
98 
 
98 
98 
96 
 
98 
90[d] 
90 
 
97 
racemic 
 
93 (R) 
94 (R) 
94 (R) 
 
90 (R) 
96 (R)f 
82 (R) 
 
88 (R) 
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37 
38 
39 
{1}Zr(NMe2)2 
 
{S-2}Zr(NMe2)2 
{S-2}Zr(NMe2)2 
{S-2}Zr(NMe2)2 
C6D6 
 
C6D6 
C6D6 
C7D8 
11 
 
1.25 
6.5 
10 
92 
 
96 
92c 
94d 
racemic 
 
90 (R) 
90 (R) 
91 (R) 
38 
 
 
40 
41 
 
42 
 
43 
44 
 
45 
{S-2}Zr(NMe2)2 
{S-2}Zr(NMe2)2 
 
{R-2}Zr(NMe2)2 
 
{S-2}Hf(NMe2)2 
{S-2}Ti(NMe2)2 
 
{S-3}Zr(NMe2)2 
THF-d8 
CD2Cl2 
 
C6D6 
 
C6D6 
C6D6 
 
C6D6 
11 
10 
 
1.25 
 
5 
5 d 
 
30 
92d 
95d 
 
96 
 
95 
75 
 
92 
94 (R) 
93 (R) 
 
90 (S) 
 
93 (R) 
83 (R) 
 
87 (R) 
 
 
46 
 
47 
48 
49 
 
50 
{1}Zr(NMe2)2 
 
{S-2}Zr(NMe2)2 
{S-2}Hf(NMe2)2 
{S-2}Ti(NMe2)2 
 
{S-3}Zr(NMe2)2 
C6D6 
 
C6D6 
C6D6 
C6D6 
 
C6D6 
15 
 
15 
48 
48 
 
48 
90 
 
24g 
0 
0 
 
0 
racemic 
 
- 
- 
- 
 
- 
a Reaction conditions: 10 mol % catalyst, r.t. unless noted. b % ee (±0.5%) was determined by 1H and/or 
19F NMR spectroscopy by integration of the spectra of Mosher amide derivatives. The absolute 
configuration assignments are based on literature reports.5d,15a c 2 mol % catalyst. d Reaction performed at 
0 °C. e Reaction performed at −30 °C. f % ee measured by 19F NMR of Mosher amides derivatives and 
HPLC of benzoylamide derivatives. g Reaction performed at 110 °C. 
The enantioselectivities were determined by integration of 19F NMR spectra of 
trifluoromethylamide derivatives. For samples with the highest % ee, the result was checked with 
HPLC using a chiral stationary phase; the two methods invariably provided the same value 
within error. Racemic products were obtained from {1}Zr(NMe2) for spectroscopic and 
chromatographic comparison with optically active heterocycles. 
Several generalizations about the influence of ancillary ligand, metal center, solvent, and 
temperature on enantioselectivity for most substrates can be identified. Overall, this group 4 
system provides pyrrolidines with excellent optical purities. For example, diphenyl-
aminopentene is cyclized at room temperature to R-configured 2-Me-pyrrolidine with 93% ee by 
{S-2}Zr(NMe2)2 (Table 2.3, entry 3) and 91% ee by {S-2}Hf(NMe2)2 (Table 2.3, entry 9), and 
93% ee by {S-3}Zr(NMe2)2 (Table 2.3, entry 14). Impressively, the enantioselectivities of 
reactions catalyzed by {S-2}Zr(NMe2)2 are high for a range of substrates that include functional 
groups on five membered rings and seven-membered rings (Tables 2.3 – 2.5). In the series of 
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pyrrolidines, spiro-cyclohexyl-pyrrolidine 12b (90%), cyclopentyl-pyrrolidine 9b (92%), 
dimethyl-pyrrolidine 10b (89%), and trisallyl-pyrrolidine 11b (93%) are obtained at room 
temperature using {S-2}Zr(NMe2)2 (Table 2.3). Furthermore, while the reaction rate is sensitive 
to the substrate and catalyst concentration, however the enantioselectivity is not. For example, 2-
10 mol % {[S-2}Zr(NMe2)2 provides 8b pyrrolidine with 93% ee at all catalyst loadings, but the 
apparent turnover rate decreases significantly as catalyst concentration decreases (Table 2.3; 
entries 3 and 4). 
In general, {S-2}Zr(NMe2)2, {S-2}Hf(NMe2)2 and {S-3}Zr(NMe2)2 provide products with 
better optical purities than the titanium-based precatalyst {S-2}Ti(NMe2)2. The 4S-isopropyl-5,5-
dimethyl-2-oxazoline ligands S-2 and R-2 often give pyrrolidines with higher % enantiomeric 
excess than 4S-tert-butyl-2-oxazoline ligand S-3. For example, tris(allyl)methylamine is cyclized 
by {S-2}Zr(NMe2)2 to give 4,4-diallyl-2-methyl-pyrrolidine in 93% ee, whereas {S-3}Zr(NMe2)2 
affords the product in 88% ee. Similar effects are observed with the cyclopentyl substrate (92% 
vs. 88%) and cyclohexyl substrate (90% vs. 87%), while diphenyl pyrrolidine forms with 
equivalent % ee with {S-2}Zr(NMe2)2 and {S-3}Zr(NMe2)2. As expected, the mirror-image 
precatalyst {R-2}Zr(NMe2)2 gives equivalent reactivity and enantioselectivity as {S-
2}Zr(NMe2)2, but provides the products with the opposite absolute configuration. Thus, an 
additional advantage of valine-derived ligands vs. tert-leucine is that both enantiomers are 
readily available for the former. 
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 The hafnium precatalyst {S-2}Hf(NMe2)2 is also highly enantioselective, and the 
examples here are the first in which hafnium complex affords hydroamination products with 
optical purities >90%. In fact, {S-2}Hf(NMe2)2 provides pyrrolidines with higher 
enantioselectivity than {S-2}Zr(NMe2)2 for about half of the aminoalkenes that were tested. In 
particular, {S-2}Hf(NMe2)2 gives higher % ee  in benzene-d6 at room temperature for 
cyclopentylpyrrolidine (9b, 94% ee) and cyclohexylpyrrolidine (12b, 93% ee). Under these 
conditions, diphenylpyrrolidine, trimethylpyrrolidine, and diallylpyrrolidine are formed with 
greater optical purities in reactions catalyzed by {S-2}Zr(NMe2)2 than {S-2}Hf(NMe2)2. The 
enantiomeric excesses were always lowest with {S-2}Ti(NMe2)2 as the precatalyst, regardless of 
the substrate. Thus, the effect of metal center on hydroamination enantioselectivity follows the 
trend Zr ≈ Hf >Ti for this mixed cyclopentadienyl-bis(oxazolinyl)borate group 4 system. 
Aside from slight variations, in general the pyrrolidine products' optical purities are high 
in benzene, toluene, methylene chloride, and THF. The apparent turnover rate is diminished in 
THF or methylene chloride compared to benzene or toluene, however, the enantioselectivity is 
enhanced. With the {S-2}Zr(NMe2)2-catalyzed cyclization of the diphenyl substrate 8a as a 
representative example, benzene-d6 and methylene chloride-d2 solvents the same 
enantioselectivity (93% ee), although the reaction is faster in benzene-d6. Higher enantiomeric 
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excess is obtained in THF at room temperature (95%; Table 2.3, entry 5) and conditions of lower 
temperature (−30 °C) in toluene-d8 solvent provide the product with 98% ee (Table 2.3, entry 7). 
In fact, the asymmetric induction is significantly enhanced at lower temperatures, 
although in several cases long reaction times are needed. For example, {S-2}Zr(NMe2)2 
catalyzes the formation of 4,4-dimethyl-pyrrolidine 10b at −30 °C with 93% enantiomeric 
excess, whereas the product is formed with only 89% ee at room temperature (Table 2.3, entries 
23 and 24). A similar trend is also observed for {S-2}Hf(NMe2)2, which mediates the formation 
of diallylpyrrolidine with 96% ee at 0 °C compared to 90% ee at room temperature (Table 2.3, 
entries 32 and 33). 
 These trends established for more common pyrrolidine products suggest that {S-
2}Zr(NMe2)2 is a highly effective and enantioselective group 4 catalyst for the cyclization of 
additional amino alkenes. Some minor optimizations, per substrate, could involve the hafnium 
catalyst, solvent modification, or temperature control as addition substrates are tested. 
Typically, cyclizations of aminohexenes and aminoheptenes have proven more difficult 
than the aminopentenes described above. In fact, the rates of cyclization of aminohexene 14a and 
15a, as catalyzed by {S-2}Zr(NMe2)2, are significantly decreased with respect to the 
aminopentenes. Additionally, the enantiomeric excesses of the 2-methylpiperidines products are 
significantly lower than the 2-methylpyrrolidines. The conversion and rate of the hafnium 
precatalyst {S-2}Hf(NMe2)2 is superior to the zirconium catalyst for piperidine formation, 
although elevated temperature is required. 
Although cyclization of aminoheptenes is also slower than the catalytic conversions of 
aminopentenes, azepanes are obtained with high enantiomeric excesses. The cyclization of 
aminoheptene substrates is catalyzed by {1}Zr(NMe2)2 to give the racemic products and by {S-
42 
 
2}Zr(NMe2)2, providing optically active homopiperidines, at room temperature (Table 2.4, 
entries 9). However, hafnium complex {S-2}Hf(NMe2), the titanium compound {S-2}Ti(NMe2)2, 
and the tert-butyl-oxazolinylborate zirconium complex {S-3}Zr(NMe2)2 are not effective at room 
or elevated temperatures. 
 
Table 2.4. Catalytic hydroamination/cyclization of aminohexenes and aminoheptenes. a  
Reactant to 
Product 
Entry Precatalyst solvent Time (h) Yield (%) ee (%)b 
 
1 
 
2 
3 
 
4 
{1}Zr(NMe2)2 
 
{S-2}Zr(NMe2)2 
{S-2}Hf(NMe2)2 
 
{S-3}Zr(NMe2)2 
C6D6 
 
C6D6 
C6D6 
 
C6D6 
11 
 
40 
30 
 
48 
87 
 
48 
85d 
 
80 
racemic 
 
31c 
26c 
 
29c 
 
5 
 
6 
 
7 
{1}Zr(NMe2)2 
 
{S-2}Zr(NMe2)2 
 
{S-2}Hf(NMe2)2 
C6D6 
 
C6D6 
 
C6D6 
4 d 
 
4 d 
 
20 
95 
 
65 
 
89d 
racemic 
 
46 
 
18 
 
8 
 
 
9 
 
{1}Zr(NMe2)2 
 
 
{S-2}Zr(NMe2)2 
C6D6 
 
 
C6D6 
5 d 
 
 
5 d 
56 
 
 
73 
racemic 
 
 
91 
 
10 
 
 
11 
{1}Zr(NMe2)2 
 
 
{S-2}Zr(NMe2)2 
C6D6 
 
 
C6D6 
4 d 
 
 
4 d 
76 
d.r. = 5.6:1 
 
85 
d.r. = 3.8:1 
racemic 
 
 
94, 90 
a Reaction conditions: 10 mol % catalyst, r.t. unless noted. b % ee (±0.5%) was determined by 1H and/or 
19F NMR spectra of Mosher amide derivatives. c % ee verified by HPLC. d 85 °C. 
The highly enantioselectivity in amino pentene cyclizations motivated further study of 
the formation of other five-membered rings. The precatalysts {S-2}Zr(NMe2)2 and {S-
2}Hf(NMe2)2 cyclize ortho-allylaniline at room temperature to generate optically active 2-
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methyl-indoline with 95% and 94% ee respectively (Table 2.5, entries 2 & 3). 2-Substituted 
indolines are important subunits in drug candidates including as eletriptan, indapamide, 
muscarine receptor agonists and antagonists.42 Previously described syntheses of highly 
enantioenriched (>90%) indoline subunit bearing a stereogenic center at the 2-position rely on 
either catalytic asymmetric hydrogenation of indoles, or the kinetic resolution of racemic mixture 
of indoles. Therefore, complexes {S-2}Zr(NMe2)2 and {S-2}Hf(NMe2)2 are promising 
precatalysts for preparation of optically active indoline building blocks from aniline derivatives. 
Two other reported hydroamination catalysts can provide 2-methyl indoline from ortho-
allylaniline with moderate enantioselectivity.14,20 
This series of group 4 precatalysts are active in methylene chloride and THF, suggesting 
that substrates containing halogen and ether functionality. We therefore investigated cyclizations 
of aminopentenes containing these functional groups. Quite promisingly, high enantioselectivity 
is obtained for the intramolecular hydroamination of 2,2-diethoxy-aminopentene 19a ({S-
2}Zr(NMe2)2, 97% ee; {S-2}Hf(NMe2)2, 96% ee; Table 2.5, entries 6 and 7). The achiral 
precatalyst {1}Zr(NMe2)2 mediates the cyclization at approximately the same rate as {S-
2}Zr(NMe2)2, but neither the 4S-tert-butyl-oxazolinylborate-based {S-3}Zr(NMe2)2 nor titanium-
based precatalyst is effective. 
2-Allyl-2-(4-bromophenyl)pent-4-enylamine 20a is cyclized by {1}Zr(NMe2)2 to a 2:1 
diastereomeric mixture of cis and trans pyrrolidines at room temperature. The assignment of the 
major isomer as cis is supported by NOE experiments in benzene-d6 in which irradiation of the 
2-methyl signal of the major isomer (1.00 ppm) results in decreased intensity of the ortho- and 
meta-phenyl resonances at 7.27 ppm and 6.69 ppm. Interestingly, the optically active precatalyst 
[S-2]Zr(NMe2)2 is more efficient (full conversion in 20 min), gives better diastereoselectivity 
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(cis:trans = 4:1), and provides the products with exceedingly high enantioselectivity (cis: 97% 
ee; trans: 95% ee). The diastereomeric ratio (trans:cis = 2:1) as well as the optical purity of the 
major enantiomer (at 93% ee) are lower with the hafnium catalyst [S-2]Hf(NMe2)2. Even higher 
optical purities are obtained with by [S-3]Zr(NMe2)2 (Table 2.5, entries 13), although the 
diastereomeric ratio is 1:1.2 (favoring the trans isomer) and the reaction time is two days. Finally 
and impressively, both diastereomers are obtained in 99% ee after cyclization at −30 °C in 
toluene with [S-2]Zr(NMe2)2 as the precatalyst. However at that temperature, the diastereomeric 
ratio (cis:trans) decreases to 1:1.3 (with the trans isomer slightly favored). 
Similar effects are observed in the cyclization of 4-aminomethyl-4-methyl-hepta-1,6-
diene, in that the fastest cyclization rates is obtained with {S-2}Zr(NMe2)2 as the precatalyst and 
the highest diastereoselectivity is obtained with {S-2}Hf(NMe2)2. The enantioselectivity is 
slightly better with {S-2}Zr(NMe2)2 whereas the diastereoselectivity for cyclization is slightly 
better with {S-3}Zr(NMe2)2. Although diastereoselectivity for bis(allyl)amine substrates is poor, 
the enantioselectivity is high. Although the absolute configuration of the stereocenters in these 
molecules are not established by X-ray crystallography, inspection of HPLC traces of benzoyl 
derivatives and 19F NMR spectra of Mosher amide derivatives suggest that the stereocenter 
obtained from C−N bond formation with {S-2}Zr(NMe2)2 is R for both diastereomers for both 
methyl and para-bromophenyl substrates. In particular, Mosher-amide derivative of S-8b 
structurally characterized by X-ray crystallography.5d 
R enantiomer elutes before the S enantiomer from a Regis (S,S)-Whelk O1 column HPLC 
column; additionally the peak from the R enantiomer is sharp whereas a broad band is apparent 
from the S isomer.2d,43 In the mixtures of diastereomers obtained from cyclization of substrates 
20a and 21a by {S-2}Zr(NMe2)2, four peaks were observed in the HPLC that appear in pairs. 
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The two peaks associated with the major R enantiomers elute together and earlier than the S 
disfavored enantiomers, following the same elusion trend established with the pyrrolidines, 
whose absolute configurations are determines either by crystallographically5d or optical 
rotation.2a,2b,2d 
These early bands are narrow, whereas the disfavored enantiomers of the diastereomeric 
pairs are broad. Likewise, in the 19F NMR spectra of the Mosher amides of 2-methyl-pyrrolidines 
20b and 21b, the R,R-pyrrolidine Mosher amide resonances are upfield and sharp whereas the 
S,R-pyrrolidine Mosher amides resonances are broad and downfield. In the 19F NMR spectra  of 
20b and 21b acquired at 60 °C, two sharp, upfield singlets were observed as the major species 
present 20b: −73.73 and −70.83; 21b: −70.83 and −71.07); the minor species were detected as a 
pair of broad downfield signals (20b: −69.98 ppm and −69.89 ppm; 21b: −70.15 ppm and −70.04 
ppm in chloroform-d). From consistent the relative peak positions and signal shape for the R 
enantiomers and the tendency of {S-2}Zr(NMe2)2 to provide the R enantiomer of 21a and 21b 
substrates, we assign the configurations of the major enantiomers of the two diastereomers as 2R 
for bromophenyl and methyl substrates.  
In case of cyclization of substrate containing internal alkene 22a only {1}Zr(NMe2)2 and 
{S-2}Zr(NMe2)2 are seen to be active precatalysts providing racemic and enantio-enriched 
pyrrolidines respectively. 2-ethyl-pyrrolidine with 89% ee is obtained using {S-2}Zr(NMe2)2 
(Table 2.5, entries 19)
 
. 
The turnover rate diminished with decreasing the steric bulk on the backbone of 
aminopentene, following the commonly cited Thorp-Ingold effect. The rate of cyclization of 
mono-phenyl aminopentene (Table 2.5, entries 22) is decreased significantly compare to the 
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substrate diphenyl substrate (Table 2.3, entries 3), and as noted above the parent aminopentene is 
not efficiently cyclized by any of these chiral oxazolinylborate catalysts. 
 
Table 2.5 Catalytic hydroamination/cyclization of aminoalkenes 
Reactant to 
Product[a]  
Entry Precatalyst Solvent Time (h) Yield (%)b ee (%)[c] 
 
1 
 
2 
3 
 
4 
 
{1}Zr(NMe2)2 
 
{S-2}Zr(NMe2)2 
{S-2}Hf(NMe2)2 
 
{S-3}Zr(NMe2)2 
C6D6 
 
C6D6 
C6D6 
 
C6D6 
72 
 
3 d 
5 d 
 
72 
90 
 
92 
80 
 
0 
racemic 
 
95 
94 
 
- 
 
5 
 
6 
7 
 
8 
{1}Zr(NMe2)2 
 
{S-2}Zr(NMe2)2 
{S-2}Hf(NMe2)2 
 
{S-3}Zr(NMe2)2 
C6D6 
 
C6D6 
C6D6 
 
C6D6 
30 
 
30 
5 d 
 
5 d 
90 
 
90 
90 
 
15 
racemic 
 
97 
96 
 
- 
HN C6H4Br
HN
C6H4Br
20b-cis
+
20b-trans
NH2
C6H4Br
20a
 
9 
 
10 
 
11 
 
12 
 
13 
 
{1}Zr(NMe2)2 
 
{S-2}Zr(NMe2)2 
 
{S-2}Zr(NMe2)2 
 
{S-2}Hf(NMe2)2 
 
{S-3}Zr(NMe2)2 
C6D6 
 
C6D6 
 
C7D8 
 
C6D6 
 
C6D6 
20 
 
0.33 
 
2 d 
 
3 
 
48 
100  
d.r. =  2:1 
100 
d.r. = 4:1 
100d, d.r. = 
1:1.3 
 90 
 d.r. = 2:1 
100 
 d.r. = 1:1.2 
racemic  
 
97, 95  
 
99, 99[e] 
 
93, 95.6 
 
96, 98 
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NH2
21a
HN
HN
21b-cis
+
21b-trans
 
14 
 
15 
 
16 
 
17 
{1}Zr(NMe2)2 
 
{S-2}Zr(NMe2)2 
 
{S-2}Hf(NMe2)2 
 
{S-3}Zr(NMe2)2 
 
 
 
C6D6 
 
C6D6 
 
C6D6 
 
C6D6 
30 
 
0.5 
 
20 
 
30 
85  
d.r. = 1.5:1 
98 
d.r. = 1.1:1 
90  
d.r. = 1.4:1 
85  
d.r. = 1.2:1 
racemic 
 
93, 92 
 
87, 63 
 
92, 91 
NH2
Ph Ph
HN Ph
Ph
22a
22b
 
18 
 
19 
 
20 
{1}Zr(NMe2)2 
 
{S-2}Zr(NMe2)2 
 
{S-2}Hf(NMe2)2 
C6D6 
 
C6D6 
 
C6D6 
 
 
4 d 
 
4 d 
 
4 d 
20 
 
85 
 
15 
racemic 
 
89 
 
- 
NH2
HN
23a
23b
Ph
Ph
 
21 
 
22 
 
23 
 
24 
 
{1}Zr(NMe2)2 
 
{S-2}Zr(NMe2)2 
 
{S-2}Hf(NMe2)2 
 
{S-2}Zr(NMe2)2 
C6D6 
 
C6D6 
 
C6D6 
 
C6D6 
20 
 
15 
 
24 
 
48 
95 
d.r. = 1.4:1 
95 
d.r. = 3:1 
90, d.r. = 
2.5:1 
20 
d.r. = 3:1 
racemic 
 
66, 57 
 
65, 58 
 
- 
 
a Reaction conditions: 10 mol % catalyst, r.t. unless noted. b ratio of diastereomers defined as cis/trans. c 
% ee (±0.5%) was determined by 1H and/or 19F NMR spectra of Mosher amide derivatives. d −30 °C. e % 
ee verified by HPLC. 
 
Spectroscopic and Kinetics Features of Catalytic Reactions  
The olefin hydroamination reactions catalyzed by {S-2}Zr(NMe2)2 are unique among 
current group 4 systems in terms of the mild conditions of conversion (room temperature to −30 
°C), their broadly high enantioselectivity, and the relative insensitivity of enantioselectivity to 
solvent choice. We have collected additional data to characterize some of the kinetic and 
stereochemical features of our system for comparison to other group 4 catalysts, to rule out 
possible catalytic pathways, and possibly identify the features that provide high rates and high 
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enantioselectivity. We have also investigated effects of ancillary ligand modifications on 
cyclization rates, and along with the kinetic data, provide a mechanistic hypothesis that we 
believe best explains the currently available data. 
 
 a. Reaction time course and its kinetic features. HNMe2 is observed by 1H NMR 
spectroscopy to upon addition of the aminoalkenes to the precatalyst. The active catalyst is not 
directly observed at room temperature by in situ 1H NMR spectroscopy of the reaction mixture. 
However, the active species is formed at room temperature within one minute after addition of 
aminoalkenes to metal diamides, based on the appearance of product in the 1H NMR spectrum of 
the reaction mixture.  
In situ 1H NMR spectra of a mixture of 1.0 equiv. of C-(1-allyl-cyclohexyl)-methylamine 
(12a) and {S-2}Zr(NMe2)2 at 230 K in toluene-d8 contained resonances assigned to HNMe2 
(2.20 ppm), new olefinic resonances (5.81 and 5.10 ppm) associated with transformation but not 
cyclization of 12a (5.69 and 4.99 ppm at 230 K), and ancillary ligand resonances. Signals at 2.82 
ppm are assigned to the remaining Zr(NMe2). Peaks from 12a and the {S-2}Zr(NMe2)2 starting 
material are not visible in this mixture. Upon warming to room temperature, the resonances in 
the olefinic region are no longer observed.  
Reaction of {S-2}Zr(NMe2)2 and two equiv. of 12a at 230 K also provides HNMe2. The 
1H NMR signals previously assigned to ZrNMe2 were absent from the spectra, as were 
resonances assigned to 12a. However the 1H NMR spectrum of the reaction mixture was 
complicated by broad overlapping resonances in the phenyl and cyclopentadienyl regions, and 
structural assignment was not possible. Similarly broad resonances for {S-2}Zr-species were 
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observed in catalytic reaction mixtures at low temperature, therefore assignment of the structure 
of a catalytic resting state is not possible at this point. 
Instead, the reaction pathway was characterized using kinetic studies. The concentrations 
of the "cyclohexyl" substrate C-(1-allyl-cyclohexyl)-methylamine (12a) and the cyclized "spiro" 
product 3-methyl-2-aza-spiro[4,5]decane (12b) were monitored by 1H NMR spectroscopy over 
the course of the catalytic conversion. Plots of ln[12a] vs. time are linear (up to 75-82% 
conversion), and this is consistent with first-order dependence on substrate concentration. Using 
the first 75% of the reaction, a series of pseudo-first order rate constant (kobs) are obtained for a 
range of initial concentrations of the precatalyst {S-2}Zr(NMe2)2. A linear relationship between 
kobs and [{S-2}Zr(NMe2)2] provides the empirical rate law: −d[12a]/dt = k'obs[12a]1[{S-
2}Zr(NMe2)2]1 (k'obs = 0.085 M-1s-1; 21 °C). 
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Figure 2.3. Plots of ln[12a] versus time for the {S-2}Zr(NMe2)2 catalyzed conversion of 12a 
into pyrrolidine 12b. Three experiments are illustrated, in which [{S-2}Zr(NMe2)2] = 9.7 mM 
and 0, 4, and 6 equiv. of the product 12b, are added prior to conversion. Linear least-squares best 
fits for ~2.5 half-lives corresponds to conversion to substrate:catalyst ratio = 2.5:1 for the three 
data sets. 
 
However, after two half lives, the reaction rate decreases to a greater degree than 
expected for a first-order reaction. Similar observations have been reported in other early-metal-
catalyzed aminoolefin cyclizations (although typically these showed zero-order substrate 
concentration dependence), and the non-linearity was attributed to product inhibition.2b,23,28,5d 
Recently, however, Schafer pointed about that the curvature might result from a change 
in rate law.28 We therefore pursued this point further. Cyclization rates of 12a catalyzed by [S-
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2]Zr(NMe2)2 were measured with 4 equiv. and 6 equiv. of product 12b (using 90% ee material) 
relative to catalyst, and  pseudo-first order rate constants (0 equiv 12b: kobs = 1.08 × 10-3 s-1; 4 
equiv 12b: kobs = 0.32  × 10-3 s-1; 6 equiv 12b: kobs = 0.22 × 10-3 s-1) were smaller in the presence 
of 12b (measured with equivalent catalyst concentration {S-2}Zr(NMe2)2). Thus, kinetic 
experiments indicate that addition of product results in slower conversion (without a change in 
rate law) consistent with product inhibition.  
Interestingly, even in the presence of 6 equiv. of 12b, plots of ln[12a] vs. time are linear 
for only ~75% conversion. In general, the ln[12a] vs. time plots deviate from first-order substrate 
dependence at a ratio of [substrate]/[catalysts] of ~2.5. This apparent effect may be related to the 
requirement that two molecules of 12a are required for catalytic turnover (see the initial rates 
experiments below). Thus, these experiments suggest that the curvature in first-order plots results 
from a change in mechanism at low substrate concentration. Furthermore, the product inhibition 
suggest that initial rate measurements, where [12b] is minimized, might better describe the 
substrate dependence of the catalytic reaction. 
An additional observable that can provide insight into possible mechanism change is the 
enantioselectivity, which is often sensitive to catalyst structure and mechanism. Therefore, the % 
ee was monitored as a function of conversion, and this is plotted in Figure 2.4. Notably, this plot 
shows that the % ee is constant from 35-70% conversion, and the enantioselectivity begins to 
decrease above 75% conversion. Furthermore, the lower enantioselectivity occurs at the same % 
conversion at which the rate appears to deviate from first order. However, we should note that at 
equivalent and full conversion, the observed % ee is invariant over experiments in which the 
total volume (and thus, the concentration) of the reaction mixture is varied. 
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Figure 2.4. Plot showing the correlation of enantiomeric excess of pyrrolidine product 12b with 
catalytic conversion of substrate 12a. 
 
Still, most mechanistic studies of early-transition metal, lanthanide, and actinide-
catalyzed hydroamination/cyclization have probed the kinetic features (isotope effects, 
temperature-dependence) based on some percentage of catalytic conversion. The same is done 
here for comparison to other hydroamination systems, using ~2.5 half-lives of data. Conversion 
of C-(1-allyl-cyclohexyl)-methylamine-ND2 (12a-d2), catalyzed by [S-2]Zr(NMe2)2, is much 
slower than conversion 12a itself. Linear least squares best fits of plots of kobs(D) versus catalyst 
concentration provide the second-order rate constant k'obs(D) and the large k'obs(H)/k'obs(D) value 
(3.5) that is consistent with a primary isotope effect (i.e., an N–H or N–D bond is broken in the 
transition state of the turnover-limiting step; Figure 2.5). 
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Figure 2.5. Plots of pseudo first order rate constants (kobs) vs. catalyst concentration. Reactions 
were performed at 295 K in toluene-d8.  
 
In addition, hydroamination mechanisms are often kinetically characterized using 
transition-state theory. Second-order rate constants (k'obs) for cyclization of 12a were measured at 
temperatures from 266 K to 314 K (Figure 2.6). The plot of ln(k’obs/T) vs. 1/T from these data 
provides the values of activation parameters:  ∆H‡ = 11.01 kcal·mol-1 and ∆S‡ = −18.3 cal·mol-
1K-1.   
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Figure 2.6. Plots of ln(k'obs/T) vs. 1/T and ln(k2/T) vs. 1/T. 
 
b. Initial rates. The effects of product inhibition should be minimized at the initial portion of the 
reaction. This potential simplification motivated investigations of the instantaneous rate 
dependence on substrate concentration for the first 20-35% of the catalytic conversion. Linear 
least squares best fit of curves obtained from [12a] vs. time provide the initial rate (d[12a]/dt)ini. 
For a series of experiments, [12a] was varied from 0.0098 to 0.154 M as [{S-2}Zr(NMe2)2] (5.39 
mM) and temperature (23 °C) were kept constant to provide a set of data that describe the rate 
dependence on substrate concentration (Figure 2.7).  
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Figure 2.7. Plot of initial cyclization rate of (−d[12a]/dt)ini vs. [substrate]ini for 12a (■) and 12a-
d2 (▲), measured in toluene-d8, 23 °C. The curves represent nonlinear least-squares fit (eq 10). 
 
At low concentrations (0.0098 to 0.07 M), the average initial substrate conversion rates 
increase linearly as the substrate concentration increases; however, at higher substrate 
concentrations (70 mM), the initial rates approaches a maximum and eventually do not increase 
with further increases in substrate concentration. A slight decrease of the initial rate is observed 
at [12a] > 70 mM. Experiments that probe initial rate dependence on substrate concentration 
performed at 273, 314, and 322 K, as well as using N-deuterated substrate 12a-d2, provide 
similar curves. As can been seen in Figure 2.7, the initial rate plots also contains a non-zero x-
intercept that coincides with precatalyst concentration, which suggests that 1 equiv. of substrate 
is required before one catalytic cycle can be completed. That statement is an approximation, in 
fact, because the low temperature experiments with 1:1 substrate to catalyst indicate that 
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cyclization can occur at that low ratio. However, as suggested by the ln[substrate] vs. time plots, 
the reaction rate drops precipitously at low substrate concentrations. 
The non-linear rate dependence on concentration indicates that the rates of the elementary 
reaction steps are inequivalently influenced by substrate concentration; the results is that 
changing substrate concentration modifies the contribution of the elementary steps to the rate of 
catalysis. Nonlinear least-squares regression analysis of the data in Figure 2.7 provides good 
correlation with eq 10, which includes the rate constant k2 for the irreversible step, the catalyst 
formation constant K' ({k-1 + k2}/k1), and the substrate inhibition constant KSI. The form of the 
rate equation resembles the Michaelis-Menten equation, with the addition of a reversible 
substrate inhibition step (eq 10).44 Additionally, the substrate concentration in eq 10 is modified 
by the approximated requirement that one equiv. of substrate 12a is needed to convert [S-
2]Zr(NMe2)2 precatalyst into the active catalyst, giving the terms {[12a]−[{S-2}Zr(NMe2)2]} in 
eq 10. 
−d[12a]
dt
=
k2[{S-2}Zr(NMe2)2]  {[12a] − [{S-2}Zr(NMe2)2]
K' + {[12a] − {S-2}Zr(NMe2)2} + KSI{[12a] − {S-2}Zr(NMe2)2}2
(10)
 
 
cat   +   12a
k1
k−1
cat. 12a
KSI 12a
k2
catalyst  +  product (12b)
cat.(12a)2
(11)
 
The rate law in equation 10 corresponds to the reaction mechanism shown in the 
following equation 11, which shows reversible substrate and catalyst association followed by an 
irreversible step. The three parameters obtained from the curve fit are k2 (1.7±0.3 × 10-2 s-1), K' 
(2.8±0.7 × 10-2 M), and KSI (5±2 M-1). The composition of the catalytic species can be partly 
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assessed from this kinetics analysis. The interaction of  substrate and catalyst in a 1:1 ratio 
provides the active catalyst that is likely [Zr(NHR)(NMe2)] (catalyst initiation; NHR = 
amidoalkene). The equilibrium step (k1/k-1) involves reversible interaction of catalyst with 
substrate giving [Zr(NHR)2] and HNMe2.  
 
c. Isotope effects. The primary kinetic isotope effect was also verified by actual rate constant k2 
obtained from the saturation kinetic plots using 12a-d2. The initial rate increased with increase of 
[12a-d2]ini until a saturation was observed similar to the proteo-analog (12a). A nonlinear least-
squares fit (R = 0.099) of –[d(12a-d2)/dt]ini vs. [12a-d2]ini at 23 °C provides a saturation curve, 
with the value of (k2)D = 7.3 x 10-3 s-1. The value of k2(H)/ k2(D) from the initial rate plots (Figure 
2.7) is 2.3 (0.5), indicates that N−H bond is involved in the turnover-limiting step. Significant 
increase of isotope effect was observed at 0 °C. The value of k2(H)/ k2(D) measured from initial rate 
plots at 0 °C is 4.5.  
 
d. Activation parameters. The second order rate constant include the substrate binding constant 
as shown in the plot of initial rate and also in rate law. Therefore, it is necessary to determine the 
actual values of the activation parameters using k2 obtained from saturation kinetics, which 
exclude the substrate binding constant. k2(H) values were determined from the initial rate plots at 
273 K, 294 K, 314 K, and 322 K (Figure 2.8). The plot of ln(k2/T) vs. 1/T provide ∆H‡ = 6.7 
kcal•mol-1 and ∆S‡ = −43 cal•mol-1K-1 (Figure 2.9). 
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Figure 2.8. Plots of initial rates of cyclization –d[12a]/dt vs. [12a]ave for cyclization of 12a by 
{S-2}Zr(NMe2)2 (0.0054 M) at 273 K, 294 K, 314 K, and 322 K. The curves represent non-linear 
least-squares regression analysis of the data to the equation: −d[substrate]/dt = 
k2[catalyst][substrate]/{K' + [substrate] + KSI[substrate]2}. 
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Figure 2.9. Plot showing a linear correlation between ln(k2/T) vs. 1/T from initial rates plots at 
273 K, 294 K, 314 K, and 322 K. From this plot, ∆H‡ = 6.7 kcal•mol-1 and ∆S‡ = −43 cal•mol-1 
K-1 are calculated. 
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e. Significant isotope effects on enantioselectivity. Significant isotopic perturbation on 
stereoselectivity was observed in hydroamination/cyclization of proteo- and deuteron-
aminoalkenes using precatalyst {S-2}Zr(NMe2)2, {R-2}Zr(NMe2)2, {S-2}Hf(NMe2)2, and {S-
3}Zr(NMe2)2.The cyclizations of deuterated aminoolefins provide deuteron-pyrrolidines with ee 
values, which are systematically and significantly higher than the values for the corresponding 
proteo-analogs. The ee values for deuteron-heterocycles (8a-d2, 95%; 12a-d2, 97%; 14a-d2, 46%) 
are higher compared to the corresponding proteo-heterocycles (8a, 93%; 12a, 90%; 14a-d2, 31%) 
for {S-2}Zr(NMe2)2. Similarly, in case of Hf-precatalyst {S-2}Hf(NMe2)2, the ee values for 
deuteron-heterocycles (8a-d2, 96%; 12a-d2, 97%; 14a-d2, 44%) are higher compared to the 
corresponding proteo-heterocycles (8a, 91%; 12a, 93%; 14a-d2, 26%). 
  For {S-2}Zr(NMe2)2, the isotope effect for the favored diastereomeric pathways 
(kHR/kDR) is 2.2(5) and for the unfavored diasteromers (kHS/kDS) is 7.7(1) (from k'H/k'D). Thus, N-
deuteration slows the S-diastereomeric pathways by a greater extent than the R-pathways. 
 
Table 2.6. Effect of N-d2 substitution on % ee in enantioselective hydroamination catalyzed by 
Zr- and Hf-catalystsa 
                         Catalysts: {S-2} 
Zr(NMe2)2 
 
{R-2} 
Zr(NMe2)2 
 
{S-2} 
Hf(NMe2)2 
 
{S-3} 
Zr(NMe2)2 
 
NH2
Ph Ph
HN Ph
Ph
8a 8b
 
ND2
Ph Ph
HN
DH2C
Ph
Ph
8a-d2 8b-d2  
 
93 (R) 
 
 
95 (R), 
97 (R) b 
 
93 (S) 
 
 
95 (S) 
 
 
 
 
91 (R) 
 
 
96 (R) 
 
93 (R) 
 
 
96 (R) 
 
NH2
12a
HN
12b
 
 
90 (R) 
 
 
 
90 (S) 
 
 
 
93 (R) 
 
 
 
86 (R) 
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ND2
12a-d2
DN
DH2C
12b-d2
 
 
97 (R), 
98 (R) c 
 
97 (S) 
 
97 (R) 
 
91 (R) 
 
NH2
14a
HN
14b
 
14b-d2
NH2
14a
HN
 
 
31 (R) 
 
 
 
 
   46 (R) 
 
 31 (S) 
 
 
 
 
46 (S) 
 
26 (R) 
 
 
 
 
44 (R) 
 
- 
 
 
 
 
- 
a Reaction Conditions: 23 °C, C6D6, >95% yield. b 0 °C in toluene or THF. c −30 °C in THF. 
 
f. Ancillary ligand-metal interactions during catalysis. The high enantioselectivity of the C1-
symmetric chiral cyclopentadienyl-bis(oxazolinyl)borate zirconium precatalyst can be 
rationalized due to the presence of non-epimerizable chiral oxazoline based ancillary ligand. The 
stereogenic center is in close proximity of the nitrogen coordinating center on the oxazoline as 
well as to the metal center in the precatalyst, which provide excellent stereochemical induction 
around the metal center. However, the coordination geometry of the zirconium center during the 
catalysis might have an important role in high activity and enantioselectivity for cyclization of 
aminoalkenes, which is unknown to this point. To probe the coordination geometry of the 
zirconium catalyst during hydroamination, the catalytic activity of complex {Ph2B(C5H4)(Ox4S-
iPr,Me2)}Zr(NMe2)2 ({S-7}Zr(NMe2)2) is compared to the precatalyst {PhB(C5H4)(Ox4S-
iPr,Me2)2}Zr(NMe2)2 ({S-2}Zr(NMe2)2). Notably, {S-7}Zr(NMe2)2 is not a precatalyst for 
hydroamination/cyclization of aminoalkenes. Diphenyl-aminopentene (8a) or diphenyl-
aminohexene (15a) is not cyclized by 10 mol% of {S-7}Zr(NMe2)2 in benzene at room 
temperature over 4 days and even after heating at 140 °C for 2 days. The inactivity of {S-
7}Zr(NMe2)2 in hydroamination/cyclization contrasts to the high activity of {PhB(C5H4)(Ox4S-
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iPr,Me2)2}Zr(NMe2)2  at room temperature. This comparison study indicates that the coordination 
of two oxazolines is required to activate the precatalyst for hydroamination. 
g. Valencies Required at Metal. To investigate the valency required at metal center of 
{PhB(C5H4)(Ox4S-iPr,Me2)2}Zr(NMe2)2 for hydroamination, the catalytic activity of a similar 
model complex {PhB(C5H4)(Ox4S-iPr,Me2)2}ZrCl(NMe2) [{S-2}ZrCl(NMe2)] is tested in 
hydroamination/cyclization. {S-2}ZrCl(NMe2) has a single readily aminolyzable amido site 
(single available valency). This complex is inert to cyclize both primary and secondary 
aminopentenes. Addition of one equiv of 2,2-diphenylaminopentene (8a) to the benzene solution 
of {S-2}ZrCl(NMe2) provided the complex {PhB(C5H4)(Ox4S-
iPr,Me2)2}ZrCl(NHCH2C(Ph2)CH2CHCH2). However, no cyclization of aminopentene was 
observed at room temperature and even at higher temperature up to 150 °C. In contrast, the 
constrained geometry complex (CGC) (Cp′SiMe2NtBu)Zr(NMe2)Cl, having a single readily 
aminolyzable amido site (single available valency), is a competent catalyst for 
cyclohydroamination.23 (Cp′SiMe2NtBu)Zr(NMe2)Cl cyclizes aminopentene significantly faster 
than (Cp′SiMe2NtBu)Zr(NMe2)2 and  insertive pathway has been proposed. 
 
h. Cyclization of secondary aminopentene in presence of primary amine. Secondary 
aminopentene is not cyclized in presence of 10 mol % of zirconium precatalyst {S-2}Zr(NMe2)2 
in toluene. Addition of 1.0, 2.0 of N-methyl-2,2-diphenyl-4-penten-1-amine to the toluene 
solution of S-2}Zr(NMe2)2 form the corresponding mono- or bis amido complexes. No formation 
of pyrrolidine was observed at room temperature and even upon heating at 90, 120 or 160 °C for 
2 days. However, addition of two equiv of noncyclizable primary amine such as amylamine or 
propylamine with respect to the precatalyst leads to cyclization of N-methyl-2,2-diphenyl-4-
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penten-1-amine at room temperature with 24% conversion. The conversion is not improved even 
after addition of variable of amounts of amine additives or performing the reaction at high 
temperature. 
 
Mechanism and Catalytic Cycle 
The first order rate dependences on both the substrate and catalyst are observed for the 
cyclization of C-(1-allyl-cyclohexyl)-methylamine (12a) using precatalyst {S-2}Zr(NMe2)2. The 
primary kinetic isotope effect suggests that the cleavage of N−H or N−D bond is involved in the 
turnover-limiting step. The significant isotopic perturbation on enantioselectivity suggests that 
N−H/N−D bond cleavage also significantly affects the configuration of the new stereocenter; i.e. 
the C−N bond formation occurs in the turnover-limiting step. 
The substrate saturation on initial rates (Figure 2.7) indicates reversible substrate-catalyst 
association followed by turnover-limiting step in the catalytic cycle. The nonzero x-intercept in 
the initial rate plots that coincides with concentration of the catalyst also indicates that 1.0 equiv 
of substrate is required to activate the precatalyst.  
Importantly, the zirconium center of the active catalyst requires two active valencies for 
cyclization of aminoalkenes as {S-2}ZrCl(NMe2) is inert in cyclization of primary and secondary 
aminopentenes. This experiment suggests that the active catalyst contains two amidoalkene 
moieties. Additionally, the cyclization of secondary aminopentene by {S-2}Zr(NMe2)2 in 
presence of catalytic amount of noncyclizable primary amine suggests the necessity of NH-
proton for C−N bond formation. 
The positive effect of N-deuteration on the enantiomeric excess of the product and the 
cyclization of secondary aminopentene in presence of primary amine additive rule out the 
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[2π+2π] cycloaddition of a Zr-imidoalkene species in the catalytic cycle because the metal-imido 
moiety is lack of NH (or ND). 
Additionally, our accumulated data including the kinetic isotope effect, the kinetic 
isotope effect for the two enantiotopic pathways, the requirement that substrate/precatalyst 
should be >2 for catalytic turnover, the cyclization of secondary aminopentene in presence of 
primary amine additive, and the inactivity of {S-2}ZrCl(NMe2) in cyclization disfavor insertion-
based mechanism, rather suggest a proton-assisted noninsertive pathway for C−N bond 
formation.  
To investigate the nature of the turnover-limiting step, the temperature dependence of the 
cyclization rate of C-(1-allyl-cyclohexyl)-methylamine (12a) was measures using both the 
second order rate constant kobs, as well as the actual rate constant k2 obtained from saturation 
kinetics at different temperature. The values of activation parameters using kobs were ∆H‡ = 
11.01 kcal·mol-1 and ∆S‡ = −18.3 cal·mol-1K-1, calculated from Eyring plot ln(kobs/T) vs. 1/T 
(Figure 2.6). These values of activation parameters were significantly different compared to 
those obtained from the plots (lnk2/T vs. 1/T) i.e. ∆H‡ = 6.7 kcal·mol-1 and ∆H‡= −43 cal·mol-1K-
1 (Figure 2.9). The marked differences of ∆H‡ and ∆S‡ values for the two Eyring plots suggest 
that the Eyring analysis of multiple steps in catalytic cycles can be greatly affected by 
equilibrium steps in the mechanism. Nevertheless, the large and negative ∆S‡ value suggests a 
highly ordered transition state. 
C−N bond formation establishes the configuration of the new stereocenter, whereas the 
new C−H bond is not attached to the stereogenic carbon. However, the stereochemical 
relationship between the N−H and the C−N bond suggests that C−N and C−H bond formation 
and N−H bond cleavage occur in a concerted fashion during the cyclization step. Given that an 
 N−H bond is broken during the turnover
NHR ligands, we propose a six-center transition state in which 
the terminal methylene of the other amidoalkene is concerted with intraligand C
formation. The two participating ligands are proposed to be two amido groups because only two 
reactive valent sites are available, kinetic
in the turnover limiting step, and the addition of a third substrate, presumably as a coordinated 
amine, inhibits the cyclization. 
intercept of the initial rate plot that is coincide with [substrate] (
least one equiv. of substrate is necessary to activate the precatalyst.
also consistent with the fact that secondary aminoalkenes ar
amine is present to form an amido that can transfer a proton.
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-limiting step and the catalytic intermediate contains two 
N−H transfer from one amide to 
s indicate that two substrates interact with the catalyst 
This proposal is related to the observation that the nonzero
Figure 2.7), which indicate at 
 Finally, this mechanism is 
e not cyclized, unless a primary 
 
−N bond 
-x 
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Figure 2.10. Proposed new catalytic cycle for hydroamination of aminoalkenes as catalyzed 
by {S-2}Zr(NMe2)2. 
 
Conclusions 
Cyclopentadienyl-bis(oxazolinyl)borate supported zirconium and hafnium diamide 
precatalysts are highly active and enantioselective precatalysts for hydroamination/cyclization of 
aminoolefins. The catalytic activity was observed at room temperature or even at −30 °C. The 
precatalysts provide nitrogen heterocycles with very high enantiomeric excesses up to 99%. 
Enantioselectivities are high with varying substituents of aminopentenes and also in the presence 
of oxo- and halogen-functional groups. The reaction rate was first order dependence on both 
substrate and precatalyst. Substrate saturation on initial rate was detected. The activation 
parameters of saturation kinetics are not the same as overall catalytic activation parameters. 
Therefore, the activation parameters of catalytic cycles can disguise individual steps and can be 
uninformative. A non-insertive mechanism involving concerted C−N/C−H bond formation was 
proposed based on the kinetics, primary isotope effects, isotopic perturbation of 
enantioselectivity, and the investigation of intermediates. The inactivity of cyclopentadienyl-
mono(oxazolinyl)borate zirconium complex in hydroamination/cyclization suggests that the 
coordination of two oxazolines is required to activate the cyclopentadienyl-bis(oxazolinyl)borato 
zirconium precatalyst.  
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Experiment 
General Procedures. All reactions were performed under a dry argon atmosphere using 
standard Schlenk techniques or under a nitrogen atmosphere in a glove box unless otherwise 
indicated. Dry, oxygen-free solvents were used throughout. Benzene, toluene, pentane and 
tetrahydrofuran were degassed by sparging with nitrogen, filtered through activated alumina 
columns, and stored under N2. Benzene-d6, toluene-d8 and tetrahydrofuran-d8 were vacuum 
transferred from Na/K alloy and stored under N2 in a glove box. sodium cyclopentadienide,45 
diphenylchloroborane,46 Zr(NMe2)4,47 Hf(NMe2)4,48 2,2-diphenyl-4-penten-1-amine (8a),2d C-(1-
allyl-cyclopentyl)-methylamine (9a),4c 2,2-dimethyl-4-penten-1-amine (10a),49 2,2-bis(2-
propenyl)-4-pentenylamine (11a),15a C-(1-allyl-cyclohexyl)-methylamine (12a),4c 4-penten-1-
amine (13a),5d 1-(3-butenyl-cyclohexyl)methylamine (14a),49 2,2-diphenyl-5-hexen-1-amine 
(15a),25a 2-diphenyl-1-amino-6-heptene (16a),21b ortho-allylaniline (18a),50 2-allyl-2-
methylpent-4-enylamine (21a),11a 2,2-diphenyl-1-amino-4-hexene (22a),51 2-phenyl-4-penten-1-
amine (23a),51 and tetrakis(trimethylsilyl)silane52 were prepared by published procedures. All 
aminoalkenes were distilled from CaH2, degassed and stored with freshly activated 4 Å 
molecular sieves in a glove box prior to use. All other chemicals used here are commercially 
available. (+)-(S)-α-methoxy-α-(trifluoromethyl)phenylacetyl chloride (S-Mosher’s chloride) was 
obtained from Alfa-Aesar (>98%, (+)-137.3). Ti(NMe2)4 and all other starting materials were 
purchased from Aldrich. 1H, 13C{1H}, 11B, and 19F{1H} NMR spectra were collected either on a 
Bruker DRX-400 spectrometer, Bruker Avance III 700 spectrometer or an Agilent MR 400 
spectrometer. 15N chemical shifts were determined by 1H-15N HMBC experiments either on a 
Bruker Avance III 700 spectrometer or on a Bruker Avance III 600 spectrometer. 15N chemical 
shifts were originally referenced to liquid NH3 and recalculated to the CH3NO2 chemical shift 
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scale by adding −381.9 ppm. 11B NMR spectra were referenced to an external sample of 
BF3·Et2O. Accurate mass ESI mass spectrometry was performed using an Agilent QTOF 6530 
equipped with the Jet Stream ESI source. An Agilent ESI test mix was used for tuning and 
calibration. Accurate mass data was obtained in the positive ion mode using a reference standard 
with ions at 121.05087 and 922.00979. The mass resolution (FWHM) was maintained at 18,000. 
Elemental analysis was performed using a Perkin-Elmer 2400 Series II CHN/S by the Iowa State 
Chemical Instrumentation Facility. [α]D values were measured on a ATAGO AP-300 polarimeter 
at 23 °C. 
 
[PhB(OxMe2)2]. A 100 mL Schlenk flask was charged with 4,4-dimethyl-2-oxazoline (1.0 mL, 
9.48 mmol), which was then degassed by three freeze-pump-thaw cycles. The degassed 
oxazoline was dissolved in 50 mL of tetrahydrofuran and the flask was cooled to −78 ºC. Using a 
syringe, nBuLi (4.0 mL, 10.0 mmol) was added to the cold solution and the resultant solution 
was stirred for 45 min at −78 ºC. Dichlorophenylborane (0.619 mL, 4.72 mmol) was added drop 
wise via syringe into the flask and the solution was stirred for 1 h at −78 ºC. Then, the solution 
was allowed to gradually warm to room temperature. After stirring for 14 h at room temperature, 
the solvent was removed under reduced pressure to afford a light yellow solid. The resultant 
solid was extracted with benzene and pump off the solvent in vacuo to yield PhB(OxMe2)2 as a 
yellow solid (1.27 g, 4.47 mmol, 94.3%). 1H NMR  (acetonitrile-d3, 400 MHz): δ 7.42 (d, 3JHH = 
7.2 Hz, 2 H, ortho-C6H5), 7.13 (m, 2 H, meta-C6H5), 7.05 (m, 1 H,  para-C6H5), 3.64 (d, 2 H, 
2JHH = 8.0 Hz, ), 3.57 (d, 2 H, 2JHH = 8.0 Hz,
 
), 1.26 (s, 6 H, 
), 1.17 (s, 6 H, ). 13C{1H} NMR (acetonitrile-d3, 150 MHz): δ 
CNCMe2CH2O CNCMe2CH2O
CNCMe2CH2O CNCMe2CH2O
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183.00 (br, ), 132.86 (ortho-C6H5), 127.58 (meta-C6H5), 125.99 (para-C6H5), 
77.79 ( ), 67.44 ( ), 28.71 ( ). 11B NMR 
(acetonitrile-d3, 128 MHz): δ −8.1. 15N{1H} NMR (acetonitrile-d3, 71 MHz): δ −147.0 (
). IR (KBr, cm-1): 3069 w, 3046 w, 2964 s, 2930 s, 2872 m, 1621 s, 1601 s, 1462 
s, 1432 s, 1384 m, 1346 w, 1260 s, 1194 s, 1126 m, 1083 w, 993 s, 970 s, 886 m, 703 s. Calcd 
for C16H21BN2O2: C, 67.63; H, 7.45, N, 9.86. Found: C, 64.69; H, 7.51; N, 8.26. Mp: 133-137  
°C. 
H[PhB(C5H5)(OxMe2)2]. A Schlenk flask was charged with PhB(OxMe2)2 (3.00 g, 10.5 mmol) 
and  Na[C5H5] (0.581 g, 6.59 mmol) in the glove box. The flask was attached to a Schlenk 
manifold, and THF (150 mL) was added via cannula addition to form a yellow solution. The 
flask was sealed and the resulting solution was stirred overnight. The solution was filtered to 
remove a precipitate that appeared overnight, and then the solvent was removed under reduced 
pressure to afford a brownish yellow solid. This crude product was purified by silica gel column 
chromatography (Hexane:EtOAc:Et3N = 12:7:1; Rf = 0.50) to afford 3.13 g of 
H[PhB(C5H5)(OxMe2)2] (4.95 mmol, 47.1%) as a mixture of three isomers. The light yellow solid 
was dissolved in benzene and stirred over P2O5 to dry without any reduction in yield. 1H NMR 
(acetonitrile-d3, 400 MHz): δ 7.14-7.04 (m, 5 H, C6H5), 6.61-6.16 (m, 3 H, C5H5-sp2), 4.09-4.00 
(m, 4 H, ), 2.90-2.88 (m, 2 H, C5H5-sp3), 1.35-1.34 (m, 12 H, ). 
13C{1H} NMR (acetonitrile-d3, 150 MHz): δ 190.50 ( ), 158.8 (br, ipso-C5H5) 
141.90 (C5H5-sp2), 140.85 (C5H5-sp2), 134.96 (C5H5-sp2), 134.74 (C5H5-sp2), 134.65 (ortho-
C6H5), 134.37 (C5H5-sp2), 134.30 (C5H5-sp2), 131.81 (C5H5-sp2), 129.71 (C5H5-sp2), 128.51 
(C5H5-sp2), 128.34 (meta-C6H5), 126.48 (C5H5-sp2), 126.24 (para-C6H5), 81.31 (
CNCMe2CH2O
CNCMe2CH2O CNCMe2CH2O CNCMe2CH2O
CNCMe2CH2O
CNCMe2CH2O CNCMe2CH2O
CNCMe2CH2O
70 
 
), 64.71 ( ), 64.68 ( ), 47.45 (C5H5-sp3), 43.48 
(C5H5-sp3), 28.47 ( ), 28.35 ( ). 11B NMR (acetonitrile-d3, 128 
MHz): δ −15.27, −15.63, −15.99. 15N{1H} NMR (benzene-d6, 71 MHz): δ −172 (
). IR (KBr, cm-1): 3080 w, 3056 w, 3028 w, 2969 m, 2929 w, 2887 w, 1589 s 
(C=N), 1461 s, 1429 s, 1416 s, 1383 m,  1365 m, 1345 w, 1318 s, 1265 m, 1195 s, 1138 w, 1090 
w, 1064 w, 1022 w, 965 s, 934 s, 891 s. Anal. Calcd for C21H27BO2N2: C, 72.01; H, 7.77; N, 
8.00.  Found: C, 71.99; H, 7.99; N, 7.84. mp 152-154 °C. 
 
{PhB(C5H4)(OxMe2)2}Zr(NMe2)2. In the glove box, H[PhB(C5H5)(OxMe2)2] (0.250 g, 0.714 
mmol) and Zr(NMe2)4 (0.193 g, 0.721 mmol) were placed in a 100 mL Schlenk round bottom 
flask. The solids were dissolved in benzene (50 mL), and the solution was stirred for 2 h. All 
volatile materials were removed under reduced pressure to afford a light yellow oil, which was 
washed with pentane to obtain a light yellow powder of  {PhB(C5H4)(OxMe2)2}Zr(NMe2)2 (0.367 
g, 0.696  mmol, 97.6%). 1H NMR  (benzene-d6, 400 MHz): δ 8.21 (d, 3JHH= 7 Hz, 2 H, ortho-
C6H5), 7.52 (t, 3JHH = 7 Hz, 2 H, meta-C6H5), 7.32 (t, 3JHH = 7 Hz, 1 H,  para-C6H5), 6.52 (m, 2 
H, C5H4), 6.15 (m, 2 H, C5H4), 3.64 (d, 2 H, 2JHH = 8.0 Hz, ), 3.56 (d, 2 H, 2JHH 
= 8.0 Hz, ),  2.69  (s, 12 H, NMe2), 1.11 (s, 6 H, ), 1.01 (s, 6 H, 
). 13C{1H} NMR (benzene-d6, 100 MHz): δ 194.65  ( ), 151.5 
(br, ipso-C6H5), 143.01 (ipso-C5H4), 135.11 (ortho-C6H5), 127.67 (meta-C6H5), 125.47 (para-
C6H5), 122.61(C5H4), 113.66 (C5H4), 78.91 ( ),  67.16 ( ), 43.94 
(NMe2), 28.91 ( ), 28.50 ( ). 15N{1H} NMR (benzene-d6, 71 
MHz): δ −135.4 ( ); Zr(NMe2)2 was not detected. 11B NMR (benzene-d6, 128 
CNCMe2CH2O CNCMe2CH2O CNCMe2CH2O
CNCMe2CH2O CNCMe2CH2O
CNCMe2CH2O
CNCMe2CH2O
CNCMe2CH2O CNCMe2CH2O
CNCMe2CH2O CNCMe2CH2O
CNCMe2CH2O CNCMe2CH2O
CNCMe2CH2O CNCMe2CH2O
CNCMe2CH2O
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MHz): δ −14.51. IR (KBr, cm-1): 3064 w, 3040 w, 2962 s, 2927 s, 2863 s, 2819 s, 2771 s, 1595 s 
(C=N), 1491 s, 1461 s, 1444 w, 1429 m, 1369 m, 1360 m, 1283 s, 1249 s, 1195 s, 1165 s, 1139 s, 
1118 s, 1050 s, 1037 w, 989 w, 963 s, 942 s, 927 s, 886 w, 871 w, 837 m, 815 m, 796 m, 783 w, 
732 s, 705 s, 688 s. Anal. Calcd for C25H37BK2O2N4: C, 56.91; H, 7.07; N, 10.62. Found: C, 
57.26; H, 6.99; N, 9.87. m.p. 107-110 °C, dec. 
 
{PhB(C5H4)(OxMe2)2}Hf(NMe2)2. A procedure analogous to that described for 
{PhBC5H4(OxMe2)2}Zr(NMe2)2, using H[PhB(C5H5)(OxMe2)2] (0.250 g, 0.714 mmol) and 
Hf(NMe2)4 (0.256 g, 0.721 mmol), provides {PhB(C5H4)(OxMe2)2}Hf(NMe2)2 as a light orange 
solid. Yield: 0.430 g (0.699 mmol, 97.9 %). 1H NMR  (benzene-d6, 400 MHz): δ 8.21 (d, 3JHH = 
7 Hz, 2 H, ortho-C6H5), 7.52 (t, 3JHH = 7 Hz, 2 H, meta-C6H5), 7.32 (t, 3JHH = 7 Hz, 1 H, para-
C6H5), 6.46 (m, 2 H, C5H4), 6.12 (m, 2 H, C5H4), 3.65 (d, 2 H, 2JHH= 8.0 Hz, ), 
3.57 (d, 2 H, 2JHH = 8.0 Hz, ), 2.74 (s, 12 H, NMe2), 1.12 (s, 6 H, 
), 1.00 (s, 6 H, ). 13C{1H} NMR (benzene-d6, 400 MHz): δ 
198.36 ( ), 150.75 (ipso-C6H5), 140.61 (ipso-C5H4), 134.79 (ortho-C6H5), 127.46 
(meta-C6H5), 125.22 (para-C6H5), 120.88 (C5H4), 112.49 (C5H4), 78.91 ( ), 67.07 
( ), 43.77(s, NMe2), 28.51 ( ), 27.90 ( ). 15N{1H} 
NMR (benzene-d6, 71 MHz): δ −132.3 ( ). 11B NMR (benzene-d6, 128 MHz): δ 
−14.6. IR (KBr, cm-1): 3064 w, 3042 w, 3012 w, 2962 s, 2928 m, 2868 s, 2853 s, 2821 s, 2773 s, 
1595 m (C=N), 1549 w, 1483 s, 1462 s, 1446 m, 1429 m, 1370 m, 1361 m, 1287 s, 1251 s, 1203 
s, 1195 s, 1183 s, 1166 m, 1138 m, 1051 m, 1037 w, 963 s, 936 s, 908 w. Anal. Calcd for 
CNCMe2CH2O
CNCMe2CH2O
CNCMe2CH2O CNCMe2CH2O
CNCMe2CH2O
CNCMe2CH2O
CNCMe2CH2O CNCMe2CH2O CNCMe2CH2O
CNCMe2CH2O
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C25H37BO2N4Hf(C6H6)0.5: C, 51.43; H, 6.17; N, 8.57. Found: C, 51.17; H, 6.20; N, 8.40. Mp: 90-
95 °C, dec. 
 
{PhB(C5H4)(OxMe2)2}Zr(NMe2)2THF. Slow diffusion of pentane into a THF solution of 2 at 
−30 °C provided analytically pure, X-ray quality crystals of {PhB(η5-
C5H4)(OxMe2)2}Zr(NMe2)2THF. The room temperature NMR spectroscopic data for 4 is identical 
to that of the THF-free species in addition to resonances due to uncoordinated THF. The 
structural difference is observed in the IR and in the analytical data. IR (KBr, cm-1): 3063 w, 
3042 m, 2995 m, 2966 s, 2930s, 2862 s, 2819 s, 2768 s, 1610 s (CN), 1533 s (CN), 1488 m, 1461 
m, 1429 m, 1367 w, 1356 w, 1281 s, 1243 s, 1196 s, 1180 s, 1149 m, 1135 m, 1059 s, 1048 s, 
1035 m, 1021 m, 991 s, 964 s, 950 s, 937 s, 873 s, 863 s, 817 s, 799 s, 774 w, 732 s, 704 s. Anal. 
Calcd for C29H45BO3N4Zr: C, 58.08; H, 7.56; N, 9.34. Found: C, 57.88; H, 7.51; N, 9.10. 
 
L-Valine methyl ester hydrochloride.52 Thionyl chloride (47.6 mL, 0.65 mol, 1.10 equiv) was 
added drop wise over 2 h to methanol (300 mL) in a three-necked flask cooled in ice-salt bath 
and connected to an oil bubbler.  L-Valine (70.0 g, 0.600 mol) was added in one portion to the 
solution, and the mixture was heated at 55 °C to dissolve all of the solids. The solution was then 
heated for 1 h. The solvent and excess reagents were removed by distillation. The resulting white 
solid was dried in vacuo for several hours and then dissolved in minimal amount of methanol (90 
mL). The methanol solution was poured into Et2O (900 mL), and then recrystallized at −30 °C. 
The solid was collected, washed with cold Et2O, and dried in vacuo to give the L-Valine methyl 
ester hydrochloride as white solid (90.7 g, 90.5%). The 1H NMR spectrum (given below) 
matches the literature values.52 1H NMR (300 MHz, chloroform-d): δ 8.91 (br, 3 H, 
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HCl⋅NH2CH(CHMe2)CO2Me), 3.93 (d, 3JHH = 4.5 Hz, 1 H, HCl⋅NH2CH(CHMe2)CO2Me), 3.84 
(s, 3 H, HCl⋅NH2CH(CHMe2)CO2Me), 2.47 (m, 1 H, HCl⋅NH2CH(CHMe2)CO2Me), 1.16 (vt, 6 
H, HCl⋅NH2CH(CHMe2)CO2Me). 
 
2S-Amino-1,1,3-trimethylbutanol. A solution of methylmagnesium bromide (180 mL, 3.0 M in 
Et2O, 0.540 mol, 6.0 equiv) was diluted with Et2O (500 mL). L-Valine methyl ester 
hydrochloride (15.0 g, 0.0896 mol) was added in portions over 1 h. The mixture was allowed to 
stir at room temperature overnight. Saturated aqueous [NH4][Cl] was added in a drop wise 
fashion to quench the reaction. The white solid was separated from the diethyl ether solution, and 
the organic solution was dried over Na2SO4. The solid was dissolved in 300 mL saturated 
[NH4][Cl] aqueous solution, and another 300 mL of distilled water was added. This aqueous 
solution was extracted with Et2O (4 × 200 mL). The organic extracts were combined and dried 
over Na2SO4. The two organic solutions were filtered, combined, and evaporated under reduced 
pressure. The crude product was distilled (96 °C, 40 mm Hg) to afford 2S-Amino-1,1,3-
trimethylbutanol as a clear, colorless oil (4.96 g, 42.3%) that is spectroscopically identical to the 
literature.53 1H NMR (300 MHz, chloroform-d): δ 2.41 (d, 3JHH = 2.7 Hz, 1 H, 
NH2CH(CHMe2)CMe2OH), 1.93 (m, 1 H, NH2CH(CHMe2)CMe2OH), 1.20 (s, 3 H, 
NH2CH(CHMe2)CMe2OH), 1.12 (s, 3 H, NH2CH(CHMe2)CMe2OH), 0.97 (d, 3JHH = 7.2 Hz, 3 
H, NH2CH(CHMe2)CMe2OH), 0.88 (d, 3JHH = 6.6 Hz, 3 H, NH2CH(CHMe2)CMe2OH). 
 
O
OMe
NH3Cl
6 MeMgBr
OH
NH2
Me2NCH(OMe)2
cat. p-tolylsulfonic acid O
N
H
2H-OxiPr,Me2
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4S-Isopropyl-5,5-dimethyl-2-oxazoline. A modification of Meyers' procedure for 2-H 
oxazoline synthesis using 2S-Amino-1,1,3-trimethylbutanol was implemented.54 DMF-DMA 
(13.7 mL, 103.3 mmol, 1.2 equiv) was added to degassed 2S-amino-1,1,3-trimethylbutanol (11.1 
g, 84.7 mmol). This mixture was allowed to reflux at 75 °C for 7 h. The volatiles were removed 
under reduced pressure, and the mixture was triturated with hexane (4 × 30 mL). Then p-
toluenesulfonic acid monohydrate (26.5 mg, 0.14 mmol, 0.0017 equiv) and hexane (40 mL) were 
added, and an addition funnel with approximately 40 mL of molecular sieves inside was placed 
on top of the flask, and a condenser was placed on top of the funnel. The solution was heated at 
90 °C at reflux for 24 h and the condensed liquids washed over the sieves as the reaction 
proceeded. The reaction mixture was washed with saturated aqueous NaHCO3 solution (30 mL) 
and then with brine (50 mL). The aqueous solutions were combined, back-extracted with Et2O 
(25 mL × 6), and then the organic extracts were combined with the organic solution and dried 
over Na2SO4 overnight and filtered. Concentration of the filtrate gave a dark red oil which was 
distilled to provide 8.11 g (57.4 mmol, 68%) of 4S-isopropyl-5,5-dimethyl-2-oxazoline as a 
clear, colorless oil. Bp: 85 °C, 18 mm Hg. 1H NMR (300 MHz, chloroform-d): δ 6.74 (s, 1 H, 
CHNC(CHMe2)HCMe2O), 3.23 (d, 3JHH = 8.4 Hz, 1 H, CHNC(CHMe2)HCMe2O), 1.80 (m, 1 H, 
CHNC(CHMe2)HCMe2O), 1.45 (s, 3 H, CHNC(CHMe2)HCMe2O), 1.29 (s, 3 H, 
CHNC(CHMe2)HCMe2O), 1.08 (d, 3JHH = 6.6 Hz, 3 H, CHNC(CHMe2)HCMe2O), 0.98 (d, 3JHH 
= 6.6 Hz, 3 H, CHNC(CHMe2)HCMe2O). 13C{1H} NMR (benzene-d6, 150 MHz): δ 152.74 
(CHNC(CHMe2)HCMe2O), 85.17 (CNC(CHMe2)HCMe2O), 80.07 (CNC(CHMe2)HCMe2O), 
29.56 (CNC(CHMe2)HCMe2O), 29.48 (CNC(CHMe2)HCMe2O), 21.53, 21.48, 21.20 
(CNC(CHMe2)HCMe2O, CNC(CHMe2)HCMe2O). 15N{1H} NMR (benzene-d6, 71 MHz): δ 
−143.3. IR (KBr, cm-1): 3069 w, 2973 s, 2874 m, 1686 w, 1632 s (CN), 1471 m, 1462 m, 1386 
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m, 1372 m, 1336 w, 1304 w, 1272 w, 1243 w, 1202 w, 1172 m, 1134 m, 1114 m, 1082 s, 1015 
m, 934 m, 894 m, 856 w, 813 w, 769 w. [α]D20 = −35.2 (C6H6). 
 
PhB(Ox4S-iPr,Me2)2. A 100 mL Schlenk flask was charged with 4S-isopropyl-5,5-dimethyl-2-
oxazoline (0.500 g, 3.54 mmol) and tetrahydrofuran (50 mL), and the flask was cooled to -78 ºC. 
Using a syringe, 2.50 M nBuLi (1.50 mL, 3.75 mmol) was added, and the solution was stirred for 
1 h at −78 ºC. Dichlorophenylborane (0.23 mL, 1.75 mmol) was slowly added, and the solution 
was stirred for 1 h at -78 ºC and then allowed to gradually warm to ambient temperature. After 
stirring for 14 h at room temperature, the solvent was removed under reduced pressure to afford 
a light yellow solid. The solid was extracted with benzene, and the solvent was evaporated to 
yield [PhB(Ox4S-iPr,Me2)2] as a light yellow, impure solid (0.60 g, 1.63 mmol) that appears to 
contain variable quantities of LiCl. This mixture is sufficiently pure, however, for further 
synthetic work and was used as obtained from the benzene extraction. 1H NMR (tetrahydrofuran-
d8, 400 MHz): δ 7.45 (d, 3JHH = 7.6 Hz, 2 H, ortho-C6H5), 6.97 (m, 2 H, meta-C6H5), 6.87 (m, 1 
H,  para-C6H5), 3.22 (d, 3JHH = 4.8 Hz, 2 H, CNCiPrHCMe2O), 3.20 (d, 3JHH = 4.8 Hz, 1 H, 
CNCiPrHCMe2O), 1.79 (m, 1 H, CNC(CHMe2)HCMe2O), 1.23-0.85 (24 H, 
CNC(CHMe2)HCMe2O). 13C{1H} NMR (tetrahydrofuran-d8, 150 MHz): δ 185.47 (br, 
CNCiPrHCMe2O), 150.50 (br, ipso-C6H5), 133.42 (ortho-C6H5), 126.37 (meta-C6H5), 124.69 
(para-C6H5), 82.66 (CNCiPrHCMe2O), 82.61 (CNCiPrHCMe2O), 79.81 (CNCiPrHCMe2O), 
79.45 (CNCiPrHCMe2O), 30.38, 30.09, 30.07, 29.92, 22.11 br, 21.58, 21.50 (overlapping 
CNC(CHMe2)HCMe2O, CNCiPrHCMe2O, and CNC(CHMe2)HCMe2O). 11B NMR (THF-d8, 
128 MHz): δ −7.5. IR (KBr, cm-1): 3070 w, 3046 w, 2963 s, 2932 s, 2872 m, 1588 s (CN), 1466 
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m, 1432 m, 1386 m, 1371 s, 1277 w, 1242 s, 1193 m, 1176 m, 1146 s, 1120 m, 1096 m, 1023 s, 
993 m, 943 m, 879 m, 849 m, 802 m, 762 w, 741 w, 726 w. Mp: 101-106 °C. 
 
H[PhB(C5H5)(Ox4S-iPr,Me2)2]. A Schlenk flask was charged with [PhB(Ox4S-iPr,Me2)2] (0.580 g, 
1.57 mmol) and  [NaC5H5] (0.082 g, 0.931 mmol). Addition of THF (60 mL) provided a yellow 
solution that was stirred overnight. A precipitate formed after 12 h, and the solution was filtered. 
Solvent was removed under reduced pressure to afford a light yellow solid. This crude product 
was purified by silica gel column chromatography (hexane:EtOAc:Et3N = 9:1:1; Rf = 0.58) to 
afford an off-white solid of H[PhB(C5H5)(Ox4S-iPr,Me2)2] as a mixture of isomers. The product was 
dissolved in benzene and stirred over P2O5 to remove residual water, giving 0.210 g of 
H[PhB(C5H5)(Ox4S-iPr,Me2)2] (0.482 mmol, 51.8%). 1H NMR (acetonitrile-d3, 400 MHz): δ 7.71-
7.0 (m, 5 H, C6H5), 6.67-6.18 (m, 3 H, C5H5), 3.39-3.25 (m, 2 H, CNCiPrHCMe2O), 2.89-2.88 
(m, 2 H, C5H5), 1.89-1.78 (m, 2 H, CNC(CHMe2)HCMe2O), 1.47-0.94 (24 H, 
CNC(CHMe2)HCMe2O). 13C{1H} NMR (acetonitrile-d3, 150 MHz): δ 133.48 (ortho-C6H5), 
129.06 (meta-C6H5), 128.22 (para-C6H5), 141.17 (C5H5; 10 sp2 resonances for 3 isomers 
observed), 140.99 (C5H5), 135.25 (C5H5), 134.76 (C5H5), 134.20 (C5H5), 133.91 (C5H5), 133.83 
(C5H5), 131.28 (C5H5), 128.90 (C5H5), 128.37 (C5H5),  94.11 (CNCiPrHCMe2O), 66.67 
(CNCiPrHCMe2O), 47.52 (C5H5-sp3), 43.18 (C5H5-sp3), 30.24 (CNC(CHMe2)HCMe2O), 29.26 
(CNC(CHMe2)HCMe2O), 29.92, 29.68, 22.09, 22.04, 21.81, 21.77, 21.38, 21.26 
(CNC(CHMe2)HCMe2O). 11B NMR (acetonitrile-d3, 128 MHz): δ −15.7 (overlapping 
resonances). IR (KBr, cm-1): 3084 w, 3066 w, 3025 w, 2971 s, 2927 m, 2870 m, 1584 s (CN), 
1567 s (CN), 1486 w, 1466 m, 1432 w, 1403 s, 1396 s, 1376 m, 1370 m, 1356 w, 1347 w, 1330 
w, 1302 w, 1244w, 1225 w, 1212 m, 1177 w, 1146 m, 1096 w, 1068 w, 1027 m, 999 w, 993 w, 
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956 m, 942 m, 890 m, 852 w, 813 w. Anal. Calcd for C27H39BN2O2: C, 74.65; H, 9.05; N, 6.45.  
Found: C, 74.29; H, 9.28; N, 6.74. Mp: 78-83 °C. [α]D20 = -62.9 (C6H6). 
  
{PhB(C5H4)(Ox4S-iPr,Me2)2}Zr(NMe2)2. A Schlenk flask was charged with H[PhB(C5H5)(Ox4S-
iPr,Me2)2] (0.100 g, 0.230 mmol) and [Zr(NMe2)4] (0.061 g, 0.228 mmol). The solids were 
dissolved in benzene (15 mL), and the resulting solution was stirred for 8 h. After filtration, the 
volatile materials were evaporated to give a light yellow gel which was triturated with pentane 
affording {PhB(C5H4)(Ox4S-iPr,Me2)2}Zr(NMe2)2 as an off-white analytically pure solid (0.135 g, 
0.221 mmol, 96.0%). 1H NMR  (benzene-d6, 400 MHz): δ 8.09 (d, 3JHH = 7.2 Hz, 2 H, ortho-
C6H5), 7.50 (m, 2 H, meta-C6H5), 7.29 (m, 1 H,  para-C6H5), 6.76 (m, 1 H, C5H4), 6.59 (m, 1 H, 
C5H4), 6.25 (m, 1 H, C5H4), 6.06 (m, 1 H, C5H4), 3.24 (d, 2 H, 3JHH = 5.6 Hz, CNCiPrHCMe2O), 
3.20 (d, 2 H, 3JHH = 5.6 Hz, CNCiPrHCMe2O),  2.80  (s, 6 H, NMe2), 2.68  (s, 6 H, NMe2), 1.73 
(m, 2 H, CNC(CHMe2)HCMe2O), 1.34 (s, 3 H, CNCiPrHCMe2O), 1.24 (s, 3 H, 
CNCiPrHCMe2O), 1.18 (s, 3 H, CNCiPrHCMe2O), 1.14 (s, 3 H, CNCiPrHCMe2O), 1.12 (d, 3JHH 
= 6.8 Hz, 3 H, CNC(CHMe2)HCMe2O), 1.09 (d, 3JHH =  6.8 Hz, 3 H, CNC(CHMe2)HCMe2O), 
0.97 (d, 3JHH = 6.8 Hz, 3 H, CNC(CHMe2)HCMe2O), 0.89 (d, 3JHH = 6.8 Hz, 3 H, 
CNC(CHMe2)HCMe2O). 13C{1H} NMR (benzene-d6, 150 MHz): δ 197.01 (br, CNCiPrHCH2O), 
194.29 (br, CNCiPrHCH2O), 151.50 (br, ipso-C6H5), 135.10 (ortho-C6H5), 127.51 (meta-C6H5), 
125.26 (para-C6H5), 123.47 (C5H4), 122.83 (C5H4), 113.93 (C5H4), 113.64 (C5H4), 85.08 
(CNCiPrHCMe2O), 84.84 (CNCiPrHCMe2O), 79.05 (CNCiPrHCMe2O), 78.89 
(CNCiPrHCMe2O), 44.51 (NMe2), 42.95 (NMe2), 30.44 (CNC(CHMe2)HCMe2O), 30.27 
(CNC(CHMe2)HCMe2O),  30.24 (CNCiPrHCMe2O), 30.02 (CNCiPrHCMe2O), 21.96 
(CNCiPrHCMe2O), 21.81 (CNCiPrHCMe2O), 20.70 (CNC(CHMe2)HCMe2O), 20.47 
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(CNC(CHMe2)HCMe2O), 20.37 (CNC(CHMe2)HCMe2O), 20.18 (CNC(CHMe2)HCMe2O). 11B 
NMR (benzene-d6, 128 MHz): δ −14.5. 15N{1H} NMR (benzene-d6, 71 MHz): δ −152.6, −155.0 
(CNCiPrHCMe2O). IR (KBr, cm-1): 3043 w, 3068 w, 2967 s, 2930 s, 2873 s, 2772 w, 1565 m 
(CN), 1489 w, 1467 s, 1431 w, 1388 m, 1369 m, 1260 s, 1194 s, 1142 s, 1093 s, 1054 s, 1023 s, 
947 s, 884 w, 855 w, 804 s, 734 s, 703 s. Anal. Calcd for C31H49BN4O2Zr: C, 60.86; H, 8.07; N, 
9.16. Found: C, 60.63; H, 8.48; N, 9.34. Mp: 68-73 °C, dec. [α]D20 = −124.7 (C6H6). 
 
{PhB(C5H4)(Ox4S-iPr,Me2)2}Hf(NMe2)2. A round bottom Schlenk flask was charged with 
H[PhB(C5H5)(Ox4S-iPr,Me2)2]  (0.125 g, 0.287 mmol) and Hf(NMe2)4 (0.101 g, 0.287 mmol). The 
solids were dissolved in benzene (20 mL), and the resulting solution was stirred for 7-8 h. After 
filtration, the volatile materials were removed in vacuo to give a light yellow gel which was 
triturated with pentane giving {PhB(C5H4)(Ox4S-iPr,Me2)2}Hf(NMe2)2 as a off white solid (0.185 g, 
0.265 mmol, 92.0%). 1H NMR  (benzene-d6, 400 MHz): δ 8.06 (d, 3JHH = 7.2 Hz, 2 H, ortho-
C6H5), 7.46 (m, 2 H, meta-C6H5), 7.26 (m, 1 H,  para-C6H5), 6.64 (m, 1 H, C5H4), 6.55 (m, 1 H, 
C5H4), 6.23 (m, 1 H, C5H4), 6.00 (m, 1 H, C5H4), 3.26 (d, 2 H, 2JHH = 5.6 Hz, CNCiPrHCMe2O), 
3.23 (d, 2 H, 2JHH = 5.6 Hz, CNCiPrHCMe2O),  2.84  (s, 6 H, NMe2), 2.76  (s, 6 H, NMe2), 1.74 
(m, 2 H, CNC(CHMe2)HCMe2O), 1.35 (s, 3 H, CNCiPrHCMe2O), 1.24 (s, 3 H, 
CNCiPrHCMe2O), 1.19 (s, 3 H, CNCiPrHCMe2O), 1.15 (s, 3 H, CNCiPrHCMe2O), 1.11 (d, 3JHH 
= 6.8 Hz, 3 H, CNC(CHMe2)HCMe2O), 1.07 (d, 3JHH =  6.8 Hz, 3 H, CNC(CHMe2)HCMe2O), 
0.99 (d, 3JHH = 6.8 Hz, 3 H, CNC(CHMe2)HCMe2O), 0.89 (d, 3JHH = 6.8 Hz, 3 H, 
CNC(CHMe2)HCMe2O).   13C{1H} NMR (benzene-d6, 100 MHz): δ 151.36 (ipso-C6H5), 135.07 
(ortho-C6H5), 127.52 (meta-C6H5), 125.28 (para-C6H5), 122.43 (C5H4), 121.55 (C5H4), 113.38 
(C5H4), 112.62 (C5H4), 85.31 (CNC(CHMe2)HCMe2O), 79.02 (CNC(CHMe2)HCMe2O), 44.20 
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(NMe2), 42.71 (NMe2), 30.51 (CNC(CHMe2)HCMe2O), 30.38  (CNC(CHMe2)HCMe2O), 30.32 
(CNC(CHMe2)HCMe2O), 30.08 (CNC(CHMe2)HCMe2O), 22.02 (CNC(CHMe2)HCMe2O), 
21.84 (CNC(CHMe2)HCMe2O), 20.42 (CNC(CHMe2)HCMe2O), 20.32 
(CNC(CHMe2)HCMe2O), 20.00 (CNC(CHMe2)HCMe2O). 15N NMR (benzene-d6, 71 MHz): δ 
−148.83, −150.66. 11B NMR (benzene-d6, 128 MHz): δ −14.6. IR (KBr, cm-1): 3071 m, 3044 m, 
2967 s, 2932 s, 2870 s, 2822 s, 2770 s, 1559 s (CN), 1469 s, 1433 m, 1393 m, 1373 m, 1353 w, 
1246 m, 1195 m, 1145 s, 1105 w, 1048 m, 1021 m, 946 s, 882 w, 856 w, 807 s, 769 w, 740 s, 
703 s. Anal. Calcd for C31H49BN4O2Hf: C, 53.26; H, 7.07; N, 8.01. Found: C, 52.78; H, 7.32; N, 
8.04. [α]D = −86.98° (C6H6). Mp: 60-65 °C, dec. 
 
{PhB(C5H4)(Ox4S-iPr,Me2)2}Ti(NMe2)2. A round bottom Schlenk flask was charged with 
H[PhB(C5H5)(Ox4S-iPr,Me2)2]  (0.050 g, 0.115 mmol) and Ti(NMe2)4 (0.026 g, 0.115 mmol). The 
solids were dissolved in benzene (5 mL), and the resulting solution was stirred for 25 h. After 
filtration, the volatile materials were removed in vacuo to give a red gel which was triturated 
with pentane giving {PhB(C5H4)(Ox4S-iPr,Me2)2}Ti(NMe2)2 as a off white solid (0.056 g, 0.099 
mmol, 86.1%). 1H NMR  (benzene-d6, 400 MHz): δ 7.73 (d, 3JHH = 7.2 Hz, 2 H, ortho-C6H5), 
7.39 (m, 2 H, meta-C6H5), 7.21 (m, 1 H,  para-C6H5), 6.88 (m, 2 H, C5H4), 6.70 (m, 1 H, C5H4), 
6.59 (m, 1 H, C5H4), 3.12 (s, 6 H, NMe2), 3.10 (s, 6 H, NMe2), 3.03 (d, 2 H, 2JHH = 5.6 Hz, 
CNCiPrHCMe2O), 2.97 (d, 2 H, 2JHH = 5.6 Hz, CNCiPrHCMe2O), 1.82 (m, 1 H, 
CNC(CHMe2)HCMe2O), 1.70 (m, 1 H, CNC(CHMe2)HCMe2O), 1.23-0.77 (24 H, 
CNC(CHMe2)HCMe2O). 13C{1H} NMR (benzene-d6, 100 MHz): δ 195.50 (br, 
CNCiPrHCMe2O), 152.97 (ipso-C6H5), 135.18 (ortho-C6H5), 134.91 (meta-C6H5), 133.46 (para-
C6H4), 127.41 (C5H4), 125.38 (C5H4), 125.35 (C5H4),  84.79 (CNC(CHMe2)HCMe2O), 84.49 
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(CNC(CHMe2)HCMe2O), 79.28 (CNC(CHMe2)HCMe2O), 78.92 (CNC(CHMe2)HCMe2O), 
44.38 (NMe2), 39.32 (NMe2), 31.51 (CNC(CHMe2)HCMe2O), 31.41 (CNC(CHMe2)HCMe2O), 
30.63 (CNC(CHMe2)HCMe2O), 30.11 (CNC(CHMe2)HCMe2O), 22.23 
(CNC(CHMe2)HCMe2O), 22.19 (CNC(CHMe2)HCMe2O), 21.72 (CNC(CHMe2)HCMe2O), 
20.53 (CNC(CHMe2)HCMe2O), 20.49 (CNC(CHMe2)HCMe2O), 20.29 
(CNC(CHMe2)HCMe2O). 11B NMR (benzene-d6, 128 MHz): δ −14.8. 15N NMR (benzene-d6, 71 
MHz): δ −153.8, −156.1. IR (KBr, cm-1): 3041 w, 2969 s, 2931 m, 2872 m, 2847 m, 2766 m, 
1560 s (CN), 1468 m, 1433 w, 1409 w, 1389 w, 1368 m, 1245 m, 1226 m, 1193 m, 1147 s, 1050 
m, 1020 m, 988 m, 941 s, 894 w, 811 w, 740 w, 703 m, 678 m. Anal. Calcd for C31H49BN4O2Ti: 
C, 65.50; H, 8.69; N, 9.86. Found: C, 59.91; H, 8.84; N, 9.51. [α]D = −94.71° (C6H6). Mp: 89-93 
°C. 
 
4R-isopropyl-5,5-dimethyl-2-oxazoline. 
D-Valine methyl ester hydrochloride. Thionyl chloride (23.8 mL, 0.33 mol, 0.55 equiv) was 
added drop wise over 2 h to methanol (150 mL) in a three-necked flask cooled in ice-salt bath 
and connected to an oil bubbler. D-Valine (35.0 g, 0.300 mol) was added in one portion to the 
solution, and the mixture was heated at 55 °C to dissolve all of the solids. The solution was then 
heated for 1 h. The solvent and excess reagents were removed by distillation. The resulting white 
solid was dried in vacuo for several hours and then dissolved in minimal amount of methanol (45 
mL). The methanol solution was poured into Et2O (500 mL), and then recrystallized at −30 °C. 
The solid was collected, washed with cold Et2O, and dried in vacuo to give the D-Valine methyl 
ester hydrochloride as white solid (45.4 g, 90.5 %). 1H NMR (300 MHz, chloroform-d): δ 8.91 
(br, 3 H, HCl⋅NH2CH(CHMe2)CO2Me), 3.93 (d, 3JHH = 4.5 Hz, 1 H, 
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HCl⋅NH2CH(CHMe2)CO2Me), 3.84 (s, 3 H, HCl⋅NH2CH(CHMe2)CO2Me), 2.47 (m, 1 H, 
HCl⋅NH2CH(CHMe2)CO2Me), 1.16 (vt, 6 H, HCl⋅NH2CH(CHMe2)CO2Me). 
 
2R-Amino-1,1,3-trimethylbutanol. A solution of methylmagnesium bromide (180 mL, 3.0 M in 
Et2O, 0.540 mol, 6.0 equiv) was diluted with Et2O (500 mL). D-Valine methyl ester 
hydrochloride (15.0 g, 0.0896 mol) was added in portions over 1 h. The mixture was allowed to 
stir at room temperature overnight. Saturated aqueous [NH4][Cl] was added in a drop wise 
fashion to quench the reaction. The white solid was separated from the diethyl ether solution, and 
the organic solution was dried over Na2SO4. The solid was dissolved in 300 mL saturated 
[NH4][Cl] aqueous solution, and another 300 mL of distilled water was added. This aqueous 
solution was extracted with Et2O (4 × 200 mL). The organic extracts were combined and dried 
over Na2SO4. The two organic solutions were filtered, combined, and evaporated under reduced 
pressure. The crude product was distilled (96 °C, 40 mm Hg) to afford to afford 2S-Amino-1,1,3-
trimethylbutanol as a clear, colorless oil (4.96 g, 42.3%). 1H NMR (300 MHz, chloroform-d): δ 
2.41 (d, 3JHH = 2.7 Hz, 1 H, NH2CH(CHMe2)CMe2OH), 1.93 (m, 1 H, 
NH2CH(CHMe2)CMe2OH), 1.20 (s, 3 H, NH2CH(CHMe2)CMe2OH), 1.12 (s, 3 H, 
NH2CH(CHMe2)CMe2OH), 0.97 (d, 3JHH = 7.2 Hz, 3 H, NH2CH(CHMe2)CMe2OH), 0.88 (d, 
3JHH = 6.6 Hz, 3 H, NH2CH(CHMe2)CMe2OH). 
 
4R-Isopropyl-5,5-dimethyl-2-oxazoline. DMF-DMA (13.7 mL, 103.3 mmol, 1.2 equiv) was 
added to degassed 2R-amino-1,1,3-trimethylbutanol (11.1 g, 84.7 mmol). This mixture was 
allowed to reflux at 75 °C for 7 h. The volatiles were removed under reduced pressure, and the 
mixture was triturated with hexane (4 × 30 mL). Then p-toluenesulfonic acid monohydrate (26.5 
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mg, 0.14 mmol, 0.0017 equiv) and hexane (40 mL) were added, and an addition funnel with 
approximately 40 mL of molecular sieves inside was placed on top of the flask, and a condenser 
was placed on top of the funnel. The solution was heated at 90 °C at reflux for 24 h and the 
condensed liquids washed over the sieves as the reaction proceeded. The reaction mixture was 
washed with saturated aqueous NaHCO3 solution (30 mL) and then with brine (50 mL). The 
aqueous solutions were combined, back-extracted with Et2O (25 mL × 6), and then the organic 
extracts were combined with the organic solution and dried over Na2SO4 overnight and filtered. 
Concentration of the filtrate gave a dark red oil which was distilled to provide 8.11 g (57.4 
mmol, 68%) of 4R-isopropyl-5,5-dimethyl-2-oxazoline as a clear, colorless oil. Bp: 85 °C, 18 
mm Hg. 1H NMR (400 MHz, chloroform-d): δ 6.73 (d, 3JHH = 6.4 Hz, 1 H, 
CHNC(CHMe2)HCMe2O), 3.23 (dd, 3JHH = 8.4 Hz, 4JHH = 2.0 Hz, 1 H, 
CHNC(CHMe2)HCMe2O), 1.78 (m, 1 H, CHNC(CHMe2)HCMe2O), 1.43 (s, 3 H, 
CHNC(CHMe2)HCMe2O), 1.28 (s, 3 H, CHNC(CHMe2)HCMe2O), 1.06 (d, 3JHH = 6.4 Hz, 3 H, 
CHNC(CHMe2)HCMe2O), 0.97 (d, 3JHH = 6.4 Hz, 3 H, CHNC(CHMe2)HCMe2O). 13C{1H} 
NMR (benzene-d6, 176 MHz): δ 152.72 (CHNC(CHMe2)HCMe2O), 85.17 
(CNC(CHMe2)HCMe2O), 80.07 (CNC(CHMe2)HCMe2O), 29.55 (CNC(CHMe2)HCMe2O), 
29.48 (CNC(CHMe2)HCMe2O), 21.52, 21.47, 21.21 (overlapping CNC(CHMe2)HCMe2O and 
CNC(CHMe2)HCMe2O). 15N NMR (benzene-d6, 71 MHz): δ −143.4. IR (KBr, cm-1): 3069 w, 
2974 s, 2874 m, 1632 s (CN), 1471 m, 1462 m, 1386 m, 1372 s, 1336 w, 1303 w, 1272 w, 1243 
w, 1202 w, 1172 m, 1134 m, 1114 s, 1082 s, 1015 m, 984 w, 936 m, 894 w, 856 w 813 w. [α]D20 
=  (+) 37.7 (C6H6).  
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H[PhB(C5H5)(Ox4R-iPr,Me2)2]. A 100 mL Schlenk flask was charged with 4R-isopropyl-5,5-
dimethyl-2-oxazoline (0.400 g, 2.83 mmol) and tetrahydrofuran (30 mL), and the flask was 
cooled to −78 ºC. Using a syringe, 2.50 M nBuLi (1.20 mL, 2.98 mmol) was added, and the 
solution was stirred for 1 h at −78 ºC. Dichlorophenylborane (0.23 mL, 1.40 mmol) was slowly 
added the flask, and the solution was stirred for 1 h at −78 ºC and then allowed to gradually 
warm to room temperature. After stirring for 14 h at room temperature, the solvent was removed 
under reduced pressure to afford a light yellow solid. The solid was extracted with benzene and 
the solvent was evaporated to yield PhB(Ox4R-iPr,Me2)2 as a light yellow solid (0.50 g, 1.36 mmol). 
1H NMR (tetrahydrofuran-d8, 400 MHz): δ 7.45 (d, 3JHH = 7.6 Hz, 2 H, ortho-C6H5), 6.98 (m, 2 
H, meta-C6H5), 6.87 (m, 1 H,  para-C6H5), 3.19 (d, 3JHH = 4.8 Hz, 2 H, CNC(CHMe2)HCMe2O), 
3.17 (d, 3JHH = 4.8 Hz, 2 H, CNCiPrHCMe2O), 1.73 (m, 2 H, CNC(CHMe2)HCMe2O), 1.22-0.95 
(24 H, CNC(CHMe2)HCMe2O). 11B NMR (tetrahydrofuran-d8, 128 MHz):  δ −7.2. IR (KBr, cm-
1): 3071 w, 3046 w, 2961 s, 2932 s, 2872 m, 1588 s (CN), 1466 m, 1432 m, 1386 m, 1371 s, 
1277 w, 1242 s, 1193 m, 1176 m, 1146 s, 1120 m, 1096 m, 1023 s, 995 m, 943 m, 879 m, 849 m, 
802 m, 759 w. 
A Schlenk flask was charged with PhB(Ox4R-iPr,Me2)2 (0.500 g, 1.36 mmol) and  Na[C5H5] 
(0.070 g, 0.799 mmol). Addition of THF (40 mL) provided a yellow solution that was stirred 
overnight. A precipitate formed after 12 h, and the solution was filtered. Solvent was removed 
under reduced pressure to afford a light yellow solid. This crude product was purified by silica 
gel column chromatography (hexane:EtOAc:Et3N = 9:1:1; Rf = 0.58) to afford an off-white solid 
of H[PhB(C5H5)(Ox4R-iPr,Me2)2] as a mixture of isomers. The product was dissolved in benzene 
and stirred over P2O5 to remove residual water, affording 0.140 g of H[PhB(C5H5)(Ox4R-iPr,Me2)2] 
(0.321 mmol, 40.5%). 1H NMR (acetonitrile-d3, 400 MHz): δ 7.71-7.00 (m, 5 H, C6H5), 6.67-
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6.19 (m, 3 H, C5H5), 3.39-3.25 (m, 2 H, CNCiPrHCMe2O), 2.89-2.88 (m, 2 H, C5H5), 1.84 (m, 2 
H, CNC(CHMe2)HCMe2O), 1.47-0.94 (24 H, CNC(CHMe2)HCMe2O). 13C{1H} NMR 
(acetonitrile-d3, 176 MHz): δ 133.46 (ortho-C6H5), 129.10 (meta-C6H5), 128.24 (para-C6H5), 
141.27 (C5H5; 10 sp2 resonances for 3 isomers observed), 140.99 (C5H4), 135.25 (C5H5), 134.75 
(C5H5), 134.20(C5H5), 133.85 (C5H5), 133.83 (C5H5), 131.28 (C5H5), 128.90 (C5H5), 128.40 
(C5H5),  94.11 (CNCiPrHCMe2O), 66.67 (CNCiPrHCMe2O), 47.49 (C5H5-sp3), 43.18 (C5H5-
sp3), 30.25 (CNC(CHMe2)HCMe2O), 29.26 (CNC(CHMe2)HCMe2O), 29.91, 29.68, 22.09, 
22.06, 21.80, 21.77, 21.38, 21.27 (CNC(CHMe2)HCMe2O). 11B NMR (acetonitrile-d3, 128 
MHz): δ  −15.6 sh. IR (KBr, cm-1): 3069 m, 3047 m, 2972 s, 2932 s, 2875 s, 1582 s (CN), 1560 s 
(CN), 1470 m, 1433 m, 1394 s, 1375 s, 1353 m, 1335 w, 1313 w, 1276 m, 1262 m , 1246 m, 
1198 m, 1177 m, 1148 m,  1104 m, 1047 m, 1030 s, 1005 m, 990 w, 958 m, 943 m, 863 m, 881 
m, 802 s, 765 m, 741 s, 703 s, 680 m. Anal. Calcd for C27H39BN2O2: C, 74.65; H, 9.05; N, 6.45.  
Found: C, 74.77; H, 8.84; N 6.06. [α]D20 = (+) 63.2 (C6H6). Mp: 80-85 °C. 
 
{PhB(C5H4)(Ox4R-iPr,Me2)2}Zr(NMe2)2. A round bottom Schlenk flask was charged with 
H[PhB(C5H5)(Ox4R-iPr,Me2)2] (0.120 g, 0.275 mmol) and Zr(NMe2)4 (0.074 g, 0.275 mmol). The 
solids were dissolved in benzene (15 mL), and the resulting solution was stirred for 7 h. After 
filtration, the volatile materials were removed in vacuo to give a light yellow gel which was 
triturated with pentane giving {PhB(C5H4)(Ox4R-iPr,Me2)2}Zr(NMe2)2 as a off white solid (0.154 g, 
0.252 mmol, 91.4%). 1H NMR  (benzene-d6, 400 MHz): δ 8.09 (d, 3JHH = 7.2 Hz, 2 H, ortho-
C6H5), 7.49 (m, 2 H, meta-C6H5), 7.29 (m, 1 H,  para-C6H5), 6.76 (m, 1 H, C5H4), 6.58 (m, 1 H, 
C5H4), 6.25 (m, 1 H, C5H4), 6.07 (m, 1 H, C5H4), 3.24 (d, 2 H, 3JHH = 5.6 Hz, CNCiPrHCMe2O), 
3.20 (d, 2 H, 3JHH = 5.6 Hz, CNCiPrHCMe2O),  2.80  (s, 6 H, NMe2), 2.68  (s, 6 H, NMe2), 1.73 
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(m, 2 H, CNC(CHMe2)HCMe2O), 1.33 (s, 3 H, CNCiPrHCMe2O), 1.24 (s, 3 H, 
CNCiPrHCMe2O), 1.18 (s, 3 H, CNCiPrHCMe2O), 1.14 (s, 3 H, CNCiPrHCMe2O), 1.12 (d, 3JHH 
= 6.8 Hz, 3 H, CNC(CHMe2)HCMe2O), 1.09 (d, 3JHH =  6.8 Hz, 3 H, CNC(CHMe2)HCMe2O), 
0.97 (d, 3JHH = 6.8 Hz, 3 H, CNC(CHMe2)HCMe2O), 0.89 (d, 3JHH = 6.8 Hz, 3 H, 
CNC(CHMe2)HCMe2O). 13C{1H} NMR (benzene-d6, 176 MHz): δ 196.92 (br, CNCiPrHCH2O), 
194.35 (br, CNCiPrHCH2O), 151.53 (br, ipso-C6H5), 135.13 (ortho-C6H5), 127.51 (meta-C6H5), 
125.26 (para-C6H5), 123.49 (C5H4), 122.83 (C5H4), 113.93 (C5H4), 113.64 (C5H4), 85.08 
(CNCiPrHCMe2O), 84.81 (CNCiPrHCMe2O), 79.11 (CNCiPrHCMe2O), 78.87 
(CNCiPrHCMe2O), 44.51 (NMe2), 42.95 (NMe2), 30.44 (CNC(CHMe2)HCMe2O), 30.27 
(CNC(CHMe2)HCMe2O),  30.24 (CNCiPrHCMe2O), 30.02 (CNCiPrHCMe2O), 21.96 
(CNCiPrHCMe2O), 21.83 (CNCiPrHCMe2O), 20.69 (CNC(CHMe2)HCMe2O), 20.46 
(CNC(CHMe2)HCMe2O), 20.37 (CNC(CHMe2)HCMe2O), 20.17 (CNC(CHMe2)HCMe2O). 11B 
NMR (benzene-d6, 128 MHz): δ −14.5. 15N NMR (benzene-d6, 71 MHz): δ −152.3, −155.1 
(CNCiPrHCMe2O). IR (KBr, cm-1): 3071 w, 3045 w, 2966 s, 2931 s, 2869 s, 2768 s, 1559 s 
(CN), 1471 m, 1433 m, 1393 m, 1374 m, 1353 m, 1276 m, 1261 m, 1244 m, 1177 m, 1147 s, 
1105 m, 1047 s, 1030 m, 1021 m, 990 w, 940 s, 881 m, 864 w, 804 s, 770 w, 741 s, 703 s, 680 w.  
Anal. Calcd for C31H49BN4O2Zr: C, 60.86; H, 8.07; N, 9.16. Found: C, 60.45; H, 7.97; N, 8.86. 
[α]D20 = 122.6 (C6H6). Mp: 66-71 °C. 
 
{PhB(C5H4)(Ox4S-tBu)2}Zr(NMe2)2. H[PhB(C5H5)(Ox4S-tBu)2] (0.100 g, 0.246 mmol) and 
Zr(NMe2)4 (0.066 g, 0.246 mmol) were dissolved in benzene (5 mL), and the solution was stirred 
for 20 min. Quick evaporation of the volatile materials yielded a light yellow powder of 
{PhB(C5H4)(Ox4S-tBu)2}Zr(NMe2)2 {S-3}Zr(NMe2)2 (0.115 g, 0.197 mmol, 80.1%). This material 
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was stored at −30 °C.
 
1H NMR  (benzene-d6, 400 MHz): δ  8.10 (d, 3JHH = 7.2 Hz, 2 H, ortho-
C6H5), 7.49 (t, 3JHH = 7.6 Hz, 2 H, meta-C6H5), 7.30 (t, 3JHH = 7.2 Hz, 1 H,  para-C6H5), 6.74 (m, 
1 H, C5H4), 6.50 (m, 1 H, C5H4), 6.28 (m, 1 H, C5H4), 6.09 (m, 1 H, C5H4), 3.83 (m, 2 H, CNCt-
BuHCH2O), 3.64 (m, 2 H, CNCt-BuHCH2O), 3.49 (m, 2 H, CNCt-BuHCH2O), 2.75 (s, 6 H, 
NMe2), 2.65 (s, 6 H, NMe2), 0.85 (s, 9 H, CNCt-BuHCH2O), 0.84 (s, 9 H, CNCt-BuHCH2O). 
13C{1H} NMR (benzene-d6, 100 MHz): δ 196.84 (br, CNCt-BuHCH2O), 153.22 (ipso-C6H5), 
135.22 (ortho-C6H5), 127.54 (meta-C6H5), 125.42 (para-C6H5), 122.87 (C5H4), 122.75 (C5H4), 
114.37 (C5H4), 114.17 (C5H4), 76.16 (CNCt-BuHCH2O), 74.74 (CNCt-BuHCMe2O), 69.25 
(CNCt-BuHCH2O), 68.16 (CNCt-BuHCH2O), 44.55 (NMe2), 43.36 (NMe2), 34.15 
(CNC(CMe3)HCH2O), 28.90 (CNC(CMe3)HCH2O), 26.59 (CNC(CMe3)HCH2O), 26.40 
(CNC(CMe3)HCH2O). 11B NMR (benzene-d6, 128 MHz): δ −14.4. 15N NMR (benzene-d6, 41 
MHz): δ −145.4, −148.1. (oxazoline). IR (KBr, cm-1): 3067 w, 3042 w, 2954 s, 2904 s, 2866 s, 
2820 m, 2770 m, 1608 m (CN), 1506 m (CN), 1479 s, 1465 m, 1430 w, 1391 m, 1362 m, 1243 
m, 1191 s, 1135 s, 1053 s, 967 s, 941 s, 848 w, 809 m, 727 m, 703 m.
 
Anal. Calcd for 
C29H45BN4O2Zr: C, 59.67; H, 7.77; N, 9.60. Found: C, 59.19; H, 7.42; N, 9.13. Mp: 128-133 °C. 
[α]D20 = −103.93° (C6H6).  
 
{PhB(C5H4)(OxMe2)2}Zr(NMe2)(NHNMe2). In a glove box, a vial was charged with 
PhB(C5H4)(OxMe2)2}Zr(NMe2)2 (0.300 g, 0.569 mmol). The solid was dissolved in 10 mL 
benzene. To the solution, 43 µL N,N’-dimethylhydrazine (0.569 mmol) was added using a 
micro-lt syringe, and the resulting solution mixture was stirred for 15 min at room temperature. 
The mixture was filtered and extracted with 5 mL benzene. All the volatiles were removed under 
vacuo to afford {PhB(C5H4)(OxMe2)2}Zr(NMe2)(NHNMe2) as a off-white solid (0.290 g, 0.534 
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mmol, 94%). 1H NMR  (benzene-d6, 400 MHz): δ 8.20 (d, 3JHH = 6.4 Hz, 2 H, ortho-C6H5), 7.49 
(t, 3JHH = 7.2 Hz, 2 H, meta-C6H5), 7.29 (t, 3JHH = 6.4 Hz, 1 H,  para-C6H5), 6.59 (m, 2 H, 
C5H4), 6.42 (m, 2 H, C5H4), 6.25 (m, 2 H, C5H4), 6.09 (m, 2 H, C5H4), 4.22 (NHNMe2), 3.68-
3.59 (m, 4 H, ), 2.82 (s, 6 H, NMe2), 2.08 (s, 3H, NHNMe2), 2.02 (s, 3 H, 
NHNMe2), 1.16 (s, 3 H, ), 1.11 (s, 3 H, ), 1.10 (s, 3 H, 
), 1.05 (s, 3 H, ). 13C{1H} NMR (benzene-d6, 100 MHz): δ 
198.42 ( ), 152.06 (br, ipso-C6H5), 143.67 (ipso-C5H4), 135.22 (ortho-C6H5), 
127.52 (meta-C6H5), 125.22 (para-C6H5), 119.89 (C5H4), 118.97 (C5H4), 115.67 (C5H4), 111.88 
(C5H4), 78.99 ( ), 78.30 ( ), 67.59 ( ), 67.24 (
), 54.26 (NHNMe2),  53.71 (NHNMe2), 49.20 (NMe2), 29.10 ( ), 
29.06 ( ), 29.04 ( ), 27.96 ( ). 11B NMR (benzene-
d6, 128 MHz): δ −15.7. 15N NMR (benzene-d6, 71 MHz): δ −133.4 (NHNMe2), −134.3 (
), −139.8 ( ), −179.9 (NHNMe2). IR (KBr, cm-1): 3308 m, 3088 
w, 3066 w, 3041 w, 2994 m, 2961 s, 2926 s, 2892 s, 2863 s, 2817 m, 2769 m, 1602 m (CN), 
1514 s (CN), 1489 w, 1461 s, 1430 w, 1367 w, 1358 w, 1281 s, 1265 w, 1248 m, 1196 s, 1159 s, 
1122 m, 1050 s, 1034 m, 994 s, 966 s, 946 s, 909 w, 871 w, 847 w, 802 s, 732 s, 703 s, 680 m, 
661 w. Anal. Calcd for C25H38BO2N5 Zr: C, 55.33; H, 7.06; N, 12.91. Found: C, 55.30; H, 6.85; 
N, 12.12. Mp: 106-111 °C.  
 
K2[PhB(C5H4)(Ox4S-iPr,Me2)2]. A round bottom Schlenk flask was charged with 
H[PhB(C5H4)(Ox4S-iPr,Me2)2] (0.122 g, 0.280 mmol) and PhCH2K (0.072 g, 0.553 mmol). The 
solids were dissolved in THF (6 mL), and the resulting yellow solution was stirred for 3 h. The 
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CNCMe2CH2O CNCMe2CH2O
CNCMe2CH2O CNCMe2CH2O
CNCMe2CH2O
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88 
 
volatile materials were removed and dry in vacuo to give K2[PhB(C5H4)(Ox4S-iPr,Me2)2] as a 
yellow solid (0.140 g, 0.274 mmol, 97.9%). 1H NMR  (tertrahydrofuran-d8, 400 MHz): δ 7.63 (d, 
3JHH = 7.2 Hz, 2 H, ortho-C6H5), 6.95 (t, 3JHH = 7.2 Hz, 2 H, meta-C6H5), 6.78 (t, 3JHH = 7.2 Hz, 
1 H,  para-C6H5), 5.60 (m, 2 H, C5H4), 5.44 (m, 2 H, C5H4), 3.02 (m, 2 H, 3JHH = 5.6 Hz, 
CNCiPrHCMe2O), 1.73 (m, 2 H, CNC(CHMe2)HCMe2O), 1.32  (s, 3 H, CNCiPrHCMe2O), 1.22 
(s, 3 H, CNCiPrHCMe2O), 1.21 (s, 3 H, CNCiPrHCMe2O), 1.15 (s, 3 H, CNCiPrHCMe2O), 1.01 
(d, 3JHH = 6.4 Hz, 6 H, CNC(CHMe2)HCMe2O), 0.93 (d, 3JHH =  6.4 Hz, 6 H, 
CNC(CHMe2)HCMe2O). 13C{1H} NMR (tertrahydrofuran-d8, 100 MHz): δ 189.90 
(CNC(CHMe2)HCH2O), 161.24 (ipso-C6H5), 134.43 (ortho-C6H5), 126.85 (meta-C6H5), 122.81 
(para-C6H5), 112.10 (C5H4), 104.48 (C5H4), 82.11 (CNC(CHMe2)HCMe2O), 81.79 
(CNC(CHMe2)HCMe2O), 81.11 (CNC(CHMe2)HCMe2O), 80.93 (CNC(CHMe2)HCMe2O), 
31.04 (CNC(CHMe2)HCMe2O), 30.61 (CNC(CHMe2)HCMe2O) overlapped, 22.37 
(CNC(CHMe2)HCMe2O), overlapped 21.96 (CNC(CHMe2)HCMe2O), 21.90 
(CNC(CHMe2)HCMe2O). 11B NMR (tertrahydrofuran-d8, 128 MHz): δ −15.2. 15N NMR 
(tertrahydrofuran-d8, 71 MHz): δ −153.4 (one 15N cross peak was observed). IR (KBr, cm-1): 
3044 w, 2967 s, 2931 s, 2872 m, 1583 s, 1467 m, 1430 w, 1384 m, 1367 m, 1331 w, 1245 m, 
1199 m, 1176 m, 1134 s, 1094 s, 1042 m, 1019 m, 984 w, 941 m, 884 s, 856 m, 790 w, 737 m, 
707 s. Anal. Calcd for C27H37BK2 N2O2: C, 63.51; H, 7.30; N, 5.49. Found: C, 63.11; H, 7.61; N, 
5.28. Mp: 138-143 °C, dec. 
 
{PhB(C5H4)(Ox4S-iPr,Me2)2}ZrCl(NMe2). In a glove box, a vial was charged with 
K2[PhB(C5H4)(Ox4S-iPr,Me2)2] (0.150 g, 0.294 mmol) and ZrCl4 (0.070 g, 0.300 mmol). The solids 
were dissolved in THF (10 mL), and the resulting solution was stirred for 1 h at room 
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temperature to afford {PhB(C5H4)(Ox4S-iPr,Me2)2}ZrCl2. Unfortunately, the complex could not be 
isolated. The complex decomposes upon removal of solvent THF. 1H NMR  (tertrahydrofuran-
d8, 400 MHz): δ 7.46 (d, 3JHH = 6.4 Hz, 2 H, ortho-C6H5), 7.03 (m, 2 H, meta-C6H5), 6.95 (m, 1 
H,  para-C6H5), 6.88 (m, 2 H, C5H4), 6.66 (m, 2 H, C5H4), 6.57 (m, 2 H, C5H4), 6.23 (m, 2 H, 
C5H4), 3.63 (m, 2 H, CNCiPrHCMe2O), 1.63 (m, 2 H, CNC(CHMe2)HCMe2O), 1.45 (s, 3 H, 
CNCiPrHCMe2O), 1.39 (s, 3 H, CNCiPrHCMe2O), 1.35  (s, 3 H, CNCiPrHCMe2O), 1.08 (s, 3 H, 
CNCiPrHCMe2O), 1.06 (d, 3JHH = 7.2 Hz, 3 H, CNC(CHMe2)HCMe2O), 0.98 (d, 3JHH =  7.2 Hz, 
3 H, CNC(CHMe2)HCMe2O), 0.94 (d, 3JHH = 7.2 Hz, 3 H, CNC(CHMe2)HCMe2O), 0.85 (d, 3JHH 
= 7.2 Hz, 3 H, CNC(CHMe2)HCMe2O). 11B NMR (tertrahydrofuran-d8, 128 MHz): δ −15.7. 
{PhB(C5H4)(Ox4S-iPr,Me2)2}ZrCl(NMe2) was synthesized using THF solution of 
{PhB(C5H4)(Ox4S-iPr,Me2)2}ZrCl2 prepared in situ. LiNMe2 (0.015 g, 0.294 mmol) was added to 
the THF solution of {PhB(C5H4)(Ox4S-iPr,Me2)2}ZrCl2 and stir for 1 h at room temperature. All the 
volatile materials were removed in vacuo, and the residue was extracted with benzene. Removal 
of solvent in vacuo provided {PhB(C5H4)(Ox4S-iPr,Me2)2}ZrCl(NMe2) as a light yellow solid 
(0.141 g, 0.233 mmol, 79.3%), which was a mixture of two diastereomers in 4:1 ratio. 1H NMR 
(tertrahydrofuran-d8, 400 MHz): δ 7.38 (d, 3JHH = 6.8 Hz, 2 H, ortho-C6H5), 7.06 (m, 2 H, meta-
C6H5), 6.96 (t, 3JHH = 6.8 Hz, 1 H,  para-C6H5), 6.19 (m, 1 H, C5H4), 6.15 (m, 1 H, C5H4), 6.07 
(m, 1 H, C5H4), 5.84 (m, 1 H, C5H4), 3.86 (m, 2 H, CNCiPrHCMe2O), 2.93 (s, NMe2), 1.72 (m, 2 
H, CNC(CHMe2)HCMe2O), 1.32  (s, 3 H, CNCiPrHCMe2O), 1.59-1.19 (24 H, 
CNC(CHMe2)HCMe2O). 13C{1H} NMR (tertrahydrofuran-d8, 100 MHz): δ 189.59 
(CNC(CHMe2)HCH2O), 161.55 (ipso-C6H5), 134.12 (ortho-C6H5), 130.42 (meta-C6H5), 128.13 
(para-C6H5), 126.53 (C5H4), 122.49 (C5H4), 111.78 (C5H4), 104.16 (C5H4), 81.79 
(CNC(CHMe2)HCMe2O), 81.48 (CNC(CHMe2)HCMe2O), 80.79 (CNC(CHMe2)HCMe2O), 
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80.61 (CNC(CHMe2)HCMe2O), 30.72 (CNC(CHMe2)HCMe2O), 30.31 
(CNC(CHMe2)HCMe2O, overlapped), 30.29 (CNC(CHMe2)HCMe2O), 30.24 
(CNC(CHMe2)HCMe2O), 22.04 (CNC(CHMe2)HCMe2O, overlapped), 21.64 
(CNC(CHMe2)HCMe2O), 21.58 (CNC(CHMe2)HCMe2O). 11B NMR (tertrahydrofuran-d8, 128 
MHz): δ −16.4. 15N NMR (tertrahydrofuran-d8, 71 MHz): δ −153.4, −154.9. IR (KBr, cm-1): 
3059 w, 2958 s, 2924 m, 2878 m, 1578 s (CN), 1567 s (CN), 1484 w, 1459 m, 1428 w, 1380 w, 
1361 m, 1342 w, 1290 m, 1250 m, 1190 m, 1120 s, 1056 w, 1037 m, 1017 w, 966 s, 936 w, 
876m, 824 s, 792 w, 777 m, 747 s, 731 s, 704 m, 661 w. Anal. Calcd for C29H43BClN3O2Zr: C, 
57.75; H, 7.19; N, 6.97. Found: C, 57.56; H, 6.49; N, 6.81. Mp: 123-127 °C, dec. [α]D20 = –
111.4°. 
 
H[Ph2B(C5H4)(Ox4S-iPr,Me2)]. A 100 mL Schlenk flask was charged with 4S-isopropyl-5,5-
dimethyl-2-oxazoline (0.500 g, 3.54 mmol) and THF (40 mL), and the flask was cooled to −78 
ºC. Using a syringe, 2.50 M nBuLi (1.20 mL, 2.98 mmol) was added, and the solution was 
stirred for 1 h at −78 ºC. A THF (20 mL) solution of Ph2BCl (0.708 g, 3.54 mmol) in another 
Schlenk flask was slowly added to the flask containing lithium oxazolide, and the solution was 
stirred for 1 h at −78 ºC and then allowed to slowly warm to room temperature. After stirring for 
12 h at room temperature, the solvent was removed under reduced pressure to afford crude 
Ph2B(Ox4S-iPr,Me2) as a light yellow solid. 
  The Ph2B(Ox4S-iPr,Me2) dissolved in 40 mL THF and Na[C5H5] (0.312 g, 3.54 mmol) was 
added. The resultant solution was stirred overnight at room temperature. The solution was 
filtered. Solvent was removed under reduced pressure to afford a yellow solid. This crude 
product was purified by silica gel column chromatography to afford an light yellow solid of 
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H[Ph2B(C5H5)(Ox4S-iPr,Me2)] as a mixture of isomers. The product was dissolved in benzene and 
stirred over P2O5 to remove residual water, affording 0.120 g of H[Ph2B(C5H5)(Ox4S-iPr,Me2)]        
(0.323 mmol, 10.7%). 1H NMR (acetonitrile-d3, 400 MHz): δ 7.70-7.12 (m, 10 H, C6H5), 6.48-
6.32 (m, 3 H, C5H5), 3.83 (d, 3JHH = 6.4 Hz, 1 H, CNCiPrHCMe2O), 2.91 (m, 2 H, C5H5), 1.84 
(m, 1 H, CNC(CHMe2)HCMe2O), 1.47-0.98 (12 H, CNC(CHMe2)HCMe2O). 13C{1H} NMR 
(acetonitrile-d3, 150 MHz): δ 135.53 (ortho-C6H5), 129.69 (meta-C6H5), 128.03 (para-C6H5), 
142.17 (C5H5; 10 sp2 resonances for 3 isomers observed), 141.95 (C5H5), 136.26 (C5H5), 134.92 
(C5H5), 134.25 (C5H5), 133.85 (C5H5), 133.23 (C5H5), 131.87(C5H5), 128.23 (C5H5), 128.57 
(C5H5),  95.09 (CNCiPrHCMe2O), 67.07 (CNCiPrHCMe2O), 48.34 (C5H5-sp3), 43.22 (C5H5-
sp3), 31.25 (CNC(CHMe2)HCMe2O), 29.77, 22.19, 21.61, 21.29 (CNC(CHMe2)HCMe2O). 11B 
NMR (acetonitrile-d3, 128 MHz): δ −10.0, −11.5, −12.4. IR (KBr, cm-1): 3087 w, 3069 w, 3035 
w, 2982 s, 2870 m, 1594 s (CN), 1474 w, 1467 m, 1424 w, 1396 s, 1370 m, 1352 m, 1347 w, 
1311 m, 1302 w, 1244w, 1227 w, 1215 m, 1167 w, 1145 m, 1096 w, 1027 m, 999 w, 956 m, 942 
m, 853 w, 829 w. Anal. Calcd for C25H30BNO: C, 80.86; H, 8.14; N, 3.77.  Found: C, 80.25; H, 
7.73; N, 3.51. Mp: 67-72 °C. [α]D20 = −55.2° (C6H6). 
  
{Ph2B(C5H4)(Ox4S-iPr,Me2)}Zr(NMe2)2. In a glove box, a vial was charged with 
H[Ph2B(C5H5)(Ox4S-iPr,Me2)] (0.040 g, 0.108 mmol) and Zr(NMe2)4 (0.029 g, 0.108 mmol). The 
solids were dissolved in benzene (4 mL), and the resulting solution was stirred for 20 min. The 
volatile materials were evaporated to afford {Ph2B(C5H4)(Ox4S-iPr,Me2)}Zr(NMe2)2 as an off-white 
solid (0.054 g, 0.098 mmol, 91.5%). 1H NMR  (benzene-d6, 400 MHz): δ  8.16 (d, 3JHH = 6.8 Hz, 
2 H, ortho-C6H5), 8.06 (d, 3JHH = 7.2 Hz, 2 H, ortho-C6H5), 7.46 (t, 3JHH = 7.6 Hz, 2 H, meta-
C6H5), 7.34 (t, 3JHH = 7.6 Hz, 2 H, meta-C6H5), 7.27 (m, 1 H,  para-C6H5), 7.17 (m, 1 H,  para-
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C6H5), 6.64 (m, 1 H, C5H4), 6.55 (m, 1 H, C5H4), 6.23 (m, 1 H, C5H4), 6.01 (m, 1 H, C5H4), 3.24 
(d, 1 H, 3JHH = 5.6 Hz, CNCiPrHCMe2O), 2.84  (s, 6 H, NMe2), 2.76 (s, 6 H, NMe2), 1.74 (m, 1 
H, CNC(CHMe2)HCMe2O), 1.35 (s, 3 H, CNCiPrHCMe2O), 1.24 (s, 3 H, CNCiPrHCMe2O), 
1.16 (d, 3JHH = 6.8 Hz, 3 H, CNC(CHMe2)HCMe2O), 0.99 (d, 3JHH =  6.8 Hz, 3 H, 
CNC(CHMe2)HCMe2O). 13C{1H} NMR (benzene-d6, 150 MHz): δ 194.29 (br, CNCiPrHCH2O), 
152.26 (br, ipso-C6H5), 151.51 (br, ipso-C6H5), 135.14 (ortho-C6H5), 133.11 (ortho-C6H5), 
127.51 (meta-C6H5), 126.42 (meta-C6H5), 125.93 (para-C6H5), 125.01 (para-C6H5), 123.51 
(C5H4), 123.33 (C5H4), 114.41 (C5H4), 113.64 (C5H4), 84.61 (CNCiPrHCMe2O), 78.03 
(CNCiPrHCMe2O), 44.51 (NMe2), 41.99 (NMe2), 30.44 (CNC(CHMe2)HCMe2O), 30.02 
(CNCiPrHCMe2O), 21.96 (CNCiPrHCMe2O), 20.68 (CNC(CHMe2)HCMe2O), 20.21 
(CNC(CHMe2)HCMe2O). 11B NMR (benzene-d6, 128 MHz): δ −11.7. 15N{1H} NMR (benzene-
d6, 71 MHz): δ −155.2 (CNCiPrHCMe2O). IR (KBr, cm-1): 3045 w, 3008 w, 2967 s, 2931 s, 
2772 w, 1562 m (CN), 1489 w, 1467 s, 1431 w, 1388 m, 1260 s, 1194 s, 1093 s, 1054 s, 947 s, 
884 w, 855 w, 804 s, 734 s. Anal. Calcd for C29H40BN3OZr: C, 63.48; H, 7.35; N, 7.66. Found: 
C, 63.31; H, 7.01; N, 7.19. Mp: 121-124 °C, dec. [α]D20 = −82.02° (C6H6). 
 
2,2-Diethoxypent-4-enenylamine. 2,2-Diethoxypent-4-enenitrile was synthesized according to 
the published procedure.55 
A oven dried 2-neck Schlenk flask fitted with reflux condenser was charged with LiAlH4 
(0.350 g, 9.22 mmol). The flask was cooled to 0 °C and diethyl ether (60 mL) was added. To the 
suspension at 0 °C, 2,2-diethoxypent-4-enenitrile (0.630 g, 3.72 mmol) was added drop wise. 
The resultant solution was stirred overnight at room temperature. Then, the solution was cooled 
to 0 °C and 3 mL water was added slowly drop wise. The solution stirred 1 h at room 
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temperature. The ether layer was decanted and the white precipitation was extracted with diethyl 
ether 3 times. All the organic solutions were combined, dried with Na2SO4 and filtered. The 
solvent was removed in vacuo to give crude 2,2-diethoxypent-4-enenylamine. Vacuum 
distillation (80 °C, 5 mm Hg) of the crude product afforded the pure 2,2-diethoxypent-4-
enenylamine as a colorless oil, which was stored in glove box with activated molecular sieve 
(0.520 g, 3.00 mmol, 80.6% yield). 1H NMR  (benzene-d6, 400 MHz): δ 5.90-5.79 (m, 1H, 
CH=CH2), 5.08-5.01 (m, 2H, CH=CH2), 3.40-3.31 (m, 4H, OCH2CH3), 2.79 (s, 2H, NH2CH2), 
2.55 (d, 3JHH = 6.8 Hz, 2H, =CHCH2), 3.40-3.31 (t, 3JHH = 6.8 Hz, 6H, OCH2CH3), 0.63 (br s, 
2H, NH2). 13C{1H} NMR (benzene-d6, 100.6 MHz): δ 134.74 (CH=CH2), 117.70 (CH=CH2), 
103.20 (C(OCH2CH3)2), 55.98 (C(OCH2CH3)2), 44.81 (CH2NH2), 37.97 (=CHCH2), 15.99 
(C(OCH2CH3)2). 15N NMR (benzene-d6, 61 MHz): δ −364.6. IR (KBr, cm-1): 3396 w, 3077 m, 
2976 s, 2930 s, 2883 s, 1641 m, 1621 w, 1481 w, 1456 m, 1443 s, 1417 w, 1389 m, 1365  w, 
1316 w, 1266 w, 1218 s, 1157 s, 1116 s, 1080 s, 1053 s, 1001 s, 915 s, 879 w, 825 s, 770 w, 677 
w. MS (ESI) exact mass Calcd for C9H19NNaO2: m/z 196.1308 ([M++Na+]), Found: 196.1303 (∆ 
2.89 ppm). 
 
2-(4-Pentenyl)-2-phenyl-6-heptenylamine. A flame-dried Schlenk flask was charged with 
diisopropylamine (2.00 mL, 14.27 mmol) and 50 mL of THF. The flask was cooled to −78 °C 
and nBuLi (5.71 mL, 14.27 mmol, 2.5 M solution in hexanes) was added in a drop wise fashion. 
The resulting solution was stirred for 60 min at 0 °C. 29 mL of this solution of lithium 
diisopropylamide (LDA) was transferred to a dropping funnel, fitted with a dried 3-neck flask 
with a water condenser containing phenylacetonitrile (0.80 mL, 6.93 mmol) in THF (50 mL). 
The flask was cooled to −78 °C and the LDA solution was added drop wise over 10 min. The 
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resultant yellow solution was stirred for 90 min at this temperature and was then treated with 5-
bromo-1-pentene (0.8 mL, 6.75 mmol) drop wise. The solution was stirred for another 15 min at 
−78 °C and was then allowed to warm to room temperature. After stirring for 90 min at rt, the 
solution was cooled back to −78 °C, and the second part of LDA was added over 10 min. The 
solution was allowed to warm to 0 °C and was stirred for 90 min. After cooling back to −78 °C, 
the solution was treated with 5-bromo-1-pentene (1.0 mL, 8.44 mmol). The resultant yellow 
reaction mixture was allowed to warm slowly to room temperature and stirred overnight. The 
reaction was quenched by addition of water (5 mL), and the solvent was removed in vacuo. The 
residue was taken up with Et2O (100 mL), washed with water (2 × 15 mL) and brine (1 × 15 
mL), and dried over Na2SO4. Concentration in vacuo gave a light yellow oil, which was purified 
by silica gel column chromatography (hexane:EtOAc:Et3N:: 9:1:1, Rf = 0.75) to afford 2-(4-
pentenyl)-2-phenyl-6-heptenenitrile (1.50 g, 5.92 mmol, 85.4%). 
An oven-dried 2-neck Schlenk flask fitted with a reflux condenser was charged with 
LiAlH4 (1.0 g, 26.35 mmol). The flask was cooled to 0 °C and diethyl ether (150 mL) was added. 
2-(4-pentenyl)-2-phenyl-6-heptenenitrile (1.50 g, 5.92 mmol) was added in a drop wise manner 
to the suspension. The resulting mixture was stirred overnight at room temperature. Then, the 
solution was cooled to 0 °C and water (5 mL) was added in a drop wise fashion. The solution 
was allowed to stir for 1 h at room temperature. The ether layer was decanted and the white 
precipitate was extracted with diethyl ether (4 × 50 mL). All the organic solutions were 
combined, dried with Na2SO4, and filtered. The solvent was removed under reduced pressure to 
give crude 2-(4-pentenyl)-2-phenyl-6-heptenylamine. The crude product was stirred with CaH2 
under argon for 3 days and then filtered to afford the pure 2-homoallyl-2-phenyl-hex-5-
enylamine as a colorless oil, which was stored in glove box with activated 4 Å molecular sieves 
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(1.36 g, 5.28 mmol, 89.2%). 1H NMR (benzene-d6, 400 MHz): δ 7.21-7.06 (m, 5 H, C6H5), 5.75-
5.65 (m, 2 H, CH=CH2), 5.01-4.94 (m, 4 H, CH=CH2), 2.74 (s, 2 H, CH2NH2), 1.93 (m, 2 H, 
H2C=CHCH2CH2CH2), 1.60 (m, 2 H, H2C=CHCH2CH2CH2), 1.15 (m, 2 H, 
H2C=CHCH2CH2CH2), 0.37 (br s, 2 H, CH2NH2). 13C{1H} NMR (100 MHz, benzene-d6): δ 
146.79 (C6H5), 139.36 (CH=CH2), 128.85 (C6H5), 127.39 (C6H5), 126.25 (C6H5), 115.01 
(CH=CH2), 48.98 (CH2NH2), 45.67 [C(C6H5)], 35.30, 35.16 (=CHCH2CH2CH2, 
(=CHCH2CH2CH2), 23.59 (=CHCH2CH2CH2). 15N NMR (benzene-d6, 61 MHz): δ −369.9. IR 
(KBr, cm-1): 3388 w, 3321 w, 3075 s, 3062 s, 3023 m, 2996 s, 2976 s, 2935 s, 2865 s, 1945 w, 
1869 w, 1824 w, 1640 s, 1601 m, 1580 w, 1498 s, 1463 s, 1443 s, 1415 m, 1372 w, 1327 w, 1260 
m, 1192 w, 1157 w, 1077 m, 1032 s, 994 s, 910 s, 804 s, 764 s, 700 s. MS (ESI) exact mass 
Calculated for C18H27N: m/z 258.2221 ([M++H+]), Found: 258.2203. 
 
4,4-Diethoxy-2-methylpyrrolidine. 1H NMR (chloroform-d, 400 MHz): δ 3.41-3.36 (m, 4 H, 
OCH2CH3), 3.22-3.17 (m, 1 H, CHMeNH),  3.01 (d, 2JHH = 11.6 Hz, 1 H, CH2NH), 2.81 (d, 2JHH 
= 11.6 Hz, 1 H, CH2NH), 2.06-2.01 (m, 1 H, CH2CHMe), 1.47 (br, 2 H, NH2), 1.43-1.37 (m, 
CH2CHMe), 1.12 (t, 3JHH = 6.8 Hz, 6 H, OCH2CH3), 1.09 (d, 3JHH = 6.4 Hz, CHMeNH). 
13C{1H} NMR (100.6 MHz, chloroform-d): δ 111.99 C(OCH2CH3)2, 57.54 (OCH2CH3), 55.39 
(CH2NH), 53.58 (CHMeNH), 44.17 (CH2CHMe), 21.37 (CHCH3), 15.61 (OCH2CH3). IR (KBr, 
cm-1): 2975 s, 2930 s, 2883 s, 1641 w, 1542 w, 1481 w, 1444 m, 1391 s, 1350 m, 1336 m, 1321 
m, 1265 m, 1234 m, 1158 s, 1126 s, 1077 s, 1054 s, 1012 m, 949 m, 888 w, 810 m. MS (ESI) 
exact mass Calcd. for C9H19NO2: m/z 174.1489 ([M++H+]), Found: 174.1488 (∆ 0.32 ppm). 
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General procedure for catalytic hydroamination/cyclization  
a) NMR scale catalysis at rt: In a typical small-scale hydroamination experiment, a J. Young 
style NMR tube with a re-sealable Teflon valve was charged with 50 µmol of aminoalkene 
substrate, 5.0 µmol of catalyst, and 0.5 mL of solvent (benzene-d6, methylene chloride-d2, 
toluene-d8 or tetrahydrofuran-d8). The vessel was sealed, and the reaction was monitored by 1H 
NMR spectroscopy at regular intervals. 
b) NMR scale catalysis at 0 °C: In the glove box, the appropriate aminoalkene (50 µmol) was 
dissolved in 0.3 mL of toluene-d8 and transferred to a NMR tube. The NMR tube was sealed with 
a rubber septum and cooled to 0 °C for 0.5 h outside of the glove box. The appropriate catalyst 
(5.0 µmol) was placed in a small test tube and dissolved in 0.2 mL of toluene-d8. The test tube 
was capped with a rubber septum and cooled to 0 °C for 0.5 h. Then, the catalyst solution was 
quickly transferred to the NMR tube at 0 °C by syringe. The NMR tube containing the reaction 
mixture was allowed to stand at 0 °C for 10 to 12 h continuously and was then checked by 1H 
NMR spectroscopy. 
c) NMR scale catalysis at −30 °C: 
In the glove box, appropriate aminoalkene (50 µmol) and catalyst (5.0 µmol) were charged into 
two separate vials. 0.4 mL toluene-d8 was added to both vials and cooled to −30 °C in the glove 
box freezer for 30 min. Then, the cold solution of aminoalkene was added to the vial containing 
catalyst and put back the solution mixture into the freezer of the glove box for couple of days. 
The cold solution was taken out from the glove box and quench immediately, and was checked 
by NMR spectroscopy.  
d) Procedure for isolation of optically active pyrrolidines. A flask was charged with the 
catalyst [{PhB(C5H4)(OxiPr,Me2)2}Zr(NMe2)2] (0.060 g, 0.103 mmol), benzene (20-30 mL) and 
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the appropriate aminoalkene (2.58 mmol). The solution was stirred at room temperature for 3 h. 
Then, the products were purified by fractional distillation in vacuo to afford the cyclic amines as 
colorless oils. 
2-methyl-4,4-diphenylpyrrolidine (8b) was purified by Kugelrohr distillation. Yield: 93%, bp: 
125 °C, 10-5 mBar (dynamic vacuum on a high vacuum line).  
2-Methyl-4,4-bis(2-propenyl)pyrrolidine (11b). Yield: 95 %, bp: 86-90 °C, 5 mm Hg. 
3-methyl-2-aza-spiro[4,5]decane (12b); yield: 94%, bp: 100-105 °C, 0.1 mm Hg (dynamic 
vacuum). 
2-methyl-6,6-diphenylazepane (16b);  
2-methyl-4,4-diethoxypyrrolidine (19b); Yield: 84%, bp: 80 °C, 5 mm Hg.  
4-allyl-2-methyl-4-(4-bromophenyl)pyrrolidine (20b): Yield: 97%, bp: 120-125 °C, 0.1 mm Hg 
(dynamic vacuum).  
4-allyl-2,4-dimethyl-pyrrolidine (21b). Yield: 95%, bp: 47-52 °C, 5 mm Hg. 
2-methyl-4-phenylpyrrolidine (23b), Yield: 92%, bp: 47-52 °C, 5 mm Hg. 
 
Procedures for NMR kinetic measurements.  Reaction progress was monitored by single scan 
acquisition of a series of 1H NMR spectra at regular intervals on a Bruker DRX400 spectrometer. 
The concentrations of C-(1-allyl-cyclohexyl)-methylamine and 3-methyl-2-aza-spiro[4,5]decane 
were determined by integration of resonances corresponding to species of interest and integration 
of a tetrakis(trimethylsilyl)silane standard of accurately known and constant concentration (4.36 
mM in toluene-d8). The temperature in the NMR probe was preset for each experiment, and it 
was kept constant and monitored during each experiment. For reactions heated above 296 K, the 
probe temperature was calibrated using an 80% ethylene glycol sample in 20% DMSO-d6 using 
98 
 
the equation: T = [(4.218−∆)/0.009132] K (∆ equals the chemical shift difference of the two 
ethylene glycol resonances). For reactions at performed at 296 K or below, the probe was 
calibrated using CH3OH using the equation T = [−23.832·∆2 − 29.46·∆ + 403] K (∆ = chemical 
shift difference of two peaks of CH3OH). 
 
Representative example: Catalytic conversion of C-(1-allyl-cyclohexyl)-methylamine into 3-
methyl-2-aza-spiro[4,5]decane using 10 mol % {PhB(C5H4)(Ox4S-iPr,Me2)2}Zr(NMe2)2 ({S-
2}Zr(NMe2)2) as a catalyst is described. A 5 mL stock solution in toluene-d8 containing a known 
concentration of the internal standard tetrakis(trimethylsilyl)silane (0.0070 g, 0.0218 mmol, 4.36 
mM) was prepared using a 5  mL volumetric flask. The stock solution (0.50 mL) was added by a 
1 mL glass syringe to a known amount of {S-2}Zr(NMe2)2  (0.0040 g, 6.52 µmol) in a glass vial. 
The resulting solution was transferred to a NMR tube, capped with a rubber septum, and a 1H 
NMR spectrum was acquired. The concentration of {S-2}Zr(NMe2)2 was determined from this 
1H NMR spectrum by comparison of integration of resonances assigned to {S-2}Zr(NMe2)2 with 
that from the internal standard. Neat substrate C-(1-allyl-cyclohexyl)-methylamine (0.010 g, 65.2 
µmol) was added to the NMR tube by injecting through the rubber septum. Then, the NMR tube 
was quickly placed in the NMR probe. Single scan spectra were acquired automatically at preset 
time intervals at 23 °C. The concentration of substrate and product at any given time was 
determined by integration of substrate and product resonances relative to the integration of the 
internal standard. A linear least squares analysis of substrate concentrations (M) vs. time 
correlated to the equation Ln[subs]t = Ln[subs]0 − kobst. 
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Measurement of initial rates of cyclization (saturation kinetics). A 5 mL stock solution in 
toluene-d8 containing a known concentration of internal standard tetrakis(trimethylsilyl)silane 
(0.0070 g, 0.0218 mmol, 4.36 mM) and catalyst (5.39 mM) was prepared using a 5 mL 
volumetric flask. The stock solution (0.50 mL) was added by a 1 mL glass syringe to a NMR 
tube, capped with rubber septum and was taken a 1H NMR spectra.  
The initial rates for the hydroamination of C-(1-allyl-cyclohexyl)-methylamine (12a) 
were measured for several substrate concentrations at constant catalyst concentration (5.39 mM). 
Linear regression fits for versus time for the first 504 s of the reaction provided the initial rate 
(d[12a]/dt) for a particular initial substrate concentration (calculated as average substrate 
concentration over 504 s). A non-linear least squares regression analysis of d[12a]/dt vs. [12a]ini 
showed good correlation to the equation: 
 
−d[12a]
dt
=
k2[{S-2}Zr(NMe2)2]  {[12a] − [{S-2}Zr(NMe2)2]
K' + {[12a] − {S-2}Zr(NMe2)2} + KSI{[12a] − {S-2}Zr(NMe2)2}2
 
 
which is a modified version of the general equation: 
 
 
Particular modifications:  
-d[substrate]
dt
=
k2[substrate][catalyst]
K' + [substrate] + [substrate]2
KSI
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(a) One equiv. of substrate is consumed in a pre-catalyst activation step. Thus, the observed 
substrate concentration must be modified to include this factor, which does not otherwise appear 
in the rate law or the reaction mechanism. Thus [substrate] = [12a] – [catalyst]. 
(b) KSI (equilibrium constant for substrate inhibition) is normally defined as: KSI = 
[substrate][catalyst-substrate]/[catalyst-substrate2] (i.e., a dissociation constant). For more 
straightforward chemical interpretation, KSI is defined here as the substrate binding constant: KSI 
= [catalyst-substrate2]/ [substrate][catalyst-substrate]. 
 
Measurement of the activation parameters.  
1. Eyring plot from second-order rate constants: Rate constants k were measured at the 
constant catalyst and initial substrate concentrations, over five temperatures ranging from 266 K 
to 314 K using the method described above. The plot ln(k'/T) vs. 1/T provides the values of  11.0 
kcal mol-1 and ∆S‡ = −24.5 cal·mol-1K-1 using standard Eyring analysis. 
2. Eyring plot from initial rates: Using the initial rate method described above, the rate 
constants k2 were measured at temperatures ranging from 273 K to 322 K, keeping the catalyst 
and initial substrate concentration constant in each experiment. The plot ln(k2/T) vs. 1/T provides 
the values of  From this plot, ∆H‡ = 6.7 kcal⋅mol-1 and ∆S‡ = −43.2 cal⋅mol-1K-1 are calculated, 
using standard Eyring analysis. 
 
Procedure for determination of enantiomeric excess of pyrrolidine products.  
NMR spectroscopy. The 1H and 19F NMR methods were used to evaluate the % ee of the 
pyrrolidines products of enantioselective hydroamination/cyclization. 2,4,4-
Trimethylpyrrolidine, 3-methyl-2-aza-spiro[4,5]decane (b.p. = 100 °C, 0.15 mBar), 3-methyl-2-
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aza-spiro[4,4]nonane (b.p. = 45 °C, 2 mBar) were separated from the catalyst by vacuum transfer 
(10-5 mBar) to a 10 mL flask. 2-Methyl-4,4-diphenylpyrrolidine (b.p. = 150 °C, 0.08 mBar) was 
purified by silica gel flash chromatography (pipette column) with 95:5 CH2Cl2:CH3OH as an 
eluent, and then all volatiles were removed by rotary evaporation.  
Benzene (2 mL) and triethylamine (5.0 equivalent based on the amount of aminoalkene 
used during catalysis) were added to the purified pyrrolidine. To this solution, (+)-(S)-α-
methoxy-α-(trifluoromethyl)phenylacetyl chloride (1.2 equivalent based on the amount of 
aminoalkene used during catalysis) was added. The solution was mixed and immediately a white 
suspension appeared ([HNEt3][Cl]). The mixture was stirred for 1 h, and all the solvents were 
removed under vacuum. The white residue was extracted with pentane. Pentane was removed 
under vacuum to give the corresponding Mosher-amide as a clear colorless oil. No further 
purification was performed, since crystallization, chromatography, or sublimation could result in 
biased results by separation of the diastereomers. The enantioselectivities were determined by 
either integration of 1H NMR (23 °C, CDCl3) or 19F NMR (60 °C, CDCl3) signals; these were 
referenced to literature values and compared against authentic diastereomers of racemic samples 
reproduced in our laboratory.  
 
HPLC analysis. The enantiomeric excess of chiral pyrrolidines were also determined by HPLC 
analysis of the naphthoyl derivatized product (flow rate = 1.0 mL/min, λ = 254 nm) using Regis 
(S,S)-Whelk O1 column (Spherical Kromasil® Silica, column dimensions = 25 cm × 4.6 mm i.d., 
particle size = 5 µm, 100 Å) following literature procedures.  
Typical procedure of derivatization: In a glove box, 1-naphthyol chloride (1.05 equiv.) or 
benzoyl chloride was added to a CH2Cl2 solution of pyrrolidine (1.0 equiv.) and triethylamine 
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(3.0 equiv.) at room temperature. The resultant mixture was stirred for 2 h, and then the volatile 
materials were removed by rotary evaporation giving a white solid. The product was extracted 
with pentane and pentane was removed in vacuo. The crude product was purified by preparative 
silica gel TLC with appropriate eluent. 
 
Chiral Stationary Phase HPLC Conditions for Determination of Enantiomeric Excess 
 
Compounds Eluent of 
preparative TLC to 
purify product 
derivative 
Eluent ratio of 
HPLC 
 
 
Back 
pressure 
during 
HPLC 
Retention 
time in 
HPLC 
O
N
PhPh
 
 
cyclohexane/EtOAc; 
3/1 
 
 
hexane:EtOH; 
75:25 
 
55 bar 
 
22.1 min 
66.4 min 
O
N
 
 
hexane/EtOAc; 2/1 
 
hexane:EtOH; 
75:25 
 
55 bar 
 
13.9 min 
82.8 min 
O
N
C6H5Br
 
 
hexane/EtOAc; 2/1 
 
hexane:EtOH; 
96:4 
 
40 bar 
42.7 min 
57.8 min 
107.7 min 
115.2 min 
O
N
 
 
hexane/EtOAc; 3/2 
 
hexane:EtOH; 
75:25 
 
56 bar 
 
11.8 min 
74.1 min 
O
N
Ph
 
 
hexane/Et2O; 1/7 
 
hexane:EtOH; 
95:5 
 
41 bar 
38.5 min 
58.6 min 
62.4 min 
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67.3 min 
O
N
 
 
hexane/EtOAc; 3/2 
 
hexane:EtOH; 
75:25 
 
52 bar 
 
11.4 min 
59.6 min 
O
N
Ph
 
 
hexane/EtOAc; 2/1 
 
hexane:EtOH; 
70:30 
 
56 bar 
7.8 min 
10.4 min 
12.8 min 
13.5 min 
 
Error analysis for enantioselectivity. % ee values are given based on average % ee determined 
from multiple (> 3) catalytic experiments run under identical conditions; the standard deviation 
for the % ee's for a particular set of conditions, calculated from 19F NMR integration, was 
determined to be ±0.5 (e.g., the % ee for 8b, cyclized in benzene-d6 at 23 °C is 93±0.5%). 1H and 
19F NMR spectra of Mosher amides, obtained by reaction of the pyrrolidine products with 
Mosher chloride are shown below for both the racemic and representative enantioenriched 
samples. 
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Chapter 3. The desymmetrization of non-conjugated aminodienes and aminodiynes 
through enantioselective and diastereoselective hydroamination 
 
Modified from a paper to be submitted to Nature Chemistry 
Kuntal Manna,‡ Aaron D. Sadow* 
 
Abstract 
The optically active cyclopentadienyl-bis(oxazolinyl)borato zirconium complex 
{PhB(C5H4)(Ox4S-iPr,Me2)2}Zr(NMe2)2 [{S-2}Zr(NMe2)2] catalyzes the cyclization of  achiral non-
conjugated aminodienes and aminodiynes to generate two stereocenters. One results from N−C 
bond formation via enantioselective hydroamination and other results from selection of one of 
the two diastereotopic unsaturated moieties. The desymmetrization of olefin moieties during 
enantioselective cyclohydroamination of aminodienes affords cyclic amines with high 
diasteromeric ratios and high enantiomeric excesses. Similarly, the desymmetrization of alkyne 
moieties in {S-2}Zr(NMe2)2-catalyzed cyclization of aminodiynes provide corresponding cyclic 
imines bearing quaternary stereocenters with enantiomeric excesses up to 93%. These 
stereoselective desymmetrization reactions are significantly affected by concentration of the 
substrate, temperature, and the presence of a noncyclizable primary amine. In addition, both the 
diastereomeric ratio and enantiomeric excess of the products are markedly enhanced by N-
deuteration of the substrates.  
 
                                                           
‡
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Introduction 
Asymmetric hydroamination of aminoolefins is a powerful approach for the synthesis of 
optically active nitrogen heterocycles, which are important in chemical and pharmaceutical 
industries.1 Despite marked advances of preparing highly enantioenriched 2-alkyl-
azacycles,2,3,4,5,6,7 challenges remain to improve the versatility of hydroamination for the 
synthesis of complex enantiopure heterocycles. Specifically, current enantioselective 
hydroamination catalysts are limited to generate a stereocenter at 2-position with respect to 
nitrogen of the cyclic amine.  
Strategies for synthesizing nitrogen hetreocycles bearing multiple stereocenters via 
hydroamination/cyclization of racemic aminoalkenes lead to the mixture of diastereomers. The 
cyclization of racemic α-alkyl substituted aminopentenes catalyzed by achiral lanthanocenes 
affords racemic 2,5-disubstituted pyrrolidines with high trans/cis diastereomeric ratio.8 The 
trans/cis ratio of product is sensitive to reaction temperature, substrate concentration, addition of 
non-cyclizable primary amine, and N-deuteration of substrate. Kinetic resolution of the racemic 
α-substituted aminopentenes using chiral hydroamination catalysts provide corresponding 2,5-
disubstituted pyrrolidines with excellent trans/cis ratios and moderate enantiomeric excesses.4c,4d 
The α-stereocenter in these racemic aminopentenes significantly affects the new stereocenter 
formed in enantioselective hydroamination due to the close proximity between the two 
stereocenters. Therefore, diastereomeric ratio of the cyclized products is highly dependent on the 
position of the existing stereocenter within the racemic aminoalkene; β-substituted racemic 
aminopentene provides corresponding pyrrolidine with equal amount of cis- and trans-
diastereomers.7b,8,9 However, enantioselective cyclization of achiral non-conjugated aminodienes 
generally provide azacycles with poor diastereomeric ratio.  
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In this context, developing enantioselective catalyst that can desymmetrize olefin 
moieties of achiral non-conjugated aminodienes during cyclohydroamination might improve the 
diastereomeric ratio of the products. Recently, a gold-catalyzed enantioselective synthesis of 
methylene pyrrolidines via desymmetrization of achiral 1,4-diynamides was reported.10 The 
cyclization of 1,4-diynamides provided methylene pyrrolidines bearing a quaternary stereocenter 
with enantioselectivities up to 93%. Herein, we disclose an interesting desymmetrization of 
achiral non-conjugated aminodienes during cyclization by a chiral zirconium catalyst to provide 
cyclic amines with high enantio- and diastereomeric excesses. The cyclization of achiral non-
conjugated aminodiynes also affords cyclic imines bearing a quaternary-stereocenter at 4-, 5-, 
and 6-positions with excellent enantioselectivity. 
 
Results and Discussion 
Catalytic hydroamination/cyclization of aminoalkenes and aminoalkynes 
Optically active cyclopentadienyl-bis(4S-isopropyl-5,5-dimethyl-2-oxazolinyl)borate- 
supported zirconium complex PhB(C5H4)(Ox4S-iPr,Me2)2Zr(NMe2)2 [{S-2}Zr(NMe2)2]11 is a 
precatalyst for cyclization 2-allyl-2-phenyl-pent-4-enylamine (1a) at room temperature to 
provide corresponding 4-allyl-2-methyl-4-phenylpyrrolidine (2b) as a mixture of diastereomers 
with cis-2b as the major product (eq 3.1). Both diastereomers are formed with high enantiomeric 
excess favoring R-configuration, but the ratio of cis- and trans-diastereomers is low (3.3:1). The 
assignment of the major isomer as cis is supported by NOE experiments in benzene-d6 in which 
irradiation of the 2-methyl signal of the major isomer (1.00 ppm) results in decreased intensity of 
the ortho- and meta-phenyl resonances at 7.27 ppm and 6.69 ppm. The 19F NMR spectrum of the 
(R)-Mosher amide of 2- methyl-pyrrolidine 2b contains two sharp upfield signals for the major 
113 
 
diastereomers and two broad downfield resonances for the minor diasteromers. Because the 19F 
NMR signals for R,R-Mosher amide of 2R-2-methyl-pyrrolidine are systematically upfield and 
sharp while the S,R-Mosher amide of 2S-2-methyl-pyrrolidines are downfield and broad, the 
configuration of the stereocenters resulting from C−N bond formation are equivalent (i.e. R) in 
the diastereomeric products. The poor cis/trans ratio, however high enantiomeric excess of each 
diastereomer suggest that the catalyst is not efficient in distinguishing the two olefins, but the N-
C bond formation is favored for the Re face for both olefins. 
NH2
Ph HN PhHN
Ph
1b-cis
+
1b-trans
Zr
B
O
N
O N
Ph
NMe2
NMe2
benzene, 23 °C
(3.1)
1a
{S-2}Zr(NMe2)2
 
Interestingly, the cis/trans ratio of the pyrrolidine 1b improves upon dilution of the 
reaction medium. As shown in Table 3.1, the cis/trans ratio increases on decreasing the substrate 
concentration using 10 mol % catalyst loading, while the enantioselectivity remains high. The 
cis/trans ratio 3.3:1 ([1a] = 65.4 mM, [{S-2}Zr(NMe2)2] = 6.54 mM) increased to 9:1 upon 
diluting the reaction mixture by 12 fold. The cis/trans ratio could be further improved to 12:1 
upon 30 fold dilution, albeit at the expense of an extended reaction time (Table 3.1; entry 5).  
Table 3.1. Catalytic cyclization of 2-allyl-2-phenyl-pent-4-enylamine (1a) with precatalyst {S-
2}Zr(NMe2)2 at different concentrations.a    
Entry [catalyst] 
mM 
[substrate-
1a] mM 
Time 
(h) 
Yield (%) d.r. b 
(cis:trans) 
% ee c 
(cis, trans) 
1 6.54 65.4 0.5 100 3.3:1 96.3, 95.9 
2 3.27 32.7 2 100 5:1 96.1, 95.5 
3 1.09 10.9 5 100 7.2:1 96.3, 95.3 
4 0.55 5.45 6 100 8.9:1 95.5, 95.4 
5 0.22 2.20 12 100 12:1 95.1, 94.8 
114 
 
a Reaction conditions: 10 mol % catalyst, r.t. b Diastereomeric ratios (cis:trans) were determined by 1H 
and/or 19F NMR spectra of Mosher amide derivatives. c The % ee values were determined by 19F NMR 
spectra of Mosher amide derivatives.  
 
The interesting effect of concentration on desymmetrization of 1a during cyclization 
catalyzed by {S-2}Zr(NMe2)2 led us to investigate whether variation of concentration of the 
substrate, catalyst, or both changes the diastereoselectivity. The cis/trans ratio of 1b is 
unchanged on varying the concentration of precatalyst {S-2}Zr(NMe2)2 (13.6 mM to 2.72 mM) 
keeping the substrate concentration unchanged (52.3 mM) (Figure 3.1). However, cis/trans ratio 
increases upon decreasing the substrate concentration (116 mM to 31 mM) at constant 
concentration of {S-2}Zr(NMe2)2 (6.45 mM) (Figure 3.2). The above experiments suggest that 
the desymmetrization of aminodiene is unaffected by catalyst concentration.  
 
 
Figure 3.1. Plot of d.r. (cis/trans) of 1b vs.                  Figure 3.2. Plot of d.r. (cis/trans) of 1b vs. 
[{S-2}Zr(NMe2)2] at constant [1a]ini                             [1a] (mM) at constant [{S-2}Zr(NMe2)2]  
 
When the cyclization of 1a is carried out in presence of amyl amine, the cis/trans ratio 
decreases. The cis/trans ratio of 1b decreases with increasing concentration of amylamine (Table 
3.4; entries 2, 3 & 4), which suggests that the coordination of an amine to the metal center favors 
trans product. Interestingly, the cis/trans ratio is unaffected by the presence of the product R-1b 
(cis:trans = 3.3:1). The ratio of cis-1b to trans-1b is the same (3.3:1) after cyclization of 1a in 
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the presence or absence of R-1b (Table 3.4; entry 5). Moreover, the cyclization of 1a in presence 
of S-1b (cis:trans = 3.3:1) don’t change cis/trans ratio of the product (Table 3.4; entry 6). 
 
Table 3.4. Cyclization of 2-allyl-2-phenyl-pent-4-enylamine (1a) catalyzed by {S-2}Zr(NMe2)2 
in presence of amyl amine or 1b. a 
NH2
Ph HN PhHN
Ph
1b-cis
+
1b-trans
Zr
B
O
N
O N
Ph
NMe2
NMe2
benzene, 23 °C
additive1a
 
Entry [catalyst] 
(mM) 
[1a]  
(mM) 
[additive] (mM) Time 
(h) 
Yield 
(%) 
d.r. b 
(cis:trans) 
% ee c 
(cis, trans) 
1 6.50 65.0 - 0.5 100 3.3:1 96.3, 95.9 
2 6.50 65.0 14.0 (amyl amine) 24 100 2.5:1 96, 96 
3 6.50 65.0 29.0 (amyl amine) 48 94 1.96:1 96, 96 
4 6.50 65.0 43.0 (amyl amine) 72 90 1.75:1 96, 96 
5 6.50 65.0 32.0 (R-1b) 24 95 3.2:1 n.a. 
6 6.50 65.0 32.0 (S-1b) 24 95 3.3:1 n.a. 
a Reaction conditions: 10 mol % catalyst, r.t. b cis/trans ratios were determined by 1H and/or 19F NMR 
spectra of Mosher amide derivatives. c The % ee values were determined by 19F NMR spectra of Mosher 
amide derivatives. 
 
A significant effect of temperature on both diastereomeric ratio and enantiomeric 
excesses of 1b was observed. The cis:trans increases on increasing temperature ranging from 0 
°C to 40 °C at constant concentration of 1a and {S-2}Zr(NMe2)2, and cis-1b is always the major 
diastereomer at any substrate concentration in this temperature range (Figure 3.3). However, the 
enantioselectivity decreases as temperature increases from −30 °C to 40 °C, and at 40 °C both 
diastereomers are obtained in poorer % ee than at −30 °C. The cis/trans ratio increases upon 
dilution of the reaction mixture at any temperature as shown in Figure 3.3. 
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Figure 3.3. Plots of d.r. (1b-cis:1b-trans) vs. [1a] at −30 °C, 0 °C, 23 °C, and 40 °C. 
 
Interestingly, cyclizations of 1a catalyzed by {S-2}Zr(NMe2)2 at −30 °C gives trans-1b 
as the major product. Impressively, both diastereomers are obtained in 99% ee (Figure 3.3; Table 
3.2, entry 4). On increasing concentration of the substrate from 32.7 M to 327 mM, the trans/cis 
ratio increases from 1.1:1 to 4.5:1 respectively (Table 3.2, entries 3 & 4). Hence, the formation 
of the trans product favors on increasing the substrate concentration and lowering the reaction 
temperature, whereas the cis product becomes favorable on decreasing substrate concentration 
and increasing temperature. Therefore, the ratio of the two diastereomers can be systematically 
tuned by controlling the substrate concentration, temperature of the reaction medium, and also by 
the addition of primary amine.  
The interesting desymmetrization of 1a during cyclization motivated further study of the 
cyclization of other achiral non-conjugated aminodienes in order to obtain cyclic amines with 
high diastereomeric ratio and enantiomeric excesses. The precatalyst {S-2}Zr(NMe2)2 cyclizes 2-
allyl-2-methyl-pent-4-enylamine (2a) to provide optically active 2,4,4-trimethylpyrrolidine (2b) 
in 92% yield with 93% (cis-2b) and 92% (trans-2b) ee. The cis/trans ratio is achieved up to 
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4.2:1 in diluted reaction medium ([2a] = 5.45 mM) at room temperature (Table 3.2, entry 7). 
Interestingly, the cyclization of 2a ([2a] = 327 mM) at −30 °C in presence of propylamine (100 
mM) affords 2b with 1:6.5 cis/trans ratio, and the trans-2b is the major product (Table 3.2, entry 
8). 
The desymmetrization of olefin moieties is also observed for halogen- and oxo-
functionalized aminodienes. 2-Allyl-2-(4-bromophenyl)pent-4-enylamine (4a) ([4a] = 65.4 mM) 
is cyclized within 0.5 h at room temperature to a  2:1 diastereomeric mixture of cis and trans 4-
allyl-2-methyl-4-(4-bromophenyl)pyrrolidine in 97% and 95% ee respectively (Table 3.2, entry 
11). Upon 12 fold dilution, the d.r. is increased to 9:1 with 95% ee of cis product (Table 3.2, 
entry 12). Similarly, cis isomer of 2-methyl-4-allyl-4-methoxypyrrolidine (5b) is obtained as a 
single enantiomer by hydroamination/cyclization of 5a (Table 3.2, entry 14). The assignment of 
the major isomer as cis-5b is supported by NOE experiments in benzene-d6 in which irradiation 
of the 2-H signal of the major isomer (3.26 ppm) results in decreased intensity of the olefin 
resonances at 5.86 and 5.04 ppm. 
 
Table 3.2. Hydroamination/cyclization of aminoalkenes catalyzed by {S-2}Zr(NMe2)2. a 
Substrate Product Entry [substrate]  
mM 
Time Yield  
% b 
d.r. 
(cis:trans) c 
% ee d 
(major, 
minor) 
NH2
Ph
1a
 
HN Ph
HN
Ph
1b-cis
+
1b-trans
 
1 
 
2 
 
3 
 
4 
 
5 
65.4 
 
5.45 
 
5.45 
 
327 
 
327 g 
0.5 h 
 
6 h 
 
4 d 
 
4 d 
 
6 d 
 
100 
 
100 
 
95 e 
 
95 e 
 
100 
3.3:1 (96) 
 
8.9:1 
 
1:1.1 
 
1:4.5 
 
1:6 
96, 96 
 
96, 95 
 
99, 99 f 
 
99, 99 
 
99, 99 
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NH2
2a
 
HN
HN
2b-cis
+
2b-trans
 
6 
 
 
7 
 
 
8 
65.4 
 
 
5.45 
 
 
327 g 
0.5 h 
 
 
2 d 
 
 
6 d 
 
100 
 
 
100 
 
 
100 e 
1.1:1 (92) 
 
 
4.2:1 
 
 
1:6.5 
93, 92 
 
 
93, 92 
 
 
96, 95 
NH2
Ph
3a
 
HN Ph
N
H
Ph
3b-cis
+
3b-trans
 
9 
 
 
10 
65.4 
 
 
10.9 
 
4 d 
 
 
8 d 
87 
 
 
81 
2:1 
 
 
8:1 
93, 95 
 
 
92, 93 
NH2
C6H4Br
4a
 
HN C6H4Br
HN
C6H4Br
4b-cis
+
4b-trans
 
11 
 
 
12 
65.4 
 
 
5.45 
0.5 h 
 
 
3 h 
100 
 
 
100 
4:1 (94) 
 
 
8.9:1 
97, 95 
 
 
95 (cis) 
NH2
OMe
5a
 
HN OMe
HN
OMe
5b-cis
+
5b-trans
 
13 
 
 
14 
327 
 
 
65.4 
48 h 
 
 
48 h 
90 
 
 
90 
10:1 
 
 
55:1 
 
 
97 (cis) 
 
 
97 (cis) 
6a
NH2
Ph
 6b
HN
Ph
 
15 
 
16 
65.4 
 
5.45 
 
 
3 d 
 
4 d 
 
90 
 
85 
2.9:12 
 
6.6:1 
 
 
33, 12 f 
 
32, 12 f 
 
7a
NH2
Ph
 
HN
7b Ph
 
17 
 
18 
65.4 
 
16.4 
4 d 
 
6 d 
90 
 
86 
2.8:1 
 
7.1:1 
89, 92 
 
89, 91 
a Reaction conditions: 10 mol % catalyst, r.t. b Yield of isolated product is given in parentheses. c cis/trans 
ratios were determined by 1H and/or 19F NMR spectra of Mosher amide derivatives. d % ee (±0.5%) was 
determined by 19F NMR spectra of Mosher amide derivatives. e  −30 °C. f  The % ee values were verified 
by HPLC.  g  Cyclization was done in presence of propyl amine (100 mM). 
 
119 
 
The effect of concentration on diastereomeric ratio is also observed in the cyclization of 
aminohexenes and aminoheptenes. The rate of cyclization of aminohexene 6a is significantly 
slower than for the aminopentenes. Additionally, the enantiomeric excesses of both cis and trans 
diastereomers of the product 5-(homoallyl)-5-phenyl-2-methyl-piperidine (6b) are marked lower 
compared to that for the pyrrolidines. The ratio of cis-6b to trans-6b is obtained up to 6.6:1 at 
room temperature (Table 3.2, entries 15 & 16). In contrast to 2-methylpiperidine (6b), 2-
methylazepane 7b is obtained with 7.1:1 cis/trans ratio and higher enantiomeric excesses (89% 
(cis) and 92% (trans) ee; Table 3.2, entry 18) at room temperature ([6a] = 16.4 mM). 
The desymmetrization of non-conjugated aminodienes catalyzed by precatalyst {S-2}Zr(NMe2)2 
inspired us to prepare enantioenriched cyclic imines from non-conjugated aminodiynes. The fact 
is, the alkynes desymmetrization is suggested by the observation that C−N stereocenter and 
desymmetrization stereocenter are inequivalently affected by the reaction conditions. The 
hydroamination/cyclization of 2-(but-2-ynyl)-2-phenylhex-4-yn-1-amine (8a) ([8a] = 6.54 mM) 
generates the corresponding cyclic imine 8b bearing a quaternary stereogenic center at the 4-
position in 95% yield with 87% ee (Table 3.3, entry 1). 8b with 91% ee is achieved upon 
performing the catalysis in 12 fold diluted reaction mixture (Table 3.3, entry 2). The cyclization 
of aminodiyne 9a requires longer reaction time than 8a. The 6-membered cyclic imine 9b is 
obtained with 93% yield and 71% ee at room temperature ([9a] = 65.4 mM). Enantioselectivity 
increases to 77% after performing the reaction with 5.45 mM of 9a (Table 3.3, entry 4). The 
enantioenriched nitrogen heterocycles bearing quaternary stereocenters are difficult to prepare in 
enatioenriched form by other methods and are found in many natural products and drug 
molecules such as (+)-Vincamine, Quadrigemine C, and Capnellene.13,14 
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Table 3.3. Hydroamination/cyclization of aminoalkynes catalyzed by {S-2}Zr(NMe2)2. a 
Substrate Product Entry [substrate] 
mM 
Time 
 
%  
conversion b 
 
% ee c 
 
NH2
Ph
8a
 
N
Ph
8b
 
1 
 
2 
65.4 
 
5.45 
 
40 min 
 
2 h 
100 (95) 
 
100 
87  
 
91  
NH2
Ph
9a
 
 
N
Ph
9b
 
3 
 
4 
65.4 
 
5.45 
20 h 
 
48 h 
 
 
100 (93) 
 
100 
71 
 
77 
NH2
Ph
Ph
Ph 10a
 
N
Ph
PhPh
10b
 
 
5 
 
 
 
5.45 
 
72 h 
 
100 
 
84 
a  Reaction conditions: 10 mol % catalyst, r.t. b Yield of isolated product is given in parentheses. c The % 
ee values were determined by HPLC using a chiral stationary phase column. 
 
Catalytic reaction mechanism 
We then turned our attention to the mechanistic features to gain insight of the 
desymmetrization processes. HNMe2 and pyrrolidine 1b was observed within 30 s of addition of 
1a to the toluene solution of precatalyst {S-2}Zr(NMe2)2. Although the active catalyst is not 
directly observed at room temperature by in situ 1H NMR spectroscopy of the reaction mixture, 
any correlation between desymmetrization pathway and change of catalyst structure can be 
eliminated by our previous observation of independency of d.r. on precatalyst concentration as 
discussed before.  
The cis/trans ratio of 1b was monitored as a function of % conversion during the course 
of the reaction and is plotted in Figure 3.4. The plot shows that the cis/trans ratio increases on 
increasing % conversion of substrate 1a. At low conversion (14-25% i.e. at higher substrate 
concentration), the cis/trans ratio of 1b is low. This plot suggests that the speciation of the 
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catalyst changes with substrate concentration. Interestingly, the % ee of 1b remain unchanged 
from 30-77% conversion, and then the enantioselectivity begins to drop as shown in Figure 3.5. 
These experiments suggest that the stereocenter formed from desymmetrization and the 
stereocenter adjacent to nitrogen formed by hydroamination are not controlled by the same step.  
 
 
Figure 3.4. Plot showing the correlation of d.r. (cis:trans) of pyrrolidine product 1b with 
catalytic conversion of substrate 1a. 
 
 
Figure 3.5. Plot showing the correlation of enantiomeric excess of pyrrolidine product 1b with 
catalytic conversion of substrate 1a. 
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The Figure 3.4 provides a hint at coordination of additional substrates to the metal center might 
have a profound role for desymmetrizing olefin moieties.  
The desymmetrization pathway was further characterized by kinetic studies. Ln[1a] 
varies linearly with time for two half-lives to provide kobs. The rate law of the catalytic 
conversion of 1a –d[1a]/dt = k[1a]1[{S-2}Zr(NMe2)2]1 (k = 0.125 M−1 s−1) is established by 
linear plot of kobs vs. [{S-2}Zr(NMe2)2]. In case of cyclization of aminodiyne 8a by {S-
2}Zr(NMe2)2, a similar second order rate law –d[1a]/dt = k'[1a]1[{S-2}Zr(NMe2)2]1 (k' = 
0.175(8) M−1 s−1)  is established for two half-lives. Conversion of 2-(but-2-ynyl)-2-phenylhex-4-
yn-1-amine-ND2 (8a-d2), catalyzed by {S-2}Zr(NMe2)2, is much slower than conversion of 8a 
itself. Linear least squares best fits of plots of k'obs(D) versus catalyst concentration provide the 
second-order rate constant k'(D) (0.042(2) M−1 s−1). The large k'obs(H)/ k'obs(D) value (4.18 (4)) that is 
consistent with a primary isotope effect, suggests an N–H or N–D bond is broken in the 
turnover-limiting step (Figure 3.6).  
 
Figure 3.6. Plots of pseudo first order rate constants (k'obs) vs. catalyst concentration for proteo- 
and deuteron-substrate. Reactions were performed at 23 °C in toluene-d8. 
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Notable, the desymmetrization of aminodienes and aminodiynes is significantly affected 
by N-deuteration of substrates. The cyclization of N-deuterated aminodienes provides deuteron-
azacycles with cis/trans ratio and ee values that are systematically and significantly higher than 
those values of the corresponding proteo-analogs (Table 3.5). In the most dramatic example, the 
cis/trans ratio of 1b increases from 8:1 to 31:1, and the ee of major cis-1b is also improved from 
95% to 99% upon N-deuteration of the substrate 1a under identical reaction conditions (Table 
3.5; entry 1 & 2). Interesting, both N-deuteration and dilution of substrate favor the cis-
diastereomer. The N-deuteration of aminodiynes also drastically increases the % ee of 5- and 6-
membered cyclic imines (Table 3.5; entry 5 & 6; entry 7 & 8).   
 
Table 3.5. The d.r. and % ee values for proteo- and deuteron-pyrrolidines obtained by 
hydroamination/cyclization of aminoalkenes and aminoalkynes catalyzed by {S-2}Zr(NMe2)2. a 
 Entry d.r. b % eec 
HN PhHN
Ph
1b-cis
+
1b-trans
NH2
Ph
1a
DN PhDN
Ph
1b-d2 (cis)
+
1b-d2 (trans)
DH2CDH2C
ND2
Ph
1a--d2
 
 
1 
 
 
 
 
2 
 
8:1 
 
 
 
 
31:1 
 
95.5, 95.4 
(cis, trans) 
 
 
 
99.6 (major-
cis) d 
 
HNHN
2b-cis
+
2b-trans
NH2
2a
DNDN
2b-d2 (cis)
+
2b-d2 (trans)
DH2CDH2C
ND2
2a--d2
 
 
3 
 
 
 
 
4 
 
2.7:1 
 
 
 
 
5.3:1 
 
93, 92 
(cis, trans) 
 
 
 
98, 95 
(cis, trans) 
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NH2
Ph
N
Ph8a 8b
ND2
Ph
N
Ph8a-d2 8b-d2
 
 
5 
 
 
 
 
6 
 
n.a. 
 
 
 
 
n.a. 
 
91d 
 
 
 
 
93 d 
NH2
Ph N
Ph9a
9b
ND2
Ph
N
Ph9a-d2 9b-d2
 
 
7 
 
 
 
 
 
8 
 
n.a. 
 
 
 
 
n.a. 
 
77d 
 
 
 
 
81 d 
a Reaction conditions: 10 mol % catalyst, r.t. b cis/trans ratios were determined by 19F NMR spectra of 
Mosher amide derivatives. c The % ee values were determined by 19F NMR spectra of Mosher amide 
derivatives. d  % ee was verified by HPLC. 
 
The H (or D) atom from the amine is central to the step that determine stereochemistry, 
which rule out the intramolecular [2π+2π] cycloaddition of a Zr-imidoolefin species in the 
catalytic cycle, because of the lack of NH (or ND) group in the imido moiety.  
To test the valence require of zirconium center for catalysis, the complex PhB(Ox4S-
iPr,Me2)2CpZrCl(NMe2) ({S-2}ZrCl(NMe2)) having one available valency was added to 10 equiv 
of aminodiene 1a or aminodiyne 8a. HNMe2 was formed immediately after addition of substrate 
to a toluene solution of {S-2}ZrCl(NMe2). However, no cyclization of aminoolefin was observed 
at room temperature, even at higher temperature up to 150 °C. This result is therefore 
inconsistent with the insertive pathways involving the insertion of olefin into a Zr-amido bond as 
the C−N bond forming step. 
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Taken together, all the accumulated data including rate law, the KIE, isotopic 
perturbation on enantioselectivity, and the inactivity of {S-2}ZrCl(NMe2) complex in cyclization 
of aminodiene and aminodiyne eliminate olefin insertion and [2π+2π] cycloaddition as possible 
mechanisms for {S-2}Zr(NMe2)2-catalyzed enantioselective C−N bond formation. Our kinetic 
and spectroscopic data rather suggest C−N and C−H bond formation and cleavage of the N−H 
bond of {S-2}Zr(amidoolefin)2 ({S-2}Zr(NHR)2) species occurring in a concerted fashion in the 
turnover-limiting step.  
However, our experimental data suggest that the desymmetrization of olefin moieties and 
enantioselective C-N bond formation are not controlled by the same step. The speciation of the 
catalyst changes on increasing primary amine concentration. The formation of trans diastereomer 
is more favorable on increasing substrate concentration and also in presence of primary amine 
additive. Our working rationalization of the cis/trans selectivity is that the reversible associate of 
catalyst {S-2}Zr(NHR)2 with primary amine generates catalytically active {S-
2}Zr(NHR)2(NH2R) intermediate, which favor trans-diastereomeric product.  
                  Scheme 1 
{S-2}Zr(NHR)2   +    RNH2 {S-2}Zr(NHR)2(NH2R)
cis product trans product
 
 
Conclusions 
In conclusion, the desymmetrization of achiral aminodienes in 
hydroamination/cyclization catalyzed by precatalyst {S-2}Zr(NMe2)2 affords cyclic amines with 
excellent diastereomeric ratio and enantiomeric excesses. The cis/trans ratio of cyclic amines can 
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be systematically tuned by controlling substrate concentration, reaction temperature, and N-
deuteration of substrate. The two stereocenters, one results from desymmetrization of alkene 
moieties and other forms from enantioselective hydroamination, are not controlled by the same 
step. We have extended the synthetic utility of {S-2}Zr(NMe2)2-catalyzed desymmetrization 
reaction to aminodiynes, which provide cyclic imines with excellent optical purities. 
Furthermore, the cyclization of aminodiynes affords enantioenriched 5-, 6-, and 7-membered 
cyclic imines bearing a quaternary stereogenic center. Therefore, the mixed cyclopentadienyl-
bis(oxazolinyl)borate ligand with zirconium highlights the potential for this class of ligands in 
asymmetric catalysis. 
 
Experiment details. 
General Procedures. All reactions were performed under a dry argon atmosphere using 
standard Schlenk techniques or under a nitrogen atmosphere in a glove box unless otherwise 
indicated. Dry, oxygen-free solvents were used throughout. Benzene, toluene, pentane and 
tetrahydrofuran were degassed by sparging with nitrogen, filtered through activated alumina 
columns, and stored under N2. Benzene-d6, toluene-d8 and tetrahydrofuran-d8 were vacuum 
transferred from Na/K alloy and stored under N2 in a glove box. PhB(C5H5)(Ox4S-
iPr,Me2)2Zr(NMe2)2,11 2-allyl-2-phenylpent-4-enylamine (1a),17 2-allyl-2-methylpent-4-enylamine 
(2a),11a,18 2-allyl-2-(4-bromophenyl)pent-4-enylamine (4a),6 and 2-(but-2-ynyl)-2-phenylhex-4-
yn-1-amine (8a)19 were prepared by published procedures. All aminoalkenes and alkynes were 
distilled from CaH2, degassed and stored with freshly activated 4 Å molecular sieves in a glove 
box prior to use. All other chemicals used here are commercially available. (+)-(S)-α-methoxy-α-
(trifluoromethyl)phenylacetyl chloride (S-Mosher’s chloride) was obtained from Alfa-Aesar 
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(>98%, (+)-137.3). 1H, 13C{1H} NMR spectra were collected either on a Bruker DRX-400 
spectrometer, Bruker Avance III 700 spectrometer or an Agilent MR 400 spectrometer. 15N 
chemical shifts were determined by 1H-15N HMBC experiments either on a Bruker Avance III 
700 spectrometer or on a Bruker Avance III 600 spectrometer. 15N chemical shifts were 
originally referenced to liquid NH3 and recalculated to the CH3NO2 chemical shift scale by 
adding −381.9 ppm. 11B NMR spectra were referenced to an external sample of BF3·Et2O. 
Accurate mass ESI mass spectrometry was performed using an Agilent QTOF 6530 equipped 
with the Jet Stream ESI source. An Agilent ESI test mix was used for tuning and calibration. 
Accurate mass data was obtained in the positive ion mode using a reference standard with ions at 
121.05087 and 922.00979. The mass resolution (FWHM) was maintained at 18,000. Elemental 
analysis was performed using a Perkin-Elmer 2400 Series II CHN/S by the Iowa State Chemical 
Instrumentation Facility. [α]D values were measured on a ATAGO AP-300 polarimeter at 23 °C. 
 
2-Allyl-2-methoxypent-4-enylamine. A flame dried Schlenk flask was charged with 
diisopropylamine (11.7 mL, 83.1 mmol) and dissolved in 50.0 mL THF. The flask was cooled to 
−78 °C and nBuLi (33.2 mL, 83.1 mmol, 2.50 M solution in hexanes) was added drop wise. The 
resulting solution was stirred for 90 min at 0 °C. 47.4 mL of this solution of lithium 
diisopropylamide (LDA) was transferred to a dropping funnel, fitted with a dried 2-neck flask 
containing methoxyacetonitrile (3.0 mL, 40.3 mmol) in THF (40.0 mL). The flask was cooled to 
−78 °C and the LDA solution was added drop wise over 20 min. The resultant yellow slurry was 
stirred for 90 min at this temperature and then was treated with allyl bromide (3.41 mL, 39.4 
mmol) drop wise and the solution became clear yellow. The solution was stirred for another 15 
min at −78 °C and was then allowed to warm to room temperature. After stirring for 90 min at rt, 
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the solution was cooled back to −78 °C, and the second part of LDA was added over 20 min. The 
solution was allowed to warm to 0 °C and was stirred for 70 min. After cooling back to –78 °C 
the solution was treated with allyl bromide (4.20 mL, 48.5 mmol). The reaction mixture was 
allowed to warm slowly to room temperature and stirred overnight. The reaction was quenched 
by addition of water (10 mL), and the solvent was removed in vacuo (40 °C, 130 mbar). The 
residue was taken up with Et2O (200 mL), washed with water (2 x 30 mL) and brine (50 mL), 
dried over Na2SO4. Concentration in vacuo (40 °C, 200 mbar) gave a red oil, which was distilled 
(88-90 °C, 30 mm Hg) to give 2-allyl-2-methoxypent-4-enenitrile as a colorless oil (1.20 g, 8.75 
mmol, 21.7%). 1H NMR (chloroform-d, 400 MHz): δ 5.86-5.75 (m, 2 H, CH=CH2), 5.27-5.21 
(m, 4 H, CH=CH2), 3.48  (s, 3 H, OCH3), 2.55 (d, 3JH-H = 7.2 Hz, 4 H, H2C=CHCH2). 
An oven dried two-neck Schlenk flask fitted with reflux condenser was charged with LiAlH4 
(0.500 g, 13.2 mmol). The flask was cooled to 0 °C and diethyl ether (100 mL) was added. To 
the suspension at 0 °C, 2-Allyl-2-methoxypent-4-enenitrile (0.600 g, 4.37 mmol) was added drop 
wise. The resultant solution was stirred overnight at room temperature. Then, the solution was 
cooled to 0 °C and 2 mL water was added slowly drop wise. The solution was stirred 1 h at room 
temperature. The ether solution was decanted and the white precipitation was extracted with 
diethyl ether (3 × 50 mL). All the organic solutions were combined, dried with Na2SO4 and 
filtered. The solvent was removed under vacuo to give crude 2-allyl-2-methoxypent-4-
enylamine. Vacuum distillation (65-67 °C, 9 mm Hg) of the crude product afforded the pure 2,2-
diethoxypent-4-enenylamine as a colorless oil (0.610 g, 3.93 mmol, 89.9%), which was stored in 
glove box with activated molecular sieve. 1H NMR (benzene-d6, 400 MHz): δ 5.86-5.76 (m, 2 H, 
CH=CH2), 5.04-5.00 (m, 4 H, CH=CH2), 2.94 (s, 3 H, OCH3), 2.52 (s, 2 H, NH2CH2), 2.18 (d, 
3JH-H = 7.2 Hz, 4 H, =CHCH2), 0.62 (br s, 2 H, NH2). 13C{1H} NMR (benzene-d6, 100.6 MHz): 
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δ 134.93 (CH=CH2), 117.67 (CH=CH2), 79.06 (C(OCH3)), 48.94 (OCH3), 45.79 (CH2NH2), 
38.10 (=CHCH2). 15N NMR (benzene-d6, 61 MHz): δ −366.1. IR (KBr, cm-1): 3389 m, 3319 w, 
3075 s, 3007 m, 2977 s, 2937 s, 2827 s, 1832 w, 1638 s, 1618 m, 1459 s, 1433 s, 1415 m, 1318 
w, 1293 w, 1262 w, 1211 m, 1183 m, 1153 w, 1079 s, 997 s, 914 s, 864 s, 821 w, 768 s, 703 w, 
670 w. MS (ESI) exact mass Calcd for C9H17NO: m/z 156.1383 ([M++H+]), Found: 156.1381 (∆ 
1.23 ppm).  
 
2-Homoallyl-2-phenyl-hex-5-enylamine. A flame-dried Schlenk flask was charged with 
diisopropylamine (5.30 mL, 37.8 mmol) and 50.0 mL of THF. The flask was cooled to −78 °C 
and nBuLi (15.2 mL, 38.0 mmol, 2.50 M solution in hexanes) was added in a drop wise fashion. 
The resulting solution was stirred for 60 min at 0 °C. 36.0 mL of this solution of lithium 
diisopropylamide (LDA) was transferred to a dropping funnel, fitted with a dried 3-neck flask 
with a water condenser containing phenylacetonitrile (2.10 mL, 18.2 mmol) in THF (50 mL). 
The flask was cooled to −78 °C and the LDA solution was added drop wise over 10 min. The 
resultant yellow solution was stirred for 90 min at this temperature and was then treated with 4-
bromo-1-butene (1.80 mL, 17.7 mmol) drop wise. The solution was stirred for another 15 min at 
−78 °C and was then allowed to warm to room temperature. After stirring for 90 min at rt, the 
solution was cooled back to –78 °C, and the second part of LDA was added over 10 min. The 
solution was allowed to warm to 0 °C and was stirred for 90 min. After cooling back to −78 °C, 
the solution was treated with 4-bromo-1-butene (2.20 mL, 21.7 mmol). The resultant yellow 
reaction mixture was allowed to warm slowly to room temperature and stirred overnight. The 
reaction was quenched by addition of water (5 mL), and the solvent was removed in vacuo. The 
residue was taken up with Et2O (150 mL), washed with water (2 × 25 mL) and brine (1 × 25 
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mL), and dried over Na2SO4. Concentration in vacuo gave 2-homoallyl-2-phenyl-hex-5-
enenitrile (4.00 g, 17.8 mmol, 97.8%) as a light yellow oil, which was sufficiently pure for the 
next step and was used without any purification. 
An oven-dried 2-neck Schlenk flask fitted with a reflux condenser was charged with  LiAlH4 
(3.00 g, 79.1 mmol). The flask was cooled to 0 °C and diethyl ether (150 mL) was added. 2-
homoallyl-2-phenyl-hex-5-enenitrile (4.00 g, 17.8 mmol) was added in a drop wise manner to the 
suspension. The resulting mixture was stirred overnight at room temperature. Then, the solution 
was cooled to 0 °C and water (5 mL) was added in a drop wise fashion. The solution was 
allowed to stir for 1 h at room temperature. The ether layer was decanted and the white 
precipitate was extracted with diethyl ether (4 × 70 mL). All the organic solutions were 
combined, dried with Na2SO4, and filtered. The solvent was removed under reduced pressure to 
give crude 2-homoallyl-2-phenyl-pent-4-enylamine. The crude product was stirred with CaH2 
under argon for 3 days and then vacuum distilled (115-120 °C, 0.5 mm Hg) to afford the pure 2-
homoallyl-2-phenyl-pent-4-enylamine as a colorless oil (4.10 g, 15.3 mmol, 86.0%), which was 
stored in glove box with activated 4 Å molecular sieves. 1H NMR (chloroform-d, 400 MHz): δ 
7.35-7.17 (m, 5 H, C6H5), 5.84-5.74 (m, 2 H, CH=CH2), 5.01-4.91 (m, 4 H, CH=CH2), 2.91 (s, 2 
H, CH2NH2), 1.93-1.75 (m, 8 H, H2C=CHCH2CH2), 0.76 (br s, 2 H, CH2NH2). 13C{1H} NMR 
(100 MHz, chloroform-d): δ 145.22 (C6H5), 139.05 (CH=CH2), 128.50 (C6H5), 126.81 (C6H5), 
126.02 (C6H5), 114.41 (CH=CH2), 48.82 (CH2NH2), 45.34 [C(C6H5)], 34.15 (=CHCH2CH2), 
28.05 (=CHCH2CH2). 15N NMR (chloroform-d, 61 MHz): δ −369.6. IR (KBr, cm-1): 3388 w, 
3322 w, 3076, 3030 s, 2997 s, 2975 s, 2934 s, 2867 s, 1824 w, 1640 s, 1601 m, 1580 s, 1541 w, 
1498 s, 1461 s, 1445 s, 1415 m, 1363 w, 1310 w, 1195 w, 1157 w, 1076 m, 1034 m, 995 s, 910 s, 
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815 s, 758 s, 700 s. MS (ESI) exact mass Calculated for C16H23N: m/z 230.1903 ([M++H+]), 
Found: 230.1897 (∆ 2.73 ppm). 
 
2-(2-Butenyl)-2-phenyl-hex-4-enylamine. A flame-dried Schlenk flask was charged with 
diisopropylamine (2.50 mL, 17.8 mmol) and 50.0 mL of THF. The flask was cooled to −78 °C 
and nBuLi (7.10 mL, 17.9 mmol, 2.50 M solution in hexanes) was added in a drop wise fashion. 
The resulting solution was stirred for 60 min at 0 °C. 30.0 mL of this solution of lithium 
diisopropylamide (LDA) was transferred to a dropping funnel, fitted with a dried 3-neck flask 
with a water condenser containing phenylacetonitrile (1.0 mL, 8.66 mmol) in THF (50 mL). The 
flask was cooled to −78 °C and the LDA solution was added drop wise over 10 min. The 
resultant yellow solution was stirred for 90 min at this temperature and was then treated with 
crotyl bromide (1.10 mL, 8.50 mmol, 85% purity from Aldrich) drop wise. The solution was 
stirred for another 15 min at −78 °C and was then allowed to warm to room temperature. After 
stirring for 90 min at rt, the solution was cooled back to –78 °C, and the second part of LDA was 
added over 10 min. The solution was allowed to warm to 0 °C and was stirred for 90 min. After 
cooling back to −78 °C, the solution was treated with crotyl bromide (1.30 mL, 10.4 mmol). The 
resultant yellow reaction mixture was allowed to warm slowly to room temperature and stirred 
overnight. The reaction was quenched by addition of water (2 mL), and the solvent was removed 
in vacuo. The residue was taken up with Et2O (100 mL), washed with water (2 × 15 mL) and 
brine (1 × 20 mL), and dried over Na2SO4. Concentration of the solution in vacuo gave a light 
yellow, which was purified by silica gel column chromatography (hexane : Et2O = 10:1; Rf = 
0.75) to yield 2-(2-butenyl)-2-phenyl-hex-4-enenitrile as colorless oil (1.42 g, 6.30 mmol, 
72.8%). 
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An oven-dried 2-neck Schlenk flask fitted with a reflux condenser was charged with LiAlH4 
(0.620 g, 16.3 mmol). The flask was cooled to 0 °C and diethyl ether (100 mL) was added. 2-
homoallyl-2-phenyl-hex-5-enenitrile (1.22 g, 5.41 mmol) was added in a drop wise manner to the 
suspension. The resulting mixture was stirred overnight at room temperature. Then, the solution 
was cooled to 0 °C and water (2.5 mL) was added in a drop wise fashion. The solution was 
allowed to stir for 1 h at room temperature. The ether layer was decanted and the white 
precipitate was extracted with diethyl ether (4 × 70 mL). All the organic solutions were 
combined, dried with Na2SO4, and filtered. The solvent was removed under reduced pressure to 
give crude 2-(2-Butenyl)-2-phenyl-hex-4-enylamine. The crude product was stirred with CaH2 
under argon for 2 days and then vacuum distilled (116-120 °C, 0.01 mm Hg) to afford the pure 
2-(2-butenyl)-2-phenyl-hex-4-enylamine as a colorless oil, which was stored in glove box with 
activated 4 Å molecular sieves (0.950 g, 4.15 mmol, 76.6%). 1H NMR (chloroform-d, 400 
MHz): δ 7.36-7.29 (m, 4 H, C6H5), 7.18 (m, 1 H, C6H5), 5.50-5.42 (m, 2 H, MeHC=CHCH2), 
5.28-5.18 (m, 2 H, MeHC=CHCH2), 2.86 (s, 2 H, CH2NH2), 2.36 (d, 2JHH = 7.2 Hz, 4 H, 
MeHC=CHCH2), 1.61 (d, 2JHH = 6.0 Hz, 6 H, MeHC=CHCH2), 0.79 (br s, 2 H, CH2NH2). 
13C{1H} NMR (100 MHz, chloroform-d): δ 145.07 (C6H5), 128.44 (C6H5), 128.06 (CH=CH2), 
127.16 (CH=CH2), 126.99 (C6H5), 125.98 (C6H5), 49.25 (CH2NH2), 46.17 [C(C6H5)], 38.68 
MeHC=CHCH2), 18.29 MeHC=CHCH2). 15N NMR (chloroform-d, 61 MHz): δ −369.3. IR 
(KBr, cm-1): 3391 w, 3323 w, 3089 m, 3058 s, 3023 s, 2917 s, 2855 s, 2732 s, 1945 w, 1871 w, 
1802 w, 1744 w, 1668 w, 1601 s, 1582 m, 1498 s, 1445 s, 1377 s, 1342 w, 1310 w, 1247 w, 1076 
m, 1036 m, 1003 m, 970 s, 915 m, 865 s, 809 s, 758 s.  
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4-Allyl-2-methoxy-2-methyl-pyrrolidine. 1H NMR  (chloroform-d, 400 MHz): δ 5.85-5.71 (m, 
CH=CH2), 5.09-5.03 (m, CH=CH2), 3.29-3.21 (m, CHMeNH), 3.07 (s, OCH3), 3.06 (s, OCH3), 
3.03-2.98 (m, CHMeNH), 2.89 (d, 2JHH = 12 Hz, CH2NH), 2.75 (d, 2JHH = 12 Hz, CH2NH), 2.27 
(d, 3JHH = 7.2 Hz,  CH2CH=CH2), 2.18 (d, 3JHH = 7.2 Hz,  CH2CH=CH2), 2.01-1.96 (m, 
CH2CHMe), 1.72-1.67 (m, CH2CHMe), 1.41-1.36 (m, CH2CHMe), 1.31 (br, NH), 1.12 (d, 3JHH = 
6.0 Hz, CHMeNH), 1.05 (d, 3JHH = 6.0 Hz, CHMeNH). 13C{1H} NMR (benzene-d6, 100.6 
MHz): δ 134.84 (CH=CH2), 134.33 (CH=CH2), 118.17 (CH=CH2), 117.89 (CH=CH2), 87.59 
[C(OCH2CH3)2], 87.17 [C(OCH2CH3)2], 57.08 (CH2NH), 56.34 (CH2NH), 55.22 (CHMeNH), 
53.92 (CHMeNH), 50.27 (OCH3), 44.84 (CH2CH=CH2), 44.59 (CH2CH=CH2), 40.22 
(CH2CHMe), 39.69 (CH2CHMe), 21.97 (CHMe), 21.77 (CHMe). IR (KBr, cm-1): 3075 m, 2962 
s, 2030 s, 2826 m, 1640 s, 1542 w, 1457 s, 1432 s, 1378 m, 1350 w, 1321 s, 1263 m, 1225 w, 
1161 w, 1079 s, 997 m, 914 m, 810 m, 764 w. MS (ESI) exact mass Calcd for C9H17NO: m/z 
156.1383 ([M++H+]), Found: 156.1380 (∆ 1.87 ppm). 
 
5-(Homoallyl)-5-phenyl-2-methyl-piperidine. 1H NMR (chloroform-d, 400 MHz): δ 7.32-7.05 
(m, C6H5), 5.66-5.57 (m, CH=CH2), 4.91-4.87 (m, CH=CH2), 3.50 (m, CHMeNH), 3.08 (m, 
CHMeNH), 2.63-2.60 (m, CH2NH), 2.52-2.47 (m, CH2NH),   2.17 (m, CH2CH2CH=CH2), 1.78-
1.23 (m, CH2CH2CH=CH2, CH2CH2CHMe), 0.95 (d, 3JH,H = 6.0 Hz, CHMeNH), 0.81 (d, 3JH,H = 
6.0 Hz, CHMeNH). 13C{1H} NMR (100 MHz, chloroform-d): δ 143.98 (C6H5), 139.23 
(CH=CH2), 128.69 (C6H5), 127.64 (C6H5), 125.78 (C6H5), 114.10 (CH=CH2), 53.09 (CH2NH),  
43.85 (CH2CH2CH=CH2), 40.81 (CHMeNH), 39.14 (C(C6H5)), 35.17 (CH2CH2CH=CH2),  31.57 
(CH2CH2CHMe), 27.94 (CH2CH2CHMe), 22.72 (CHMe). 15N NMR (chloroform-d, 61 MHz): 
δ −333.5, −334.9. IR (KBr, cm-1): 3060 m, 3023 m, 2928 s, 2856 s, 2796 m, 2737 m, 1945 w, 
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1871 w, 1817 w, 1640 s, 1601 m, 1580 w, 1497 s, 1447 s, 1415 w, 1376 s, 1319 w, 1191 w, 1157 
w, 1131 m, 1114 m, 1078 w, 995 m, 909 s, 851 m, 805 w, 759 s, 737 s, 700 s. MS (ESI) exact 
mass calculated for C16H23N: m/z 230.1903 ([M++H+]), Found: 230.1861. 
 
Procedure for determination of enantiomeric excess of pyrrolidine products.  
NMR spectroscopy. Benzene (3 mL) and triethylamine (5.0 equivalent based on the amount of 
aminoalkene used during catalysis) were added to the purified pyrrolidine. To this solution, (+)-
(S)-α-methoxy-α-(trifluoromethyl)phenylacetyl chloride (1.2 equivalent based on the amount of 
aminoalkene used during catalysis) was added. The solution was mixed and immediately a white 
suspension appeared ([HNEt3][Cl]). The mixture was stirred for 1 h, and all the solvents were 
removed under vacuum. The white residue was extracted with pentane. Pentane was removed 
under vacuum to give the corresponding Mosher-amide as a clear colorless oil. No further 
purification was performed, since crystallization, chromatography, or sublimation could result in 
biased results by separation of the diastereomers. The enantioselectivities were determined by 
either integration of 1H NMR (23 °C, CDCl3) or 19F NMR (60 °C, CDCl3) signals; these were 
referenced to literature values and compared against authentic diastereomers of racemic samples 
reproduced in our laboratory.  
HPLC analysis. The enantiomeric excess of chiral pyrrolidines, piperidines, and cyclic imines 
were determined by HPLC analysis (flow rate = 1.0 mL/min, λ = 254 nm) using Regis (S,S)-
Whelk O1 column (Spherical Kromasil® Silica, column dimensions = 25 cm × 4.6 mm i.d., 
particle size = 5 µm, 100 Å). The chiral pyrrolidines and piperidines were converted to their 
benzoyl-derivative prior to HPLC analysis. Pure sample of cyclic imines were used to determine 
their enantiomeric excesses by HPLC. 
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Typical procedure of derivatization of pyrrolidines and piperidines: In a glove box, benzoyl 
chloride (1.05 equiv.) was added to a CH2Cl2 solution of pyrrolidine (1.0 equiv.) and 
triethylamine (3.0 equiv.) at room temperature. The resultant mixture was stirred for 2 h, and 
then the volatile materials were removed by rotary evaporation giving a white solid. The product 
was extracted with pentane and pentane was removed in vacuo. The crude product was purified 
by preparative silica gel TLC with appropriate eluent. 
 
Chiral Stationary Phase HPLC Conditions for Determination of Enantiomeric Excess 
 
Compounds Eluent of 
preparative TLC 
to purify product 
derivative 
Eluent ratio of 
HPLC 
 
 
Back 
pressure 
during 
HPLC 
Retention 
time in 
HPLC 
O
N
Ph 1b 
 
hexane/EtOAc;  
3/2 
 
hexane:EtOH; 
90:10 
 
 
44 bar 
16.9 min 
23.3 min 
33.1 min 
37.4 min 
O
N
C6H5Br 4b 
 
hexane/EtOAc; 
2/1 
 
hexane:EtOH; 
96:4 
 
40 bar 
42.7 min 
57.8 min 
107.7 min 
115.2 min 
O
N
Ph
 6b 
 
hexane/EtOAc; 
2/1 
 
hexane:EtOH; 
70:30 
 
56 bar 
7.8 min 
10.4 min 
12.8 min 
13.5 min 
N
Ph 8b 
 
- 
 
hexane:EtOH; 
99:1 
 
55 bar 
 
19.9 min 
56.5 min 
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N
Ph 9b 
 
- 
 
hexane:EtOH; 
99:1 
 
55 bar 
 
34.3 min 
108.5 min 
 
 
 
References 
(1) Müller, T. E.; Hultzsch, K. C.; Yus, M.; Foubelo, F.; Tada, M. Chem. Rev. 2008, 108, 3795-
3892. 
(2) a) Gagne, M. R.; Brard, L.; Conticello, V. P.; Giardello, M. A.; Stern, C. L.; Marks, T. J. 
Organometallics 1992, 11, 2003-2005. b) Giardello, M. A.; Conticello, V. P.; Brard, L.; Gagne, 
M. R.; Marks, T. J. J. Am. Chem. Soc. 1994, 116, 10241-10254. c) Douglass, M. R.; Ogasawara, 
M.; Hong, S.; Metz, M. V.; Marks, T. J. Organometallics 2002, 21, 283-292. d) Hong, S.; Tian, 
S.; Metz Matthew, V.; Marks Tobin, J. J. Am. Chem. Soc 2003, 125, 14768-14783. e) Ryu, J.-S.; 
Marks, T. J.; McDonald, F. E. J. Org. Chem. 2004, 69, 1038-1052. f) Yu, X.; Marks, T. J. 
Organometallics 2007, 26, 365-376. 
(3) a) Collin, J.; Daran, J.-C.; Schulz, E.; Trifonov, A. Chem. Commun. 2003, 3048-3049. b) 
Collin, J.; Daran, J.-C.; Jacquet, O.; Schulz, E.; Trifonov, A. Chem. Eur. J. 2005, 11, 3455-3462. 
c) Riegert, D.; Collin, J.; Meddour, A.; Schulz, E.; Trifonov, A. J. Org. Chem. 2006, 71, 2514-
2517. d) Riegert, D.; Collin, J.; Daran, J.-C.; Fillebeen, T.; Schulz, E.; Lyubov, D.; Fukin, G.; 
Trifonov, A. Eur. J. Inorg. Chem. 2007, 1159-1168. e) Aillaud, I.; Lyubov, D.; Collin, J.; Guillot, 
R.; Hannedouche, J.; Schulz, E.; Trifonov, A. Organometallics 2008, 27, 5929-5936. f) 
Hannedouche, J.; Aillaud, I.; Collin, J.; Schulz, E.; Trifonov, A. Chem. Commun. 2008, 3552-
3554. g) Chapurina, Y.; Ibrahim, H.; Guillot, R.; Kolodziej, E.; Collin, J.; Trifonov, A.; Schulz, 
137 
 
E.; Hannedouche, J. J. Org. Chem. 2011, 76, 10163-10172. h) Queffelec, C.; Boeda, F.; Pouilhès, 
A.; Meddour, A.; Kouklovsky, C.; Hannedouche, J.; Collin, J.; Schulz, E. ChemCatChem 2011, 3, 
122-126. 
(4) a) Gribkov, D. V.; Hultzsch, K. C.; Hampel, F. Chem. Eur. J. 2003, 9, 4796-4810. b) 
Gribkov, D. V.; Hampel, F.; Hultzsch, K. C. Eur. J. Inorg. Chem. 2004, 4091-4101. c) Gribkov, 
D. V.; Hultzsch, K. C. Chem. Commun. 2004, 730-731. d) Gribkov, D. V.; Hultzsch, K. C.; 
Hampel, F. J. Am. Chem. Soc. 2006, 128, 3748-3759. e) Reznichenko, A. L.; Hampel, F.; 
Hultzsch, K. C. Chem. Eur. J. 2009, 15, 12819-12827. f) Vitanova, D. V.; Hampel, F.; Hultzsch, 
K. C. J. Organomet. Chem. 2007, 692, 4690-4701. g) Reznichenko, A. L.; Nguyen, H. N.; 
Hultzsch, K. C. Angew. Chem., Int. Ed. 2010, 49, 8984-8987. 
(5) a) Kim, J. Y.; Livinghouse, T. Org. Lett. 2005, 7, 1737-1739. b) Kim, H.; Kim, Y. K.; Shim, 
J. H.; Kim, M.; Han, M.; Livinghouse, T.; Lee, P. H. Adv. Synth. Catal. 2006, 348, 2609-2618. c) 
Meyer, N.; Zulys, A.; Roesky, P. W. Organometallics 2006, 25, 4179-4182. d) Benndorf, P.; 
Jenter, J.; Zielke, L.; Roesky, P. W. Chem. Commun. 2011, 47, 2574-2576. e) Xiang, L.; Wang, 
Q.; Song, H.; Zi, G. Organometallics 2007, 26, 5323-5329. f) Wang, Q.; Xiang, L.; Song, H.; Zi, 
G. Inorg. Chem. 2008, 47, 4319-4328. g) Zi, G.; Xiang, L.; Song, H. Organometallics 2008, 27, 
1242-1246. 
(6) Manna, K.; Kruse, M. L.; Sadow, A. D. ACS Catalysis 2011, 1, 1637-1642. 
(7) a) Watson, D. A.; Chiu, M.; Bergman, R. G. Organometallics 2006, 25, 4731-4733. b) Wood, 
M. C.; Leitch, D. C.; Yeung, C. S.; Kozak, J. A.; Schafer, L. L. Angew. Chem., Int. Ed. 2007, 46, 
354-358. c) Gott, A. L.; Clarke, A. J.; Clarkson, G. J.; Scott, P. Chem. Commun. 2008, 1422-
1424. d) Reznichenko, A. L.; Hultzsch, K. C. Organometallics 2010, 29, 24-27. e) Shen, X.; 
Buchwald, S. L. Angew. Chem. Int. Ed. 2010, 49, 564-567. f) Reznichenko, A. L.; Emge, T. J.; 
138 
 
Audörsch, S.; Klauber, E. G.; Hultzsch, K. C.; Schmidt, B. Organometallics 2011, 30, 921-924. 
g) Zhang, X.; Emge, T. J.; Hultzsch, K. C. Angew. Chem. Int. Ed. 2012, 51, 394-398.  
(8) Gagne, M. R.; Stern, C. L.; Marks, T. J. J. Am. Chem. Soc. 1992, 114, 275-294. 
(9) a) Lauterwasse, F.; Hayes,P. G.; Piers,W. E.; Schafer, L. L.; Brase, S. Adv. Synth. Catal. 
2011, 353, 1384-1390. b) Ayinla, R. O.; Gibson, T.; Schafer, L. L. J. Organomet. Chem. 2011, 
696, 50-60. 
(10) Mourad, A. K.; Leutzow, J.; Czekelius, C. Angew. Chem. Int. Ed. 2012, 51, 11149-11152. 
(11) Manna, K.; Xu, S.; Sadow, A. D. Angew. Chem. Int. Ed. 2011, 50, 1865-1868. 
(12) Rho, H. S.; Oh, S. H.; Lee, J. W.; Lee, J. Y.; Chin, J.; Song, C. E. Chem. Commun., 2008, 
1208-1210. 
(13) For reviews, see a) Fuji, K. Chem. Rev. 1993, 93, 2037. b) Christoffers, J.; Baro, A. Adv. 
Synth. Catal. 2005, 347, 1473. c) Trost, B. M.; Jiang, C. Synthesis 2006, 369. d) Hawner, C.; 
Alexakis, C. A. Chem. Commun. 2010, 46, 7295. e) Ward, R. S. Chem. Soc. Rev. 1990, 19, 1.  
(14) a) Lebsack, A. D.; Link, J. T.; Overman, L. E.; Stearns, B. A. J. Am. Chem. Soc. 2002, 124, 
9008. b) Willis, M. C.; Powell, L. H.W.; Claverie, C. K.; Watson, S. J. Angew. Chem. 2004, 116, 
1269; Angew. Chem. Int. Ed. 2004, 43, 1249. c) Lee, J. Y.; You, Y. S.; Kang, S. H. J. Am. Chem. 
Soc. 2011, 133, 1772. 
(15) Stubbert, B. D.; Marks, T. J. J. Am. Chem. Soc. 2007, 129, 6149-6167. 
(16) Leitch, D. C.; Platel, R. H.; Schafer, L. L. J. Am. Chem. Soc. 2011, 133, 15453-15463. 
(17) a) Ciganek, E. J. Org. Chem. 1995, 60, 5803-5807. (b) Majumder, S.; Odom, A. L. 
Organometallics 2008, 27, 1174-1177. 
(18) Bender, C. F.; Widenhoefer, R. A.  J. Am. Chem. Soc., 2005, 127, 1070-1071.   
(19) Sperger, C. A.; Fiksdahl, A. J. Org. Chem. 2010, 75, 4542-4553. 
139 
 
Chapter 4. Concerted C–N and C–H bond formation in highly enantioselective 
yttrium(III)-catalyzed hydroamination: Comparison of stereoinduction with zirconium 
analogs 
Modified from a paper to be submitted to Organometallics 
Kuntal Manna,‡ Marissa L. Kruse, Arkady Ellern, Aaron D. Sadow* 
 
Abstract 
Cs- and C1-symmetric cyclopentadienyl-bis(oxazolinyl)borato yttrium alkyl complexes 
PhB(C5H4)(OxR)2}YCH2SiMe3 [{1}YCH2SiMe3, OxR = 4,4-dimethyl-2-oxazoline; {S-
2}YCH2SiMe3, OxR = 4S-isopropyl-5,5-dimethyl-2-oxazoline; {S-3}YCH2SiMe3, OxR = 4S-tert-
butyl-2-oxazoline) are highly active precatalysts in hydroamination/cyclization of aminoolefins 
to corresponding cyclic amines. These yttrium complexes are synthesized by reaction of 
proligand H[PhB(OxR)2(C5H5)] with one equiv of Y(CH2SiMe3)3(THF)2 at room temperature. 
The optically active yttrium complex {S-3}YCH2SiMe3 is highly enantioselective in the 
cyclization of aminoalkenes at room temperature, affording S-configured pyrrolidine, piperidine, 
and azepane with enantiomeric excesses up to 96%. Interestingly, the configuration of 
pyrrolidines obtained by using these optically active yttrium precatalysts are opposite compared 
to the ones prepared by the corresponding zirconium precatalysts, even though the identical 
chiral ancillary ligand is present. A cationic zirconium monoamide complex [{S-
2}Zr(NMe2)][B(C6F5)4] is also synthesize via amide abstraction of {S-2}Zr(NMe2)2 using 
[Ph3C][B(C6F5)4]. This cationic zirconium complex cyclizes primary aminopentenes to afford 
                                                           
‡
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*
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pyrrolidines with S-configuration similar to those obtained using yttrium catalysts. The kinetic 
studies of {S-3}YCH2SiMe3 catalyzed intramolecular hydroamination reveal significant isotope 
effects on reaction rate, which is first order dependence on substrate concentration. Additionally, 
substrate saturation on initial reaction rates is observed that indicates the existence of reversible 
substrate-catalyst association preceding the turn-over limiting step in the catalytic cycle. The 
nonzero x-intercept in the initial rate plot that coincides with concentration of the precatalyst 
indicates that 1.0 equiv. of substrate is required to activate the precatalyst. Based on the rate law 
for conversion, substrate saturation under initial rates conditions, kinetic isotope effects and 
isotopic perturbation of enantioselectivity, a noninsertive mechanism involving a six-membered 
transition state by a concerted C−N bond formation and N−H bond cleavage is proposed for {S-
3}YCH2SiMe3-catalyzed cyclization. These features are conserved between neutral 
cyclopentadienyl-bis(oxazolinyl)borate yttrium and zirconium-mediated aminoalkene 
cyclizations, suggesting related transition states for these systems. However, inversion of the 
products’ absolute configuration between yttrium and zirconium catalysts highlights dissimilar 
mechanisms of stereoinduction.  
 
Introduction 
Stereochemistry is an extremely powerful tool for mechanistic investigations applicable 
to a wide range of reactions such as nucleophilic substitutions reactions, α-olefin hydrogenation, 
and polymerization.1-4 Early transition-metal and rare earth catalyzed enantioselective 
hydroamination of olefins have been shown to be related to the latter two reactions, as proposed 
mechanisms involving insertion of an olefin into a M−N bond could play a significant role in 
determining the absolute configuration of valuable chiral amine products.5-7 Thus, the products' 
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stereochemistry, as well as the factors that influence products' stereochemistry, can provide 
important informations for understanding reaction mechanism.  
Among catalytic systems, rare earth complexes stand out for their very high turnover 
rates, particularly for intramolecular cyclization reactions of aminoalkenes,8-11 in addition to their 
high activity in insertion-based catalyses such as hydrogenation, hydrosilylation, and 
polymerization.12-16 Despite generally well-understood stereochemical effects for olefin insertion 
into M–H and M–C bonds, stereochemical studies of alkene insertion into M−N bonds are poorly 
developed. In this context, some features of rare earth-catalyzed hydroamination/cyclization are 
dissimilar from the characteristics associated with olefin insertions into M–C and M–H bonds, 
including large kinetic isotope effects on cyclization rates and significant isotope effects on the 
diastereoselectivity of cyclization of racemic aminoalkenes.9 On the basis of these observation, a 
proton-assisted insertion mechanism has been proposed (Scheme 4.1; A).9,17,18 However, rare 
earth-mediated proton-assisted insertion is disfavored to simple olefin insertion without proton-
assistance as suggested by computational studies.19-22 
Interestingly, the cationic zirconocene system Cp2ZrMe2/B(C6F5)3 also follows insertive 
mechanism in hydroamination/cyclization of aminoolefins (Scheme 4.1; B). This cation catalyst 
system is only active for cyclization of secondary aminoolefins, as primary aminoolefins form 
catalytically inactive Zr=N species.23 Several other zirconium cationic catalysts shown similar 
features in olefin hydroamination.24 In contrast, neutral Zr-catalysts typically cyclize only 
primary aminoalkenes via formation of Zr=N imido, followed by [2π+2π] cycloaddition (Scheme 
4.1; C).25,28, However, neutral dipyrrolylmethane group 4 complexes cyclize both primary and 
secondary aminoolefins26. Thus, investigation of structure-activity relationship of catalysts and 
understanding of the mechanism help designing catalysts for solving many synthetic problems in 
142 
 
hydroamination, such as general substrate applicability, enantioselectivity, diastereoselectivity, 
and enantioselective intermolecular hydroamination. 
 
Scheme 4.1. Proposed pathways for C−N bond formation in d0 and fnd0 metal catalyzed 
aminopentene cyclizations. 
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Previously, we reported highly enantioselective neutral cyclopentadienyl-
bis(oxazolinyl)borato zirconium(IV) hydroamination catalysts, which are proposed to cyclize 
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aminoolefins via non-insertive concerted C−N/C−H bond formation in the turnover-limiting 
step.27 Key evidences of this non-insertive six-center mechanism is the significant isotopic 
perturbation on enantioselectivity, the requirement of two valencies of zirconium, the 
requirement of substrate/precatalyst >2 for catalytic turnover, and the cyclization of secondary 
aminoalkenes requires a primary amine additive. 
A similar six-center proton-transfer pathway was suggested in a related zirconium 
catalyst, but ultimately ruled out in favor of [2π + 2π] cycloaddition mechanism.28 The two-
substrate pathways have been recently proposed for magnesium and calcium,29 rare earth,30 and 
other zirconium-based31 hydroamination catalysts. However, these studies have not included the 
stereochemical effects that are an important mechanistic tool. 
Therefore, the excellent enantioselectivity as well as several unusual mechanistic features 
of our neutral cyclopentadienyl-bis(oxazolinyl)borato zirconium(IV) hydroamination 
catalysts27,32 motivated us to investigate optically active cyclopentadienyl-bis(oxazolinyl)borate 
supported cationic zirconium and its isoelectronic yttrium catalyzed aminoalkene cyclization. 
Our current studies on these systems have addressed the substrates scope in enantioselective 
hydroamination, stereochemical and kinetic properties, and also the effect of the oxazoline 
groups on catalysts’ stability, activity, and stereoselectivity. Additionally, the stereochemical and 
other mechanistic features of these Y- and cationic Zr-catalysts are compared to other optically 
active oxazolinylborato systems to rationalize the mechanism of stereoinduction.  
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Results and discussion 
 
Synthesis and characterization of mixed cyclopentadienyl-bis(oxazolinyl)borate supported 
yttrium and zirconium cation compounds. 
 
The general scheme for synthesizing cyclopentadienyl-bis(oxazolinyl)borato yttrium 
complexes involves the reaction of Y(CH2SiMe3)3(THF)2 with protonated proligands 
H[PhB(C5H5)(OxMe2)2] [H2{1}], H[PhB(C5H5)(Ox4S-iPr,Me2)2] [H2{S-2}], H[PhB(C5H5)(Ox4S-tBu)2] 
[H2{S-3}] via alkane elimination (eq 4.1).33 11B and 15N NMR chemical shifts, and infrared C=N 
stretching frequencies for all the achiral and optically active yttrium complexes are reported in 
Table 4.1. 
Ph
C5H5
OxR
OxR
H +    Y(CH2SiMe3)3(THF)2
Ph B
OxR
OxR
Y CH2SiMe3 (4.1)
−2 SiMe4
−2 THF
 
The treatment of isomeric mixture of achiral proligand H2{1} with one equiv of 
Y(CH2SiMe3)3(THF)2 in THF at room temperature affords {PhB(C5H4)(OxMe2)2}YCH2SiMe3 
({1}YCH2SiMe3) with the elimination of 2.0 equiv of SiMe4. This yttrium alkyl complex 
decomposes fast at room temperature by SiMe4 elimination (t1/2 = 40 min, THF), however 
analytically pure, THF-free material is obtained by vapor diffusion of pentane into THF solution 
at −30 °C in 87% yield. The 1H NMR spectrum in tetrahydrofuran-d8 showed one set of 
oxazoline resonances as two singles (1.29 and 1.21 ppm) for inequivalent methyl groups and two 
doublets for inequivalent methylene groups (3.87 and 3.82 ppm). The 1H NMR multiplets 
associated with the three C5H5B isomers are replaced with two resonances (6.38 and 6.18 ppm) 
assigned to C5H4B. The pattern of this 1H NMR suggests that {1}YCH2SiMe3 is CS-symmetric. 
The 11B NMR spectrum in tetrahydrofuran-d8 showed one resonance at −15.2 ppm. Only one νCN 
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band (1549 cm-1, KBr) was observed in the IR spectrum of {1}YCH2SiMe3 at lower energy than 
that for non-coordinated 4,4-dimethyl-2-oxazoline (νCN = 1630 cm-1). The single νCN infrared 
band of {S-2}YCH2SiMe3 suggests that both oxazolines are coordinated to yttrium in the solid 
state. 
 
H
B
O
N
O N
Ph Y(CH2SiMe3)3(THF)2
B
O
N
O N
Ph
Y CH2SiMe3
THF, 10 min
−2 SiMe4
(4.2)
{1}YCH2SiMe3;  87%
 
An enantiopure yttrium complex {S-2}YCH2SiMe3 is synthesized following a similar 
route using chiral proligand H[PhB(C5H5)(Ox4S-iPr,Me2)2}] (H2{S-2}). H2{S-2} and 
Y(CH2SiMe3)3(THF)2 react rapidly in benzene at room temperature affording {PhB(C5H4)(Ox4S-
iPr,Me2)2}YCH2SiMe3 ({S-2}YCH2SiMe3) in 78% yield (eq 4.3). Two sets of oxazoline 
resonances (e.g., two septets and four doublets assigned to the isopropyl groups and four singlets 
for the 5-methyl groups) and four downfield multiplets ranging from 6.92 to 6.61 ppm for the 
cyclopentadienyl group in the 1H NMR spectrum suggested C1-symmetric species for {S-
2}YCH2SiMe3. Two multiplets were observed for the two diastereotopic methylene protons of 
CH2SiMe3. Additionally, the broad 11B NMR resonance at −15.7 ppm resulting from overlapping 
signals from isomers of H2[S-2] is replaced with a sharper signal at −15.9 ppm (76 Hz at half-
height). 1H-15N HMBC experiment provided the 15N NMR chemical shift and displayed two 
signals at −154.4 and −156.8 ppm for C1-symmetric {S-2}YCH2SiMe3. These 15N chemical 
shifts are upfield of free 2H-Ox4S-iPr,Me2 (−143.0 ppm).27 Additionally, the solid state IR spectrum 
revealed one νCN stretching frequency of oxazolines (1558 cm−1) in lower energy than that of 2H-
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Ox4S-iPr,Me2 (1632 cm−1). The 15N NMR and infrared data of {S-2}YCH2SiMe3 suggest that both 
oxazolines are coordinated to yttrium in solid state and also in benzene. 
H
B
O
N
O N
Ph Y(CH2SiMe3)3(THF)2
B
O
N
O N
Ph
Y CH2SiMe3
benzene, 10 min
−2 SiMe4
(4.3)
{S-2}YCH2SiMe3;  78%
 
 
Table 4.1. 11B, 15N NMR chemical shifts and νCN values for cyclopentadienyl-
bis(oxazolinyl)borate zirconium and yttrium complexes. 
Compound 11B NMR (δ) 
benzene-d6 
15N NMR (δ) 
benzene-d6 
νCN 
(KBr, cm−1) 
{PhB(C5H4)(Ox4S-iPr,Me2)2}Zr(NMe2)2  
{S-2}Zr(NMe2)2 
−14.5 −152.6, −155.0 1565 
[{PhB(C5H4)(Ox4S-iPr,Me2)2}Zr(NMe2)] 
[B(C6F5)4] 
[{S-2}Zr(NMe2)][B(C6F5)4] 
−15.1, −15.9 −159.1, −164.4 1554 
{PhB(C5H4)(OxMe2)2}YCH2SiMe3 
{1}YCH2SiMe3 
−15.2 n.a. 1549 
{PhB(C5H4)(Ox4S-iPr,Me2)2}YCH2SiMe3 
{S-2}YCH2SiMe3 
−15.9 −154.4, −156.8 1558 
{PhB(C5H4)(OxS-tBu)2}YCH2SiMe3 
{S-3}YCH2SiMe3 
−15.7 −148.5, −150.2 1586 
Tl2[PhB(C5H4)(OxMe2)2] 
Tl2{1} 
−17.0 −99.8 1578, 1567 
{PhB(C5H4)(OxMe2)2}YNHtBu 
{1}YNHtBu 
−15.8 −146.6 1577 
Tl2[PhB(C5H4)(OxS-tBu)2] 
Tl2{S-3} 
−16.0 −125.2 1559 
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{PhB(C5H4)(OxS-tBu)2}YCl 
{S-3}YCl 
−15.9 −148.5, −150.2. 1552 
 
Another optically active yttrium complex {PhB(C5H4)(OxS-tBu)2}YCH2SiMe3 ({S-
3}YCH2SiMe3) is prepared by reaction of Y(CH2SiMe3)3(THF)2 and chiral proligand 
H[PhB(C5H5)(OxS-tBu)2] [H2{S-3}] in benzene at room temperature (eq 4.4). {S-3}YCH2SiMe3 is 
C1-symmetric as shown by two sets of oxazoline resonances and four downfield 
cyclopentadienyl resonances (6.82, 6.77, 6.64 and 6.53 ppm) in its 1H NMR spectrum. Symmetry 
cannot establish the coordination geometry, however the 15N NMR chemical shifts (−148.5 and 
−150.2 ppm) are upfield of 4S-2H-OxtBu (−148.0 ppm).33 A single strong νCN band at 1586 cm−1 
(KBr) in the IR spectrum, which is also lower is energy than free 4S-2H-OxtBu (1635 cm−1) 
suggests that both oxazolines are coordinated to yttrium. A sharp resonance at −15.7 ppm in the 
11B spectrum indicates that a single product is formed. {S-3}YCH2SiMe3 is stable in benzene for 
about 2 h at room temperature followed by slow decomposition by elimination of SiMe4. 
H
B
O
N
O N
Ph Y(CH2SiMe3)3(THF)2
benzene, 10 min
−2 SiMe4
(4.4)
{S-3}YCH2SiMe3;  85%
Y CH2SiMe3
B
O
N
O N
Ph
 
              An achiral yttrium amido complex {1}YNHtBu and its optically active analog {S-
3}YNHtBu are synthesized via salt metathesis route. The reaction of H2{1} with two equiv of 
TlOEt in Et2O for 8 h provides the thallium salt of achiral cyclopentadienyl-
bis(oxazolinyl)borate ligand [Tl2{1}] in 91% yield (eq 4.5). The 1H NMR multiplets of three 
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C5H5B isomers of H2{1} are replaced with two resonances (6.18 and 5.84 ppm). One 11B NMR 
resonance was observed at −17.0 ppm.  
H
B
O
N
O N
Ph 2 TlOEt
B
O
N
O N
Ph
Y NHtBu
Et2O, 8 h
−2 EtOH (4.5)
{1}YNHtBu;  77%
Tl2{1}
B
O
N
O N
Ph
Y Cl
{1}YCl
91%
THF, 1 h
−2 TlCl
YCl3(THF)3 tBuNHLi
THF
−LiCl
H2{1}
 
X-ray quality single crystals are obtained from concentrated solution of Et2O cooled to 
−30 °C, and the ORTEP view of the crystal structure is presented in Figure 4.1. 
Tl2[PhB(OxMe2)2Cp] is monomeric in the solid state. Two thallium atoms are in opposite face of 
C5H4 ring. One of the thallium atoms (Tl1) is dicoordinated by nitrogen atom (N1) of an 
oxazoline and a carbon atom of C5H4 ring. Second thallium atom (Tl2) is η5-coordinated to the 
C5H4 ring and to the nitrogen atom (N2) of the second oxazoline. The C5H4 is unsymmetrically 
bonded to Tl2 with Tl−C bond lengths ranging from 2.687(16) to 2.881(18) Å. The two 
Tl−Noxazoline distances are within 0.01 Å [Tl1−N1, 2.705(15); Tl2−N2, 2.695(14) Å]. 
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Figure 4.1. ORTEP diagram of Tl2[PhB(OxMe2)2Cp] [Tl2{1}]. Ellipsoids are plotted at 50% 
probability, and hydrogen atoms are not illustrated for clarity. Selected bond distances (Å): 
Tl1−N1, 2.705(15); Tl1−C21, 2.896(18); Tl2−N2, 2.695(14); Tl2−C17, 2.687(16); Tl2−C18, 
2.721(16); Tl2−C19, 2.881(18); Tl2−C21, 2.848(17). 
 
Tl2{1} reacts with YCl3(THF)3 in THF at room temperature to afford 
{PhB(C5H4)(OxMe2)2}YCl ({1}YCl). The 1H NMR spectrum in tetrahydrofuran-d8 contained one 
set of oxazoline resonances (e.g., two singlets for methyl groups at 1.18 and 1.17 ppm, two 
doublets at 3.84 and 3.77 ppm for methylene groups) and two multiplets for C5H4B group (6.26 
and 6.05 ppm) suggesting a Cs-symmetric species. One 11B resonance at −16.0 ppm suggested 
the formation of a single product. Unfortunately, {1}YCl decomposes upon evaporation of THF, 
and is unable to isolate. Therefore, {1}YCl is prepared in situ for the synthesis of the desire 
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compound {1}YNHtBu. {1}YNHtBu is prepared by treatment of one equiv of tBuNHLi to THF 
solution of {1}YCl prepared in situ. After removal of LiCl and volatiles, {1}YNHtBu is obtained 
as a white solid in 77% yield (eq 4.5). Unlike {1}YCH2SiMe3, {1}YNHtBu is unchanged in THF 
even after 7 days at room temperature. The 1H NMR of {1}YNHtBu in tetrahydrofuran-d8 
showed broad resonances of oxazolines and cyclopentadienyl protons. One single 11B peak was 
observed at −15.8 ppm. Upon cooling to 220 K, the proton resonances became sharp and 
revealed a C1-symmetric species. Four singlets in a 1:1:1:1 for four methyl groups and a pair of 
doublets for methylene protons of oxazolines, and four multiplets of C5H4B were observed for 
{1}YNHtBu. The variable temperature NMR experiments suggest that {1}YNHtBu is fluxional 
in solution due to dissociation and coordination of oxazolines to yttrium. At 220 K, this dynamic 
process is slower than NMR time scale, and thus C1-symmetric species is observed.  
The optically active yttrium amide complex {PhB(C5H4)(OxS-tBu)2}YNHtBu [{S-
3}NHtBu] is synthesized using H2{S-3} (eq 4.6). Tl2{S-3} is first prepared by reaction of H2{S-
3} and TlOEt in 93% yield. The treatment of Tl2{S-3} with YCl3(THF)3 affords {PhB(C5H4)( 
OxS-tBu)2}YCl ({S-3}YCl) as a white solid in 89% isolated yield. The 1H NMR resonances 
associated with the ancillary ligand indicated {S-3}YCl as C1-symmetric as expected. In the next 
step, {S-3}YCl reacts with one equiv of tBuNHLi in THF at room temperature to provide {S-
3}NHtBu in 83% yield (eq 4.6). In the 1H NMR spectrum of {S-3}NHtBu, two singlet 
resonances at 0.97 and 0.91 ppm were assigned to tert-butyl substituents on two inequivalent 
oxazoline groups, and four downfield multiplets ranging from 6.55 to 5.96 ppm were assigned to 
the cyclopentadienyl group.  
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                Additionally, an optically active cationic zirconium complex is synthesized to compare 
the catalytic activity in hydroamination and also the configuration of amine products with 
analogous yttrium and neutral tetravalent zirconium catalysts. The treatment of {S-2}Zr(NMe2)2 
with one equiv of [Ph3C][B(C6F5)4] in benzene at room temperature affording [{S-
2}Zr(NMe2)][B(C6F5)4] as a light yellow solid in 73.4% yield (eq 4.7). The 1H NMR in 
bromobenzene-d5 showed two septets, four doublets and four singlets assigned to oxazoline 
isopropyl and methyl groups for C1-symmetric [{S-2}Zr(NMe2)][B(C6F5)4]. One strong νCN band 
at 1554 cm−1 (KBr) was observed in the IR spectrum. 
[Ph3C][B(C6F5)4]
benzene, 10 min
−Ph3CNMe2
[{S-2}Zr(NMe2)][B(C6F5)4]
[B(C6F5)4]−
(4.7)B
O
N
O N
Ph
Zr NMe2
NMe2
B
O
N
O N
Ph
Zr NMe2
+
 
 
Catalytic Hydroamination/Cyclization of Aminoalkenes.  
                  The cyclopentadienyl-bis(oxazolinyl)borate coordinated neutral yttrium alkyl and 
cationic zirconium monoamide complexes are tested as precatalysts for the cyclization of 
aminoolefins to cyclic amines at room temperature. The enantioselectivities were determined by 
integration of 19F NMR spectra of Mosher-amide derivatives and by HPLC analysis using chiral 
stationary phase column. 
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                  The achiral {1}YCH2SiMe3 is a precatalyst for cyclization of primary and secondary 
aminoalkenes at room temperature, providing racemic cyclic amines in excellent yields (Table 
4.2; entries 1, 6, 11, 16, 21, 26). The optically active yttrium alkyl complexes {S-2}YCH2SiMe3 
and {S-3}YCH2SiMe3 are also precatalysts in cyclohydroamination of aminoolefins at room 
temperature. However, the ancillary ligands in these precatalysts affect the enantioselectivity 
significantly, following the trend {S-3}YCH2SiMe3>{S-2}YCH2SiMe3. This trend is opposite 
for neutral zirconium catalysts, where {S-2}Zr(NMe2)2 is more enantioselective than {S-
3}Zr(NMe2)2.27,33 Interestingly, the absolute configuration of the product depends on the nature 
of the metal center as shown in Scheme 4.2. {S-2}YCH2SiMe3 provides S-pyrrolidine (S-4b) 
from 2,2-diphenyl-4-penten-1-amine (4a), whereas R-pyrrolidine (R-4b) is obtained from {S-
2}Zr(NMe2)2 even though both catalysts contain identical {S-2}-chiral ancillary ligand. The 
change of stereoinduction during cyclization is also observed between {S-3}-coordinated neutral 
yttrium and zirconium catalysts. {S-3}YCH2SiMe3 and {S-3}Zr(NMe2)2 catalyze cyclization of 
4a to provide S-4b and R-4b respectively (Scheme 4.2 and Table 4.2). Additionally, the 
configurational flip of products is observed between cationic zirconium monoamide complex 
[{S-2}Zr(NMe2)][B(C6F5)4] and neutral zirconium bisamide complex {S-2}Zr(NMe2)2. [{S-
2}Zr(NMe2)][B(C6F5)4] is less active and enantioselective than {S-2}Zr(NMe2)2 in cyclization of 
aminopentenes providing S-pyrrolidines as the major enantiomer. 
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Scheme 4.2. Cyclization of 2,2-diphenylaminopentene 4a and absolute configuration of products 
4b for optically active Y- and Zr-catalyzed hydroamination 
NH2
Ph Ph
HN Ph
Ph
4a S-4b
5 mol % {S-2}YCH2SiMe310 mol % {S-2}Zr(NMe2)2
HN Ph
Ph
R-4b
quantitative; 42% ee; S95% yield; 93% ee; R
HN Ph
Ph
S-4b
95% yield; 66% ee; S
C6H6, 1.25 h, r.t. C6H6, 10 min, r.t.
C6H6, 2 d, r.t.
10 mol % [{S-2}Zr(NMe2)][B(C6F5)4]
C6H6, 10 min, r.t.
5 mol % {S-3}YCH2SiMe3
HN Ph
Ph
S-4b
quantitative; 94% ee; S
 
  
                    In general, the chiral yttrium precatalysts cyclize several aminoalkenes to give 
optically active pyrrolidines, piperidines, and azepanes at room temperature, and these results are 
summarized in Table 4.2-4.3. These tables are organized by substrate type: Table 4.2 shows 
conditions and products in cyclization of aminopentenes 4a-9a that have aliphatic or aromatic 
2,2-disubsititution; Table 4.3 contains cyclizations of functionalized substrates 10a-11a that give 
halogenated and acetal, and also contains 6- and 7-membered rings from substrates 13a-14a.  
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Table 4.2. Cyclization of aminoalkenes and absolute configurations of products for Y- and Zr-
catalyzed hydroamination a 
Substrate Entry Precatalyst b Time  Yield (%)c ee (%)d 
NH2
Ph Ph
HN Ph
Ph
4a
4b
 
1 
 
2 
 
3 
 
4 
 
5 
{1}YCH2SiMe3 
 
{S-2}YCH2SiMe3 
 
{S-3}YCH2SiMe3 
 
[{S-2}Zr(NMe2)][B(C6F5)4] 
 
{S-2}Zr(NMe2)2 
10 min 
 
10 min 
 
10 min 
 
2 d 
 
1.25 h 
100  
 
100 
 
100 (93) 
 
95 
 
95 
racemic 
 
42 (S) 
 
94 (S) 
 
66 (S) 
 
93 (R) 
NH2
HN
5a
5b
 
6 
 
7 
 
8 
 
9 
 
10 
{1}YCH2SiMe3 
 
{S-2}YCH2SiMe3 
 
{S-3}YCH2SiMe3 
 
[{S-2}Zr(NMe2)][B(C6F5)4] 
 
{S-2}Zr(NMe2)2 
10 min 
 
10 min 
 
10 min 
 
3 d 
 
1.25 h 
100 
 
100 
100 (95) 
 
90 
 
95 
racemic 
 
34 (S) 
 
93 (S) 
 
79 (S) 
 
90 (R) 
NH2
HN
6a
6b
 
11 
 
12 
 
13 
 
14 
 
15 
{1}YCH2SiMe3 
 
{S-2}YCH2SiMe3 
 
{S-3}YCH2SiMe3 
 
[{S-2}Zr(NMe2)][B(C6F5)4] 
 
{S-2}Zr(NMe2)2 
10 min 
 
10 min 
 
3 h 
 
3 d 
 
4 h 
100 
 
100 
 
95 
 
92 
 
88 
racemic 
 
34 (S) 
 
89 (S) 
 
81 (S) 
 
92 (R) 
NH2
HN
7a
7b
 
16 
 
17 
 
18 
 
19 
 
20 
{1}YCH2SiMe3 
 
{S-2}YCH2SiMe3 
 
{S-3}YCH2SiMe3 
 
[{S-2}Zr(NMe2)][B(C6F5)4] 
 
{S-2}Zr(NMe2)2 
10 min 
 
10 min 
 
10 min 
 
2 d 
 
0.75 h 
100 
 
100 
 
100 (97) 
 
92 
 
98 
racemic 
 
51 (S) 
 
96 (S) 
 
69 (S) 
 
93 (R) 
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NH2
HN
8a
8b
 
21 
 
22 
 
23 
 
24 
 
25 
{1}YCH2SiMe3 
 
{S-2}YCH2SiMe3 
 
{S-3}YCH2SiMe3 
 
[{S-2}Zr(NMe2)][B(C6F5)4] 
 
{S-2}Zr(NMe2)2 
 
25 min 
 
10 min 
 
15 min 
 
2 d 
 
30 min 
100 
d.r. = 1.2:1 
100 
d.r. = 1.2:1 
100 (95) 
d.r. = 1.2:1 
94 
d.r. = 1.4:1 
95  
d.r. = 1.1:1 
racemic 
 
43, 40 
 
95, 95 
 
72, 67 
 
93, 92  
NH2
HN
Ph
Ph
9a
9b
 
26 
 
27 
 
28 
 
29 
 
30 
{1}YCH2SiMe3 
 
{S-2}YCH2SiMe3 
 
{S-3}YCH2SiMe3 
 
[{S-2}Zr(NMe2)][B(C6F5)4] 
 
{S-2}Zr(NMe2)2 
 
15 min 
 
10 min 
 
15 min 
 
2 d 
 
30 min 
100 
d.r. = 1.1:1 
100 
d.r. = 1.2:1 
100 (96) 
d.r. = 1.2:1 
100 
d.r. = 1.5:1 
95  
d.r. = 3.3:1 
racemic 
 
46, 42 
 
95, 96 
 
84, 83 
 
96, 96  
a Reaction conditions: C6H6, r.t. b Catalyst loading Zr: 10 mol %; Y: 5 mol %. c Yield of isolated product is 
given in parentheses. d  % ee (±0.5%) was determined by 19F NMR spectra of Mosher amide derivatives. 
Absolute configuration assignments based on literature reports.17 
 
                           The enantioselectivities of reactions catalyzed by {S-3}YCH2SiMe3 are high for 
a range of aminopentene and aminoheptene substrates. A series of pyrrolidines such as diphenyl-
pyrrolidine (4b; 94% ee), spiro-cyclohexyl-pyrrolidine (5b; 93%), cyclopentyl-pyrrolidine (6b; 
89%), and diallyl-pyrrolidine (7b; 96%) are afforded at room temperature with excellent optical 
purities (Table 4.2). {S-3}YCH2SiMe3 also catalyzes cyclization of 2-allyl-2-methyl-pent-4-
enylamine (8a) and 2-allyl-2-phenyl-pent-4-enylamine (9a) at room temperature to provide 
diastereomeric mixture of cis and trans pyrrolidines (Table 4.2; entries 23 and 28). Although the 
distereoselectivity (cis:trans) is poor, however impressively, the enatiomeric excesses of 8b (cis: 
95% ee; trans: 95% ee; d.r.; cis:trans = 1:1.2) and 9b (cis: 95% ee; trans: 96% ee; d.r.; cis:trans 
= 1.2:1) are very high for both diastereomers. No significant effects of temperature and 
concentration on enantioselectivity and cis/trans ratio were observed. 
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In contrast to {S-3}YCH2SiMe3, {S-2}YCH2SiMe3 is much less enantioselective 
regardless of the substrate. {S-2}YCH2SiMe3 provides S-pyrrolidines (4b-9b) at room 
temperature with 34-51% ee (Table 4.2; entries 2, 7, 12, 17, 22, and 27). Changing the reaction 
conditions such as temperature, concentration and catalysts loading don’t improve the 
enantioselectivity.  
The cationic zirconium [{S-2}Zr(NMe2)][B(C6F5)4] is relatively lower active and 
enantioselective in cyclohydroamination compared to {S-3}YCH2SiMe3 and {S-2}Zr(NMe2)2, 
and therefore longer reaction time is required. For example, 2,2-diphenyl-4-penten-1-amine (4a) 
is cyclized by [{S-2}Zr(NMe2)][B(C6F5)4] at room temperature over 2 days to afford S-diphenyl-
pyrrolidine (S-4b) in 66% ee (Table 4.2; entry 4), whereas {S-2}Zr(NMe2)2 affords R-4b at room 
temperature in 93% ee within 1.25 h (Table 4.2; entry 5). Relatively lower optical purities are 
also observed for other azacycles mediated by [{S-2}Zr(NMe2)][B(C6F5)4] (S-5b: 79%; S-7b: 
69%) in comparison to {S-2}Zr(NMe2)2 (S-5b: 90%; S-7b: 93%). 
 The high enantioselectivity of {S-3}YCH2SiMe3 in aminopentene cyclization motivated 
further study of the formation of other five-membered rings containing oxo- or halogen- 
functional groups. 2,2-Diethoxypent-4-enenylamine (10a) is cyclize by {S-3}YCH2SiMe3 
affording diethoxy-pyrrolidine (10b) in 4 h at room temperature with 94% ee (Table 4.3; entry 
3). The {S-2}YCH2SiMe3 and achiral {1}YCH2SiMe3 also catalyze the cyclization at 
approximately the same rate as {S-3}YCH2SiMe3, however, [{S-2}Zr(NMe2)][B(C6F5)4] is 
inactive even at elevated temperature with prolonged reaction time. 
2-Allyl-2-(4-bromophenyl)pent-4-enylamine (11a) is cyclized quantitatively by achiral 
{1}YCH2SiMe3 to a 2.7:1 diastereomeric mixture of cis and trans pyrrolidines within 10 min at 
room temperature (Table 4.3; entry 5). The optically active {S-2}YCH2SiMe3 precatalyst is also 
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efficient in cyclization of 11a, however it provides 11b with low diastereomeric ratio (cis:trans = 
2:1) and low optical purity (cis: 38% ee; trans: 33% ee) (Table 4.3; entry 6). Not surprisingly, 
{S-3}YCH2SiMe3 again displays high enantioselectivity for cyclization of 11a. Although the 
distereoselectivity (cis:trans = 2:1) is low, 95% ee for cis-11b and 92% ee of trans-11b are 
obtained at room temperature (Table 4.3; entry 7). 
 
Table 4.3. Catalytic hydroamination/cyclization of aminoalkenes. a 
Substrate Entry Precatalyst b 
 
Time Yield (%)c ee (%)d 
NH2
EtO OEt
HN OEt
OEt
10a
10b
 
1 
 
2 
 
3 
 
4 
{1}YCH2SiMe3 
 
{S-2}YCH2SiMe3 
 
{S-3}YCH2SiMe3 
 
[{S-2}Zr(NMe2)][B(C6F5)4] 
4 h 
 
4 h 
 
4 h 
 
2 d 
90 
 
95 
 
90 
 
0 
racemic 
 
23 (S) 
 
94 (S) 
 
n.a. 
NH2
HN
C6H4Br
C6H4Br
11a
11b
 
5 
 
6 
 
7 
 
8 
{1}YCH2SiMe3 
 
{S-2}YCH2SiMe3 
 
{S-3}YCH2SiMe3 
 
[{S-2}Zr(NMe2)][B(C6F5)4] 
10 min 
 
15 min 
 
15 min 
 
1.5 d 
100 
d.r. = 2.7:1 
100 
d.r. = 2:1 
100 (94) 
d.r. = 1.9:1 
100 
d.r. = 1.5:1 
racemic 
 
38, 33 
 
95, 92 
 
73, 65 
 
 
NH2
HN
12a
12b
Ph
Ph
 
9 
 
10 
 
11 
 
12 
{1}YCH2SiMe3 
 
{S-2}YCH2SiMe3 
 
{S-3}YCH2SiMe3 
 
[{S-2}Zr(NMe2)][B(C6F5)4] 
3 h 
 
2.5 h 
 
2.5 h 
 
3 d 
100 
 
100 
 
100 (93) 
 
20 
racemic 
 
63, 56 
 
21, 20 
 
n.a. 
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NH2
Ph Ph
13a
HN
Ph
Ph
13b
 
13 
 
14 
 
15 
 
16 
{1}YCH2SiMe3 
 
{S-2}YCH2SiMe3 
 
{S-3}YCH2SiMe3 
 
[{S-2}Zr(NMe2)][B(C6F5)4] 
6 h 
 
50 min 
 
20 h 
 
2 d 
100 
 
100 
 
87 
 
85 
racemic 
 
22 (S) 
 
58 (S) 
 
41 (S) 
NH2
Ph Ph
14a
HN
Ph
Ph
14b
 
17 
 
18 
 
19 
 
20 
{1}YCH2SiMe3 
 
{S-2}YCH2SiMe3 
 
{S-3}YCH2SiMe3 
 
[{S-2}Zr(NMe2)][B(C6F5)4] 
2 d 
 
3 d 
 
3 d 
 
4 d 
84 
 
92 
 
89 
 
0 
racemic 
 
14 (S) 
 
84 (S) 
 
n.a. 
H
N
Ph Ph
MeN Ph
Ph
15a
15b
 
21 
 
22 
 
23 
 
24 
 
25 
{1}YCH2SiMe3 
 
{S-2}YCH2SiMe3 
 
{S-3}YCH2SiMe3 
 
[{S-2}Zr(NMe2)][B(C6F5)4] 
 
{S-2}Zr(NMe2)2 
12 h 
 
20 h 
 
24 h 
 
3 d 
 
3 d 
100 
 
100 
 
95 
 
0 
 
0 
racemic 
 
9 
 
44 
 
n.a. 
 
n.a. 
N CH3
Ph
Ph
H
N
Ph Ph
N Ph
Ph
+
16a
16b
16c
 
26 
 
27 
 
28 
 
29 
 
30 
{1}YCH2SiMe3 
 
{S-2}YCH2SiMe3 
 
{S-3}YCH2SiMe3 
 
[{S-2}Zr(NMe2)][B(C6F5)4] 
 
{S-2}Zr(NMe2)2 
4 d 
 
3 d 
 
3 d 
 
3 d 
 
3 d 
40 
 
88 (16b + 
16c) 
85 (16b) 
 
0 
 
0 
racemic 
 
21(16b) 
 
70 
 
n.a. 
 
n.a. 
a Reaction conditions: C6H6, r.t. b Catalyst loading Zr: 10 mol %; Y: 5 mol %. c Yield of isolated product is 
given in parentheses. d % ee (±0.5%) was determined by 19F NMR spectra of Mosher amide derivatives.  
 
The high catalytic activity and enantioselectivity of {S-3}YCH2SiMe3 in cyclization of 
aminopentenes motivated to prepared enantioenriched larger heterocycles. The rate of 
cyclization of 2,2-diphenyl-5-hexen-1-amine (13a) catalyzed by {S-2}YCH2SiMe3 is marked 
decreased compared to 2,2-diphenyl-4-penten-1-amine (4a). In addition, the % ee of the 2-
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methyl-5,5-diphenyl piperidine 13b (58% ee; Table 4.3; entry 15) is significantly lower than the 
2-methyl-4,4-diphenyl pyrrolidines (4b; 94% ee). Interestingly, piperidines obtained by {S-2} 
and {S-3}-based yttrium catalysts have S-configuration, whereas R-configured piperidines are 
obtained by all neutral {S-2} and {S-3}-containing group 4 catalysts. 
The cyclization of aminoheptene 14a is also slower than aminopentenes. Azepane 14b is 
obtained using {S-2}YCH2SiMe3 and {S-3}YCH2SiMe3 at room temperature with 14% and 84% 
ee respectively (Table 4.3; entries 18 and 19). However, [{S-2}Zr(NMe2)][B(C6F5)4] is inactive 
to cyclize 14a at room or elevated temperatures. 
Finally, all Y- and Zr-precatalysts are tested for cyclization of secondary aminopentenes. 
Both {S-2}YCH2SiMe3 and {S-3}YCH2SiMe3 precatalysts are poor enantioselective in 
cyclization of N-methyl-2,2-diphenyl-4-penten-1-amine (15a) to corresponding N-methyl-
pyrrolidine (15b) (Table 4.3, entries 22 and 23). N-Allyl-2,2-diphenylpent-4-enylamine (16a) is 
cyclized by {S-2}YCH2SiMe3 at room temperature in benzene to give a mixture of N-allyl-2,2-
phenyl-2-methyl-pyrrolidine (16b) via monocyclization and 2,2-diphenyl-6-methyl-pyrrolizine 
(16c) (mixture of cis and trans) via hydroamination/bicyclization with low enantiomeric 
excesses (Table 4.3, entry 27). Interestingly, {S-3}YCH2SiMe3 provides only the monocyclized 
product 16b at room temperature with 70% ee (Table 4.3, entry 28). No pyrrolizine is formed by 
{S-3}YCH2SiMe3 even after 7 days at room temperature. Unfortunately, [{S-
2}Zr(NMe2)][B(C6F5)4] is inactive to cyclize secondary amines (Table 4.3, entries 24 and 29). 
 
Spectroscopic and mechanistic features of catalytic reaction 
 The high enantioselectivity in {S-3}YCH2SiMe3 catalyzed cyclization of aminoolefins 
inspired us to investigate the possible catalytic mechanism. We have collected kinetic and 
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spectroscopic data of {S-3}YCH2SiMe3 system, and compared to other reported rare earth 
catalysts to identify the possible catalytic pathways. Additionally, the kinetic, spectroscopic and 
stereochemical features of trivalent {S-3}YCH2SiMe3 are compared to tetravalent {S-
2}Zr(NMe2)2 system to understand the change of stereoinduction during cyclization between 
these two systems, and obtain a model that rationalizes the stereochemical outcomes.  
 SiMe4 and pyrrolidine are observed within 30 s of addition of C-(1-allyl-cyclohexyl)-
methylamine (5a) to {S-3}YCH2SiMe at room temperature. Although the active catalyst is not 
directly observed, it is formed quickly at room temperature after addition of 5a, based on the 
appearance of pyrrolidine product 5b in the 1H NMR spectrum of the reaction mixture. 
For three half-lives, ln[5a] varies linearly with time to provide kobs, and this is consistent 
with first-order dependence on substrate concentration (Figure 4.1). First-order dependence on 
aminoalkene concentration is uncommon for rare earth catalysts, that typically gives rate laws for 
aminoolefin cyclization: rate = k[catalyst]1[substrate]0.9,17 First-order substrate dependence has 
been reported for zirconium-,27,32 yttrium-,30 and alkaline-earth29a,20b metal-catalyzed aminoolefin 
cyclizations. A linear relationship between kobs and [{S-3}YCH2SiMe] provides the empirical 
rate law −d[5a]/dt = k'[{S-3}YCH2SiMe]1[5a]1 (k' = 0.105(5) M−1 s−1) (Figure 4.2) 
161 
 
 
Figure 4.1. Plots of ln[5a] vs. time for the cyclization of C-(1-allyl-cyclohexyl)-methylamine 
catalyzed by {S-3}YCH2SiMe3 showing first-order dependence on substrate in the cyclization at 
296 K. 
 
To measure the effect of N-deuteration on reactions with {S-3}YCH2SiMe3 as 
precatalyst, the conversion of substrate C-(1-allyl-cyclohexyl)-methylamine-ND2 (5a-d2) was 
investigated. Conversion of C-(1-allyl-cyclohexyl)-methylamine-ND2 (5a-d2), catalyzed by [S-
2]Zr(NMe2)2, is much slower than conversion 5a itself. Linear least squares best fits of plots of 
kobs(D) vs. catalyst concentration provide the second-order rate constant k'(D) [0.040(5) M−1 s−1], 
giving a large k'obs(H)/k'obs(D) value equal to 2.6(4) (Figure 4.3). This primary isotope effect 
indicates that N–H or N–D bond is broken in the turnover-limiting step. 
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Figure 4.2. Plots of ln[5a-d2] vs. time for the conversion of N-d2 aminoalkene substrate into the 
corresponding pyrrolidine catalyzed by {S-3}YCH2SiMe3 at 296 K. 
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Figure 4.3. Plot of kobs vs. catalyst concentration for the cyclization of 5a to 5b and 5a-d2 to 5b-
d2 by {S-3}YCH2SiMe3; kobs values are taken from slopes of linear regression analysis obtaining 
in Figures 4.1 and 4.2. The rate law for the cyclization is: −d[5a]/dt = k'[{S-3}YCH2SiMe3]1[5a]1 
k' = 0.105(5) M−1 s−1 (k'D = 0.040(5) M−1 s−1). The error was estimated from the standard 
deviation of values of k' obtained from kobs/[cat]. From the slopes of the two curves, kH/kD = 
2.6(4). 
 
To investigate the nature of the turnover-limiting step, the temperature dependence of the 
cyclization rate of 5a was measured by determining the second order rate constant k' at different 
temperature ranging from 271 K to 315 K (Figure 4.4). The standard Eyring plot ln(k'/T) vs. 1/T 
generated from these data provides the values of activation parameters:  ∆H‡ = 7.5(3) kcal·mol−1 
and ∆S‡ = −38(1) cal·mol−1K−1. 
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Figure 4.4. Plot of ln(k'/T) vs. 1/T for cyclization of 5a. From this plot, ∆H‡ = 7.5(3) kcal mol−1 
and ∆S‡ = −38(1) cal mol−1 K−1. 
 
Substrate saturation on initial rate is observed in {S-3}YCH2SiMe3 catalyzed 
hydroamination.
 
The initial cyclization rates were measured over 8.97–118 mM [5a] range at 
constant {S-3}YCH2SiMe3 concentration (5.23 mM, 296 K). The initial cyclization rate 
increases on increasing [5a] until saturation is observed at around 84 mM. At higher [5a] (>85 
mM), the initial rates decrease slightly due to inhibitory association of another equivalent of 
substrate. The plot also contains a non-zero x-intercept that coincides with precatalyst 
concentration [{S-3}YCH2SiMe3]. A non-linear least squares regression analysis of the data 
provides good correlation with eq 4.1, corresponding to the reaction mechanism shown in eq 4.2 
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that describes the initial portion of the reaction.34 At 296 °C, saturation is observed at [5a] = 
0.045 M ([cat] = 0.00523M). For comparison [5a] = 0.07 M ([{S-2}Zr(NMe2)2] = 0.0054 M) at 
saturation for the {S-2}Zr(NMe2)2, i.e. saturation of initial rates with {S-3}YCH2SiMe3 occurs as 
at lower substrate concentration than with {S-2}Zr(NMe2)2. 
−d[5a]
dt
=
k2[{S-3}YCH2SiMe3]1 {[5a] − [{S-3}YR]}1
{[5a] − [{S-3}YR]} + K' + KSI{[5a] − [{S-3}YR]}2
(4.1)
 
 
cat   +   5a
k1
k−1
cat. 5a
KSI 5a
k2 products
5a.cat.5a
(4.2)
 
The three parameters obtained from the fit are k2 (2.4±0.3 × 10−2 M−1s−1), K' (1.64±0.7 × 
10−2 M; (k−1 + k2)/k1), and KSI (3.9±1 M−1; [catalyst·subs2]/[subs][catalyst⋅subs]; substrate 
inhibition). The curve does not pass through the origin because one equiv of substrate is required 
to form the active catalyst giving the terms ([subs]−[cat]; i.e., corrected substrate concentration). 
This analysis separates the turnover-limiting step (k2) from the substrate binding constant (K'), 
allowing the measurement of the isotope effect (kH/kD) for k2. A non-linear least squares fit (R = 
0.99) of −d[5a-d2]/dt)ini vs. [5a-d2]ini provides a curve with the values: k2(D) = 7.1±0.5 × 10−3 
M−1s−1, K'(D) = 1.1±0.2 × 10−2 M, and KSI(D) = 5.6±1.3 M−1. The kinetic isotope effect (KIE) from 
initial rate plots k2(H)/k2(D) (3.5) and from second-order rate constants, k'obs(H)/k'obs(D) = 2.6 indicate 
that N−H (or N−D) bond is broken in the turnover-limiting step.  
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Figure 4.5. Plots of initial rates of cyclization –d[5a]/dt vs. [5a]ave (and –d[5a-d2]/dt vs. [5a-
d2]ave for cyclization of 5a and 5a-d2 by {S-3}YCH2SiMe3 (0.00523 M).  The curves represent 
non-linear least-squares regression analysis of the data to the equation: −d[substrate]/dt = 
k2[catalyst][substrate]/{K' + [substrate] + KSI[substrate]2}. 
 
To gain an insight of the nature of the transition state, activation parameters were 
measured by the saturation kinetics at different temperatures. The initial rate plots at constant 
catalyst concentration (5.23 mM) for temperatures at 273, 285, 296 and 312 K provided the rate 
constant k2 for the corresponding temperature. The linear Eyring plot using the k2 values gives the 
activation parameters ∆H‡ = 7.4 kcal.mol−1, ∆S‡ = −40.8 cal⋅mol−1K−1. The temperature 
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dependence of the overall cyclization based on the second order rate constant k' is also measured, 
that provide ∆H‡ = 7.3 kcal⋅mol−1 and ∆S‡ = −38.6 cal⋅mol−1K−1.  
 
Figure 4.6. Plots of initial rates of cyclization –d[5a]/dt vs. [5a]ave for cyclization of 5a by {S-
3}YCH2SiMe3 (0.00523 M) at 273, 285, 296 and 312 K.  The curves represent non-linear least-
squares regression analysis of the data to the equation: −d[substrate]/dt = 
k2[catalyst][substrate]/{K' + [substrate] + KSI[substrate]2}. 
 
Importantly, the % ee's for deutero-pyrrolidines are systematically and significantly lower 
than the values for the corresponding proteo pyrrolidines using {S-3}YCH2SiMe3. This effect 
contrasts all the bisoxazolinylborato zirconium catalyzed hydroamination, where 
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enantioselectivity increases upon N-deuteration of substrate (Table 4.4). For example, the % ee 
values for deuteron-heterocycles (4b-d2, 83%; 5b-d2, 87%) are lower compared to the 
corresponding proteo-heterocycles (4b, 94%; 5b, 92%) for {S-3}YCH2SiMe3. In contrast, the ee 
values for deuteron-heterocycles (4b-d2, 96%; 5b-d2, 91%) are higher than corresponding proteo-
heterocycles (4b, 93%; 5b, 86%) for precatalyst {S-3}Zr(NMe2)2. 
 
Table 4.4. Effect of N-d2 substitution on % ee in {S-3}YCH2SiMe3, {S-3}Zr(NMe2)2, and 
[{S-2}Zr(NMe2)][B(C6F5)4]-catalyzed enantioselective hydroamination 
Substrate → Product Entry {S-3} 
YCH2SiMe3 
{S-3} 
Zr(NMe2)2 
[{S-2} 
Zr(NMe2)][B(C6F5)4] 
NH2
Ph Ph
HN Ph
Ph
4a 4b
ND2
Ph Ph
HN
DH2C
Ph
Ph
4a-d2 4b-d2
 
 
1 
 
 
 
2 
 
94 (S) 
 
 
 
83 (S) 
 
93 (R) 
 
 
 
96 (R) 
 
66 (S) 
 
 
 
61 (S) 
 
NH2
5a
HN
5b
ND2
5a-d2
DN
DH2C
5b-d2
 
 
3 
 
 
 
4 
 
92 (S) 
 
 
 
87 (S) 
 
86 (R) 
 
 
 
91 (R) 
 
79 (S) 
 
 
 
76 (S) 
 
 
 
 
Mechanism of enantioselective C−N bond formation 
 {S-3}YCH2SiMe3 catalyze cyclization of aminoolefin at room temperature affording S-
configured cyclic amines with high enantiomeric excesses. The observed substrate saturation on 
the initial rates suggests the presence of a reversible step followed by turnover-limiting step in 
the catalytic cycle. The primary kinetic isotope effect {2.4(4)} obtained from second order rate 
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law, and also from initial rate plots {3.8(2)} indicate the cleavage of an N−H or N−D bond in the 
turnover-limiting step. The similarity of activation parameters determined using k2(H) (from 
initial rates measurements) and k'(H) (for overall conversion) indicates that the reaction 
mechanism remains consistent from the initial portion through at least two half-lives. Two 
plausible mechanistic scenarios are consistent with these observed distinct features in {S-
3}YCH2SiMe3 catalyzed cyclization. First, a concerted C−N and C−H bond formation through 
N–C ring closure concurrent with amino proton delivery at the terminal methylene unit. Another 
pathway involves a stepwise σ-insertive pathway that involves a reversible migratory olefin 
insertion into the Y–N amido σ-bond followed by turn-over limiting Y–C bond protonolysis. 
 In this context, concerted C−N/C−H bond forming mechanism is established in neutral 
tetravalent {S-2}Zr(NMe2)2 catalyzed cyclization of aminoolefins, which is supported by the 
second order rate law, the primary KIE, isotopic perturbation of enantioselectivity, the KIE for 
the two enantiotopic pathway, and inability of complex {S-2}ZrCl(NMe2) to cyclize 
aminoalkene.27 The {S-3}YCH2SiMe3-catalyzed cyclizations have also similar kinetic and 
spectroscopic features. However, the configurational flip between Y- and neutral Zr- catalysts 
indicate different mechanisms of stereoinduction. 
The significant isotope effects on enantioselectivity in {S-2} and {S-3}-supported yttrium 
and zirconium catalyzed hydroamination suggest that N−H or N−D bond is involved in the 
stereochemistry-determining step for all systems. For {S-3}YCH2SiMe3, the isotope effect for 
the favored diastereomeric pathway (kHS/kDS) is 2.7(4) and for the unfavored diastereomers 
(kHR/kDR) is 1.6(3) (from k'H/k'D). The zirconium catalyst {S-2}Zr(NMe2)2 is characterized by 
k'H/k'D = 3.5, kHS/kDS = 7.7(1) and kHR/kDR = 2.2(5).27 Interestingly, N-deuteration slows the S-
diastereomeric pathway by a greater extent than the R-pathway for both yttrium- and zirconium-
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catalyzed reactions. This similarity provides a powerful argument that the S transition-states for 
Zr and Y catalysts are similar, as are the R transition-states, even though the energetically 
favored diastereomeric pathways are opposite.  
Interestingly, the cationic zirconium [{S-2}Zr(NMe2)][B(C6F5)4] also catalyze cyclization 
of primary aminopentenes. The catalytic activity of [{S-2}Zr(NMe2)][B(C6F5)4] contrasts to 
other reported cationic group 4 catalysts that cyclize only secondary aminoalkenes.23 The 
observed isotopic perturbation on stereoselectivity in [{S-2}Zr(NMe2)][B(C6F5)4] catalyzed 
hydroamination rule out the involvement of [2π+2π] cycloaddition in a zirconium imidoalkene 
species, as an NH group is absent in the imido species. Additionally, the formation of S-
configured products mediated by [{S-2}Zr(NMe2)][B(C6F5)4] and {S-3}YCH2SiMe3 suggests 
that the nature of stereochemistry determining turnover-limiting steps are similar for both 
trivalent catalysts. 
Our kinetic and spectroscopic data show that cyclopentadienyl-bis(oxazolinyl)borate 
containing trivalent yttrium, tetravalent neutral zirconium, and trivalent cationic zirconium 
catalysts have similar catalytic pathways. Two substrates are required for cyclization in all these 
systems and also the catalytic cycle contains a reversible catalyst-substrate association followed 
by the turnover-limiting step. In all these systems, the turnover-limiting step involves N−H bond 
cleavage. In addition, N−H bond cleavage also significantly affects the configuration of the new 
stereocenter (i.e., it is associated with C−N bond formation) in the chiral Zr and Y systems. All 
these observations disfavor the olefin insertion mechanism for the {S-3}YCH2SiMe3-system; a 
concerted C−H and C−N bond formation via a six-center cyclic transition state is proposed as the 
C−N bond forming step (Figure 4.7).  
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Figure 4.7. Proposed catalytic cycle for {S-3}YCH2SiMe3 catalyzed hydroamination of 
aminoalkenes 
 
Although the general mechanistic features of the C−N bond forming step (and even the 
two diastereomeric transition-states) appear to be related for Zr and Y catalysts, the oppositely 
configured stereocenters in the catalytic products reveal that mechanisms for stereoinduction are 
not equivalent for Y and Zr. Our working rationalization of the stereochemistry is that the C1-
symmetric ancillary differentiates the two amidoalkenes in the transition-state in the zirconium 
system (Figure 4.8, i), whereas the configuration of the two diastereomeric intermediates {S-
3}YNHR(NH2R) significantly influences the favored diastereomeric pathway in the trivalent 
system (Figure 4.8, ii). 
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Figure 4.8. Proposed stereomechanism for Zr- and Y-catalyzed hydroamination. 
 
Conclusions 
Cyclopentadienyl-bis(oxazolinyl)borato yttrium complex {PhB(C5H4)(OxS-
tBu)2}YCH2SiMe3 is a highly enantioselective precatalyst for hydroamination/cyclization of 
aminoolefins. The precatalyst provides nitrogen heterocycles with high enantiomeric excesses up 
to 96%. Enantioselectivities are remained high with substrate substitution patterns and also in the 
presence of oxo- and halogen-functional groups. A non-insertive mechanism involving concerted 
C−N/C−H bond formation was proposed based on the kinetics, primary isotope effects, isotopic 
perturbation of enantioselectivity, the non-linear effect of concentration on cyclization rate, and 
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the requirement of substrate/precatalyst >2 for catalytic turnover. Similar stereochemical and 
kinetic features of optically active cyclopentadienyl-bis(oxazolinyl)borate containing yttrium as 
well as cationic and neutral zirconium catalyzed hydroamination  suggest similar transition states 
in all these systems. 
 
Experiment details. 
General Procedures. All reactions were performed under a dry argon atmosphere using 
standard Schlenk techniques or under a nitrogen atmosphere in a glove box unless otherwise 
indicated. Dry, oxygen-free solvents were used throughout. Benzene, toluene, pentane and 
tetrahydrofuran were degassed by sparging with nitrogen, filtered through activated alumina 
columns, and stored under N2. Benzene-d6, toluene-d8 and tetrahydrofuran-d8 were vacuum 
transferred from Na/K alloy and stored under N2 in a glove box. Bromobenzene-d5 was degassed 
with three freeze-pump-thaw cycles and dried over activated molecular sieves in the glove box. 
Y(CH2SiMe3)3(THF)2,35 sodium cyclopentadienide,36  H[PhB(C5H5)(OxMe2)2],32 
H[PhB(C5H5)(Ox4S-iPr,Me2)2],27 2,2-diphenyl-4-penten-1-amine (4a),37 C-(1-allyl-cyclohexyl)-
methylamine (5a),38 2-allyl-2-methylpent-4-enylamine (6a),39 2,2-diphenyl-5-hexen-1-amine 
(7a),40 N-methyl-2,2-diphenyl-4-penten-1-amine (8a),41 2-allyl-2-phenyl-pent-4-enylamine 
(10a),42,26 2,2-bis(2-propenyl)-4-pentenylamine (12a)43 and tetrakis(trimethylsilyl)silane44 were 
prepared by published procedures. All aminoalkenes were distilled from CaH2, degassed and 
stored with freshly activated 4 Å molecular sieves in a glove box prior to use. All other 
chemicals used here are commercially available. (+)-(S)-α-methoxy-α-
(trifluoromethyl)phenylacetyl chloride (S-Mosher’s chloride) was obtained from Alfa-Aesar 
(>98%, (+)-137.3). 1H, 13C{1H}, 11B, 19F and 29Si{1H} NMR spectra were collected either on a 
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Bruker DRX-400 spectrometer or an Agilent MR400 spectrometer. 15N chemical shifts were 
determined either by 1H-15N CIGARAD experiments on an Agilent MR400 spectrometer or by 
1H-15N HMBC experiments on a Bruker Avance II 700 spectrometer with a Bruker Z-gradient  
inverse TXI 1H/13C/15N 5 mm cryoprobe. 15N chemical shifts were originally referenced to liquid 
NH3 and recalculated to the CH3NO2 chemical shift scale by adding −381.9 ppm. 11B NMR 
spectra were referenced to an external sample of BF3·Et2O. Accurate mass ESI mass 
spectrometry was performed using an Agilent QTOF 6530 equipped with the Jet Stream ESI 
source. An Agilent ESI test mix was used for tuning and calibration. Accurate mass data was 
obtained in the positive ion mode using a reference standard with ions at 121.05087 and 
922.00979. The mass resolution (FWHM) was maintained at 18,000. Elemental analysis was 
performed using a Perkin-Elmer 2400 Series II CHN/S by the Iowa State Chemical 
Instrumentation Facility. [α]D values were measured on a ATAGO AP-300 polarimeter at 23 °C. 
 
{PhB(C5H4)(OxMe2)2}YCH2SiMe3. H[PhB(C5H5)(OxMe2)2] (0.200 g, 0.571 mmol) was dissolved 
in a mixture of tetrahydrofuran (4 mL), and this solution was cooled to −30 °C. 
Y(CH2SiMe3)3(THF)2 (0.282 g, 0.571 mmol) was placed in a separate flask, and the solid was 
cooled to −30 °C. The cooled solution was quickly added to Y(CH2SiMe3)3(THF)2, and the 
resulting solution was gently agitated for 5 min. Cold pentane (5 mL) was added, and a yellow 
solid precipitated. The mixture was cooled to −30 °C and filtered. The solid was dried in vacuo 
for 10 min affording {PhB(C5H4)(OxMe2)2}YCH2SiMe3 as a light yellow solid (0.260 g, 49.6 
mmol, 87.0% yield). This material was stored at −30 °C in the dark. 1H NMR  (tetrahydrofuran-
d8, 400 MHz): δ  7.55 (d, 3JHH =  6.8 Hz, 2 H, ortho-C6H5), 6.97 (t, 3JHH = 6.8 Hz, 2 H, meta-
C6H5), 6.88 (t, 3JHH = 7.2 Hz, 1 H,  para-C6H5), 6.38 (m, 2 H, C5H4), 6.18 (m, 2 H, C5H4), 3.87 
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(d, 2 H, 2JHH = 8.4 Hz, CNCMe2CH2O), 3.82 (d, 2 H, 2JHH = 8.4 Hz, CNCMe2CH2O), 1.29 (s, 6 
H, CNCMe2CH2O), 1.21 (s, 6 H, CNCMe2CH2O),
 
0.01 (s, 9 H, CH2SiMe3), −0.35 (d, 2JYH = 7.2 
Hz, 2 H, YCH2SiMe3). 13C{1H} NMR (tetrahydrofuran-d8, 100 MHz): δ 192.51  
(CNCMe2CH2O), 136.54 (ortho-C6H5), 126.22 (meta-C6H5), 124.37 (para-C6H5), 121.45 (C5H4), 
112.82 (C5H4), 80.42  (CNCMe2CH2O),  70.77  (CNCMe2CH2O), 35.61 (d, 1JYC = 35 Hz, 
YCH2SiMe3), 30.80 (CNCMe2CH2O), 28.87 (CNCMe2CH2O), 5.16 (CH2SiMe3). 11B NMR 
(tetrahydrofuran-d8, 128 MHz): δ −15.2. IR (KBr, cm-1): 3068 w, 3045 w, 2958 s, 2891 s, 1549 
(s, νCN), 1490 w, 1462 m, 1431 w, 1387 w, 1368 m, 1352 w, 1272 m, 1264 m, 1249 s, 1237 s, 
1195 s, 1176 s, 1155 s, 1104 w, 1066 w, 1051 m, 1034 w, 1022 w, 993 w, 971 m, 917 w, 860 s, 
813 s, 776 s, 732 s, 704 s, 668 m. Anal. Calcd for C25H36BN2O2SiY: C, 57.26; H, 6.92; N, 5.34. 
Found: C, 57.13; H, 6.88; N, 4.97. Mp: 90-95 °C, dec. 
 
{PhB(C5H4)(Ox4S-iPr,Me2)2}YCH2SiMe3. H[PhB(C5H5)(Ox4S-iPr,Me2)2] (0.060 g, 0.138 mmol) and 
Y(CH2SiMe3)3(THF)2 (0.065 g, 0.131 mmol) were dissolved in benzene (5 mL) at room 
temperature. The resulting solution was stirred for 10 min and then was filtered. Evaporation of 
the filtrate provided light yellow gel. The gel was triturated with pentane, giving 
{PhB(C5H4)(Ox4S-iPr,Me2)2}YCH2SiMe3 as a light yellow solid (0.065 g, 0.107 mmol, 77.5% 
yield). This material was stored at −30 °C. 1H NMR  (benzene-d6, 400 MHz): δ 7.74 (d, 3JHH =  
7.2 Hz, 2 H, ortho-C6H5), 7.38 (m, 2 H, meta-C6H5), 7.21 (m, 1 H,  para-C6H5), 6.92 (m, 1 H, 
C5H4), 6.80 (m, 1 H, C5H4), 6.72 (m, 1 H, C5H4), 6.61 (m, 1 H, C5H4), 3.26 (d, 2 H, 3JHH = 6.0 
Hz, CNCi-PrHCMe2O), 3.14 (d, 2 H, 3JHH = 6.0 Hz, CNCi-PrHCMe2O), 1.88 (m, 2 H, 
CNC(CHMe2)HCMe2O), 1.27-0.90 (24 H, CNC(CHMe2)HCMe2O), 0.32 (s, 9 H, CH2SiMe3), 
−0.42 (m, 1 H, CH2SiMe3), −0.60 (m, 1 H, CH2SiMe3). 13C{1H} NMR (benzene-d6, 100 MHz): δ 
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193.41 (br, CNCi-PrHCH2O), 141.50 (br, ipso-C6H5), 135.10 (ortho-C6H5), 127.51 (meta-C6H5), 
125.26 (para-C6H5), 122.36 (C5H4), 120.49 (C5H4), 118.30 (C5H4), 116.79 (C5H4), 87.75 (CNCi-
PrHCMe2O), 86.99 (CNCi-PrHCMe2O), 78.22 (CNCi-PrHCMe2O), 76.61 (CNCi-PrHCMe2O), 
36.74 (d, 1JYC = 35 Hz, YCH2SiMe3),  30.44 (CNC(CHMe2)HCMe2O), 30.27 
(CNC(CHMe2)HCMe2O), 30.94 (CNCi-PrHCMe2O), 30.09 (CNCi-PrHCMe2O), 29.26 (CNCi-
PrHCMe2O), 28.89 (CNCi-PrHCMe2O), 22.28 (CNC(CHMe2)HCMe2O), 21.55 
(CNC(CHMe2)HCMe2O), 21.28 (CNC(CHMe2)HCMe2O), 20.82 (CNC(CHMe2)HCMe2O), 4.93 
(CH2SiMe3). 15N NMR (benzene-d6, 71 MHz): δ −154.4, −156.8. 29Si{1H} NMR (79.5 MHz, 
benzene-d6): δ −2.79. 11B NMR (benzene-d6, 128 MHz): δ −15.9. IR (KBr, cm-1): 3071 w, 3041 
w, 2962 s, 2891 s, 2770 m, 1558 s (CN), 1482 m, 1464 m, 1425 w, 1397 m, 1365 m, 1344 w, 
1272 m, 1262 w, 1248 s, 1234 m, 1192 s, 1169 s, 1155 s, 1114 w, 1060 w, 1052 m, 1032 w, 
1019 m, 995 w, 917 w, 860 s, 805 s, 786 s, 743 s, 711 m. Anal. Calcd for C32H48BN2O2SiY: C, 
61.19; H, 7.95; N, 4.60. Found: C, 60.74; H, 7.73; N, 4.26. [α]D = −39.23° (C6H6). Mp: 155-160 
°C, dec. 
 
4S-2H-OxtBu .Error! Bookmark not defined.Error! Bookmark not defined. 15N NMR (acetonitrile-d3, 
71 MHz): δ −148.0. 
 
{PhB(C5H4)(Ox4S-tBu)2}YCH2SiMe3. H[PhB(C5H5)(Ox4S-tBu)2] (0.048 g, 0.119 mmol) was 
dissolved in benzene (2 mL) and added to Y(CH2SiMe3)3(THF)2 (0.056 g, 0.113 mmol) to give a 
light yellow solution. This solution was allowed to stir for 3 min at room temperature. The 
solution was quickly filtered, and the filtrate was concentrated under vacuum to give a yellow 
gel. The gel was triturated with pentane to provide {PhB(C5H4)(Ox4S-tBu)2}YCH2SiMe3 as a light 
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yellow solid (0.055 g, 0.095 mmol, 84.6% yield), which was stored at −30 °C. 1H NMR  
(benzene-d6, 400 MHz): δ 7.67 (d, 3JHH =  7.6 Hz, 2 H, ortho-C6H5), 7.34 (m, 2 H, meta-C6H5), 
7.18 (m, 1 H,  para-C6H5), 6.82 (m, 1 H, C5H4), 6.77 (m, 1 H, C5H4), 6.64 (m, 1 H, C5H4), 6.53 
(m, 1 H, C5H4), 3.68-3.56 (m, 4 H, CNCt-BuHCH2O), 3.16-3.03 (m, 2 H, CNCt-BuHCH2O), 
0.67 (s, 9 H, CNCt-BuHCH2O), 0.64 (s, 9 H, CNCt-BuHCH2O), 0.01 (s, 9 H, CH2SiMe3), -0.34 
(m, 1 H, CH2SiMe3), -0.51 (m, 1 H, CH2SiMe3). 13C{1H} NMR (benzene-d6, 100 MHz): δ 
195.31 (br, CNCt-BuHCH2O), 150.38 (ipso-C6H5), 134.90 (ortho-C6H5), 127.97 (meta-C6H5), 
125.95 (para-C6H5), 123.73 (C5H4), 123.64 (C5H4), 115.46 (C5H4), 115.25 (C5H4), 74.24 (CNCt-
BuHCH2O), 72.62 (CNCt-BuHCMe2O), 68.31 (CNCt-BuHCH2O), 67.25 (CNCt-BuHCH2O), 
38.25 (d, 1JYC = 35 Hz, YCH2SiMe3), 32.37 (CNC(CMe3)HCH2O), 27.52 (CNC(CMe3)HCH2O), 
25.41 (CNC(CMe3)HCH2O), 25.20 (CNC(CMe3)HCH2O), 5.24 (CH2SiMe3). 15N NMR 
(benzene-d6, 41 MHz): δ −148.5, −150.2. 11B NMR (benzene-d6, 128 MHz): δ −15.7.  29Si{1H} 
NMR (79.5 MHz, benzene-d6): δ −3.28. IR (KBr, cm-1): 3068 w, 3044 w, 2955 s, 2902 s, 2870 s, 
1586 (s, νCN), 1540 w, 1479 s, 1431 w, 1419 w, 1397 w, 1369 m, 1320 w, 1287 m, 1249 s, 1238 
s, 1207 s, 1184 s, 1108 w, 1065 w, 1048 w, 1026 w, 1001 w, 969 s, 860 s, 814 m, 793 w, 726 s, 
703 s, 677 w. Anal. Calcd for C29H44BN2O2SiY: C, 60.00; H, 7.64; N, 4.83. Found: C, 59.62; H, 
7.32; N, 5.06. [α]D = −46.74° (C6H6). Mp: 120-125 °C, dec. 
 
Tl2[PhB(C5H4)(OxMe2)2]. In a glove box, a vial was charged with H[PhB(C5H5)(OxMe2)2]  (0.214 
g, 0.611 mmol) and dissolved in Et2O (7 mL). To the solution, thallium(1) ethoxide (86.5 µL, 
1.22 mmol) was added by a microliter syringe. The resulting solution was stirred at room 
temperature for 8 h. During stirring, a yellow solid crushed out from the solution. The solution 
was decanted to get the yellow solid precipitation in the glove box. The solid was washed with 
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Et2O and dried in vacuo to give Tl2[PhB(C5H4)(OxMe2)2] as a yellow solid (0.420 g, 0.555 mmol, 
90.8%), which was stored in glove box. 1H NMR  (tertrahydrofuran-d8, 400 MHz): δ 7.34 (d, 
3JHH = 6.8 Hz, 2 H, ortho-C6H5), 7.05 (t, 3JHH = 7.2 Hz, 2 H, meta-C6H5), 6.96 (t, 3JHH = 7.2 Hz, 
1 H,  para-C6H5), 6.18 (m, 2 H, C5H4), 5.84 (m, 2 H, C5H4), 3.74 (4 H, ), 1.30 
(s, 6 H, ), 1.28 (s, 6 H, ). 13C{1H} NMR (tertrahydrofuran-d8, 
100 MHz): δ 198.62 (br, ), 155.95 (br, ipso-C6H5), 137.58 (ipso-C5H4), 133.61 
(ortho-C6H5), 127.35 (meta-C6H5), 124.47 (para-C6H5), 116.90 (C5H4), 111.29 (C5H4), 80.08 (
), 67.82 ( ), 29.67 ( ), 29.51 ( ). 
11B NMR (tertrahydrofuran-d8, 128 MHz): δ −17.0. 15N NMR (tertrahydrofuran-d8, 71 MHz): 
δ −99.8. IR (KBr, cm-1): 3059 w, 2958 s, 2924 m, 2878 m, 1578 s, 1567 s, 1484 w, 1459 m, 1428 
w, 1380 w, 1361 m, 1342 w, 1290 m, 1250 m, 1190 m, 1120 s, 1056 w, 1037 m, 1017 w, 966 s, 
936 w, 876m, 824 s, 792 w, 777 m, 747 s, 731 s, 704 m, 661 w. Anal. Calcd for 
C21H25BO2N2Tl2: C, 33.32; H, 3.33; N, 3.70. Found: C, 32.61; H, 2.94; N, 3.72. Mp: 195-200 °C, 
dec. 
 
{PhB(C5H4)(OxMe2)2}YNHtBu. In a glove box, a vial was charged with Tl2[PhB(C5H4) 
(OxMe2)2] (0.276 g, 0.364 mmol)  and YCl3(THF)3 (0.150 g, 0.364 mmol). THF (5 mL) was 
added and immediately a white slurry was formed. The mixture was stirred at room temperature 
for 1 h. The solution was filtered to obtain the THF solution of {PhB(C5H4)(OxMe2)2}YCl. 
Unfortunately, the complex couldn’t be isolated in pure form. 
1H NMR  (tertrahydrofuran-d8, 400 MHz): δ 7.55 (d, 3JHH = 6.8 Hz, 2 H, ortho-C6H5), 6.99 (t, 
3JHH = 7.2 Hz, 2 H, meta-C6H5), 6.90 (t, 3JHH = 6.4 Hz, 1 H,  para-C6H5), 6.26 (m, 2 H, C5H4), 
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6.05 (m, 2 H, C5H4), 3.84 (d, 3JHH = 7.6 Hz, 2 H, ), 3.76 (d, 3JHH = 7.6 Hz, 2 H, 
), 1.37 (s, 6 H, ), 1.34 (s, 6 H, ). 11B NMR 
(tertrahydrofuran-d8, 128 MHz): δ −16.0. 
{PhB(C5H4)(OxMe2)2}YNHtBu was synthesized using the THF solution of 
{PhB(C5H4)(OxMe2)2}YCl prepared in situ. tBuNHLi (0.029 g, 0.365 mmol) was added to the 
THF solution of {PhB(C5H4)(OxMe2)2}YCl and then stirred for 2 h at room temperature. The 
solution was filtered to remove LiCl. Removal of solvent in vacuo provided 
{PhB(C5H4)(OxMe2)2}YNHtBu as a white solid (0.143 g, 0.281 mmol, 77.2%). 1H NMR  
(tertrahydrofuran-d8, 400 MHz): δ 7.39 (d, 3JHH = 6.8 Hz, 2 H, ortho-C6H5), 7.05 (t, 3JHH = 6.8 
Hz, 2 H, meta-C6H5), 6.96 (t, 3JHH = 7.2 Hz, 1 H,  para-C6H5), 5.85 (m, 1 H, C5H4), 5.57 (m, 1 
H, C5H4), 5.47 (m, 1 H, C5H4), 4.95 (m, 1 H, C5H4), 4.72 (d, 2JYH = 7.2 Hz, 1 H, NHtBu), 3.70 
(d, 3JHH = 7.2 Hz, 2 H, ), 3.43 (d, 3JHH = 7.6 Hz, 2 H, ), 1.37 (s, 
9 H, tBu), 1.27 (s, 3 H, ), 1.11 (s, 3 H, ), 1.06 (s, 3 H, 
), 1.00 (s, 3 H, ). 13C{1H} NMR (tertrahydrofuran-d8, 100 
MHz): δ 198.62 (br, ), 154.91 (br, ipso-C6H5), 132.98 (ortho-C6H5), 127.42 
(meta-C6H5), 122.07 (para-C6H5), 115.87 (C5H4), 110.38 (C5H4), 80.67 ( ), 66.82 
( ), 30.59 ( ), 29.73 ( ), 28.98 (NHCMe3), 26.40 
(NHCMe3). 11B NMR (tertrahydrofuran-d8, 128 MHz): δ −15.8. 15N NMR (tertrahydrofuran-d8, 
71 MHz): δ  −146.6 ( ). IR (KBr, cm-1): 2965 s, 2927 m, 2877 m, 1576 s, 1460 s, 
1430 m, 1367 s, 1303 w, 1260 m, 1192 s, 1149 w, 994 m, 970 s, 897 m, 779 m, 730 s, 703 s, 684 
w. Anal. Calcd for C25H35BN3O2Y: C, 58.96; H, 6.93; N, 8.25. Found: C, 58.61; H, 6.49; N, 
6.82. Mp: above 200°C. 
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Tl2[PhB(C5H4)(Ox4S-tBu)2]. In a glove box, a vial was charged with H[PhB(C5H5)(Ox4S-tBu)2]  
(0.300 g, 0.738 mmol) and dissolved in Et2O (7 mL). To the solution, thallium(1) ethoxide (104 
µL, 1.476 mmol) was added by a microliter syringe. The resulting solution was stirred at room 
temperature for 12 h. During stirring, an off white solid crushed out from the solution. The 
solution was decanted to obtain the solid precipitation. The solid was washed with Et2O twice 
and dried in vacuo to give Tl2[PhB(C5H4)(Ox4S-tBu)2] as a yellow solid (0.560 g, 0.689 mmol, 
93%), which was stored in glove box. 1H NMR  (tertrahydrofuran-d8, 400 MHz): δ 7.86 (d, 3JHH 
=  7.2 Hz, 2 H, ortho-C6H5), 7.47 (t, 3JHH =  7.6 Hz, 2 H, meta-C6H5), 7.28 (t, 3JHH =  7.6 Hz, 1 
H,  para-C6H5), 6.36 (m, 2 H, C5H4), 6.21 (m, 2 H, C5H4), 3.95-3.90 (m, 3 H, CNCt-BuHCH2O, 
CNCt-BuHCH2O, overlapped), 3.74 (t, 3JHH =  8.8 Hz, 1 H, CNCt-BuHCH2O), 3.47-3.42 (m, 2 
H, CNCt-BuHCH2O), 0.78 (s, 9 H, CNCt-BuHCH2O), 0.76 (s, 9 H, CNCt-BuHCH2O). 13C{1H} 
NMR (benzene-d6, 150 MHz): δ 199.81 (br, CNCt-BuHCH2O), 157.28 (ipso-C6H5), 138.67 
(ipso-C5H4), 134.12 (ortho-C6H5), 128.68 (meta-C6H5), 127.82 (para-C6H5), 125.06 (C5H4), 
117.07 (C5H4), 76.42 (CNCt-BuHCH2O), 75.60 (CNCt-BuHCH2O), 69.92 (CNCt-BuHCH2O), 
68.99 (CNCt-BuHCH2O), 33.88 (CNC(CMe3)HCH2O), 33.82 (CNC(CMe3)HCH2O), 27.28 
(CNC(CMe3)HCH2O), 26.92 (CNC(CMe3)HCH2O). 15N NMR (tertrahydrofuran-d8, 71 MHz): 
δ −125.2. 11B NMR (tertrahydrofuran-d8, 128 MHz): δ −16.0. IR (KBr, cm-1): 3061 m, 2955 s, 
2889 m, 2866 m, 1559 s, 1479 m, 1426 w, 1390 w, 1361 m, 1349 w, 1327 w, 1279 w, 1206 w, 
1182 m, 1170 m, 1144 s, 1061 m, 1036 m, 1025 m, 995 w, 962 s, 930 w, 901 w, 868 w, 847 m, 
779 w, 735 s, 711 m, 698 m, 659 s. Anal. Calcd for C25H33BO2N2Tl2: C, 36.93; H, 4.09; N, 3.45. 
Found: C, 36.55; H, 4.01; N 2.98. Mp: 186-190 °C. 
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{PhB(C5H4)(OxS-tBu)2}YCl. In a glove box, YCl3(THF)3 (0.101 g, 0.245 mmol) was dissolved in 
THF (5 mL) and the solution was transferred to a vial containing Tl2[PhB(C5H4)(OxS-tBu)2]  
(0.200 g, 0.245 mmol). The resultant white slurry was stirred for 1 h at room temperature, and 
then filtered to remove TlCl byproduct. Removal of volatiles of the filtrate in vacuo provided 
{PhB(C5H4)(OxS-tBu)2}YCl as a white solid (0.115 g, 0.218 mmol, 89.0%). 1H NMR  
(tetrahydrofuran-d8, 400 MHz): δ 7.59 (d, 3JHH =  7.2 Hz, 2 H, ortho-C6H5), 7.06 (t, 3JHH =  6.8 
Hz, 2 H, meta-C6H5), 6.95 (t, 3JHH =  6.8 Hz, 1 H,  para-C6H5), 6.44 (m, 1 H, C5H4), 6.31 (m, 1 
H, C5H4), 6.27 (m, 1 H, C5H4), 5.95 (m, 1 H, C5H4), 4.30-3.97 (m, 6 H, CNCt-BuHCH2O, CNCt-
BuHCH2O; overlapped), 0.93 (s, 9 H, CNCt-BuHCH2O), 0.87 (s, 9 H, CNCt-BuHCH2O). 
13C{1H} NMR (benzene-d6, 100 MHz): δ 193.01 (br, CNCt-BuHCH2O), 134.81 (ortho-C6H5), 
128.69 (meta-C6H5), 125.11 (para-C6H5), 123.91 (C5H4), 122.62 (C5H4), 116.66 (C5H4), 115.19 
(C5H4), 73.04 (CNCt-BuHCH2O), 72.38 (CNCt-BuHCMe2O), 68.56 (CNCt-BuHCH2O), 67.11 
(CNCt-BuHCH2O), 33.21 (CNC(CMe3)HCH2O), 28.17 (CNC(CMe3)HCH2O), 25.82 
(CNC(CMe3)HCH2O), 25.01 (CNC(CMe3)HCH2O). 15N NMR (benzene-d6, 41 MHz): δ −148.5, 
−150.2. 11B NMR (tetrahydrofuran-d8, 128 MHz): δ −15.9. IR (KBr, cm-1): 3069 w, 3045 w, 
2958 s, 2906 m, 2870 m, 1552 s, 1478 s, 1429 w, 1396 w, 1367 m, 1349 w, 1286 w, 1263 w, 
1184 s, 1053 m, 1039 m, 960 s, 850 m, 785 s, 725 s, 659 m. Anal. Calcd for C25H33BClN2O2Y: 
C, 56.79; H, 6.29; N, 5.30. Found: C, 56.03; H, 6.11; N, 4.86. Mp: above 200 °C. 
 
[PhB(C5H4)(Ox4R-iPr,Me2)2Zr(NMe2)][B(C6F5)4]. In a glove box, {PhB(C5H4)(Ox4R-
iPr,Me2)2}Zr(NMe2)2 (0.150 g, 0.245 mmol) was dissolved in 5 mL benzene and the solution was 
transferred to a vial containing [Ph3C][B(C6F5)4] (0.226 g,  0.245 mmol). The mixture was stirred 
for 5 min, and a light yellow precipitate formed. The solution was decanted, and the precipitate 
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was washed with pentane. The solid was dried in vacuum to afford [PhB(C5H4)(Ox4R-
iPr,Me2)2Zr(NMe2)][B(C6F5)4] as a light yellow solid (0.226 g, 0.181 mmol, 73.9%), which was 
stored at −30 °C in glove box. 1H NMR  (bromobenzene-d5, 400 MHz): δ 7.97 (d, 3JHH = 7.2 Hz, 
2 H, ortho-C6H5), 7.46 (m, 2 H, meta-C6H5), 7.37 (m, 1 H,  para-C6H5), 6.67 (m, 1 H, C5H4), 
6.50 (m, 1 H, C5H4), 6.23 (m, 1 H, C5H4), 6.12 (m, 1 H, C5H4), 3.31 (d, 2 H, 3JHH = 6.6 Hz, 
CNCiPrHCMe2O), 3.24 (d, 2 H, 3JHH = 6.6 Hz, CNCiPrHCMe2O),  2.76  (s, 6 H, NMe2), 1.67 
(m, 2 H, CNC(CHMe2)HCMe2O), 1.31-0.93 (24 H, CNC(CHMe2)HCMe2O). 13C{1H} NMR 
(bromobenzene-d5, 150 MHz): δ 153.42 (br, ipso-C6H5), 148.01 (br, C6F5), 145.96 (br, C6F5), 
138.25 (br, C6F5), 135.99 (br, C6F5), 134.74 (br, C6F5), 133.71 (ortho-C6H5), 128.90 (meta-
C6H5), 124.02 (para-C6H5), 123.57 (C5H4), 119.62 (C5H4), 113.37 (C5H4), 112.82 (C5H4), 87.21 
(CNCiPrHCMe2O), 85.63 (CNCiPrHCMe2O), 79.85 (CNCiPrHCMe2O), 78.49 
(CNCiPrHCMe2O), 45.40 (NMe2), 31.04 (CNC(CHMe2)HCMe2O), 31.57 
(CNC(CHMe2)HCMe2O),  30.84 (CNCiPrHCMe2O), 30.44 (CNCiPrHCMe2O), 21.96 
(CNCiPrHCMe2O), 21.81 (CNCiPrHCMe2O), 20.75 (CNC(CHMe2)HCMe2O), 20.52 
(CNC(CHMe2)HCMe2O), 20.41 (CNC(CHMe2)HCMe2O), 20.25 (CNC(CHMe2)HCMe2O). 19F 
NMR (bromobenzene-d5, 376 MHz, 25 °C): δ −132.1 (s br, ortho-F), −161.8 (t, 3JFF = 21.1 Hz, 
para-F), −165.7 (t, 3JFF = 16.8 Hz, meta-F). 11B NMR (bromobenzene-d5, 128 MHz): δ −15.1, 
−15.9. 15N{1H} NMR (benzene-d6, 71 MHz): δ −159.1, −164.4 (CNCiPrHCMe2O). IR (KBr, 
cm−1): 2972 m, 2966 w, 1554 s, 1464 s, 1375 w, 1275 m, 1088 m, 980 s, 887 w, 821 w, 775 m, 
756 m, 684 m, 662 m. Anal. Calcd for C53H43B2F20N3O2Zr: C, 51.06; H, 3.48; N, 3.37. Found: C, 
50.41; H, 3.04; N, 2.97. Mp: 133-137°C, dec.  
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N-Allyl-2,2-diphenylpent-4-enylamine (16a). 2,2-diphenylpent-4-enal was prepared according 
to the literature procedure.44 A flame dried flask was charged with MgSO4 (1.00 g) and a 
solution of 2,2-diphenylpent-4-enal (0.639 g, 2.70 mmol) in 7 mL methylene chloride. The flask 
was cooled to 0 °C and then excess allylamine (3.0 mL, 40.0 mmol) was added by a syringe. The 
solution mixture was stirred at room temperature overnight. The solution was filtered and 
extracted with methylene chloride. All the volatiles were removed under vacuo to give the imine 
as a light yellow gel (0.720 g, 2.61 mmol, 96.6%). 1H NMR (chloroform-d, 400 MHz): δ  8.01 
(s, 1 H, CH=N), 7.32-7.18 (m, 10 H, C6H5), 6.04-5.94 (m, 1 H, H2C=CHCH=N), 5.73-5.63 (m, 1 
H, H2C=CHCH2C), 5.16-5.08 (m, 2 H, H2C=CHCH=N), 4.91-4.85 (m, 2 H, H2C=CHCH2C), 
4.09 (d, 3JHH = 8.0 Hz, 2 H, H2C=CHCH=N), 3.19 (d, 3JHH = 8.0 Hz, 2 H, H2C=CHCH2C). 
13C{1H} NMR (100 MHz, chloroform-d): δ 168.73 (CH=N), 143.93 (C6H5), 136.12 (CH=CH2), 
135.19 (CH=CH2), 129.07 (C6H5), 128.36 (C6H5), 126.75 (C6H5), 117.60 (CH=CH2), 115.91 
(CH=CH2), 63.34 (H2C=CHCH=N), 56.65 [C(C6H5)2], 41.55 (H2C=CHCH2C). 
A flame dried flask was charged with solution of imine (0.720 g, 2.61 mmol) in 5 mL dry 
methanol. The flask was cooled to 0 °C and then NaBH4 (0.090 g, 2.38 mmol) was added in 
small portions under argon flow. The reaction mixture was stirred at room temperature 
overnight. Aqueous NaOH (25%, 2.5 mL) was added at 0 °C and then stir at room temperature 
for 1 h. The organic layer was separated and the aqueous layer was extracted with diethyl ether 
(3 x 20 mL). The combined organic layers were dried with Na2SO4. After removal of the solvent, 
a light yellow gel was obtained that was purified by short silica gel column chromatography 
(hexane:EtOAc = 3:1, Rf = 0.68) to yield N-allyl-2,2-diphenylpent-4-enylamine as a colorless  
gel (0.544 g, 1.96 mmol, 75.1%). The amine was dissolved in dry pentane in glove box, stir with 
CaH2 for 3 days and then filter. Removal of solvent provided dry N-allyl-2,2-diphenylpent-4-
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enylamine, and was used in catalysis. 1H NMR (chloroform-d, 400 MHz): δ 7.28-7.16 (m, 10 H, 
C6H5), 5.82-5.73 (m, 1 H, H2C=CHCH2N), 5.42-5.32 (m, 1 H, H2C=CHCH2C), 5.09-4.91 (m, 4 
H, H2C=CHCH2N), 3.18 (s, 2 H, CH2NH), 3.16 (d, 3JHH = 6.0 Hz, 2 H, H2C=CHCH2N), 3.00 (d, 
3JHH = 6.8 Hz, 2 H, H2C=CHCH2C), 0.56 (1 H, NH). 13C{1H} NMR (100 MHz, chloroform-d): δ 
147.05 (C6H5), 137.60 (CH=CH2), 135.10 (CH=CH2), 128.27 (C6H5), 128.16 (C6H5), 126.17 
(C6H5), 117.81 (CH=CH2), 115.73 (CH=CH2), 55.48 (CH2NH), 53.02 (CH2NH), 50.26 
[C(C6H5)2], 41.84 (H2C=CHCH2C). IR (KBr, cm-1): 3059 s, 3024 s, 2977 s, 2912 s, 2817 s, 1947 
w, 1875 w, 1806 w, 1751 w, 1639 s, 1598 m, 1580 w, 1495 s, 1445 s, 1414 s, 1333 m, 1315 m, 
1292 m, 1259 m, 1186 w, 1147 m, 1114 m, 1032 m, 996 s, 915 s, 785 m, 757 s, 729 m, 699 s, 
657 w. MS (ESI) exact mass Calcd. for C20H23N: m/z 278.1903 ([M++H+]), Found: 278.1909 (∆ 
−2.07 ppm). 
 
N-Allyl-2,2-phenyl-2-methyl-pyrrolidine (16b). 1H NMR (chloroform-d, 400 MHz): δ 7.27-
7.01 (m, 10 H, C6H5), 5.92-5.82 (m, 1 H, H2C=CHCH2N), 5.14-4.99 (m, 2 H, H2C=CHCH2C), 
3.75 (d, 3JHH = 10.0 Hz, 1 H, Ph2CCH2N), 3.42 (m, 1 H, H2C=CHCH2C), 2.78 (m, 1 H, 
Ph2CCH2N), 2.72 (d, 3JHH = 10.0 Hz, 1 H, H2C=CHCH2C), 2.67 (m, 1 H, CH2CHMe), 2.60 (m, 1 
H, CH2CHMe), 2.07 (m, 1 H, CH2CHMe), 1.02 (d, 3JHH = 6.0 Hz, 3 H, CHMeNH). 13C{1H} 
NMR (100 MHz, chloroform-d): δ 150.69 (C6H5), 149.10 (C6H5), 136.80 (CH=CH2), 128.43 
(C6H5), 128.23 (C6H5), 127.63 (C6H5), 127.42 (C6H5), 126.06 (C6H5), 125.73 (C6H5), 116.86 
(CH=CH2), 66.80 (Ph2CCH2N), 59.93 (CHMe), 57.18 (H2C=CHCH2C), 52.74 [C(C6H5)2], 48.21 
(CH2CHMe), 19.59 (CHMe). MS (ESI) exact mass Calcd. for C20H23N: m/z 278.1903 
([M++H+]), Found: 278.1909 (∆ −2.07 ppm). 
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2,2-Diphenyl-6-methyl-pyrrolizine (diastereomeric mixture of cis and trans) (16c) 
N CH3
Ph
Ph
a
b
c
d
e
f
g
h
 
1H NMR (chloroform-d, 400 MHz): δ 7.43-7.12 (m, 10 H, C6H5), 4.08-4.05 (d, 2JHH = 9.2 Hz, 1 
H, f), 3.62-3.54 (m, 1 H, e), 3.32-3.28 (m, 1 H, d), 2.91-2.89 (d, 2JHH = 9.6 Hz, 1 H, f), 2.67-2.59 
(m, 1 H, g), 2.50-2.42 (m, 1 H, c), 2.21-2.17 (m, 2 H, d and g overlapped), 2.09-2.01 (m, 1 H, b), 
1.20-1.12 (m, 1 H, b), 1.06-1.04 (d, 2JHH = 6.8 Hz, 3 H, a),  1.02-1.00 (d, 2JHH = 6.8 Hz, 3 H, a). 
13C{1H} NMR (100 MHz, chloroform-d): δ 128.66 (C6H5), 128.51 (C6H5), 127.14 (C6H5), 
127.05 (C6H5), 126.22 (C6H5), 126.17 (C6H5), 66.93 (f), 66.84 (f), 65.36 (d), 65.20 (d), 59.80 (e), 
59.74 (e), 52.20 (h), 52.16 (h), 48.41 (g), 48.55 (g), 35.09 (b), 35.04 (b), 34.29 (c), 34.21 (c), 
17.75 (a), 17.60 (a). MS (ESI) exact mass Calcd. for C20H23N: m/z 278.1903 ([M++H+]), Found: 
278.1907 (∆ −1.35 ppm). 
 
General procedure for catalytic hydroamination/cyclization.  
Procedures for micro-molar scale catalysis, kinetics, and determination of % ee for optically 
active pyrrolidines are described here specifically for the yttrium chemistry. 
Micromolar-scale catalysis. In a typical small-scale hydroamination experiment, a J. Young 
style NMR tube with a re-sealable Teflon valve was charged with 0.120 mmol of an aminoalkene 
substrate, 6 µmol of catalyst {PhB(C5H4)(OxS-tBu)2}YCH2SiMe3, and 0.5 mL of solvent 
(benzene-d6 or toluene-d8). The tube was sealed, and the reaction was monitored by 1H NMR 
spectroscopy at regular intervals. 
Procedure for isolation of optically active pyrrolidines. A flask was charged with the catalyst 
{PhB(C5H4)(OxS-tBu)2}YCH2SiMe3 (0.060 g, 0.103 mmol), benzene (20-30 mL) and the 
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appropriate aminoalkene (2.58 mmol). The solution was stirred at room temperature for 3 h. 
Then, the products were purified by fractional distillation in vacuo to afford the pyrrolidine 
products as colorless oils.  
2-methyl-4,4-diphenylpyrrolidine (4b) was purified by Kugelrohr distillation. Yield: 93%, bp: 
125 °C, 10-5 mBar (dynamic vacuum on a high vacuum line).  
3-methyl-2-aza-spiro[4,5]decane (5b); yield: 95%, bp: 100-105 °C, 0.1 mm Hg (dynamic 
vacuum). 
2-Methyl-4,4-bis(2-propenyl)pyrrolidine (7b). Yield: 97%, bp: 86-90 °C, 5 mm Hg. 
4-allyl-2,4-dimethyl-pyrrolidine (8b). Yield: 95%, bp: 47-52 °C, 5 mm Hg. 
4-allyl-2-methyl-4-phenyl-pyrrolidine (10b). Yield: 96%, bp: 148-153 °C, 2 mm Hg. 
4-allyl-2-methyl-4-(4-bromophenyl)pyrrolidine (11b): Yield: 94%, bp: 120-125 °C, 0.1 mm Hg 
(dynamic vacuum).  
 
Procedures for NMR kinetic measurements.  Reaction progress was monitored by single scan 
acquisition of a series of 1H NMR spectra at regular intervals on a Bruker DRX400 spectrometer. 
The concentrations of C-(1-allyl-cyclohexyl)-methylamine and 3-methyl-2-aza-spiro[4,5]decane 
were determined by integration of resonances corresponding to species of interest and integration 
of a tetrakis(trimethylsilyl)silane standard of accurately known and constant concentration (4.36 
mM in toluene-d8). The temperature in the NMR probe was preset for each experiment, and it 
was kept constant and monitored during each experiment. For reactions heated above 296 K, the 
probe temperature was calibrated using an 80% ethylene glycol sample in 20% DMSO-d6 using 
the equation: T = [(4.218−∆)/0.009132] K (∆ equals the chemical shift difference of the two 
ethylene glycol resonances). For reactions at performed at 296 K or below, the probe was 
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calibrated using CH3OH using the equation T = [−23.832·∆2 − 29.46·∆ + 403] K (∆ = chemical 
shift difference of two peaks of CH3OH).46 
  
Method for measuring kinetics of conversion of aminoalkene to pyrrolidine. Catalytic 
conversion of C-(1-allyl-cyclohexyl)-methylamine into 3-methyl-2-aza-spiro[4,5]decane using 
{PhB(C5H4)(OxS-tBu)2}YCH2SiMe3 as a catalyst is described. The stock solution of Si(SiMe3)4 in 
toluene-d8 (0.50 mL) was added by a 1 mL glass syringe to a known amount of {PhB(C5H4)(OxS-
tBu)2}YCH2SiMe3 (0.0040 g, 6.89 µmol) in a glass vial. The resulting solution was transferred to 
a NMR tube, capped with a rubber septum, and a 1H NMR spectrum was acquired. The 
concentration of catalyst was determined from this 1H NMR spectrum by comparison of 
integration of resonances assigned to catalyst with that from the internal standard. Neat substrate 
C-(1-allyl-cyclohexyl)-methylamine (0.021 g, 137.8 µmol) was added to the NMR tube by 
injecting through the rubber septum. Then, the NMR tube was quickly placed in the 
spectrometer. Single scan spectra were acquired automatically at preset time intervals at a 
constant temperature. The concentrations of substrate and product at any given time were 
determined by integration of substrate and product resonances relative to the integration of the 
internal standard. A linear least squares regression analysis of substrate concentrations (M) vs. 
time correlated to the equation ln[subs]t = ln[subs]0 − kobst. 
 
Procedure for measuring initial rates of cyclization. A 5 mL stock solution in toluene-d8 
containing a known concentration of internal standard tetrakis(trimethylsilyl)silane (0.0070 g, 
0.0218 mmol, 4.36 mM) and catalyst (5.89 mM) was prepared using a 5 mL volumetric flask. 
The stock solution (0.50 mL) was added to a NMR tube, which was capped with rubber septum. 
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The substrate C-(1-allyl-cyclohexyl)-methylamine (0.021 g, 137.8 µmol) was added to the NMR 
tube by injecting through the rubber septum. Then, the NMR tube was quickly placed in the 
NMR spectrometer. Single scan spectra were acquired automatically at preset time intervals at a 
constant temperature. 
The initial rates for the cyclization of C-(1-allyl-cyclohexyl)-methylamine were measured for 
concentrations of the substrate ranging from 0.10 – 0.123 M at constant catalyst concentration 
(5.89 mM). Linear regression fits for [substrate] vs. time for the first 126 s of the reaction 
provided the initial rate (d[subs]/dt) for a particular initial substrate concentration (calculated as 
average substrate concentration over 126 s). A non-linear least squares regression analysis of 
d[subs]/dt vs. [subs]ini showed good correlation to the equation: 
 
 
Equation 1 is contains modifications from the standard enzymatic equation for inhibition by 
excess substrate shown in equation 2.47 
 
(2) 
 
  
e0 is the total enzyme concentration, a is the substrate concentration, k2 is the rate constant 
turnover-limiting step, K'm is a modified Michaelis constant (K'm = (k-1 + k2)/k1). Equation 2 
describes the general enzymatic mechanism of equation 3: 
 
υ =
k2e0a
K 'm + a +
a2
KSI
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Equation 2 was modified to give equation 1 by considering the activation of the catalyst, which 
consumes one equivalent of substrate according to equation 4: 
 
Thus a in equation 2 is modeled as ([subs]-[cat]) in equation 1. 
Equation 2 was further modified by altering the definition of KSI. The value KSI (equilibrium 
constant for substrate inhibition) is normally defined as:  
KSI = EA/AEA = [substrate][catalyst•substrate]/[substrate•catalyst•substrate]  
(i.e., a dissociation constant).15 KSI is defined here as the substrate binding constant: KSI = 
[substrate•catalyst•substrate]/[substrate][catalyst•substrate] = {[sub] – cat]}[cat]{[sub] – 
[cat]}/{[sub] – [cat]}{[cat•sub}. Thus, a larger KSI value corresponds to greater inhibition. 
 
Measurement of the activation parameters.  
1. Eyring plot from second-order rate constants: Rate constants k were measured at the 
constant catalyst and initial substrate concentrations, over five temperatures ranging from 271 K 
to 315 K using the method described above. The plot ln(k'/T) vs. 1/T provides the values of  
7.5(3) kcal mol-1 and ∆S‡ = −38(1) cal·mol-1K-1 using standard Eyring analysis.48 
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2. Eyring plot from initial rates: Using the initial rate method described above, the rate 
constants k2 were measured at temperatures ranging from 273 K to 312 K, keeping the catalyst 
and initial substrate concentration constant in each experiment. The plot ln(k2/T) vs. 1/T provides 
the values of  From this plot, ∆H‡ = 7(1) kcal⋅mol-1 and ∆S‡ = −40(4) cal⋅mol-1K-1 are calculated, 
using standard Eyring analysis. 
 
Procedure for determination of enantiomeric excess of pyrrolidine products.  
NMR spectroscopy. The 1H and 19F NMR spectroscopic methods were used to evaluate the % 
ee of the pyrrolidines products of enantioselective hydroamination/cyclization. 3-methyl-2-aza-
spiro[4,5]decane (5b), 4-allyl-2,4-dimethyl-pyrrolidine (8b),  3-methyl-2-aza-spiro[4,4]nonane 
(6b), 4-allyl-2-methyl-4-phenyl-pyrrolidine (9b), and 2-Methyl-4,4-bis(2-propenyl)pyrrolidine 
(7b) were separated from the catalyst by vacuum transfer (10-5 mBar) to a 10 mL flask. 2-
Methyl-4,4-diphenylpyrrolidine (4b) and 4-allyl-2-methyl-4-(4-bromophenyl)pyrrolidine (11b), 
2-methyl-5,5-diphenylpiperidine (13b) were purified by silica gel flash chromatography (pipette 
column) with 95:5 CH2Cl2:CH3OH as an eluent, and then all volatiles were removed by rotary 
evaporation.  
Benzene (2 mL) and triethylamine (5.0 equivalent based on the amount of aminoalkene 
used during catalysis) were added to the purified pyrrolidine. To this solution, (+)-(S)-α-
methoxy-α-(trifluoromethyl)phenylacetyl chloride (1.2 equivalent based on the amount of 
aminoalkene used during catalysis) was added. The solution was mixed and immediately a white 
suspension appeared ([HNEt3][Cl]). The mixture was stirred for 1 h, and all the solvents were 
removed under vacuum. The residue was extracted with pentane. Pentane was removed under 
vacuum to give the corresponding Mosher-amide as a colorless oil. No further purification was 
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performed, since crystallization, chromatography, or sublimation could result in biased results by 
separation of the diastereomers. The enantioselectivities were determined by either integration of 
19F NMR (60 °C or 83 °C in CDCl3, or 125 °C in C6D5Br). 
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Chapter 5. Acceptorless thermal decarbonylation of alcohols catalyzed by oxazolinylborato 
iridium complexes 
Modified from a paper to be submitted to J. Am. Chem. Soc. 
Kuntal Manna,‡ Naresh Eedugurala, Hung-An Ho, Arkady Ellern, Aaron D. Sadow* 
 
Abstract 
 A series of bis- and tris(oxazolinyl)borato iridium and rhodium complexes are 
synthesized with bis(4,4-dimethyl-2-oxazolinyl)phenylborane [PhB(OxMe2)2]n, tris(4,4-dimethyl-
2-oxazolinyl)borane [B(OxMe2)3]n, and tris(4,4-dimethyl-2-oxazolinyl)phenylborate [ToM]− as 
proligands. [PhB(OxMe2)2]n reacts with [M(µ-Cl)(η4-C8H12)]2 in methylene chloride at room 
temperature providing the corresponding complexes PhClB(OxMe2)2M(η4-C8H12) (M = Ir, Rh) 
via halide abstraction. The B-Cl moiety of PhClB(OxMe2)2M(η4-C8H12) can be substituted by 
treatment with nucleophiles to afford R(Ph)B(OxMe2)2M(η4-C8H12) (R = Ph, Ph3SiO). Likewise, 
the reaction of [B(OxMe2)3]n and [Rh(µ-Cl)(CO)2]2 in THF affords ClB(OxMe2)2Rh(CO)2 via 
chloride abstraction. Tris(4,4-dimethyl-2-oxazolinyl)phenylborato iridium and rhodium 
complexes ToMM(η4-C8H12) (M = Ir, Rh) are also prepared by treatment of TlToM (thallium 
tris(4,4-dimethyl-2-oxazolinyl)phenylborate) and [M(µ-Cl)(η4-C8H12)]2 in benzene. All these 
newly synthesized rhodium and iridium complexes were examined in acceptorless 
dehydrogenative decarbonylation of primary alcohols. The catalysts survey shows that the 
compound ToMIr(η4-C8H12) is the most active for the conversion of primary alcohols into alkane, 
H2, and CO at 180 °C in toluene. Several aliphatic and aromatic primary alcohols are 
                                                           
‡
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decarbonylated in the catalytic conditions. Furthermore, ToMIr(η4-C8H12) is also able to 
decarbonylate polyols such as ethylene glycol and glycerol to syngas (H2 and CO) at 180 °C. 
 
Introduction 
 Biofuels are increasingly important, driven by high oil price, depletion of petroleum 
resources, and political concerns about fossil fuels. The industrial production of biofuels from 
biomass feedstocks is primarily based on fermentation and gasification processes.1 The catalytic 
defunctionalization such as decarbonylation, deoxygenation, or denitrogenation of highly-
functionalized biorenewable materials to hydrocarbons is an alternative approach to produce 
biofuels. The removal of oxygen- and nitrogen-containing functional groups however requires 
hydrogen as the stoichiometric reductant.2 Therefore, the development of catalytic reactions for 
selective defunctionalization without using any stoichiometric reductant or sacrificial reagents is 
very crucial to improve hydrogen and carbon efficiency in biofuel production.3 
 In this context, the catalytic alcohol deoxygenation via tandem 
dehydrogenation/decarbonylation is particularly interesting because of its potential application 
for transforming highly oxygenated biomass-derived materials such as polyols and cellulose into 
hydrocarbon fuels.4 Furthermore, the enthalpy content of the products is higher than reactants 
(ΔHrxn>0), and the byproduct is syngas i.e. H2 and CO (Scheme 5.1).5 
 
RCH2OH
O
R H
dehydrogenation decarbonylation
RH ∆H = 22-30 kcal/mol
−H2 −CO
 
Scheme 5.1. Catalytic hydrocarbon formation from alcohol via tandem dehydrogenation and 
decarbonylation processes. 
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Numerous examples of stoichiometric alcohol decarbonylation have been demonstrated.6 
Several iridium,6a,6h,6g,6m rhodium,6i and ruthenium6e,6b,6f,6j,6l complexes can decarbonylate  
primary alcohols stoichiometrically under thermal or photochemical conditions to give carbonyl-
incorporated complex as the product. Catalytic acceptorless dehydrogenation of alcohols7 and the 
decarbonylation of aldehydes8 are also well documented. However, these two steps are rarely 
coupled in catalytic processes because dehydrogenation catalysts are often inhibited by CO 
product of decarbonylation. Therefore, the catalytic decarbonylation of alcohol typically requires 
a CO trap. In the pioneering studies of acceptorless alcohol decarbonylation, the conversions of 
ethanol into CO/CO2, H2, and CH4 were accomplished by rhodium(I) phosphine catalysts under 
basic conditions at 150 °C.9 Similarly, the decarbonylation of alcohol was employed as a CO 
source  in  intramolecular Pauson–Khand reactions catalyzed by [{(dppp)RhCl(CO)}2] [dppp = 
bis(diphenylphosphino)propane].10 Recently, sunlight-driven dehydrogenation and 
hydrogenolysis of benzyl alcohol have been achieved by semiconductor-metal photocatalysts.11 
 Our group recently reported an acceptorless decarbonylation of several aliphatic and 
aromatic primary alcohols to hydrocarbons, CO, and H2 catalyzed by ToMRh(CO)2 [ToM = 
tris(4,4-dimethyl-2-oxazolinyl)phenylborate].12 The decarbonylation reactions were performed 
under UV irradiation at room temperature in neutral solution. However, the low quantum yields 
and the inability to decabonylate polyols limit this photocatalysis for conversion of oxygenates. 
These limitations motivated us to search for catalysts for acceptorless alcohol decarbonylation 
under thermal conditions. Herein, we report acceptorless thermal decarbonylation of primary 
alcohols catalyzed by an oxazolinylborato iridium complex. Furthermore, the iridium catalyst 
has been applied for conversions of polyols to syngas. 
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Results and discussion 
Synthesis and characterization of proligands 
 A series of iridium and rhodium compounds containing bis(oxazozolinyl)borate and 
tris(oxazolinyl)borate ligands are synthesized. We used both borane and borate precursors for 
metallation. The precursors for bis(oxazolinyl)borate compounds were bis(4,4-dimethyl-2-
oxazolinyl)phenylborane [PhB(OxMe2)2]n and bis(4,4-dimethyl-2-oxazolinyl)diphenylborate 
[Ph2B(OxMe2)2]−. Additionally, tris(4,4-dimethyl-2-oxazolinyl)borane [B(OxMe2)3]n and tris(4,4-
dimethyl-2-oxazolinyl)phenylborate [ToM]− were used as precursors for synthesizing 
tris(oxazolinyl)borate complexes. 
 The synthesis and characterization of oligomeric [PhB(OxMe2)2]n was described in the 
chapter 2.13 [B(OxMe2)3]n is synthesized through a similar method as [PhB(OxMe2)2]n from 4,4-
dimethyl-2-H-oxazoline (2H-OxMe2) by two steps (eq 5.1).  
N
O
H
nBuLi
THF, −78 °C N
O
Li B O
N
O
NN
O
0.33 BCl3
−78 °C to rt
48 h
(5.1)
2H-OxMe2 [B(OxMe2)3]n
5.1
 
Deprotonation of 2H-OxMe2 with nBuLi in THF at −78 °C occurs selectively at the 2-position to 
give the 4,4-dimethyl-2-lithio-2-oxazolide (2Li-OxMe2). Addition of 0.33 equiv of BCl3 in hexane 
to the THF solution of 2Li-OxMe2 followed by stirring at room temperature for 36 h generates a 
white precipitate, which is isolated as [B(OxMe2)3]n (5.1) in 72% yield. 5.1 is insoluble in 
hydrocarbon solvents including benzene, toluene, THF, and acetonitrile, however it is soluble in 
methanol. The poor solubility of [B(OxMe2)3]n suggests that it is an oligomeric species resulting 
from coordination of one oxazoline to the boron center of another B(OxMe2)3 monomer. The 
similar oligomeric nature of [PhB(OxMe2)2]n was characterized by solid state 11B NMR, which 
199 
 
was discussed in chapter 2.13 The 1H NMR of 5.1 in methanol-d4 showed one set of oxazoline 
resonances as one singlet at 1.23 ppm for inequivalent methyl groups and another singlet at 3.78 
ppm for inequivalent methylene protons of the three oxazolines. The pattern of the 1H NMR 
suggests that 5.1 is C3v symmetric in methanol-d4. The 11B NMR spectrum of [B(OxMe2)3]n in 
methanol-d4 contains one broad singlet at −8.1 ppm (width at half-height, ∆ν1/2 = 190 Hz). 
Comparison of 11B NMR chemical shifts and linewidths with [PhB(OxMe2)2]n (−4.1 ppm in 
methanol-d4, ∆ν1/2 = 82 Hz) and the lithium salt of tris(4,4-dimethyl-2-oxazolinyl)phenylborate14 
(Li[ToM], −17.0 ppm in acetonitrile-d3, ∆ν1/2 = 12.5 Hz) suggests that [B(OxMe2)3]n contains a 
neutral four-coordinated boron center, and it is assigned to the solvent adduct B(OxMe2)3(OHMe).  
In the solid state IR spectrum of 5.1, a single oxazoline-based band (νCN = 1608 cm-1, KBr) was 
observed at lower energy than that of 4,4-dimethyl-2-H-oxazoline (νCN = 1630 cm-1). This IR 
data is consistent with boron-oxazoline interactions through the imidine nitrogen of 5.1 in the 
solid state.  
 A monoanionic ligand thallium bis(4,4-dimethyl-2-oxazolinyl)diphenylborate (5.3) is 
synthesized by two steps from [PhB(OxMe2)2]n (eq 5.2). The treatment of PhLi with 
[PhB(OxMe2)2]n in THF followed by silica gel column chromatography provide 
bis(oxazolinyl)diphenyl borate (5.2) as protonated species in 38% yield. The single and sharp 11B 
NMR resonance of 5.2 at −14.5 ppm (∆ν1/2 = 50.5 Hz) indicates 5.2 as a four coordinated borate. 
In the next step, the reaction of 5.2 and TlOEt in Et2O at room temperature yields the thallium 
salt of bis(4,4-dimethyl-2-oxazolinyl)diphenylborate Tl[Ph2B(OxMe2)2] (5.3) as a white solid in 
91% yield. One set of oxazoline resonances in the 1H NMR spectrum, and one sharp singlet at 
−13.1 ppm (∆ν1/2 = 31.0 Hz) in 11B NMR spectrum were observed in benzene-d6. A single 15N 
NMR signal of −107.1 ppm references to nitromethane suggests that both oxazolines in 5.3 are 
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coordinated to thallium metal. For comparison, the 15N NMR chemical shift of thallium salt of 
tris(4,4-dimethyl-2-oxazolinyl)phenylborate ligand (TlToM) is −117.3 ppm.15 
B O
N
O
NPh B O
N
O
N
H
Ph
Ph
B O
N
O
N
Tl
Ph
Ph
PhLi
THF, 12 h
silica gel
TlOEt
Et2O
(5.2)
5.2 5.3
-EtOH
[PhB(OxMe2)2]n
 
 
Table 5.1. 11B, 15N NMR chemical shifts, and νCN values for oxazolinylboranes, 
oxazolinylborates, and their iridium and rhodium complexes. a 
Compound 11B NMR (δ) a 
 
15N NMR (δ) a 
 
νCN 
(KBr, cm-1) 
PhB(OxMe2)2 (4) in acetonitrile-d3 −8.1 −147.0 1551 
B(OxMe2)3 (5.1) in methanol-d4 −8.6 n.a. 1608 
H[Ph2B(OxMe2)2] (5.2) −14.5 −170.5 1580 
Tl[Ph2B(OxMe2)2] (5.3) −13.1 −107.1 1593, 1581 
PhClB(OxMe2)2Ir(η4-C8H12) (5.4) −7.6 −182.5 1564 
PhClB(OxMe2)2Rh(η4-C8H12) (5.5) −6.8 −180.5 1578 
PhClB(OxMe2)2Rh(CO)2 (5.6) −8.3 −199.0 1580, 1551 
Ph(Ph3SiO)B(OxMe2)2Rh(η4-C8H12) 
(5.7) 
−4.5 −185.5 1575 
Ph(Ph3SiO)B(OxMe2)2Li(THF)2 (5.8)  −6.1 −151.1 1601, 1586 
Ph2B(OxMe2)2Ir(η4-C8H12) (5.9) −12.8 −152.2 1588, 1555 
ClB(OxMe2)3Rh(CO)2 (5.10) −9.3 n.a. 1599 
ToMIr(η4-C8H12) (5.11) −16.4 −154.9, −192.9 1607, 1558 
ToMRh(η4-C8H12) (5.12) −16.3 −161.1, −169.2 1611, 1567 
a 11B and 15N NMR was taken in benzene-d6, otherwise noted. 
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Synthesis and characterization of bis- and tris(oxazolinyl)borato iridium and rhodium 
compounds 
 Two general routs provide oxazolinylborato iridium and rhodium complexes. The first 
route involves reaction of oxazolinylboranes and metal chlorides, followed by substitution of 
chlorine with a nucleophile (e.g., RLi; eq 5.3). A second approach involves salt metathesis of 
thallium oxazolinylborate salts and metal chlorides. We will first describe the synthesis and 
structural characterization of bis(oxazolinyl)borato iridium and iridium complexes. Then, the 
synthesis and properties of tris(oxazolinyl)borate complexes will be discussed. 
Cl B
O
N MLn
O
N
Ph
B O
N
O
NPh
0.31 [M(µ-Cl)(L)n]2
R B
O
N MLn
O
N
Ph
RLi
−LiCl
(5.3)
 
 [PhB(OxMe2)2]n contains variable amount of LiCl, and therefore excess [PhB(OxMe2)2]n is 
needed to prepare bis(oxazolinyl)borato metal complexes. [PhB(OxMe2)2]n reacts with 0.31 equiv 
of [M(µ-Cl)(η4-C8H12)]2 (M = Ir, Rh) in methylene chloride at room temperature over 12 h to 
provide PhClB(OxMe2)2Ir(η4-C8H12) (5.4) and PhClB(OxMe2)2Rh(η4-C8H12) (5.5) (Scheme 5.2). 
Analytically pure materials 5.4 and 5.5 are obtained as orange and deep yellow solids 
respectively after recrystallization at −30 °C. These air-sensitive complexes are unchanged in 
benzene for 6 h at 60 °C, however they decomposes slowly at 80 °C. In the 1H NMR spectrum, 
one set of oxazoline resonances (e.g., two singlets assigned to diastereotopic methyl groups at 
1.01 and 0.80 ppm, and two doublets at 3.57 and 3.39 ppm for methylene groups) suggest Cs-
symmetric species for 5.4. Additionally, the 11B NMR spectrum of 5.4 exhibited a single 
resonance at −7.6 ppm in benzene-d6. One 15N NMR signal was observed at −182.5 ppm, which 
was 54.6 ppm upfield in comparison to that for 2H-OxMe2 (−127.9 ppm). Furthermore, only one 
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signal assigned to a CN stretching frequency of oxazolines was observed in the IR spectrum at 
1565 cm-1, which is again lower in energy compared to that for non-coordinated oxazoline (νCN = 
1630 cm-1). These 15N NMR and IR data suggest that both oxazolines coordinate to the iridium 
center in 5.4. Similar spectroscopic patterns in the NMR and infrared spectra were observed for 
PhClB(OxMe2)2Rh(η4-C8H12) (5.5). 
Cl B
O
N M
O
N
Ph
B O
N
O
NPh +    0.31 [M(µ-Cl)(η4-C8H12)]2
rt, 12 h
M = Ir (5.4); 91%
M = Rh (5.5); 87%
methylene chloride
 
Scheme 5.2. Synthesis of bis(oxazolinyl)borato iridium and rhodium complexes from [PhB(OxMe2)2]n via 
chloride abstraction. 
 
 X-ray quality crystals of PhClB(OxMe2)2Ir(η4-C8H12) (5.4) and PhClB(OxMe2)2Rh(η4-
C8H12) (5.5) are obtained from concentrated solution mixture of toluene and pentane cooled to 
−30 °C. Single crystal diffraction studies confirmed the structures and the formation of a B−Cl 
bond in both 5.4 (Figure 5.1) and 5.5 (Figure 5.2). Both structures have a crystallographic mirror 
plane. The crystal structure of 5.4 shows both oxazolines coordinate to iridium, and the two 
nitrogen-iridium distances are equivalent (Ir1 −N1, 2.110(2) Å). Chelation forms a six-
membered ring, and B1−C10−N1−Ir1−N1i−C10i atoms in the ring adopt a boat conformation. 
The phenyl group is pseudoaxial, and the chlorine is pseudoeuatorial. The phenyl group is closer 
to the iridium than chlorine atom. The B−Cl distance in 5.4 is 1.894(3) Å. The rhodium complex 
5.5 has similar crystal structure of 5.4. The two nitrogen-rhodium distances are also equivalent 
[Rh1−N1, 2.110(2) Å], and the B−Cl distance in 5.5 is 1.900(4) Å. 
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Figure 5.1. ORTEP diagram of PhClB(OxMe2)2Ir(η4-C8H12) (5.4). Ellipsoids are plotted at 50% 
probability, and hydrogen atoms are not illustrated for clarity. Bond distances (Å): Ir1−N1, 2.110(2); 
Ir1−C4, 2.112(2); Ir1−C3, 2.123(2); B1−Cl1, 1.894(3). 
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Figure 5.2. ORTEP diagram of PhClB(OxMe2)2Rh(η4-C8H12) (5.5). Ellipsoids are plotted at 50% 
probability, and hydrogen atoms are not illustrated for clarity. Bond distances (Å): Rh1−C12, 1.852(3); 
Rh(1)−C(11), 2.127(3); Rh(1)−N(1), 2.123(2); B1−Cl1, 1.900(4). 
 
 The abstraction of hydride, alkyl, and amido group from metal center by Lewis acids 
such as B(C6F5)3, PhB(C6F5)3, BPh3, [Ph3C][B(C6F5)3], and others are well documented in 
literature.16 However, the chloride abstractions from [M(µ-Cl)(η4-C8H12)]2 (M = Ir, Rh) by 
phenyl-bis(oxazolinyl)borane [PhB(OxMe2)2]n are rare examples of halide abstraction from a 
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metal-halogen bond by a Lewis acid. Presumable, the strong Lewis acidity of the boron center in 
[PhB(OxMe2)2]n13 and the coordination of oxazolines facilitate the cleavage of metal-chlorine 
bond and simultaneous formation of B−Cl bond. 
 The synthesis of bis(oxazolinyl)borato metal complexes using [PhB(OxMe2)2]n via 
chlorine abstraction motivated us to synthesize analogous bis- and tris(oxazolinyl)borato 
rhodium dicarbonyl complexes. [PhB(OxMe2)2]n reacts with 0.31 equiv of [Rh(µ-Cl)(CO)2]2 
affording PhClB(OxMe2)2Rh(CO)2 (5.6) as a dark brown solid in 86% yield after recrystallization 
(eq 5.4). One set of oxazolinyl resonances in 1H NMR spectrum and a single 15N chemical shift 
(−199.0 ppm) in benzene-d6 suggest 5.6 as a Cs-symmetric species, in which both oxazolines 
coordinate to rhodium.  
B
Cl
Ph N
N
O O
Rh
CO
CO
B O
N
O
NPh
0.31 [Rh(µ-Cl)(CΟ)2]2
methylene chloride, rt, 6 h
(5.4)
5.6;  86%
 
 Crystallization in methylene chloride at −30 °C affords X-ray quality single crystals of 
5.6 (an ORTEP diagram is shown in Figure 5.3). The crystallized structure contains a square-
planar rhodium center (∑L-Rh-L’ = 359.93°). The chlorine blocks one face of the square-planar 
complex. The nitrogens of both oxazolines have the same distances to rhodium [2.089(2) Å]. B1-
C5-N1-Rh1-N1i-C5i atoms form a six-membered ring adopting a boat conformation, in which 
the phenyl group is pseudoeuatorial and the chlorine is pseudoaxial. Interestingly, the position of 
phenyl group and chlorine is reversed in the similar boat conforming six-membered ring of 
PhClB(OxMe2)2Rh(η4-C8H12) (5.5) as shown in Figure 5.2. 
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Figure 5.3. ORTEP diagram of PhClB(OxMe2)2Rh(CO)2 (5.6). Ellipsoids are plotted at 50% probability, 
and hydrogen atoms are not illustrated for clarity. Selected bond distances (Å): Rh1−N1, 2.089(2); 
Ir1−C4, 2.112(2); Ir1−C3, 2.123(2); B1−Cl1, 1.894(3). 
 
 Interestingly, all the above metal complexes 5.2-5.6 can be easily derivatized by 
substituting chlorine atom of B-Cl moiety with nucleophiles. The presence of a B−Cl bond in 
these ligand-metal pairs therefore provide an excellent opportunity to modify the ligand 
structures in order to tune the electronic properties of the metal centers and also the stability of 
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the metal complexes. The treatment of Ph3SiOK with PhClB(OxMe2)2Rh(η4-C8H12) (5.5) in 
benzene at room temperature affords Ph(Ph3SiO)B(OxMe2)2Rh(η4-C8H12) (5.7), which is isolated 
as a yellow solid in 94% yield (eq 5.5).   
Ph3SiO B
O
N
Rh
O
N
Ph
Ph3SiOK (5.5)
benzene, rt, 2 h
−KCl
Cl B
O
N
Rh
O
N
Ph
5.7
 
Complex 5.7 is Cs-symmetric similar to 5.5, according to the 1H NMR spectrocopy. A downfield 
11B resonance of 5.7 at −4.5 ppm in benzene-d6 compared to that for 5.5 at −6.8 ppm suggests 
that the chlorine is replaced by more electron withdrawing oxygen at the boron center. 5.7 is also 
synthesized by an alternative route as shown in eq 5.6. The reaction of [PhB(OxMe2)2]n and 
Ph3SiOLi in THF at room temperature affords Ph(Ph3SiO)B(OxMe2)2Li(THF)2 (5.8) in 83% 
yield.  
B O
N
O
NPh
0.31 Ph3SiOLi
THF, rt, 10 h
B
Ph O
O
N N
O
Li
OO
SiPh3
0.5 [Rh(µ−Cl)(η4-C8H12)]2
benzene, rt, 20 h
−LiCl
Ph3SiO B
O
N
Rh
O
N
Ph
(5.6)
5.8 5.7
 
5.8 crystallized from a concentrated solution in toluene at −30 °C. The X-ray crystal structure of 
5.8 in Figure 5.4 shows the ‘B−O−Si’ moiety in the molecule. B1−O1−Si1 bond angle is 
150.57(19)°. The Si1−O1 distance is 1.580(2) Å and B1−O1 distance is 1.457(4) Å. The 
nitrogens of two oxazolines are coordinated to a lithium atom. Two lithium-nitrogen bond 
distances are not equivalent [Li1−N1, 1.965(6) Å; Li1−N2, 1.997(6) Å]. 
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Figure 5.4. ORTEP diagram of Ph(Ph3SiO)B(OxMe2)2Li(THF)2 (5.8). Ellipsoids are plotted at 50% 
probability, and hydrogen atoms are not illustrated for clarity. Selected bond distances (Å): Si1−O1, 
1.580(2); B1−O1, 1.457(4); Li1−N1, 1.965(6); Li1−N2, 1.997(6). Selected bond angles (°): B1−O1−Si1, 
150.57(19). 
 
In the next step, addition of 0.5 equiv of [Rh(µ-Cl)(η4-C8H12)]2 to the benzene solution of 5.8 
provided the desire rhodium complex 5.7 at room temperature.  
Bis(4,4-dimethyl-2-oxazolinyl)diphenylborato iridium complex Ph2B(OxMe2)2Ir(η4-
C8H12) (5.9) is prepared by substituting the chlorine of PhClB(OxMe2)2Ir(η4-C8H12) with a phenyl 
group (eq 5.7). PhClB(OxMe2)2Ir(η4-C8H12) (5.4) and PhLi react rapidly in benzene at room 
temperature to afford 5.10 in 90% yield. The chemical shift of 11B NMR at −12.8 ppm (∆ν1/2 = 
63.0 Hz) indicates the replacement of chlorine by phenyl group at the boron center.  
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Ph B
O
N Ir
O
N
Ph
PhLi
5.9;  90%
benzene, rt, 2 h
−LiCl
Cl B
O
N Ir
O
N
Ph
(5.7)
5.4
 
An alternative preparation of 5.10 is also performed by reaction of Tl[Ph2B(OxMe2)2] (5.3) and 
0.5 equiv of [Ir(µ-Cl)(η4-C8H12)]2 in benzene at room temperature (eq 5.8). The complex 5.9 is 
unchanged in benzene at 80 °C for 20 h, however it decomposes slowly at 120 °C. 
Ph B
O
N Ir
O
N
Ph
B O
N
O
N
Tl
Ph
Ph
0.5 [Ir(µ-Cl)(η4-C8H12)]2
benzene, rt, 20 h
−TlCl
(5.8)
5.9
 
In the related synthesis, addition of 0.5 equiv of [Rh(µ-Cl)(CO)2]2 to a slurry of 
tris(oxazolinyl)borane [B(OxMe2)3]n in THF results a clear yellow solution after stirring for 1 h at 
room temperature. Removal of the volatiles affords ClB(OxMe2)3Rh(CO)2 (5.7) as a yellow solid 
in 94% yield (eq 5.5). One singlet at 3.75 ppm for inequivalent methyl groups and another 
singlet at 1.79 ppm for methylene groups of oxazolines in 1H NMR spectrum in tetrahydrofuran-
d8 suggest that 5.7 is C3v-symmetric. 
B O
N
O
N 0.5 [Rh(µ-Cl)(CΟ)2]2
methylene chloride, rt, 3 h
5.10;  94%
(5.9)N
O
B
O
N
Cl N
N
O O
Rh
CO
CO
 
 
 Tris(oxazolinyl)borato iridium and rhodium complexes ToMM(η4-C8H12) are prepared by 
the reaction of TlToM with 0.5 equiv of [M(µ-Cl)(η4-C8H12)]2 in benzene [eq 5.10; 5.11 (M = Ir): 
210 
 
60 °C, 4 h, 93%; 5.12 (M = Rh): 23 °C, 1 h, 90%]. In contrast to the reaction with TlToM, the 
reaction of 2 equiv of Li[ToM] with [Ir(µ-Cl)(η4-C8H12)]2 in benzene or THF provides a dimeric 
LiCl adduct, (LiCl)2[(κ2-ToMIr(η4-C8H12)]2.17 ToMRh(η4-C8H12) (5.12) is stable in air for 12 h at 
room temperature in solid form and also in benzene. In contrast, the analogous iridium complex 
5.11 is air sensitive; however, no decomposition of 5.11 was observed even after heating in dry 
toluene at 60 °C for 3 days and at 180 °C for 10 h. 
0.5 [M(µ-Cl)(η4-C8H12)]2
benzene
−TlCl
Tl[ToM]
Ph B
N
O
O
N Tl
O
N
Ph B
N
O
O
N M
O
N
Ph B
N
O
O
N M
O
N
(5.10)
5.11 (M = Ir)
5.12 (M = Rh)
 
1H NMR spectra of ToMIr(η4-C8H12) (5.11) and ToMRh(η4-C8H12) (5.12) complexes in 
benzene-d6 at room temperature contained three singlets for methyl and three singlets for 
methylene groups of three oxazolines. These spectra are consistent with Cs-symmetric structures, 
and also suggest bidentate coordination mode of ToM-ligand in the metal complexes. However, 
two observed 15N chemical shifts of oxazoline nitrogens (5.11: −154.9, −192.9 ppm; 5.12: 
−161.1, −169.2 ppm) are significantly upfield compared to that of non-coordinated 4,4-dimethyl-
2-H-oxazoline (−127.0 ppm). These NMR data doesn’t confirm the presence of a pendant non-
coordinated oxazoline; rather suggest a dynamic exchange process between the pendent 
oxazoline and the two coordinated oxazolines in solution. Fluxional behaviors of 5.11 and 5.12 
are further supported by variable temperature NMR (VT NMR) studies (Figure 5.5).  
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Figure 5.5. 1H NMR spectra of ToMIr(η4-C8H12) (5.11) showing coalesce of oxazoline resonances as 
temperature is increased. 
 
 
The variable temperature 1H NMR spectra of 5.11 acquired from 295 K to 360 K in 
benzene-d6 showed resonances of oxazolines and cyclopentadiene that broaden as the 
temperature was increased. At 340 K, the three sets of oxazoline resonances coalesced into one 
set. At 360 K, one sharp singlet at 1.12 ppm for methyl and one singlet at 3.63 ppm for 
methylene groups of oxazolines suggest that 5.11 is C3v-symmetric. The VT NMR experiments 
suggest that the rapid exchange between pendent oxazoline and coordinated oxazolines is faster 
than 1H NMR time scale above coalesce temperature that make the three oxazolines of ToM 
ligand indistinguishable.  
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 In the solid state, the ToM ligand in 5.11 and 5.12 is bidentate, as evident by two νCN 
bands in IR spectra corresponding to coordinated (5.11: 1558 cm-1; 5.12: 1567 cm-1) and 
uncoordinated (5.11: 1607 cm-1; 5.12: 1611 cm-1) oxazolines. X-ray quality single crystals of 
5.12 are obtained by vapor diffusion of pentane into a toluene solution at −30 °C. The solid state 
structure of 5.12 is established by X-ray crystallography, which also reveals κ2-ToM coordination 
(Figure 5.6). Rhodium is coordinated to nitrogens of two oxazolines and to 1,5-cyclooctadiene. 
The six-membered chelate ring in 5.12 forms the boat configuration. The phenyl group is 
pseudoaxial, and the pendant oxazoline is pseudoequatorial.  
 
Figure 5.6. ORTEP diagram of ToMRh(η4-C8H12) (5.12). Ellipsoids are plotted at 50% probability, and 
hydrogen atoms are not illustrated for clarity. Selected bond distances (Å): Rh1−N1, 2.116(6); Rh1−C15, 
2.099(9); Rh1−C16, 2.120(10).  
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Catalytic alcohol decarbonylations 
 All the above bis- and tris(oxazolinyl)borato iridium and rhodium complexes are tested as 
precatalysts for thermal decarbonylation of primary alcohols without any CO acceptor. Our 
effort to develop a direct acceptorless thermal decarbonylation of alcohols began with studies of 
the reaction of cyclohexanemethanol (CyCH2OH) as the substrate with 10 mol % of iridium or 
rhodium complexes in toluene-d8. These screening reactions were conducted in milligram scale 
within a sealed J-Young style NMR tube by gradual increment of temperature ranging from 60 
°C to 180 °C. The progress of the reaction was monitored by 1H NMR spectroscopy and the 
analysis by GC-MS. Selected results of these experiments are shown in Table 5.2. 
The previous findings from our group that ToMRh(H)2CO and ToMRh(CO)2 catalyze the 
photolytic decarbonylation of CyCH2OH to cyclohexane led us first to test the identical reaction 
under thermal conditions.12 The mixture of CyCH2OH and 10 mol % of ToMRh(H)2CO or 
ToMRh(CO)2 in toluene was heated at 120 °C for 48 h, however the resulting mixture contained 
only the alcohol starting material and a black precipitate due to the catalyst decomposition (Table 
5.2, entries 1−2). We then investigated several other known rhodium and iridium carbonyl and 
chloride complexes in this reaction. Unfortunately, none of these complexes showed any activity 
for the conversion of CyCH2OH (Table 5.2, entries 3−7). Reaction of CyCH2OH with 10 mol % 
of either [IrCl(η4-C8H12)]2 or [RhCl(η4-C8H12)]2 at 180 °C contain a small amount of cyclohexane 
and some black precipitate (Table 5.2, entries 8 & 9). This finding motivated to screen several 
known or newly synthesized iridium and rhodium cyclooctadienyl complexes for CyCH2OH 
decarbonylation (Table 5.2, entries 10 & 21). Tp*Ir(η4-C8H12) [Tp* = tris(3,5-
dimethylpyrazolyl)borate)] fails to convert alcohol to alkane, even after prolonged heating at 180 
°C (Table 5.2, entry 10). 
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Table 5.2. Conditions and catalysts tested for the catalytic decarbonylation of CyCH2OH.a 
OH Ir or Rh cat.
toluene-d8
+   H2   +    CO
 
Entry Catalyst Temperature Time (days) Yield (%)b 
1 ToMRh(H)2CO 120 °C 2  0 
2 ToMRh(CO)2 180 °C 4  0 
3 ToMIr(CO)2 180 °C 4  0 
4 [Rh(dppp)2Cl] 180 °C 4  0 
5 [Rh(CO)Cl(dppp)]2 180 °C 4  0 
6 [Rh(dppe)2Cl] 180 °C 4  0 
7 [Rh(dppe)ClCO] 180 °C 4  0 
8 [IrCl(η4-C8H12)]2 180 °C 4  <10 
9 [RhCl(η4-C8H12)]2 180 °C 4  <10 
10 Tp*Ir(η4-C8H12) 180 °C 4  0 
11 PhClB(OxMe2)2Ir(η4-C8H12) (5.4) 130 °C 4  <10 
12 PhClB(OxMe2)2Rh(η4-C8H12) (5.5) 130 °C 2  <10 
14 PhClB(OxMe2)2Rh(CO)2 (5.6) 130 °C 4  0 
15 Ph(Ph3SiO)B(OxMe2)2Rh(η4-C8H12) (5.7) 130 °C 2 0 
16 Ph2B(OxMe2)2Ir(η4-C8H12) (5.9) 130 °C 2  54 
17 ClB(OxMe2)3Rh(CO)2 (5.10) 130 °C 4  0 
18 
19 
ToMIr(η4-C8H12) (5.11) 130°C 
180 °C 
4  
4  
0 
86 
20 
21 
ToMRh(η4-C8H12) (5.12) 130°C 
180 °C 
4  
4  
0 
10 
a
 Reaction conditions: 10 mol % catalyst, toluene as the solvent, b NMR yield. 
 
 PhClB(OxMe2)2Ir(η4-C8H12) (5.4) and PhClB(OxMe2)2Rh(η4-C8H12) (5.5) display small 
activity in alcohol decarbonylation at 130 °C, however rapid decomposition of catalysts hinder 
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further conversion. Notably, 10 mol % Ph2B(OxMe2)2Ir(η4-C8H12) (5.10) catalyzes 
decarbonylation of CyCH2OH to CyH, CO, and H2 with 54% conversion after heating at 130 °C 
for two days (Table 5.2, entries 17). During the course of the reaction although no black 
precipitate of iridium is formed, however complex 5.10 is slowly convert to catalytically inactive 
unidentified complex that precipitates out from the reaction mixture. We then examined the 
catalytic activity of ToMIr(η4-C8H12) (5.11), which is more thermally stable in toluene than 
Ph2B(OxMe2)2Ir(η4-C8H12) (5.10). Surprising, ToMIr(η4-C8H12) 5.11 is inert to react with CyCH2OH 
at temperatures up to 150 °C. However, 5.11 is an active precatalyst for decarbonylation of 
CyCH2OH at 180 °C in toluene. CyCH2OH is converted to cyclohexane, CO, and H2 by 10 mol 
% of 5.11 in 86% conversion after heating at 180 °C for 4 days (Table 5.2, entries 19).  GC 
analysis of the gas mixture collected from the head space of the J-Young NMR tube confirmed 
the formation of CO and H2 in the reaction. Interestingly, in contrast to Ph2B(OxMe2)2Ir(η4-C8H12) 
(5.10) and ToMIr(η4-C8H12) (5.11), all bis- and tris(oxazolinyl)borato rhodium complexes don’t 
provide detectable quantity of cyclohexane from CyCH2OH. 
 We then investigated the decarbonylation of a series of primary alcohols using 5 mol % 
of ToMIr(η4-C8H12) (5.11) and Ph2B(OxMe2)2Ir(η4-C8H12) (5.10), and the results are summarized in 
Table 5.3. Complexes 5.11 and 5.10 catalyze the conversion of cyclopentanemethanol to 
cyclopentane in 73% and 45% yield respectively (Table 5.2, entries 3 and 4). Several benzyl 
alcohols, the central components of lignin,18 are also decarbonylated to provide corresponding 
arenes. Notably, ToMIr(η4-C8H12) (5.11) tolerates ether, ester, oxo, and chloro functional groups. 
Furfurylalcohol is transformed to furan by 5.11 at 180 °C in 45% yield (Table 5.2, entry 13). 
Importantly, 5.11 also catalyzes decarbonylation of polyols such as ethylene glycol and glycerol 
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into syngas at 180 °C (Table 5.2, entries 15 and 17). More than 90% conversion of ethylene 
glycol was achieved by heating with 10 mol % 5.11 in toluene at 180 °C over 4 days. 
 
 
Table 5.3. ToMIr(η4-C8H12) (5.11) and Ph2B(OxMe2)2Ir(η4-C8H12) (5.10) catalyzed alcohol 
conversion into RH, H2, and CO. a 
 
Substrate Product Entry Catalyst Time 
(days) 
Yield 
(%)b,c 
OH
  
1 
 
2 
ToMIr(η4-C8H12) 
 
Ph2B(OxMe2)2Ir(η4-C8H12) 
4 
 
2 
84  
 
52 
OH
 
 
 
3 
 
4 
ToMIr(η4-C8H12) 
 
Ph2B(OxMe2)2Ir(η4-C8H12) 
4 
 
2 
73 (65) 
 
45 
OH
  
5 
 
6 
ToMIr(η4-C8H12) 
 
Ph2B(OxMe2)2Ir(η4-C8H12) 
4 
 
2 
85 
 
41 
OH
EtOOC
 
EtOOC
 
7 
 
8 
ToMIr(η4-C8H12) 
 
Ph2B(OxMe2)2Ir(η4-C8H12) 
4 
 
4 
81 
 
25 
OH
  
9 
 
10 
ToMIr(η4-C8H12) 
 
Ph2B(OxMe2)2Ir(η4-C8H12) 
4 
 
2 
72 (66) 
 
33 
OH
Cl
 
Cl
 
11 
 
12 
ToMIr(η4-C8H12) 
 
Ph2B(OxMe2)2Ir(η4-C8H12) 
4 
 
4 
67 
 
10 
O
OH
 
O
 
13 
 
14 
ToMIr(η4-C8H12) 
 
Ph2B(OxMe2)2Ir(η4-C8H12) 
4 
 
4 
45 
 
0 
OHHO
 
CO + H2 15 
 
16 
ToMIr(η4-C8H12) 
 
Ph2B(OxMe2)2Ir(η4-C8H12) 
4 
 
4 
90 
 
0 
OH
OHHO
 
CO + H2 17 
 
18 
ToMIr(η4-C8H12) 
 
Ph2B(OxMe2)2Ir(η4-C8H12) 
4 
 
4 
n.a. 
 
0 
a Reaction conditions: 5 mol % catalyst, toluene as the solvent, 180 °C. b % yield was determined by GC 
using cyclooctane as an internal standard. c Isolated yield.  
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Preliminary investigations of catalytic pathways 
 The interesting thermal decarbonylation of alcohols without any CO acceptor catalyzed 
by ToMIr(η4-C8H12) (5.11) led us to investigate the possible catalytic pathways. CyCH2OH is inert 
to react with catalytic or stoichiometric amount of 5.11 at temperatures up to 160 °C, however, 
reaction initiates at 170 °C. During the course of the catalytic decarbonylation reaction, a small 
quantity of aldehyde was always observed as detected by 1H NMR spectroscopy and GC-MS 
analysis. This observation suggests that the dehydrogenation of alcohol to an aldehyde is likely 
involves in the first step of dehydrogenative decarbonyation of alcohol as mentioned before. We 
therefore performed a stoichiometric decarbonylation reaction to identify intermediate of this 
dehydrogenative process. CyCH2OH is completely converted into cyclohexane, when a mixture 
of equivalent amounts of ToMIr(η4-C8H12) (5.11) and CyCH2OH in toluene-d8 was heated at 180 
°C for 6 h. In 1H NMR spectroscopy, four iridium hydride resonances were detected at −15.87, 
−16.62, −18.53 and −20.37 ppm. No free 4,4-dimethyl-2-oxazoline (2H-OxMe2) was observed. 
Structural assignment of any ToMIr-species was impossible from this 1H NMR spectrum due to 
the overlapping resonances. 11B NMR spectrum showed one broad peak at –17.9 ppm. 
OH
+
170 °C
toluene-d8
+    ToMIr-hydrides (5.11)
5.11
Ph B
N
O
O
N Ir
O
N
 
We then investigated the interaction of aldehyde with 5.11. CyCHO is converted to 
cyclohexane in 84% yield after heating at 180 °C for 2 days by 10 mol % 5.11 (Table 5.4; Entry 
1). Likewise, 5.11 also catalyzes the decarbonylation of cyclopentane aldehyde (Table 5.4; Entry 
2) and benzaldehyde (Table 5.4; Entry 3). Although full conversion of aldehydes is not achieved, 
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however, the decarbonylation of an aldehyde is much faster than the 
dehydrogenation/decarbonylation of an alcohol under the identical reaction conditions. The 
above observations i.e. the formation of aldehyde during catalysis and the fast decarbonylation of 
aldehyde suggest a sequential dehydrogenation/decarbonylation pathway of an alcohol in the 
catalytic cycle. 
 
           Table 5.4. ToMIr(η4-C8H12) (5.11) catalyzed decarbonylation of aldehydes. a 
 
Entry Substrate Product Time (days) Yield (%)b 
1 O
H
 
 
2 
 
 
84 
 
2 
 
 
O
H
 
 
 
2 
 
 
81 
 
 
3 O
H
 
 
2 
 
72 
 
 
                  a Reaction conditions: 10 mol % catalyst, toluene as the solvent, 180 °C. b NMR yield  
 
Conclusion 
 We have demonstrated a catalytic acceptorless thermal dehydrogenative decarbolylation 
of alcohols. ToMIr(η4-C8H12) (5.11) is an active precatalyst for decarbonylation of several 
aliphatic and aromatic primary alcohols containing ether, ester, oxo, and chloro functional 
groups. Polyols such as ethylene glycol and glycerol are decarbonylated to syngas by ToMIr(η4-
C8H12). Although the mechanism of catalytic decarbonylation is not entirely studied, our 
preliminary mechanistic investigations suggest a pathway involving dehydrogenation of alcohol 
to aldehyde, followed by decarbonylation of aldehyde in the catalytic cycle. Therefore, our 
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current efforts are focused on identifying and synthesizing possible intermediates, and study the 
mechanism via kinetics. 
 
Experiment details. 
General Procedures. All reactions were performed under a dry argon atmosphere using 
standard Schlenk techniques or under a nitrogen atmosphere in a glove box unless otherwise 
indicated. Dry, oxygen-free solvents were used throughout. Benzene, toluene, pentane and 
tetrahydrofuran were degassed by sparging with nitrogen, filtered through activated alumina 
columns, and stored under N2. Benzene-d6, toluene-d8 and tetrahydrofuran-d8 were vacuum 
transferred from Na/K alloy and stored under N2 in a glove box. All organic reagents were 
purchased from Aldrich. Tl[ToM],15 PhB(OxMe2)2,13 [Ir(µ-Cl)( η4-C8H12)]2,19 [Rh(µ-Cl)( η4-
C8H12)]2,20 [Rh(µ-Cl)(CO)2]2,21 and PhLi22 were prepared by published procedures. 1H, 13C{1H}, 
11B NMR spectra were collected either on a Bruker DRX-400 spectrometer, Bruker Avance III 
700 spectrometer or an Agilent MR 400 spectrometer. 15N chemical shifts were determined by 
1H-15N HMBC experiments either on a Bruker Avance III 700 spectrometer or on a Bruker 
Avance III 600 spectrometer. 15N chemical shifts were originally referenced to liquid NH3 and 
recalculated to the CH3NO2 chemical shift scale by adding −381.9 ppm. 11B NMR spectra were 
referenced to an external sample of BF3·Et2O. GC-MS was conducted with Agilent 6890 GC 
system equipped with Agilent DB-5 column. Mass detection is processed by Micromass GCT. 
Elemental analysis was performed using a Perkin-Elmer 2400 Series II CHN/S by the Iowa State 
Chemical Instrumentation Facility.  
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B(OxMe2)3 (5.1). A 250 mL Schlenk flask was charged with 4,4-dimethyl-2-oxazoline (3.00 mL, 
28.4 mmol), which was then degassed by three freeze-pump-thaw cycles. The degassed 
oxazoline was dissolved in 150 mL of THF and the flask was cooled to −78 ºC. nBuLi (12.0 mL, 
30.0 mmol) was added via syringe to the reaction flask, and the resulting solution was stirred for 
45 min at −78 ºC. Trichloroborane (1.0 M in heptanes) (9.18 mL, 9.18 mmol) was added slowly 
via syringe into the flask, which was then allowed to gradually warm to room temperature. After 
stirring for 36 h at room temperature, a white precipitate formed, which was separated from the 
solution. The white solid was washed with THF (3 × 50 mL) and dried in vacuo to afford 
tris(oxazolinyl)borane [B(OxMe2)3] (2.03 g, 6.64 mmol, 72.3%). 1H NMR (methanol-d, 400 
MHz): δ 1.22 (s, 6 H, ), 3.78 (s, 18 H, ). 13C{1H} NMR 
(methanol-d, 150 MHz): δ 78.08 ( ), 66.41 ( ), 27.83 (
). 11B NMR (methanol-d, 128 MHz): δ −8.6. IR (KBr, cm-1): 2962 s, 2935 s, 
2876 s, 1608 s, 1464 s, 1385 w, 1364 m, 1342 w, 1258 s, 1193 m, 1158 m, 1128 s, 1093 s, 1000 
s, 975 s, 944 m, 917 w, 883 s, 831 m, 796 m. 
 
H[Ph2B(OxMe2)2] (5.2). A Schlenk flask was charged with PhB(OxMe2)2 (2.00 g, 7.04 mmol) and  
PhLi (0.455 g, 5.41 mmol) in the glove box. Then, THF (50 mL) was added to the flask to form a 
light brown solution. The flask was sealed and the resulting solution was stirred overnight. The 
solvent was removed under reduced pressure to afford a light yellow solid. This crude product 
was purified by silica gel column chromatography (hexane:CH2Cl2:Et3N = 5:5:1; Rf = 0.72) to 
afford H[Ph2B(OxMe2)2] (0.750 g, 2.07 mmol, 38.3%). The off white solid was dissolved in 
benzene and stirred over P2O5 to dry without any reduction in yield. 1H NMR (benzene-d6, 700 
CNCMe2CH2O CNCMe2CH2O
CNCMe2CH2O CNCMe2CH2O
CNCMe2CH2O
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MHz): δ 7.86 (d, 3JHH = 5.6 Hz, 4 H, ortho-C6H5), 7.42 (m, 4 H, meta-C6H5), 7.25 (m, 2 H, para-
C6H5), 3.36 (s, 4 H, ), 0.85 (s, 12 H, ). 13C{1H} NMR (benzene-
d6, 150 MHz): δ 194.78 (br s, ), 150.20 (br s, ipso-C6H5), 135.06 (ortho-C6H5), 
128.00 (meta-C6H5), 126.05 (para-C6H5), 80.19 ( ), 63.36 ( ), 
28.00 ( ). 11B NMR (benzene-d6, 128 MHz): δ −14.5. 15N NMR (benzene-d6, 71 
MHz): δ −170.5 ( ). IR (KBr, cm-1): 3044 w, 3015 w, 2996 w, 2967 s, 2928 m, 
2871 w, 1580 s, 1490 m, 1460 s, 1431 m, 1415 m, 1383 m, 1317 m, 1261 s, 1195 m, 1172 w, 
1135 w, 1105 w, 1022 w, 964 s, 888 w, 866 w, 841 w, 803 m, 739 s, 703 s, 642 w, 620 w. Anal. 
Calcd for C22H27BO2N2: C, 72.94; H, 7.51; N, 7.73.  Found: C, 72.76; H, 7.31; N, 7.23. Mp: 146-
152 °C. 
 
Tl[Ph2B(OxMe2)2] (5.3). A Schlenk flask was charged with H[Ph2B(OxMe2)2]  (0.214 g, 0.611 
mmol) and dissolved in Et2O (7 mL). To the solution, thallium(1) ethoxide (86.5 µL, 1.22 mmol) 
was added by a microliter syringe. The resulting solution was stirred at room temperature for 8 h. 
During stirring, a yellow solid crushed out from the solution. The solution was decanted to get 
the white solid precipitation in the glove box. The solid was washed with Et2O and dried in 
vacuo to give Tl[Ph2B(OXMe2)2] as a white solid (0.420 g, 0.555 mmol, 90.8%), which was 
stored in glove box. 1H NMR (benzene-d6, 400 MHz): δ 7.79 (d, 3JHH = 6.4 Hz, 4 H, ortho-
C6H5), 7.39 (t, 3JHH = 7.2 Hz, 4 H, meta-C6H5), 7.22 (t, 3JHH = 7.2 Hz, 2 H, para-C6H5), 3.45 (s, 4 
H, ), 0.93 (s, 12 H, ). 13C{1H} NMR (benzene-d6, 700 MHz): δ 
195.57 (br s, ), 154.12 (br s, ipso-C6H5), 136.12 (ortho-C6H5), 127.80 (meta-
C6H5), 125.81 (para-C6H5), 79.69 ( ), 66.75 ( ), 28.99 (
CNCMe2CH2O CNCMe2CH2O
CNCMe2CH2O
CNCMe2CH2O CNCMe2CH2O
CNCMe2CH2O
CNCMe2CH2O
CNCMe2CH2O CNCMe2CH2O
CNCMe2CH2O
CNCMe2CH2O CNCMe2CH2O
 ). 11B NMR (benzene
δ −107.1 ( ). IR (KBr, cm
2888 w, 2868 w, 1593 s, 1581 s, 1488 w, 1460 m, 1430 w, 1384 w, 1366 m, 1345 w, 1251 m, 
1186 m, 1129 m, 1095 s, 1066 w, 990 s, 963 s, 877 m, 828 w, 787 w, 742 s, 731 s, 705 s. Anal. 
Calcd for C22H26BO2N2Tl: C, 46.71; H, 4.63; N, 4.95. Found: C, 46.44; H, 4.91; N, 4.58. Mp: 
182-187 °C, dec. 
 
PhClB(OxMe2)2Ir(η4-C8H12) (5.4).
In a glove box, PhB(OxMe2)2 (0.460 g, 1.62 mmol) and [Ir(
were placed in a vial. The solids were dissolved in methylene chloride (15 mL), and the solution 
was stirred overnight. The resultant orange solution was filtered to another vial and the fil
was concentrated under reduced pressure. Few drops of pentane were added to the solution and 
cooled to −30 °C. Orange crystals precipitated out, which was isolated from the rest of the 
solution and was dried under vacuum to afford PhClB(Ox
(0.570 g, 0.919 mmol, 91.0%). 1
7.36 (m, 2 H, meta-C6H5), 7.24 (m, 1 H,  
C8H12), 3.57 (d, 2 H, 2JHH = 4.8 Hz, 
), 1.89 (br s, 2 H, C8H12), 1.20 (br m, 4 H, C
C8H12), 0.80 (s, 6 H, 
), 148.35 (ipso-C
C6H5), 82.70 ( ), 69.72 (
(C8H12), 30.24 (C8H12), 28.16 (
CNCMe2CH2O
CNCMe2CH2O
CNCMe2CH2O
CNCMe2CH2O
222 
-d6, 128 MHz): δ −13.1. 15N NMR (benzene
-1): 3063 w, 3041 w, 3017 w, 2992 w, 2962 s, 2926 w, 
  
η
4
-C8H12)Cl]2 (0.340 g, 0.506 mmol) 
Me2)2Ir(η4-C8H12) as an orange solid 
H NMR  (benzene-d6, 400 MHz): δ 7.58  (m, 2 H, 
para-C6H5), 4.04 (br s, 2 H, C8H12), 3.70 (br s, 2 H, 
), 3.39 (d, 2 H, 2JHH = 4.8 Hz, 
8H12), 1.01 (s, 6 H, 
). 13C{1H} NMR (benzene-d6, 400 MHz): 
6H5), 133.89 (ortho-C6H5), 128.68 (meta-C6H
), 63.86 (C8H12), 60.30 (C
), 27.20 ( ). 15N NMR (benzene
CNCMe2CH2O
CNCMe2CH2O CNCMe2CH2O
-d6, 71 MHz): 
trate 
ortho-C6H5), 
), 0.88 (m, 2 H, 
δ 187.95 (br,
5), 126.39 (para-
8H12),  31.47 
-
 d6, 71 MHz): δ −182.5 (
1): 3061 w, 3000 m, 2964 m, 2942 m,
w, 1371 m, 1288 s, 1201 s, 1157 s, 1048 m, 990 s, 965 s, 914 w, 893 m, 867 w, 846 m, 820 w, 
765 m, 724 s, 706 s. EA: Anal. Calcd for C
4.32. Found: C, 45.08; H, 5.12; N, 4.21. Mp: 189
 
PhClB(OxMe2)2Rh(η4-C8H12) (5.5).
a vial containing PhB(OxMe2)2 
mmol). The resultant yellow solution was stirred overnight. The solution was filtered and the 
filtrate was concentrated under reduced pressure. Few drops of pentane were added to the 
solution and then cooled to −30 °C. Deep yellow crystals
and dried in vacuo to afford PhClB(Ox
mmol, 87.0%). Crystals suitable for X
at −30 °C. 1H NMR  (benzene-d
meta-C6H5), 7.29 (t, 1 H,  para-C
2 H, ), 3.37 (d, 2 H, 
1.33 (br m, 4 H, C8H12), 1.03 (s, 6 H, 
). 13C{1H} NMR (methylene chloride
), 151.67 (ipso-C
C6H5), 82.02 ( ), 79.935, 79.814 (d, 
JRh-C = 12.1 Hz, C8H12), 69.31 (
), 27.73 (
CNCMe2CH2O
CNCMe2CH2O
CNCMe2CH2O CNC
223 
). 11B NMR (benzene-d6, 128 MHz): δ −7.6. IR (KBr, cm
 2927 m, 2881 m, 2831 m, 1564 s, 1464 m, 1431 m, 1390 
24H33BClIrN2O2(CH2Cl2)0.33: C, 45.08; H, 5.23; N, 
-191 °C. 
  In the glove box, methylene chloride (15 mL) was added to 
(0.560 g, 1.95 mmol) and [RhCl(η4-C8H12)]2 
 precipitated out, which was isolated 
Me2)2Rh(η4-C8H12) as a deep yellow solid (0.560 g, 1.06 
-ray diffraction were grown from toluene/pentane solution 
6, 400 MHz): δ  7.74 (br s, 2 H, ortho-C6H5), 7.41 (br s, 2 H, 
6H5), 4.21 (br m, 2H, C8H12), 3.92 (br m, 2H, C
2JHH = 8.4 Hz, ),  1.97 (br m, 2 H, C
), 0.87 (m, 2 H, C8H12
-d2, 100 MHz): 
6H5), 133.71 (ortho-C6H5), 128.40 (meta-C6H
JRh-C = 12.1 Hz, C8H12), 77.045, 76.919 (d, 
), 30.60 (C8H12), 29.23 (C
). 15N NMR (benzene-d6, 71 MHz): 
CNCMe2CH2O
Me2CH2O
-
(0.300 g, 0.608 
8H12), 3.55 (br s, 
8H12), 
), 0.72 (s, 6 H, 
δ 187.76 (br,
5), 126.58 (para-
8H12), 28.46 (
δ −180.5 (
 ). 11B NMR (benzene
3001 m, 2966 s, 2967 s, 2875 m, 2831 w, 1578 s, 1460 m, 1431 m, 1389 w, 1366 m, 1334 w, 
1280 s, 1196 s, 1156 s, 1020 w, 987 s, 961 s, 912 w, 896 w, 865 w. EA: Anal. Calcd for 
C24H33BClRhN2O2(CH2Cl2)0.33: C, 52.28; H, 6.07; N, 5.01. Found: C, 52.65; H, 6.04; N, 4.97. 
Mp: 152-156 °C. 
 
PhClB(OxMe2)2Rh(CO)2 (5.6). 
[Rh(CO)2Cl]2 (0.300 g, 0.772 mmol) were weighing out in two different vials. [Rh(CO)
dissolved in methylene chloride (15 mL), and was transferred to the vial contai
PhB(OxMe2)2. The solution mixture was stirred for 6 h. The resultant deep brown solution was 
filtered, and the volume of the filtrate was reduced under vacuo. Pentane was added to the 
solution and then the solution was recrystallized at 
crystals of  PhClB(OxMe2)2Rh(CO)
chloride-d2, 400 MHz): δ 7.33 (d, 
7.19 (t, 1 H,  para-C6H5), 4.23 (d, 2 H, 
Hz, ),  1.41 (s, 6 H, 
(methylene chloride-d2, 150 MHz): 
149.22 (ipso-C6H5), 132.89 (ortho
), 68.90 (
15N NMR (methylene chloride-d
chloride-d2, 128 MHz):  δ −8.3. 
m, 2895 m, 2872 m, 2076 s, 1993 s, 1580 s, 1551 m, 14
CNCMe2CH2O CNCM
224 
-d6, 128 MHz): δ −6.8. IR (KBr, cm-1): 3063 w, 3043 w, 
In the glove box, PhB(OxMe2)2 (0.483 g, 1.70 mmol) and 
−30 °C overnight to obtain deep brown 
2 (0.320 g, 0.666 mmol, 86.3%). 1H NMR  (methylene 
3JHH = 7.0 Hz, 2 H, ortho-C6H5), 7.25 (t, 2 H, 
2JHH = 8.4 Hz, ), 4.18 (d, 2 H, 
), 1.32 (s, 6 H, 
δ 190.31 (br, ), 184.95 (CO), 184.57 (
-C6H5), 128.05 (meta-C6H5), 126.97 (para
), 28.94 ( ), 28.77 (
2, 71 MHz): δ −199.0 (s, ). 11B NMR (methylene 
IR (KBr, cm-1): 3076 w, 3053 w, 3037 w, 3008 m, 2963 s, 2929 
93 w, 1460 s, 1431 m, 1390 w, 1370 s, 
CNCMe2CH2O
e2CH2O CNCMe2CH2O C
2Cl]2 was 
ning 
meta-C6H5), 
2JHH = 8.4 
). 13C{1H} NMR 
CO), 
-C6H5), 80.95 (
). NCMe2CH2O
 1290 s, 1257 w, 1204 s, 1163 m, 1085 w, 1025 w, 993 m, 961 s, 949 s, 926 w, 892 w, 841 w, 804 
m, 782 w, 728 m, 704 m. EA: Anal. Calcd for C
Found: C, 44.54; H, 4.44; N, 5.25. 
 
Ph(Ph3SiO)B(OxMe2)2Rh(η4-C8H
g, 0.087 mmol) and Ph3SiOK (0.027 g,  0.087 mmol) were placed in a vial. The solids were 
dissolved in benzene (15 mL), and the solution was stirred 
was filtered. The filtrate was concentrated and recrystallized at 
(OXMe2)2Rh(η4-C8H12) as a yellow solid (0.063 g, 0.082 mmol, 94.2 %). 
400 MHz): δ 8.06-7.14 (20 H, C
3.45 (d, 2 H, 2J = 8.4 Hz, 
2H, C8H12), 1.48-1.40 (m, 4 H, C
(s, 6H, ). 13C{1H} NMR (benzene
141.21 [ipso-(C6H5)B], 136.65 [(C
2J = 2.2 Hz, ipso-(C6H5)3Si], 128.86 [(C
), 79.584- 79.464 (d, 
C8H12), 68.18 ( ), 30.78 (C
). 15N NMR (benzene
(benzene-d6, 128 MHz): δ −4.5. 
w, 2834 w, 1575 s, 1483 w, 1459 w, 1428 s, 1386 w, 1365 m, 1333 w, 1303 w, 1279 s, 1199 s, 
1156 s, 1113 s, 1099 s, 1029 w, 995 m, 979 m, 894 w, 878 w, 836 w, 798 w, 742 m, 704 s. EA: 
CNCMe2CH2O
CNCMe2CH2O
CNCMe2CH2O
225 
18H23BClN2O4Rh: C, 44.99; H, 4.82; N, 5.83. 
Mp: 107-111 °C. 
12) (5.7). In the glove box, PhClB(OxMe2)2Rh(
for 36 h. The resultant yellow solution 
−30 °C to afford Ph(Ph
1H NMR  (benzene
6H5; overlapped), 4.27 (br s, 2H, C8H12), 3.98 (br s, 2H, C
), 3.22 (d, 2 H, 2J = 8.4 Hz, 
8H12), 1.14 (m, 2 H, C8H12), 1.05 (s, 6H, 
-d6, 100 MHz): δ 193.59 (br,
6H5)3Si], 134.89 [(C6H5)B], 129.66 [(C6H5)B], 128.91 [d, 2 H, 
6H5)B], 127.63 [(C6H5)3Si], 126.03 [(C
JRh-C = 12.0 Hz, C8H12), 75.840-75.713 (d, 
8H12), 29.59 (C8H12), 28.05 (
-d6, 71 MHz): δ −185.5 (
IR (KBr, cm-1): 3065 m, 3044 m, 2997 m, 2963 s, 2918 w, 2880 
C
CNCMe
η
4
-C8H12) (0.050 
3SiO)B 
-d6, 
8H12), 
),  2.02 (m, 
), 0.75 
), 
6H5)3Si], 80.85 (
JRh-C = 12.7 Hz, 
), 27.78 (
). 11B NMR 
NCMe2CH2O
2CH2O
 Anal. Calcd for C42H48BN2O3RhSi: C, 65.46; H, 6.28; N, 3.64. Found: C, 65.18; H, 6.0; N, 3.53. 
Mp: 193-197 °C, dec. 
 
Ph(Ph3SiO)B(OxMe2)2Li(THF)2
3.52 mmol) and  Ph3SiOLi (0.621 g, 2.20 mmol) in the glove box. The flask w
Schenk manifold and THF (60 mL) was added to form a yellow solution. The flask was sealed 
and the resulting solution was stirred overnight. The solution was filtered to remove a precipitate 
that appeared overnight, and then the solvent was
light yellow solid. This solid was dissolved in toluene and layered with pentane and kept at 
°C to afford Ph(Ph3SiO)B(OxMe2
1H NMR  (acetonitrile-d3, 400 MHz): 
H, ortho-C6H5), 7.30 {m, 9 H, meta
(t, 1 H,  para-C6H5), 3.64 (m, 8 H, THF), 3.38 (d, 2 H, 
2 H, 2JHH = 8.0 Hz,
 
(s, 6 H, ). 13
), 156.10 (ipso-
132.53 (ortho-C6H5), 129.75 {meta
125.56 (para-C6H5), 77.32 (
), 29.19 (
(acetonitrile-d3, 71 MHz): δ −151.1 (s, 
δ −6.1. IR (KBr, cm-1): 3064 m, 3048 m, 2967 s, 2929 m, 2883 m, 1601 s, 1586 m, 1484 w, 1461 
m, 1428 s, 1381 w, 1362 m, 1347 w, 1259 s, 1186 s, 1160 s, 1113 s, 1055 s, 1029 w, 991 s, 972 
CNCMe2CH
CNCMe2CH2O
CNCMe2CH2O
CNCMe2CH2O CNCM
226 
 (5.8). A Schlenk flask was charged with PhB(Ox
 removed under reduced pressure to afford a 
)2Li(THF)2 as colorless crystals (1.290 g, 1.82 mmol, 83.0%).
δ 7.66 {m, 6 H, ortho-(C6H5)3Si}, 7.50 (d, 
-(C6H5)3Si, para-(C6H5)3Si)}, 7.06 (t, 2 H, meta
2JHH = 8.0 Hz, 
), 1.80 (m, 8 H, THF), 1.05 (s, 6 H, 
C{1H} NMR (acetonitrile-d3, 150 MHz): 
C6H5), 141.28 {ipso-(C6H5)3Si)}, 136.76 {ortho
-(C6H5)3Si)}, 128.39 (meta-C6H5), 127.67 {para
), 68.69 ( , THF), 67.35 (
), 28.77 ( ), 26.65 (THF).
). 11B NMR (acetonitrile
CNCMe2
2O CNCM
CNCMe2CH2O CNCMe2CH2O
e2CH2O CNCMe2CH2O
Me2)2 (1.00 g, 
as attached to a 
−30 
 
3JHH = 6.4 Hz, 2 
-C6H5), 6.97 
), 3.06 (d, 
), 1.04 
δ 186.34 (br,
-(C6H5)3Si)}, 
-(C6H5)3Si)},  
 
15N NMR 
-d3, 128 MHz):  
CH2O
e2CH2O
 m, 881 m, 830 w, 796 w, 740 m, 731 m, 703 s. EA: Anal. Calcd for. C
H, 7.37; N, 3.94. Found: C, 70.67; H, 7.45; N, 3.94.
 
Ph2B(OxMe2)2Ir(η4-C8H12) (5.9). 
C8H12)  (0.160 g, 0.258 mmol) and PhLi (0.022 g, 0.258 mmol). The solids were dissolved in 
benzene (7 mL), and the solution was stirred for 2 h. The resultant yellow solution was filtered to 
remove the LiCl precipitate. The filtrate was evaporated to dryness 
Ph2B(OxMe2)2Ir(η4-C8H12) as an orange solid (0.171 g, 0.231 mmol, 89.5%). 
d6, 400 MHz): δ 7.57-7.25 (m, 10 H, C
C8H12), 3.41 (m, 4 H, 
m, 2 H, C8H12), 1.08 (s, 6 H, 
). 13C{1H} NMR (benzene-d6, 400 MHz): 
126.53 (meta-C6H5), 125.23 (para
64.02 (C8H12), 60.52 (C8H12),  31.44 (C
). 15N NMR (benzene
(benzene-d6, 128 MHz): δ −12.8. IR (KBr, cm
m, 1588 m, 1555 s, 1463 m, 1431 m, 1389 
1022 w, 991 m, 965 s, 892 m, 841 w, 785 w, 703 s, 678 s. EA: Anal. Calcd for C
C, 54.46; H, 5.79; N, 4.23. Found: C, 54.21; H, 5.63; N, 3.78. Mp: 97
 
ClB(OxMe2)3Rh(CO)2 (5.10). In a glove box, THF (10 mL) was added to a vial containing 
B(OxMe2)3 (200 mg, 0.655 mmol) and [Rh(CO)
CNCMe2CH2O
227 
42H52BLiN
 Mp: 137-141 °C. 
In a glove box, a vial was charged with PhClB(Ox
in v
1H NMR  (benzene
6H5 overlapped), 4.09 (br s, 2 H, C8H12), 3.76 (br s, 2 H, 
), 1.94 (br s, 2 H, C8H12), 1.33 (br s, 2 H, C
), 0.93 (m, 2 H, C8H12), 0.81 (s, 6 H, 
δ 193.18 (br, ), 133.83 (
-C6H5), 82.73 ( ), 68.84 (
8H12), 30.23 (C8H12), 28.10 (
-d6, 71 MHz): δ −152.2 (
-1): 3037m, 3000 m, 2963 s, 2927 s, 2881 s, 2834 
w, 1370 m, 1330 w, 1285 s, 1197 s, 1157 s, 1078 w, 
-102 °C. 
2Cl]2 (120 mg, 0.308 mmol). The resultant 
CNCMe2CH2O
CNCMe2CH2O C
CNCMe2
2O5Si: C, 70.98; 
Me2)2Ir(η4-
acuo, affording 
-
8H12), 1.23 (br 
ortho-C6H5), 
), 
), 27.14 (
). 11B NMR 
30H38BIrN2O2: 
NCMe2CH2O
CH2O
 mixture was stirred at room temperature for 3 h. Then, the mixture was filtered and the filtrate 
was evaporated to dryness providing a white solid. The solid was washed with pentane (3 x 5 
mL) and dried under vacuum yielding ClB(Ox
mmol, 94.2%). 1H NMR (tetrahydrofuran
(s, 18 H, ). 13C{1H} NMR (tetrahydrofuran
), 80.01 (
11B NMR (benzene-d6, 128 MHz): 
m, 1462 w, 1370 w, 1272 w, 1162 s, 1100 s, 1049 s, 991 m, 842 s, 750
 
ToMIr(η4-C8H12) (5.11). A Schlenk flask was charged with TlTo
[IrCl(η4-C8H12)]2 (0.411 g, 0.611 mmol) in the glove box. Then, benzene (20 mL) was added to 
the flask. The flask was sealed and the resulting solution was heated for 4 h at 60 °C. The solvent 
was filtered and the residue was extracted with benzene. The solvent was removed
pressure to afford ToMIr(η4-C8H12
(benzene-d6, 400 MHz): δ 7.59  (d, 
meta-C6H5), 7.22 (t, 3JHH = 7.2 Hz, 1 H,  
, C8H12 overlapped), 3.59 (s, 2 H, 
1.91 (br m, 2 H, C8H12), 1.31 (s, 6 H, 
), 0.81 (s, 8 H, 
150 MHz): δ 193.92 (br,
(meta-C6H5), 125.10 (para-C
), 68.26 (2
CNCMe2CH2O CNCM
CNCM
CNCMe2CH2O CNC
228 
Me2)3Rh(CO)2 as a white powder (0.308 g, 0.617 
-d8, 400 MHz): δ 3.75 (s, 6 H, 
-d8, 150 MHz): 
), 67.16 ( ),  27.96 (
δ −9.3. IR (KBr, cm-1): 2917 w, 2847 w, 2237 s, 2082 s, 1599 
 m. 
M
 (0.700 g, 1.19 mmol) and 
) as a deep yellow solid (0.758 g, 1.11 mmol, 93.3%). 
3JHH = 6.4 Hz, 2 H, ortho-C6H5), 7.37 (t, 3JHH
para-C6H5), 4.05 (br m, 2 H, C8H12), 3.72 (br m, 4 H, 
), 3.49 (s, 2 H, 
), 1.21 (br m, 4 H, C8H12
, C8H12 overlapped). 13C{1H} NMR (benzene
), 152.44 (ipso-C6H5), 134.48 (ortho
6H5), 82.62 (2  overlapped), 77.05 (
, overlapped), 62.77 (C8H12), 59.25 (C
e2CH2O CNCMe2CH2O C
e2CH2O
CNCMe2CH2O
Me2CH2O
),  1.29 
δ 186.53 (br,
). 
 under reduced 
1H NMR  
 = 7.2 Hz, 2 H, 
), 
), 1.06 (s, 6 H, 
-d6, 
-C6H5), 127.39 
8H12), 31.18 (2 
NCMe2CH2O
 C8H12, overlapped), 29.90 (C8H
). 15N NMR (benzene
NMR (benzene-d6, 128 MHz): δ −16.4
2881 s, 2835 m, 1607 m, 1558 s, 1462 m, 1433 w, 1388 w, 1370 m, 1329 w, 1284 s, 1254 
1198 s, 1158 s, 1131 m, 1002 s, 967 s, 892 w, 875 w, 839 w, 817 w, 785 w, 739 m, 704 m. EA: 
Anal. Calcd for C29H41BIrN3O3: C, 51.02; H, 6.05; N, 6.16. Found: C, 51.00; H, 5.53; N, 6.03. 
Mp: 175-180 °C. 
 
ToMRh(η4-C8H12) (5.12). A Schlenk flask was charge
[RhCl(η4-C8H12)]2 (0.189 g, 0.384 mmol) in the glove box. Then, benzene (20 mL) was added to 
the flask. The flask was sealed and the resulting solution was stirred for 4 h at room temperature. 
The solvent was filtered and the residue was extracted with benzene. The solvent was removed 
under reduced pressure to afford To
90.3%). 1H NMR  (benzene-d6, 400 MHz): 
3JHH = 7.6 Hz, 2 H, meta-C6H5), 7.28 (t, 
3.96 (br m, 2 H, C8H12), 3.73 (s, 2 H, 
H, ), 1.99 (br s, 2 H, C
1.08 (s, 8 H, , C8
(benzene-d6, 150 MHz): δ  192.77 (br,
C6H5), 125.57 (para-C6H5), 81.78 (
75.65 (C8H12), 68.46 (
CNCMe2CH2O
CNCMe2
229 
12), 29.15 ( ), 27.80 (
-d6, 71 MHz): δ −154.9, −192.9 (
. IR (KBr, cm-1): 3063 w, 3036 w, 3000 m, 2965 s, 2928 s, 
d with TlToM (0.440 g, 0.749 mmol) and  
MRh(η4-C8H12)  as a deep yellow solid (0.205 g, 0.345 mmol, 
δ 7.75 (d, 3JHH = 6.4 Hz, 2 H, ortho
3JHH = 7.6 Hz, 1 H,  para-C6H5), 4.24 (br m, 2H, C
), 3.57 (s, 2 H, 
8H12), 1.37 (br s, 4H, C8H12), 1.32 (s, 6 H, 
H12 overlapped), 0.72 (s, 6 H, ). 
), 135.41 (ortho-C6H5
), 79.33 (C8H12), 77.39 (
), 67.61 ( ),  30.81 (C8H12
CNCMe2CH2O CNCMe2
CNCMe2CH2O
CNCMe2CH2O C
CH2O CNCMe2CH2O
), 26.78 (
). 11B 
w, 
-C6H5), 7.43 (t, 
8H12), 
), 3.46 (s, 2 
), 
13C{1H} NMR 
), 127.84 (meta-
), 
), 29.50 (C8H12, 
CH2O
NCMe2CH2O
  overlapped), 28.13 (
(benzene-d6, 71 MHz): δ −161.1, 
δ −16.3. IR (KBr, cm-1): 3063 w, 3042 w, 2999 m, 2963 s, 2927 s, 2879 s, 2834 m, 1611 m, 1567 
s, 1485 w, 1461 m, 1432 w, 1387 w, 1365 m, 1335 w, 1303 w, 1276 s, 1252 m, 1194 s, 1155 m, 
1130 w, 995 s, 968 s, 894 w, 874 w, 838 w, 816 w, 775 w, 729 m, 704 m. EA: Anal. Calcd for 
C29H41BN3O3Rh:  C, 58.70; H, 6.96; N, 7.08.  Found: C, 58.57; H, 6.77; N, 7.01. Mp: 180
°C, dec. 
 
Representative example of catalytic alcohol decarbonylation.
cyclohexanemethanol (0.09 mmol), To
mmol) as an internal standard and toluene
tube. The tube was sealed and heated at 180 °C for 4 days. The progress of the reaction was 
monitored by 1H NMR spectroscopy. After the reaction, the solution was diluted with CH
and the yield of cyclohexane was determined by GC
 
Procedure for Preparative Scale Catalysis. 
C8H12) (5.11) (0.11 mmol), substrate (2.1 mmol), and toluene (10 mL).  
180 °C for 4 days. After the catalysis, 
in vacuo, or by silica gel column chromatography. 
Cyclopentane from cyclopentanemethanol 
mmol) was isolated by fractional distillation (47
tert-Butylbenzene from 4-(tert-
1.39 mmol) was purified by silica gel column chromatography (hexane:EtOAc = 3:1; R
in 66.2% yield. 
CNCMe2CH2O
230 
), 27.55 (
−169.2 ( ). 11B NMR (benzene
 A mixture of 
MIr(η4-C8H12) (5.11) (0.005 mmol), cyclooctane (0.09 
-d8 (0.6 mL) was loaded into a J-Young style NMR 
-MS from a calibration curve.
A Schlenk tube was charged with the 
The tube was 
the products were purified either by fractional distillation 
 
(Table 5.3; entry 3). The product (0.138 g, 1.38 
-50 °C) in 65.7% yield. 
butyl)benzylalcohol (Table 5.3; entry 9). The product (0.187 g, 
CNCMe2CH2O CNCMe2CH ). 15N NMR 
-d6, 128 MHz): 
-185 
2Cl2 
 
ToMIr(η4-
heated at 
f = 0.93) 
2O
231 
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Chapter 6 – Conclusion 
 
 The design and synthesis of chiral ligands remain an important area of developing metal-
catalyzed asymmetric transformations. In particular, developing ligands for enantioselective 
olefin hydroamination has seen tremendous growth in the past two decades. Despite significant 
advances, enantioselective hydroamination catalysts are typically limited by poor substrate 
scopes, low enantioselectivity and diastereoselectivity. We have synthesized a new class of chiral 
ligands cyclpentadienyl-bis(oxazolinyl)borates and their yttrium and zirconium complexes for 
enantioselective hydroamination of aminoolefins.  
 Our cyclopentadienyl-bis(oxazolinyl)borato zirconium and hafnium complexes are 
unusually active for catalytic cyclization of aminoolefins at room temperature or even at −30 °C, 
in contrast to other group 4 hydroamination catalysts that requires elevated temperature. Both 
zirconium and hafnium precatalysts provide several 2-methyl-pyrrolidines with very high 
enantiomeric excesses up to 99%. The zirconium precatalysts is also oxo- and halogen-functional 
group tolerant. Additionally, the zirconium precatalyst cyclizes aminoheptenes at room 
temperature affording optically active seven-membered azepanes with greater than 90% ee. Our 
mechanistic investigations suggest a non-insertive mechanism involving concerted C−N/C−H 
bond formation in the turn-over limiting step of the catalytic cycle. 
 {PhB(C5H4)(Ox4S-iPr,Me2)2}Zr(NMe2)2 also desymmetrizes olefin moieties of achiral non-
conjugated aminodienes and aminodiynes during cyclization. The dsymmetrization of 
aminodienes affords diastereomeric mixture of cis and trans cylic amines with high 
diasteromeric ratios and excellent enantiomeric excesses. Similarly, the desymmetrization of 
alkyne moieties in {S-2}Zr(NMe2)2-catalyzed cyclization of aminodiynes provides 
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corresponding cyclic imines bearing quaternary stereocenters with enantiomeric excesses up to 
93%. The cis/trans ratio can be systematically tunes in favor of either cis or trans diastereomer 
by controlling the concentration of the substrate, temperature, N-deuteration of the substrate, and 
the primary amine additive.  
 Cyclopentadienyl-bis(oxazolinyl)borato yttrium complex {PhB(C5H4)(Ox4S-
tBu)2}YCH2SiMe3 displays highly enantioselective in the cyclization of aminoalkenes at room 
temperature affording cyclic amines with enantiomeric excesses up to 96%. The yttrium 
precatalyst provides cyclic amines with S-configuration, whereas R-configured amines are 
obtained by the corresponding zirconium precatalysts even though the identical chiral ancillary 
ligand is present. A noninsertive mechanism involving a six-membered transition state by a 
concerted C−N bond formation and N−H bond cleavage is proposed for PhB(C5H4)(Ox4S-
tBu)2}YCH2SiMe3-catalyzed hydroamination based on the kinetic, spectroscopic, and 
stereochemical features. 
 Cyclopentadienyl-bis(oxazolinyl)borates have been proven as superior chiral ancillary 
ligands in asymmetric olefin hydroamination. The group 3 and group 4 complexes containing 
cyclopentadienyl-bis(oxazolinyl)borates could be useful catalyst to prepare various azacycles 
that are important building blocks for synthesizing natural products and drug molecules.  
Additionally, several other cyclopentadienyl-bis(oxazolinyl)borate containing main group and 
transition metal complexes could be synthesized, which might find application as catalysts in 
various industrially important processes such as stereoselective olefin copolymerization and 
olefin hydrosilation. 
 In this thesis, we have also reported several bis- and tris(oxazolinyl)borato iridium and 
rhodium complexes for acceptorless dehydrogenative decarbonylation of primary alcohols. Our 
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catalysts survey shows that the compound ToMIr(η4-C8H12) is the most active for the conversion 
of primary alcohols into alkane, H2, and CO at 180 °C in toluene. Several aliphatic and aromatic 
primary alcohols are decarbonylated in the catalytic conditions. Furthermore, ToMIr(η4-C8H12) is 
also able to decarbonylate polyols such as ethylene glycol and glycerol to syngas (H2 and CO) at 
180 °C.  
 In industry, the production of syngas from biomass relies on gasification at high 
temperature (above 400 °C). In this respect, the decarbonylation of polyols to syngas catalyzed 
by ToMIr(η4-C8H12) at 180 °C is remarkable. Therefore, ToMIr(η4-C8H12) will be tested as 
catalysts for conversion of cellulose and sugars to syngas at low temperature. Additionally, the 
future directions will be continued on grafting the oxazolinylborato iridium catalysts on 
mesoporous silica nanoparticles for developing heterogeneous catalysts for acceptorless 
decarbonylation of alcohols . 
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